Quarterlytics / Technology / Semiconductors / Lam Research

Lam Research

lrcx · NASDAQ Technology
Claim this profile
Ticker lrcx
Exchange NASDAQ
Sector Technology
Industry Semiconductors
Employees 5001-10,000
← All annual reports
FY2010 Annual Report · Lam Research
Sign in to download
Loading PDF…
2010 Annual Report

Lam Research

30 years

PROD UCT AN D T EC HN OLOGY MILESTONES

1981

1987 

1988 

1992 

1995 

2000 

2003 

Introduced first  
product, the  
AutoEtch 480, for  
poly-silicon etch

Introduced  
Rainbow® 
Etch Series,  
successor to  
AutoEtch

Introduced SEZ® 
spin technology  
for single-wafer  
clean

Introduced first 
Transformer Coupled 
Plasma™ based 
products, the TCP® 
9400 for silicon etch 
and the TCP® 9600 
for metal etch

Introduced first  
product incorporating 
Dual Frequency 
Confined™ technology 
for dielectric etch

Launched 2300® 
platform, offering  
200 mm and  
300 mm capability

Launched Da Vinci® 
spin clean platform

CORP ORATE MIL EST ONES

1980

1982

1985

1990

1995

1997

1997

Company  
founded by 
David K. Lam

Appointed  
Roger D. Emerick  
as Chief Executive  
Officer 

Established a global  
presence with offices  
in Asia and Europe

Lam Research  
10th Anniversary

Achieved $1 billion 
Revenue

Appointed  
James W. Bagley  
as Chief Executive 
Officer

Appointed  
Stephen G. Newberry 
as Chief Operating 
Officer

This year, Lam Research proudly celebrates 30 years of innovation and achievement as a major supplier of wafer 

fabrication equipment and services to the semiconductor industry. Our strong Company performance is the result of 

practicing a values-based approach to business and dedication to the success of our customers. As we reflect on  

our important achievements over the years, illustrated by the milestones below, we want to take this opportunity  

to acknowledge the contributions of our employees. Without their passion, commitment, and diverse talents,  

Lam Research would not be the recognized industry leader it is today.

2004 

2006 

2007 

2008 

2009 

2010 

Introduced 2300® 
Exelan® Flex™ and
2300® Versys® Kiyo® 
products for dielectric 
and conductor etch

Introduced C3™ linear 
wet clean technology

Introduced DV-Prime™ 
next-generation spin 
clean system

Launched 2300® Kiyo® 
C Series next-generation 
conductor etch system

Shipped first 300 mm 
2300® Syndion® system 
for TSV etch

Shipped next-generation 
linear clean product

Introduced 2300® 
Flex™ D Series next-
generation dielectric 
etch system

Launched 2300® 
Coronus® plasma
bevel clean system

Shipped 7,500th etch 
process module for  
the 2300® platform

Shipped 3,000th 
single-wafer spin clean 
process module 

Shipped 2300® Kiyo® 
E Series and 2300® 
Flex™ E Series etch 
proproducd ts
products

2000

2005

2006

2008

2009

2010
2010

Lam Research  
20th Anniversary

Appointed  
Stephen G. Newberry 
as President and Chief 
Executive Officer

Achieved $2 billion 
Revenue

Acquisition of Bullen 
Semiconductor (now 
Silfex™, Inc.)

Appointed  
Martin B. Anstice as 
Executive Vice President 
and Chief Operating 
Officer

Acquisition of SEZ AG 
(now Lam Research AG)

Launched  
Silfex™, Inc., 
a division of  
Lam Research

Lam Research  
30th Anniversary

LETTER TO  STO CKHOL DE R S

To Our Stockholders: 

Lam Research marked its 30th anniversary in 2010. As we reflect back on the Company’s three decades of 

growth and leadership, we also look ahead and are excited by our opportunities for the future.

Our view of the future is supported by what we have achieved over the course of last year’s dynamic industry 

environment. As we began our fiscal year, the semiconductor industry was just starting to recover from the 

impact of a historic global macroeconomic downturn. Our business volumes improved rapidly throughout  

the year as our customers resumed capital spending more quickly than we had anticipated. We returned  

to profitability early in fiscal 2010 and concluded this year with revenues nearly doubling to $2.1 billion.  

Our GAAP earnings per share totaled $2.71, in contrast to the $2.41 loss per share reported for fiscal 2009.  

Lam Research generated approximately $350 million in operating cash flow and ended the year with more  

than $825 million in cash and short-term investments, a figure that reflects both solid operating performance 

and closely managed valuable cash resources during the recession.

The dramatic improvement in Lam’s performance is a result of our strategic efforts to manage our growth 

across the semiconductor industry’s inevitable cycles. The variable business model we implemented early in 

this decade remains central to our success, having set the bar among our peers for operating performance 

efficiency and enabling us to react quickly to industry swings. We scaled down variable expenses during 

the downturn while continuing to invest in our products, enabling us to maintain a strong portfolio offering 

differentiated technical solutions at the leading edge of our industry. 

In our etch business, our highly respected and trusted management team continued to work closely with our 

customers to understand their challenges, their plans, and their needs. The result − Lam Research is expected 

to achieve a market share position, based on current shipment volumes, of greater than 50% by the end of 

calendar 2010, an unprecedented accomplishment in the etch market.

We have made rapid advances in etch over the last ten years resulting in market share leadership. We are 

implementing a similar approach in single-wafer clean as we deliver on our strategy to expand into adjacent 

wafer fabrication equipment markets. 

The timing of our entry into the clean market a few years ago coincided with customer migration to single-

wafer from batch processes. Today, single-wafer clean represents over half of the total served available market 

in clean and translates to a greater than $1 billion market opportunity. With a strong product line and a solid 

position among the foundry and memory customers leading the migration to single-wafer clean, Lam Research 

shipped its 3,000th single-wafer clean system during fiscal 2010 and continues to focus on winning new 

applications that should result in future market share expansion. 

To sustain and build on the gains we are achieving in etch and clean, we place high priority on world-class 

customer support. We are partnering closely with our customers to improve their productivity and yields, while 

also lowering their cost of ownership. Our upgrades and refurbishment business is successfully addressing this 

latter goal, meeting the growing demand for used equipment as chipmakers balance increasing demand with 

lingering capital constraints as the global economy recovers. Over the past year, Lam Research is proud to 

have been recognized by many of our key customers as one of their leading and most trusted suppliers.  

This recognition illustrates our dedication to our customers. 

Lam Research is well positioned as we look out over the next several years. Underlying semiconductor demand 

appears healthy, though the pace and trajectory of economic recovery remain unpredictable. We are seeing a 

period of innovation in consumer electronics, featuring growing semiconductor content in an array of devices, 

which should support continued demand for logic and memory chips. Equally important demand drivers are 

the continued global penetration of smartphones and the long-delayed corporate PC refresh cycle, now finally 

underway. Should industry fundamentals remain strong, spending for capacity additions will continue to support 

semiconductor demand growth, fueling what could be a sustained period of strength in wafer fabrication 

equipment spending.

Lam’s track record for consecutively improving its performance exiting each of the last two semiconductor 

industry downturns suggests continued growth opportunities for the Company in the next cycle. We have 

expanded our served available markets, which now comprise well over 15% of the entire wafer fabrication 

equipment market. Continued application wins and customer recognition of our strong support organization 

demonstrate that we are executing to the needs of our customers. We are operating the business at a high 

degree of efficiency, with fast cycle times in order fulfillment and strong cash flow generation. In short, we 

believe that our technology and market leadership combined with operational excellence translates to a 

sustainable competitive advantage for Lam Research at a time when our end-markets are strengthening. 

We would like to close by thanking two groups in particular who are instrumental in Lam’s success: our 

global employee organization, which has delivered exceptional results in a challenging environment, and our 

customers, for whose partnership and support we are very grateful. Thank you also to our shareholders for  

your belief in Lam Research and our future prospects. We are looking forward to the next 30 years.

Sincerely,

Stephen G. Newberry  

James W. Bagley

President and Chief Executive Officer  

Executive Chairman of the Board

OCTOBER 1, 2010

INDEPENDENT REGISTERED PUBLIC   

CAUTIONS REGARDING FORWARD-LOOKING 

ACCOUNTING FIRM
Ernst & Young LLP 

San Jose, California

LEGAL COUNSEL
Jones Day
San Francisco, California

TRANSFER AGENT AND REGISTRAR
For a response to questions regarding 
misplaced stock certificates, changes of 
address, or the consolidation of accounts, 
please contact the Company’s transfer 
agent.

BNY Mellon Shareowner Services 
P.O. Box 358015 
Pittsburgh, PA 15252-8015

1.877.265.2630 

TDD for Hearing Impaired: 
1.800.231.5469

Foreign Shareowners:  
1.201.680.6578

TDD Foreign Shareowners: 
1.201.680.6610

Website Address: 
www.bnymellon.com/shareowner/isd

STOCK LISTING
The Company’s common stock is traded 
on the NASDAQ Global Select MarketSM 
under the symbol LRCX. Lam Research is 
a NASDAQ-100® company. 

INVESTOR RELATIONS
Lam Research Corporation welcomes 
inquiries from its stockholders and other 
interested investors. For additional 
copies of this report or other financial 
information, please contact:

Investor Relations 
Lam Research Corporation 
4650 Cushing Parkway 
Fremont, California 94538 
1.510.572.1615 
investor.relations@lamresearch.com

ANNUAL MEETING
The Annual Meeting of Stockholders  
will be held at 11:00 a.m. Pacific Time 
on Thursday, November 4, 2010, at the 
Company’s corporate headquarters.

STATEMENTS

With the exception of historical facts, the 
statements contained in this Letter to Our 
Stockholders (“Letter”) are forward-looking 
statements. Forward-looking statements 
are subject to the safe harbor provisions 
created by the Private Securities Litigation 
Reform Act of 1995. We have identified 
certain, but not necessarily all, of the forward-
looking statements in the Letter by use of 
future-oriented words and phrases such 
as “look ahead”, “in the future”, “expect”, 
and “should”. However, our identification 
of certain statements as “forward-looking” 
does not mean that other statements not 
specifically identified are not forward-looking. 
Forward-looking statements include, but 
are not limited to, statements that relate 
to: our general prospects for the future; 
projections of future market share position 
in our etch business; the market opportunity 
for single-wafer clean products and our 
prospects for market share expansion; the 
health of semiconductor demand; the impact 
of innovations in consumer electronics on 
future demand for logic and memory chips; 
the timing of the corporate PC refresh cycle 
and its impact on semiconductor demand; 
prospects for a sustained period of strength 
in wafer fabrication equipment spending; 
growth opportunities for the Company in the 
current semiconductor industry upturn; the 
Company’s ability to sustain a competitive 
advantage; and the strengthening of our 
end markets. These statements are based 
on current expectations and are subject to 
risks, uncertainties, and changes in condition, 
significance, value and effect, including 
without limitation those discussed under the 
heading “Risk Factors” within Item 1A of our 
fiscal 2010 Form 10-K; under the heading 
“Cautionary Statement Regarding Forward-
Looking Statements” at the beginning of  
Part I of the Form 10-K; and other documents 
we file from time to time with the Securities 
and Exchange Commission, such as 
our quarterly reports on Form 10-Q and 
current reports on Form 8-K. These risks, 
uncertainties and changes in condition, 
significance, value and effect could cause our 
actual results to differ materially from those 
expressed in this Letter and in ways that are 
not readily foreseeable. Readers are cautioned 
not to place undue reliance on these forward-
looking statements, which speak only as 
of the date of this Letter and are based on 
information currently and reasonably known 
to us. We do not undertake any obligation to 
update any forward-looking statements, or to 
release the results of any revisions to these 
forward-looking statements, to reflect the 
impact of anticipated or unanticipated events 
or circumstances that occur after the date of 
this Letter. 

TRADEMARK INFORMATION
The Lam Research logo, Lam Research, 
and all Lam Research product and service 
names used in this report are either registered 
trademarks or trademarks of Lam Research 
Corporation in the United States and/or other 
countries. All other marks mentioned herein 
are the property of their respective owners.

 
October 4, 2010

Dear Lam Research Stockholders,

We  cordially  invite  you  to  attend,  in  person  or  by  proxy,  the  Lam  Research  Corporation  2010  Annual 
Meeting  of  Stockholders.  The  Annual  Meeting  will  be  held  on  Thursday,  November  4,  2010,  at  11:00  a.m. 
Pacific  Standard  Time  at  the  principal  executive  offices  of  Lam  Research  Corporation,  which  are  located  at 
4650 Cushing Parkway, Fremont, California 94538. You may also listen to the Annual Meeting via webcast by 
clicking on Calendar/Webcasts link at http://investor.lamrc.com.

At this year’s Annual Meeting, the agenda includes the following items:

Agenda Item 

Board Recommendation 

Proposal No. 1:  Election of Directors 

Proposal No. 2:  Approval of the 2004 Executive Incentive Plan, as 

amended and restated

Proposal No. 3:  Ratification of the appointment of Ernst & Young LLP 

as the Company’s independent registered public 
accounting firm for fiscal 2011

FOR

FOR

FOR

Please refer to the Proxy Statement for detailed information about the Annual Meeting and each of the 
Proposals, as well as voting instructions. Your vote is important, and we strongly urge you to cast your vote 
via the Internet, phone or mail.

Sincerely yours,

Lam Research Corporation

James W. Bagley
Executive Chairman of the Board

(This page intentionally left blank.)

4650 Cushing Parkway 
Fremont, California 94538 
Telephone: 510-572-0200

NOTICE OF 2010 ANNUAL MEETING OF STOCKHOLDERS

DATE AND TIME  Thursday, November 4, 2010 at 11:00 a.m. Pacific Standard Time 

PLACE 

INTERNET 

Principal executive offices of Lam Research Corporation, 4650 Cushing Parkway, 
Fremont, California 94538 

Listen to the Annual Meeting online by clicking on the Calendar/Webcasts link at 
http://investor.lamrc.com. The proxy materials are also available at that website and at 
www.proxyvote.com.

AGENDA 

Vote on Proposal No. 1:  Election of Directors to serve for the ensuing year, and until 

their respective successors are elected and qualified

Vote on Proposal No. 2:  Approval of 2004 Executive Incentive Plan, as amended and 

restated

Vote on Proposal No. 3:  Ratification of the appointment of Ernst & Young LLP as 
the Company’s independent registered public accounting 
firm for the fiscal year ending June 26, 2011

Transact other business that may properly come before the Annual Meeting (including 
any adjournment or postponement)

RECORD DATE 

September 10, 2010. Only stockholders of record at the close of business on the Record 
Date are entitled to notice of and to vote at the Annual Meeting.

VOTING

Please vote as soon as possible, even if you plan to attend the Annual Meeting in 
person. You have three options for submitting your vote before the Annual Meeting: 
by the Internet, phone or mail. The Proxy Statement and the accompanying proxy card 
provide detailed voting instructions.

By Order of the Board of Directors

George M. Schisler, Jr.
Secretary

This Proxy Statement is first being mailed to our stockholders on or about October 4, 2010

 
 
 
LAM RESEARCH CORPORATION

PROXY STATEMENT 
FOR
2010 ANNUAL MEETING OF STOCKHOLDERS 
To Be Held November 4, 2010

 TABLE OF CONTENTS

   Page

Information Concerning Solicitation and Voting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Other Meeting Information  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Proposal No. 1: Election of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Nominees for Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Security Ownership of Certain Beneficial Owners and Management  . . . . . . . . . . . . . . . . . . . . . . . . .   

Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Director Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Section 16(a) Beneficial Ownership Reporting Compliance  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Executive Compensation and Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Compensation Discussion and Analysis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Compensation Committee Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Compensation Committee Interlocks and Insider Participation  . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Executive Compensation Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Securities Authorized for Issuance under Equity Compensation Plans  . . . . . . . . . . . . . . . . . . . . . . . .   

Proposal No. 2: Approval of the 2004 Executive Incentive Plan, as Amended and Restated . . . . . .   

Proposal No. 3: Ratification of the Appointment of Ernst & Young LLP as the Independent 

Registered Public Accounting Firm for Fiscal 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Audit Committee Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Relationship with Independent Registered Public Accounting Firm  . . . . . . . . . . . . . . . . . . . . . . . . . .   

Certain Relationships and Related Transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Other Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   

Appendix A (2004 Executive Incentive Plan, as Amended and Restated) . . . . . . . . . . . . . . . . . . . . . . . .   

1

3

6

6

10

11

17

19

19

19

38

39

39

46

47

51

52

53

54

54

55

iv

 
 LAM RESEARCH CORPORATION

PROXY STATEMENT FOR 2010 ANNUAL MEETING OF STOCKHOLDERS

Our Board of Directors (the “Board”) solicits your proxy for the 2010 Annual Meeting of Stockholders 
and any adjournment or postponement of the meeting, for the purposes described in the “Notice of 2010 Annual 
Meeting of Stockholders.” The table below shows important details about the Annual Meeting and voting. We 
use the terms “Lam Research,” the “Company,” “we,” “our,” “Lam’s,” and “us” in this Proxy Statement to refer 
to Lam Research Corporation, a Delaware corporation.

Record Date

Shares
Outstanding

Quorum

Inspector of 
Elections

Effect of  
Abstentions and 
Broker Non-Votes

September 10, 2010. Only stockholders of record at the close of business on the 
Record Date are entitled to receive notice of and to vote at the Annual Meeting.

122,873,314 shares of common stock outstanding as of the Record Date.

A majority of shares outstanding on the Record Date constitutes a quorum. A 
quorum is required to transact business at the Annual Meeting.

The Company will appoint an Inspector of Elections to determine whether a 
quorum is present. The Inspector will also tabulate the votes cast by proxy or at the 
Annual Meeting.

Shares voted “abstain” and broker non-votes (shares held by brokers that do not 
receive voting instructions from the beneficial owner of the shares, and do not 
have discretionary authority to vote on a matter) will be counted as present for 
purposes of determining whether we have a quorum. For purposes of voting results, 
abstentions and broker non-votes will not be counted.

Voting by Proxy

Stockholders may vote by Internet, phone, or mail, per the instructions on the 
accompanying proxy card.

Voting at the 
Meeting

Changing 
Your Vote

Stockholders can vote in person during the meeting. Stockholders of record will be 
on a list held by the Inspector of Elections. Each beneficial owner (an owner who 
is not the record holder of their shares) must obtain a proxy from the beneficial 
owner’s brokerage firm, bank, or the stockholder of record holding such shares 
for the beneficial owner, and present it to the Inspector of Elections with a ballot. 
Voting in person by a stockholder will replace any previous votes of that stockholder 
submitted by proxy.

Stockholders of record may change their votes by revoking their proxies. This may 
be done at any time before the polls close by (a) submitting a later-dated proxy 
by the Internet, telephone or mail, (b) submitting a vote in person at the Annual 
Meeting, or (c) delivering voting instructions to our Corporate Secretary before the 
Annual Meeting (to the attention of George M. Schisler, Jr., Office of the Secretary, 
Lam Research Corporation, 4650 Cushing Parkway, Fremont, California 94538). 
If a beneficial owner holds shares through a bank or brokerage firm, or another 
stockholder of record, the beneficial owner must contact the stockholder of record in 
order to revoke any prior voting instructions.

1

Voting 
Instructions

Voting Results

Availability of 
Proxy Materials

Proxy Solicitation 
Costs

If a stockholder completes and submits proxy voting instructions, the persons 
named on the proxy card as proxy holders (the “Proxy Holders”) will follow the 
stockholder’s instructions. If a stockholder submits proxy voting instructions but 
does not include voting instructions for each item, the Proxy Holders will vote as 
the Board recommends on each item for which the stockholder did not include an 
instruction. The Proxy Holders will vote on any other matters properly presented at 
the Annual Meeting in accordance with their best judgment.

We will announce preliminary results at the Annual Meeting. We will report final 
voting results at http://investor.lamrc.com and in a Form 8-K to be filed shortly after 
the Annual Meeting.

We mailed this Proxy Statement and the accompanying proxy card and 
2010 Annual Report to stockholders entitled to vote at the Annual Meeting 
beginning on October 4, 2010. These materials are also available on our website 
at http://investor.lamrc.com and at www.proxyvote.com. We will furnish, 
without charge, a physical copy of these materials and our 2010 Annual Report 
(including exhibits) on request by phone (510-572-1615), by mail (to Investor 
Relations, 4650 Cushing Parkway, Fremont, California 94538), or by email (to 
investor.relations@lamresearch.com).

The Company will bear the cost of all proxy solicitation activities. Our directors, 
officers and other employees may solicit proxies personally or by telephone, e-mail 
or other communication means, without any cost to Lam Research. We are required 
to request that brokers and nominees who hold stock in their names furnish our 
proxy materials to the beneficial owners of the stock, and we must reimburse these 
brokers and nominees for the expenses of doing so in accordance with statutory 
fee schedules.

2

OTHER MEETING INFORMATION

Voting on Proposals

Each  share  is  entitled  to  one  vote  on  Proposals  No.  2  and  No.  3.  Votes  may  be  cast  “for,”  “against”  or 

“abstain” on each of those proposals.

Pursuant to Proposal No. 1, Board members will be elected at the Annual Meeting to fill seven seats on the 
Board under a “majority vote” standard. The majority voting standard means that, even though there are only 
seven nominees for the seven Board seats, a nominee will be elected only if he or she receives an affirmative 
“for” vote from stockholders owning, as of the Record Date, at least a majority of the shares present and voted 
at the meeting in such nominee’s election by proxy or in person. Each stockholder may cast one vote (“for” or 
“withhold”), per share held, for each of the seven nominees. Stockholders may not cumulate votes in the election 
of directors.

If a stockholder votes by means of the proxy solicited by this Proxy Statement and does not instruct the 

Proxy Holders how to vote, the Proxy Holders will vote in favor of all individuals nominated by the Board.

Voting by 401(k) Plan Participants

Each employee participant in Lam’s 401(k) Savings Plus Plan (the “401(k) Plan”) who held unitized interests 
in the Company’s common stock in his or her personal 401(k) Plan account as of the Record Date will receive this 
Proxy Statement so that each participant may vote, by proxy, his or her interest in the Company’s common stock 
as held by the 401(k) Plan. The 401(k) Plan trustee, or the Company’s Savings Plus Plan, Lam Research 401(k) 
Committee as the 401(k) Plan administrator, will aggregate and vote proxies in accordance with the instructions 
in the proxies of employee participants that they receive.

Stockholder Accounts Sharing the Same Last Name and Address

To reduce the expense of delivering duplicate proxy materials to stockholders who may have more than one 
account holding Lam Research stock but who share the same address, we have adopted a procedure approved by 
the Securities and Exchange Commission (the “SEC”) called “householding.” Under this procedure, stockholders 
of record who have the same address and last name will receive only one copy of our Proxy Statement and Annual 
Report  unless  one  of  the  stockholders  notifies  our  Investor  Relations  Department  that  they  want  to  receive 
separate copies. This procedure reduces duplicate mailings and therefore saves printing and mailing costs, as 
well as natural resources. Stockholders who participate in householding will continue to have access to all proxy 
materials at http://investor.lamrc.com, as well as the ability to submit separate proxy voting instructions for each 
account through the Internet or by phone.

Stockholders  may  request  separate  copies  of  the  proxy  materials  for  multiple  accounts  holding  Lam 
Research stock by contacting the Company by phone (510-572-1615), by mail (to Investor Relations, 4650 Cushing 
Parkway, Fremont, California 94538) or by email (to investor.relations@lamresearch.com).  Stockholders may 
also request consolidation of proxy materials mailed to multiple accounts at the same address.

Stockholder-Initiated Proposals and Nominations for 2011 Annual Meeting

Proposals Submitted under SEC Rules. Stockholder-initiated proposals (other than director nominations) 
may be eligible for inclusion in our Proxy Statement for next year’s 2011 Annual Meeting (in accordance with 
SEC Rule 14a-8) and for consideration at the Annual Meeting. The Company must receive a stockholder proposal 
no later than June 6, 2011 for the proposal to be eligible for inclusion. Further, on August  25, 2010 the SEC 
adopted its new “proxy access” rule (SEC Rule 14a-11); this rule is expected to be effective prior to our next 
annual meeting, and if so will permit inclusion in our proxy statement of nominees for director that meet all of 
the requirements of the new rule (including, without limitation, stockholding requirements and receipt of any 
such nomination not earlier than May 7, 2011 and not later than June 6, 2011). Any stockholder interested in 
submitting a proposal or nomination is advised to contact legal counsel familiar with the detailed securities law 
requirements for submitting proposals or nominations for inclusion in a company’s proxy statement.

3

Proposals  and  Nominations  under  Company  Bylaws.  Stockholders  may  also  submit  proposals  for 
consideration, and nominations of director candidates for election, at the Annual Meeting by following certain 
requirements  set  forth  in  our  Bylaws.  The  current  applicable  provisions  of  our  Bylaws  are  described  below. 
Proposals  will  not  be  eligible  for  inclusion  in  the  Company’s  Proxy  Statement  unless  they  are  submitted  in 
compliance with then applicable SEC rules as referenced above; however, they will be presented for discussion 
at the Annual Meeting if the requirements established by our Bylaws for stockholder proposals and nominations 
have  been  satisfied.  Our  Bylaws  establish  requirements  for  these  stockholder  proposals  and  nominations. 
Assuming that the 2011 Annual Meeting takes place at roughly the same date next year as the 2010 Annual 
Meeting (and subject to any change in our Bylaws—which would be publicly disclosed by the Company—and 
to any provisions of then applicable SEC rules), the principal requirements for the 2011 Annual Meeting would 
be as follows:

For proposals and for nominations:
• 

A stockholder of record (“the Stockholder”) must submit the proposal or nomination in writing; it 
must be received by the Secretary of the Company no earlier than July 21, 2011, and no later than 
August 22, 2011;

• 

The  Stockholder’s  notice  to  the  Secretary  of  a  proposal  or  nomination  must  state  for  each  of  the 
Stockholder  and  the  beneficial  owner  of  Company  common  stock,  if  any,  on  behalf  of  whom  the 
proposal or nomination is being made (a “Beneficial Owner”):
• 
• 

the class, series and number of shares of capital stock of the Company that are owned beneficially 
or of record by the Stockholder and the Beneficial Owner;

the name and record address of the Stockholder and the Beneficial Owner;

• 

• 

• 

• 

• 

• 

a  description  of  any  options,  warrants,  convertible  securities,  or  similar  rights  held  by  the 
Stockholder  or  the  Beneficial  Owner  with  respect  to  the  Company’s  stock,  and  any  other 
opportunities by the Stockholder or the Beneficial Owner to profit or share in any profit derived 
from  any  increase  or  decrease  in  the  value  of  shares  of  the  Company,  including  through  a 
general or limited partnership or ownership interest in a general partner;

a description of any proxies, contracts, or other voting arrangements to which the Stockholder 
or the Beneficial Owner is a party concerning the Company’s stock;

a  description  of  any  short  interest  held  by  the  Stockholder  or  the  Beneficial  Owner  in  the 
Company’s stock;

a description of any rights to dividends separated or separable from the underlying shares of the 
Company to which the Stockholder or the Beneficial Owner are entitled;

any  other  information  relating  to  the  Stockholder  or  the  Beneficial  Owner  that  would  be 
required to be disclosed in a proxy statement or other filings required to be made in connection 
with solicitations of proxies for, as applicable, the proposal and/or for the election of directors 
in  a  contested  election  pursuant  to  Section  14  of  the  Securities  Exchange  Act  of  1934  (the 
“Exchange Act”) and the rules and regulations pursuant thereto; and

a  statement  whether  or  not  the  Stockholder  or  the  Beneficial  Owner  will  deliver  a  proxy 
statement and form of proxy to holders of, in the case of a proposal, at least the percentage of 
voting power of all of the shares of capital stock of the Company required under applicable law 
to carry the proposal or, in the case of a nomination or nominations, at least the percentage of 
voting power of all of the shares of capital stock of the Company reasonably believed by the 
Stockholder or the Beneficial Owner, as the case may be, to be sufficient to elect the nominee or 
nominees proposed to be nominated by the Stockholder or Beneficial Owner under a majority 
voting standard. 

4

Additionally, for nominations, the notice must:
• 

Set forth, as to each person whom the Stockholder proposes to nominate for election or reelection as a 
director, all information relating to such person as would be required to be disclosed in solicitations of 
proxies for the election of such nominees as directors pursuant to Regulation 14A under the Exchange 
Act; and

• 

Be accompanied by a written consent of each proposed nominee to be named as a nominee and to 
serve as a director if elected.

Additionally, for proposals, the notice must set forth a brief description of such business, the reasons for 
conducting such business at the meeting and any material interest in such business of such Stockholder and the 
Beneficial Owner, if any, on whose behalf the proposal is made.

For  a  full  description  of  the  requirements  for  submitting  a  proposal  or  nomination,  see  the  Company’s 
Bylaws.  Submissions  or  questions  should  be  sent  to:  George  M.  Schisler,  Jr.,  Office  of  the  Secretary, 
Lam Research Corporation, 4650 Cushing Parkway, Fremont, California 94538.

5

 PROPOSAL NO. 1
ELECTION OF DIRECTORS

NOMINEES FOR DIRECTOR

A board of seven directors is to be elected at the 2010 Annual Meeting, consistent with resolutions adopted 
by the Board establishing the size of the Board as seven members. In general, the seven nominees who receive the 
highest number of “for” votes will be elected. However, any nominee who fails to receive affirmative approval 
from holders of a majority of the votes cast in such nominee’s election at the Annual Meeting, either by proxy 
or in person, will not be elected to the Board, even if he or she is among the top seven nominees in total “for” 
votes. This requirement reflects the majority vote provisions implemented by the Company in November 2009. 
The term of office of each person elected as a director will be for the ensuing year, and until his or her successor 
is elected and qualified.

Unless  otherwise  instructed,  the  Proxy  Holders  will  vote  the  proxies  received  by  them  for  the  seven 
nominees named below, each of whom is currently a director of the Company. The proxies cannot be voted for 
more than seven nominees. If any nominee of the Company should decline or be unable to serve as a director as 
of the time of the Annual Meeting, the proxies will be voted for any substitute nominee designated by the present 
Board of Directors to fill the vacancy. The Company is not aware of any nominee who will be unable, or will 
decline, to serve as a director.

The individuals in the table below who are shown as nominees for re-election have been nominated for election to 
the Board of Directors in accordance with the criteria and procedures discussed below in “Corporate Governance.” 

THE BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS A VOTE “FOR” 
EACH OF THE NOMINEES FOR DIRECTOR SET FORTH BELOW.

The  following  table  sets  forth  certain  information  concerning  the  nominees  to  the  Board,  and  their 

qualifications to serve:

Board Member Name  
and Current Board Role(s)

James W. Bagley, age 71

Nominee for re-election

Executive Chairman

Principal Occupation and Business Experience During Past Five Years

  Mr. Bagley is the Executive Chairman of the Board of Directors, a position 
he has held since 2005. He served as Chairman from 1998 to 2005. From 
1997 until 2005, Mr. Bagley also served as Lam’s Chief Executive Officer.

Mr. Bagley joined Lam’s Board following the 1997 merger of Lam Research 
and OnTrak Systems, Inc., a supplier of silicon chip cleaning equipment 
where Mr. Bagley served as Chairman and Chief Executive Officer prior to 
the merger. He was formerly Chief Operating Officer and Vice Chairman of 
the Board of Applied Materials, Inc., where he also served in other executive 
positions during his 15-year tenure.

Mr. Bagley serves on the boards of directors of Micron Technology, Inc. and 
Teradyne Inc., both of which are publicly traded companies. He holds M.S. 
and B.S. degrees in electrical engineering from Mississippi State University.

The Board has concluded that Mr. Bagley is qualified to serve as a director 
of the Company because of his deep industry knowledge including his 
experience as Chairman and Chief Executive Officer, as Executive 
Chairman, and as a director of the Company, his extensive executive 
management experience, and his broad experience on other boards, 
including service on Audit, Compensation and Nominating and Governance 
committees and as a lead independent director. 

6

 
Board Member Name  
and Current Board Role(s)

David G. Arscott, age 66

Nominee for re-election

Audit Committee member

Robert M. Berdahl, age 73

Nominee for re-election

Lead independent director

Compensation Committee 
member

Nominating and Governance 
Committee Chair

Principal Occupation and Business Experience During Past Five Years

Mr. Arscott has been a director of the Company since 1980, and was 
Chairman of the Board of Directors from 1982 to 1984. In 1988, Mr. Arscott 
co-founded Compass Technology Group, an investment management firm, 
where he has been General Partner since 1988. Prior to that, Mr. Arscott 
co-founded Arscott, Norton & Associates, a venture capital firm, where he 
served as Managing General Partner.

Mr. Arscott serves on the boards of directors of Dragnet Solutions, Inc., 
Percutaneous Systems, Inc., and Toolwire, Inc., each of which is a privately 
held company. He earned his B.A. degree from the College of Wooster in 
Wooster, Ohio and his M.B.A. from the University of Michigan.

The Board has concluded that Mr. Arscott is qualified to serve as a director 
of the Company because of his service on the Board, his industry and 
technology expertise and his global economic expertise.

Dr. Berdahl has been a director of the Company since 2001. He has been the 
President of the Association of American Universities since 2006. From 1997 
to 2004, Dr. Berdahl served as Chancellor of the University of California, 
Berkeley (“UC Berkeley”). From 2004 to 2006, he was a history professor 
at UC Berkeley and a professor of public policy at UC Berkeley’s Goldman 
School of Public Policy.

Prior to serving as Chancellor at UC Berkeley, Dr. Berdahl held several 
academic leadership positions, including President of the University of Texas 
at Austin and Vice Chancellor of Academic Affairs at the University of 
Illinois at Urbana-Champaign.

Dr. Berdahl has received numerous honors and awards, including a Fulbright 
Research Fellowship, and election to the American Academy of Arts and 
Sciences. He received his B.A. from Augustana College in Sioux Falls, 
South Dakota, his M.A. from the University of Illinois, and his Ph.D. from 
the University of Minnesota.

The Board has concluded that Dr. Berdahl is qualified to serve as a 
director of the Company because of his prior service on the Board, the 
strong leadership skills he brought to bear as Chancellor at UC Berkeley 
and other leadership positions at large, complex organizations, his ability 
to contribute to the diversity of perspectives on the Board, due to his 
background as an academic and service as President of the Association of 
American Universities, his crisis management experience, and his global 
economic expertise.

7

 
Board Member Name  
and Current Board Role(s)

Eric K. Brandt, age 48

Nominee for re-election

Board Member

Appointed to Audit Committee, 
effective October 11, 2010

Principal Occupation and Business Experience During Past Five Years

Mr. Brandt was elected to the Company’s board on September 10, 2010. 
Mr. Brandt serves as Executive Vice President and Chief Financial Officer 
of Broadcom Corporation, a role in which he has served since joining 
Broadcom in March 2007. Previously, from September 2005 to March 
2007, Mr. Brandt served as President and Chief Executive Officer of Avanir 
Pharmaceuticals. Prior to Avanir, Mr. Brandt was Executive Vice President-
Finance and Technical Operations and Chief Financial Officer of Allergan 
Inc., where he also held a number of other senior positions following his 
arrival there in 1999. Previously, Mr. Brandt spent ten years with The Boston 
Consulting Group, a privately-held global business consulting firm, most 
recently serving as Vice President and Partner.

Mr. Brandt serves as a member of the board of directors and a member of the 
compensation committee of Dentsply International, Inc., a public company. 
He previously served as a member of the boards of directors of Avanir and of 
Vertex Pharmaceuticals, Inc., where he was chair of the audit committee.

Mr. Brandt received a B.S. in Chemical Engineering from the Massachusetts 
Institute of Technology and an M.B.A. from Harvard Business School.

The Board has concluded that Mr. Brandt is qualified to serve as a director 
of the Company because of his financial expertise including service as an 
active chief financial officer of a publicly traded company, his experience in 
the semiconductor industry, and his service on other boards of directors.

Grant M. Inman, age 68

Nominee for re-election

Mr. Inman has been a director of the Company since 1981. He is currently 
General Partner of Inman Investment Management, a venture investment 
firm that he founded in 1998. He also co-founded and served as general 
partner of Inman & Bowman, a venture capital firm formed in 1985. 

Compensation Committee Chair

Nominating and Governance 
Committee member

Mr. Inman was a general partner of the investment banking firm Hambrecht 
& Quist from 1980 to 1985.Mr. Inman has served on the board of directors of 
Paychex, Inc., a publicly traded company, since 1983. In addition, he serves 
on the board of directors of AlphaCard Systems, a privately held company. 
He holds a B.A. degree in economics from the University of Oregon and an 
M.B.A. from the University of California, Berkeley. Mr. Inman now serves 
as a Trustee of the UC Berkeley Foundation. Mr. Inman previously served as 
a director of Wind River Systems Inc.

The Board has concluded that Mr. Inman is qualified to serve as a director 
of the Company because of his 30-year tenure as a director of the Company, 
his industry knowledge, his extensive experience on other boards (including 
as chairman of Audit, Compensation and Nominating and Governance 
committees), and the entrepreneurial perspective he brings from his venture 
investment experience.

8

 
Board Member Name  
and Current Board Role(s)

Catherine P. Lego, age 54

Nominee for re-election

Audit Committee Chair

Principal Occupation and Business Experience During Past Five Years

Ms. Lego has been a director of the Company since 2006. From 1999 to 
2009, she was the General Partner of The Photonics Fund, LLP, a venture 
capital investment firm that she founded. Prior to forming The Photonics 
Fund, she founded Lego Ventures LLC in 1992 to provide consulting 
services to early stage electronics companies.

Ms. Lego currently serves on the board of directors, and chairs the audit 
committee, of SanDisk Corporation, a publicly traded company. She 
received a B.A. from Williams College and an M.S. in Accounting from the 
New York University Graduate School of Business. Ms. Lego received her 
CPA in connection with her work at Coopers & Lybrand earlier in her career.

The Board has concluded that Ms. Lego is qualified to serve as a director 
of the Company because of her prior service on the Board, her substantial 
accounting and financial expertise, her knowledge of the electronics industry 
and the perspective of companies that purchase semiconductors from our 
customers, and experience on other boards, including her current service as 
chairman of the audit committee of SanDisk. 

Stephen G. Newberry, age 56

Nominee for re-election

Board member

Mr. Newberry has been a director of the Company since 2005. He 
also serves as the Company’s President and Chief Executive Officer. 
Mr. Newberry joined the Company in August 1997 as Executive Vice 
President and Chief Operating Officer. He was appointed President and 
Chief Operating Officer in July 1998, and President and Chief Executive 
Officer in June 2005.

Prior to joining the Company, Mr. Newberry held various executive 
positions at Applied Materials, Inc. during his 17-year tenure there. 
Mr. Newberry serves on the boards of directors of Amkor Technology, Inc., 
a publicly traded company, and of SEMI, a global semiconductor industry 
trade association. Mr. Newberry previously served as a director of Nextest 
Systems Corporation from October 2000 to January 2008. Mr. Newberry 
is a graduate of the U.S. Naval Academy and the Harvard Graduate School 
of Business.

The Board has concluded that Mr. Newberry is qualified to serve as 
a director of the Company because of his 30 years’ experience in the 
semiconductor equipment industry, his comprehensive understanding of 
the Company and its products, markets, and strategies gained through his 
role as our President and Chief Executive Officer, his active role in the 
semiconductor industry’s trade association, and his strong leadership and 
operations expertise.

In addition to the biographical information above regarding each director’s specific experience, attributes, 
positions and qualifications, we believe that each of our directors serving during fiscal 2010 has performed his or 
her duties with critical attributes such as honesty, integrity, wisdom, and an adherence to high ethical standards. 
Each nominee has demonstrated strong business acumen, an ability to make independent analytical inquiries, an 
ability to understand the Company’s business environment, and an ability to exercise sound judgment, as well as 
a commitment to the Company and its core values.

9

 
 
SECURITY OWNERSHIP 
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The table below sets forth the beneficial ownership of shares of Lam’s Common Stock by: (i) each person 
or entity who the Company believes beneficially owned more than 5% of Lam’s common stock on the date set 
forth below; (ii) each current director of the Company; (iii) each named executive officer identified below in the 
“Executive Compensation” section; and (iv) all current directors and current executive officers as a group. With the 
exception of 5% owners, the information below reflects holdings as of September 17, 2010, unless otherwise noted, 
which is the most recent practicable date for such determination. For 5% owners, holdings are as of June 30, 2010, 
which is the more practicable date for determining their holdings. The percentage of the class owned is calculated 
using 122,876,056 as the number of shares of Lam’s Common Stock outstanding on that date.

Name of Person or Identity of Group
5% Stockholders
FMR LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

82 Devonshire 
Boston, MA 02109

Shares 
Beneficially 
Owned (1) 
(2) 

Percentage 
of 
Class

18,929,920

15.4%

Turner Investment Partners  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

7,773,204

6.3%

1205 Westlakes Drive, Suite 100 
Berwyn PA 19312

Directors
James W. Bagley . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
David G. Arscott . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Robert M. Berdahl  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Eric K. Brandt(3)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard J. Elkus, Jr.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Grant M. Inman  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Catherine P. Lego . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stephen G. Newberry (also a Named Executive Officer)  . . . . . . . . . . .
Named Executive Officers
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
All current directors and executive officers as a group 

182,000
94,983
44,948
0
81,618
106,248
22,248
10,650

4,869
17,917
8,771
9,402
5,013

(15 people) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

623,215

*
*
*
*
*
*
*
*

*
*
*
*
*

*

* 

(1) 

(2) 

(3) 

Less than 1%. 

Includes shares subject to outstanding stock options that are now exercisable or will become exercisable 
within 60 days after September 17, 2010, as follows:

David G. Arscott

Robert M. Berdahl

Richard J. Elkus, Jr.

Grant M. Inman

Martin B. Anstice

Ernest E. Maddock

All directors and current executive
officers as a group (15)

39,000 
options
27,000 
options
27,000 
options
27,000 
options

2,849 
options
3,050 
options
132,199 
options

Information regarding beneficial ownership by the 5% stockholders is based on their most recent respective 
publicly filed Schedule 13D, 13F, or 13G prior to September 17, 2010. 

The  total  shares  beneficially  owned  by  Mr.  Brandt  are  as  of  September  10,  2010,  the  date  that  he  was 
appointed to the board.

10

CORPORATE GOVERNANCE

Our Board of Directors and members of management are committed to responsible corporate governance 
that  will  ensure  that  the  Company  is  managed  for  the  long-term  benefit  of  its  stockholders.  To  that  end,  the 
Board of Directors and management periodically review and update, as appropriate, the Company’s corporate 
governance  policies  and  practices.  As  part  of  that  process,  the  Board  and  management  review  published 
guidelines and recommendations of institutional shareholder organizations; published guidelines of a selection 
of other public companies; the requirements of the Sarbanes-Oxley Act of 2002 and other rules and regulations 
of the SEC; and the listing standards for the NASDAQ Global Select Market (“NASDAQ”).

Corporate Governance Policies

We  have  instituted  a  variety  of  policies  and  procedures  to  foster  and  maintain  responsible  corporate 

governance, including the following:

Board  Committee  Charters.  Each  of  the  Board’s  standing  committees  —  Audit,  Compensation  and 
Nominating and Governance Committees — has a written charter adopted by the Board that establishes practices 
and procedures for the committee in accordance with applicable corporate governance rules and regulations. 
Each  committee  reviews  its  charter  annually  and  recommends  changes  to  the  Board,  as  appropriate.  Each 
Committee Charter is available on the investors’ page of Lam’s web site at http://investor.lamrc.com. Please also 
refer to “Board Meetings and Committees,” below, for a description of responsibilities of the Board’s standing 
committees.

Corporate  Governance  Guidelines.  We  adhere  to  written  Corporate  Governance  Guidelines,  adopted 
by the Board and reviewed annually by the Nominating and Governance Committee and the Board. Selected 
provisions of the Guidelines are discussed below, including in the “Board Nomination Policies and Procedures,” 
“Director Independence Policies” and “Other Governance Practices” sections below.

Corporate  Code  of  Ethics.  We  maintain  a  Code  of  Ethics  that  applies  to  all  employees,  officers,  and 
members of the Board. The Code of Ethics establishes standards reasonably necessary to promote honest and 
ethical  conduct,  including  the  ethical  handling  of  actual  or  apparent  conflicts  of  interest  between  personal 
and  professional  relationships;  and  full,  fair,  accurate,  timely,  and  understandable  disclosure  in  the  periodic 
reports  we  file  with  the  SEC  and  in  other  public  communications.  We  will  promptly  disclose  to  the  public 
any amendments to, or waivers from, any provision of the Code of Ethics, to the extent required by applicable 
laws. We intend to make this public disclosure by posting the relevant material on our website, to the extent 
permitted by applicable laws. A copy of the Code of Ethics is available on the investors’ page of Lam’s web site 
at http://investor.lamrc.com.

Global Standards of Business Conduct Policy. Lam Research maintains written standards of appropriate 

business conduct in a variety of business situations that apply to employees worldwide.

Insider Trading Policy. Our Insider Trading Policy restricts the trading of Company stock by Lam Research 
directors, officers, and employees, and includes provisions addressing insider blackout periods, margin accounts 
and hedging transactions.

Board Nomination Policies and Procedures

Board Membership Criteria. Under our Corporate Governance Guidelines, the Nominating and Governance 
Committee is responsible for assessing the appropriate balance of experience, skills and characteristics required 
for  the  Board  and  for  recommending  director  nominees  to  the  independent  directors.  The  Guidelines  direct 
the  Committee  to  consider  all  factors  it  considers  appropriate.  The  Committee  need  not  consider  all  of  the 
same factors for every candidate. Factors considered may include, among other things: diversity with respect to 
any attribute(s) the Board considers desirable; experience; business acumen; wisdom; integrity; judgment; the 
ability to make independent analytical inquiries; the ability to understand the Company’s business environment; 
the candidate’s willingness and ability to devote adequate time to Board duties; specific skills, background or 
experience considered necessary or desirable for Board or committee service; specific experiences with other 
businesses or organizations that may be relevant to the Company or its industry; and the interplay of a candidate’s 
experiences and skills with the experiences and skills of other Board members.

11

Prior  to  nominating  an  incumbent  non-employee  director  for  re-election  to  the  Board,  the  Committee 
reviews  the  experiences,  skills  and  qualifications  of  the  director  to  assess  the  continuing  relevance  of  the 
director’s experiences, skills and qualifications to those considered necessary or desirable for the Board at that 
time.

Board members may not serve on more than four boards of public companies (including Lam’s Board), and 

Board nominees must be under the age of 75 years when nominated.

Nomination Procedure. The Nominating and Governance Committee identifies, evaluates and recommends 
qualified candidates for election to the Board. The Committee considers recommendations from a variety of 
sources, including search firms, Board members, executive officers and stockholders. Formal nominations are 
made by the independent members of the Board.

The following provisions of our Bylaws currently apply to the nomination or recommendation of candidates 

by a stockholder:

• 

• 

• 

In  the  case  of  an  annual  meeting,  the  stockholder  is  required  to  provide  advance  notice  of  the 
nomination, generally between 75 and 45 days prior to the anniversary of the mailing of the previous 
year’s proxy statement;

In the case of a special meeting, the stockholder is required to provide advance notice of the nomination 
by the later of 90 days prior to the special meeting and the tenth day following the announcement of 
the date of the special meeting; and

A stockholder is required to provide additional disclosure regarding, among other things, derivative 
instruments and short positions in the Company’s stock held by the stockholder.

Additional  information  regarding  the  nomination  procedure  is  provided  in  the  section  above  captioned 

“Stockholder-Initiated Proposals and Nominations for 2011 Annual Meeting .”

Director Independence Policies

Board  Independence  Requirements.  Our  Corporate  Governance  Guidelines  require  that  at  least  a 
majority of the Board members be independent in accordance with NASDAQ rules. No director will qualify 
as  “independent”  unless  the  Board  affirmatively  determines  that  the  director  has  no  relationship  that  would 
interfere with the exercise of independent judgment as a director. In addition, no non-employee director may 
serve as a consultant or service provider to the Company without the approval of a majority of the independent 
directors, and no more than two management executives may serve on the Board at the same time.

Board  Member  Independence. The Board has determined that all directors, other than Mr.  Bagley and 

Mr. Newberry, are independent in accordance with NASDAQ criteria for director independence.

Board  Committee  Independence.  All  members  of  the  Board’s  three  standing  committees  —  Audit, 
Compensation,  and  Nominating  and  Governance  Committees  —  must  be  independent  in  accordance  with 
applicable  NASDAQ  criteria  as  well  as,  in  the  case  of  the  Compensation  Committee,  applicable  rules  under 
Section 162(m). See “Board Meetings and Committees” below for a description of the responsibilities of the 
Board’s standing committees.

Lead  Independent  Director.  Our  Corporate  Governance  Guidelines  authorize  the  Board  to  designate 
a  Lead  Independent  Director  from  among  the  independent  Board  members.  The  Lead  Independent  Director 
is  responsible  for  coordinating  the  activities  of  the  independent  members  of  the  Board,  consulting  with  the 
Executive Chairman regarding matters such as schedules of and agendas for Board meetings and the retention 
of  consultants  reporting  to  the  Board,  and  developing  the  agenda  for  and  moderating  executive  sessions  of 
the  Board’s  independent  directors.  Director  Robert  Berdahl  has  served  as  the  Lead  Independent  Director 
since 2004.

Executive Sessions of Independent Directors. The Board and its standing committees hold meetings of the 
independent directors and Committee members, without management present, at the discretion of the Board or 
committee, as applicable.

12

Board Access to Independent Advisors. The Board as a whole, and each of the Board committees separately, 
may retain, at Lam’s expense, and terminate, in their discretion, any independent consultants, counselors, or 
advisors as they deem necessary or appropriate.

Leadership Structure of the Board

The current leadership structure of the Board consists of an Executive Chairman and a Lead Independent 
Director. The Executive Chairman is a former executive officer of the Company. Our Chief Executive Officer 
also serves on the Board. All directors other than Messrs. Bagley and Newberry are independent board members 
under applicable legal and regulatory requirements.

The Company believes that having both an Executive Chairman and a Lead Independent Director is the 
appropriate leadership structure for the Board at this time. The Company is fortunate to have a former Chief 
Executive Officer of the Company to serve as its Executive Chairman, as he can bring to bear his management 
experience  in  leading  the  Board  in  its  oversight  role.  At  the  same  time,  the  Company  and  its  stockholders 
benefit from having a Lead Independent Director to provide independent Board leadership, and from having 
the Company’s President and Chief Executive Officer on the Board to provide detailed and in-depth knowledge 
of the issues, opportunities and challenges facing the Company and to bring his perspective to bear in Board 
discussions and decisions.

Other Governance Practices

In addition to the principal policies and procedures described above, we have established a variety of other 

practices to enhance our corporate governance, including the following.

Board and Committee Assessments. At least bi-annually, the Board conducts a review of the functioning of 

the Board and its standing committees.

Director  Resignation  or  Notification  of  Change  in  Executive  Officer  Status.  Under  our  Corporate 
Governance Guidelines, any Lam Research director who is also an executive officer of the Company must offer 
to submit his or her resignation as a director to the Board if the director ceases to be an executive officer of Lam 
Research. The Board may accept or decline the offer, in its discretion. The Corporate Governance Guidelines also 
require a non-employee director to notify the Nominating and Governance Committee if the director changes 
his or her executive position at another company. The Nominating and Governance Committee will review the 
appropriateness of the director’s continued Board membership under the circumstances, and the director will be 
expected to act in accordance with the Nominating and Governance Committee’s recommendations.

Director and Executive Stock Ownership. Under the Corporate Governance Guidelines, each director is 
expected to own at least 5,000 shares of Lam Research common stock by the later of the fifth anniversary of 
his or her initial election to the Board or December 31, 2010. We also have guidelines for stock ownership by 
other members of the executive management team, including the Chief Executive Officer, the Chief Financial 
Officer, and other officers designated by the Compensation Committee. These executives are expected to own 
a number of shares of Lam Research common stock equal in value to a multiple of each executive’s base annual 
salary or a specified minimum number of shares, whichever is lower. The salary multiple or specific number of 
shares varies according to the seniority of the office. In recognition of the limitations of our stock ownership 
guideline  structure  in  a  cyclical  business,  the  guidelines  are  expressed  as  the  lesser  of  a  dollar  amount  or  a 
share amount, to allow for changes in the trading price of Lam’s stock. Each designated executive is expected to 
acquire and maintain ownership of shares of our common stock, in the quantities indicated below, by the later of 
December 31, 2011, or the fifth anniversary of the executive officer’s hire or promotion date:

Position
Chief Executive Officer . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lesser of three times base salary, or 65,000 shares
Lesser of two times base salary, or 25,000 shares
Chief Operating Officer; Chief Financial Officer . . . . . . . .
Lesser of two times base salary, or 20,000 shares
Group Vice Presidents  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lesser of one times base salary, or 10,000 shares
Other designated executives . . . . . . . . . . . . . . . . . . . . . . . . .

Stock Ownership Guideline

13

Insider Trading Restrictions. Our Global Standards of Business Conduct Policy prohibits employees from 
engaging in “short sales” of Lam Research securities or from purchasing “put” or “call” options for Lam Research 
securities (other than through our equity incentive plans or employee stock purchase plans). These measures help 
to ensure that our employees and Board members will not benefit from a decline in Lam’s stock price, but will 
remain focused on our business success.

Communications  with  Board  Members.  Any  stockholder  who  wishes  to  communicate  directly  with  the 
Board of Directors, any Board Committee or with any individual director regarding the Company may write 
to the Board or the director c/o George M. Schisler, Jr., Office of the Secretary, Lam Research Corporation, 
4650 Cushing Parkway, Fremont, CA 94538. The Office of the Secretary will forward all such communications 
to the appropriate director(s).

Any stockholder, employee, or other person may communicate any complaint regarding any accounting, 
internal accounting control, or audit matter to the attention of the Board’s Audit Committee by sending written 
correspondence to: Lam Research Corporation, Attention: Board Audit Committee, P.O. Box 5010, Fremont, 
CA 94536. The Audit Committee has established procedures to ensure that employee complaints or concerns 
regarding audit or accounting matters will be received and treated anonymously (if the complaint or concern is 
submitted anonymously) and confidentially.

We expect our directors to attend the annual meeting of stockholders each year and to respond to appropriate 

questions. All our directors nominated for re-election in 2009 attended the 2009 annual meeting.

Board Meetings and Committees

Meeting  Attendance.  Our  Board  of  Directors  held  a  total  of  six  meetings  during  fiscal  2010.  All  of 
the  directors  who  served  for  the  entire  fiscal  year  attended  at  least  75%  of  the  aggregate  number  of  Board 
meetings  that  they  were  entitled  to  attend  and  meetings  of  Board  committees  on  which  they  served  during 
fiscal 2010. Patricia Wolpert, who passed away during the fiscal year, attended fewer than 75% of the Board and 
Compensation Committee meetings held during her tenure. The Board of Directors has as standing committees 
an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee.

Audit  Committee.  The  purpose  of  the  Audit  Committee  is  to  oversee  Lam’s  accounting  and  financial 
reporting processes and the audits of our financial statements. The Audit Committee is not, however, responsible 
for planning or conducting our audits, or determining whether our financial statements are complete and accurate 
or prepared in accordance with generally accepted accounting principles.

During fiscal 2010, the Audit Committee consisted of Board members Arscott, Elkus and Lego, each of 
whom served for the entire fiscal year, and former Board member Seiichi Watanabe, who served for a portion 
of the fiscal year. The Audit Committee held fifteen meetings during fiscal 2010. The Board concluded that all 
Audit Committee members are non-employee directors who are independent in accordance with the NASDAQ 
criteria for audit committee member independence. The Board also determined that Ms. Lego, the chair of the 
committee during fiscal 2010, is a “financial expert” as defined in SEC rules.

The Audit Committee’s responsibilities include (but are not limited to) the following:
• 

Appoint and provide for the compensation for Lam’s independent registered public accounting firm 
(the “Accounting Firm”), and approve, in accordance with and in a manner consistent with the laws, 
rules  and  regulations  applicable  to  the  Company,  all  professional  services  to  be  provided  to  Lam 
Research by the Accounting Firm

Oversee the work of, and evaluate the performance of, the Accounting Firm

• 
•  Meet  with  management  and  the  Accounting  Firm  to  discuss  the  annual  financial  statements 
and  the  Accounting  Firm’s  report  on  them,  and  to  discuss  the  adequacy  of  internal  control  over 
financial reporting

•  Meet  quarterly  with  management  and  the  Accounting  Firm  to  discuss  the  quarterly  financial 

statements prior to the filing of the Company’s Form 10-Q with the SEC

14

• 

• 
• 
• 

At  least  annually,  review  and  reassess  the  Internal  Audit  Charter  and,  if  appropriate,  recommend 
proposed changes

Review the scope, results and analysis of internal audits (if any)

Review and approve all related-party transactions

Establish a procedure for receipt, retention and treatment of any complaints received by the Company 
about  its  accounting,  internal  accounting  controls  or  auditing  matters,  and  for  the  confidential 
and  anonymous  submission  by  employees  of  concerns  regarding  questionable  accounting  or 
auditing matters

Compensation  Committee.  The  purpose  of  the  Compensation  Committee  is  to  discharge  certain 
responsibilities of the Board relating to executive compensation, to oversee incentive, equity-based and other 
compensatory plans in which Lam’s executive officers and directors participate and to produce an annual report 
on executive compensation for inclusion as required in the Company’s Proxy Statement.

During fiscal 2010, the Compensation Committee consisted of Board members Berdahl and Inman, each 
of whom served for the entire fiscal year, former Board member Jack Harris, who served until his retirement 
from  the  Board  in  November  2009,  and  former  Board  member  Patricia  Wolpert,  who  served  until  passing 
away during fiscal year 2010. The Board concluded that all members of the Compensation Committee are non-
employee directors who are independent in accordance with the NASDAQ criteria for director independence. 
The Compensation Committee held eight meetings during fiscal 2010.

The Compensation Committee’s responsibilities include (but are not limited to) the following:
• 

Develop,  and  from  time  to  time  review,  compensation  policies  and  practices  applicable  to  Lam’s 
executive  officers,  including  the  criteria  upon  which  executive  compensation  is  based  and  the 
composition of executive compensation in terms of base salary, deferred compensation, incentive- or 
equity-based compensation and other benefits

• 

• 

• 

• 

• 

Establish and review corporate goals and objectives as relevant to the Chief Executive Officer (the 
“CEO”) and the Executive Chairman, evaluate their performance in light of these goals and objectives 
and based on this evaluation recommend the CEO’s and Executive Chairman’s compensation packages 
for approval by the independent members of the Board

Determine compensation packages for other executive officers consistent with policies approved by 
the independent members of the Board

Review and recommend to the Board for final approval all cash, equity-based or other compensation 
arrangements applicable to the independent members of the Board

Review and approve, subject to stockholder or Board approval as required, the creation or amendment 
of any equity-based compensatory plans and other compensatory plans as the Board designates

Oversee  management’s  determination  as  to  whether  the  Company’s  compensation  policies  and 
practices create risks that are reasonably likely to have a material adverse effect on the Company

Nominating and Governance Committee. The purpose of the Nominating and Governance Committee is to 
identify individuals qualified to serve as members of the Board of the Company, recommend nominees for election 
as directors of the Company, evaluate the Board’s performance, develop and recommend to the Board corporate 
governance guidelines, and provide oversight with respect to corporate governance and ethical conduct.

During fiscal 2010, the Nominating and Governance Committee consisted of Board members Berdahl, 
Elkus, and Inman. The Board concluded that all Nominating and Governance Committee members are non-
employee directors who are independent in accordance with the NASDAQ criteria for director independence. 
The Nominating and Governance Committee held five meetings during fiscal 2010.

15

The  Nominating  and  Governance  Committee’s  responsibilities  include  (but  are  not  limited  to) 

the following:

•  Make  recommendations  to  the  independent  members  of  the  Board  of  nominees  for  election  as 
directors of the Company at the next annual or special meeting of stockholders at which directors are 
to be elected, and identify, evaluate and recommend individuals to fill any vacancies or newly created 
directorships that may occur between meetings

•  Make recommendations to the Board annually after consultation with the Chairman of the Board and 
the Lead Independent Director, if any, with respect to assignment of Board members to committees 
and for committee chairs

• 

• 

Recommend to the Board the adoption of corporate governance guidelines, and from time to time 
review and assess the guidelines and recommend changes for approval by the Board

Conduct from time to time a review of the Board and the Board committees in accordance with the 
Company’s Corporate Governance Guidelines and the committee charters, and report the evaluation 
to the Board

The Nominating and Governance Committee recommended the slate of nominees for director set forth 
in Proposal No. 1. The independent members of the Board approved the recommendations and nominated the 
proposed slate of nominees.

The Nominating and Governance Committee will consider for nomination persons properly nominated 
by stockholders in accordance with the Company’s Bylaws and other procedures described above in the section 
captioned  “Stockholder-Initiated  Proposals  and  Nominations  for  2011  Annual  Meeting.”  Subject  to  then-
applicable law, stockholder nominations for director will be evaluated by Lam’s Nominating and Governance 
Committee in accordance with the same criteria as are applied to candidates identified by the Nominating and 
Governance Committee or other sources.

Board’s Role in Risk Oversight

The  Board  of  Directors  has  oversight  responsibility  with  respect  to  the  Company’s  risk  management 
activities. The  Board has delegated oversight responsibility for certain areas of  risk exposure to its standing 
committees.

The  Audit  Committee  oversees  risk  management  activities  relating  to  the  Company’s  accounting  and 
financial reporting, internal controls, and the auditing of the Company’s annual financial statements. The Audit 
Committee  also  oversees  the  Company’s  independent  registered  public  accounting  firm  and  the  Company’s 
internal audit function. The Audit Committee meets privately with the Company’s independent registered public 
accounting firm at least quarterly.

The  Compensation  Committee  oversees  risk  management  activities  relating  to  the  design  of  equity, 
executive  and  board  level  compensation  policies  and  plans.  The  Compensation  Committee  works  with  an 
independent compensation consultant and meets privately with that consultant as appropriate.

Assessment of Compensation Risk

Management conducted a compensation risk assessment in 2010 and concluded that the Company’s current 

compensation programs are not reasonably likely to have a material adverse effect on the Company’s business.

16

DIRECTOR COMPENSATION

Board members who are also employees do not receive any additional compensation for service on the 
Board. The compensation of our non-employee directors is reviewed and determined annually by the Board, 
upon recommendation from the Compensation Committee. Committee chairs and the lead independent director 
receive additional cash retainers. The Board endeavors to maintain forms and amounts of director compensation 
that will attract and retain directors of the caliber desired by the Company and that align director interests with 
those of stockholders.

Our director compensation plans run on a calendar-year basis. However, SEC rules require us to report 
compensation in this Proxy Statement on a fiscal-year basis. For calendar year 2010 (the first half of which was 
the second half of fiscal 2010), each of the Company’s non-employee directors received an annual retainer of 
$42,000. An additional $12,500 fee was paid to the chair of the Compensation Committee and to the chair of 
the Audit Committee. A $12,500 fee was paid to the Lead Independent Director and chair of the Nominating 
and Governance Committee for his service in both of those roles. The rate of cash compensation for calendar 
year 2009 (the second half of which was the first half of fiscal 2010) was a $42,000 annual retainer, $10,000 
for the Audit Committee Chair and $7,500 for the Compensation Committee and Nominating and Governance 
Committee chairs and for the Lead Independent Director.

Beginning in calendar year 2010, each new non-employee director is eligible to receive an initial equity 
grant in the form of restricted stock units (“RSUs”), upon the date of the first regularly scheduled board meeting 
attended by that director after first being appointed or elected to the Board, with a targeted grant date value equal 
to $250,000 (calculated as the fair market value of a share of the Company’s common stock on the grant date, 
times the number of shares granted). The initial RSUs vest in four equal annual installments from the date of 
grant. Each non-employee director is also eligible to receive an annual equity grant in January of each year (or, 
if the designated date falls within a blackout window under applicable Company policies, on the first business 
day such grant is permissible under those policies) with a targeted grant date value equal to $160,000 (calculated 
as the fair market value of a share of the Company’s common stock on the grant date, times the number of shares 
granted). Those grants generally vest on November 1 in the year of grant. All equity grants are subject to the 
terms and conditions of the Company’s 2007 Stock Incentive Plan and the applicable grant award agreements.

Each non-employee director who was on the Board on February 1, 2010 received a grant of 4,750 RSUs 
for services during calendar year 2010. Each RSU grant was issued on February 1, 2010, and, generally subject 
to a director’s continued service on the Board, vests in full on November 1, 2010, with receipt deferred until 
January 28, 2011.

The following table shows cash and equity compensation for fiscal 2010: (1)

Fees 
Earned or 
Paid in 
Cash ($)

Stock 
Awards
Name
($) (2) (3)
David G. Arscott . . . . . . $42,000 $159,695
Robert M. Berdahl  . . . . $55,750 $159,695
Richard J. Elkus, Jr.  . . . $42,000 $159,695
Grant M. Inman  . . . . . . $52,000 $159,695
Catherine P. Lego . . . . . $53,250 $159,695
0
Jack R. Harris . . . . . . . . $21,000 $
Seiichi Watanabe  . . . . . $21,000 $
0
Patricia S. Wolpert . . . . $45,750 $159,695

Option 
Awards ($)
$0
$0
$0
$0
$0
$0
$0
$0

Non-Equity 
Incentive Plan 
Compensation 
($)
$0
$0
$0
$0
$0
$0
$0
$0

Nonqualified 
Deferred 
Compensation 
Earnings ($)
$0
$0
$0
$0
$0
$0
$0
$0

All Other 
Compensation 
($) (4)
$2,097
$1,736
$1,468
$1,468
$1,032
$8,780(5)
$
$

0
0

Total
$203,792
$217,181
$203,163
$213,163
$213,977
$ 29,780
$ 21,000
$205,445

(1)  Mr. Brandt was elected to the Company’s board on September 10, 2010, which was after the close of fiscal 
2010.  Accordingly,  he  did  not  receive  any  compensation  as  a  member  of  the  Company’s  board  during 
fiscal 2010.

17

(2)  On February 1, 2010, each Director who was on the Board was granted 4,750 restricted stock units based 
on  the  closing  price  of  the  Company’s  Common  Stock  of  $33.62,  for  a  target  value  of  $160,000.  Other 
than  the  units  granted  to  Ms.  Wolpert,  the  units  vest  on  November  1,  2010,  with  receipt  deferred  until 
January 28, 2011. The units granted to Ms. Wolpert vested upon her death.

(3) 

(4) 

(5) 

The amounts shown in this column represent the grant date fair value of unvested restricted stock unit awards 
granted during fiscal 2010 in accordance with Accounting Standards Codification 718, Compensation — 
Stock Compensation (“ASC 718”). However, pursuant to SEC rules, these values are not reduced by an 
estimate for the probability of forfeiture. The assumptions used to calculate the fair value of the restricted 
stock units in fiscal year 2010 are set forth in Note 11 in the Notes to Consolidated Financial Statements of 
the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2010.

Represents the portion of dental reimbursement insurance premiums paid by the Company.

Represents  the  portion  of  dental  and  retiree  medical  reimbursement  insurance  premiums  paid  by 
the Company.

In  addition,  members  of  the  Board  who  have  retired  from  the  Board  can  participate  in  the  Company’s 
Executive Retirement Medical and Dental Plan if they meet certain eligibility requirements. The most recent 
valuation  of  the  Company’s  accumulated  post-retirement  benefit  obligation  under  Accounting  Standards 
Codification 715, Compensation-Retirement Benefits (“ASC 715”), as of June 2010, for the current directors who 
may become eligible is shown below:

Name
David G. Arscott . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Robert M. Berdahl  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard J. Elkus, Jr.  . . . . . . . . . . . . . . . . . . . . . . . . . .
Grant M. Inman  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Catherine P. Lego . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Accumulated Post-Retirement 
Benefit Obligation, as of June 2010
$224,000
$179,000
$164,000
$202,000
$196,000

18

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Exchange Act requires our executive officers, directors, and people who own more than 
10% of a registered class of our equity securities to file an initial report of ownership (on a Form 3) and reports 
on  subsequent  changes  in  ownership  (on  Forms  4  or  5)  with  the  SEC  by  specified  due  dates.  Our  executive 
officers, directors, and greater-than-10% stockholders are also required by SEC rules to furnish us with copies 
of all Section 16(a) forms they file. We are required to disclose in this Proxy Statement any failure to file any of 
these reports on a timely basis. Based solely on our review of the copies of the forms that we received from the 
filers, and on written representations from certain reporting persons, we believe that all of these requirements 
were satisfied during fiscal 2010, with the exception of one late filing of a Form 4 in October 2009 with respect 
to Sarah A. O’Dowd, covering one transaction.

EXECUTIVE COMPENSATION AND OTHER INFORMATION

COMPENSATION DISCUSSION & ANALYSIS

Overview

This  Compensation  Discussion  and  Analysis  (the  “CD&A”)  describes  the  Company’s  executive 
compensation program and discusses how we made executive compensation decisions for our executive officers 
during fiscal 2010.

Richard A. Gottscho, our Senior Vice President, Global Products;

Stephen G. Newberry, our President and Chief Executive Officer;

For fiscal 2010, our “named executive officers” (as defined in SEC rules) were:
• 
•  Martin B. Anstice, our Executive Vice President and Chief Operating Officer;
• 
Ernest E. Maddock, our Senior Vice President and Chief Financial Officer;
• 
• 
• 
We refer to these individuals collectively in this CD&A as the “Named Executive Officers” or “NEOs.” 
Mr. Hariri is included as an NEO because, while he was not an executive officer of the Company at the end of 
fiscal 2010, his compensation exceeded that of the next-lowest compensated NEO. We refer to calendar years as 
“CY”, and fiscal years as “FY”, throughout this CD&A.

Jeffrey Marks, our Vice President and General Manager, Clean Business; and

Abdi Hariri, our Group Vice President, Global Operations.

The compensation tables included in this CD&A report the compensation of the Named Executive Officers 
for FY 2010. However, our executive compensation program is designed and evaluated on a calendar year basis 
rather than a fiscal year basis to correspond with our annual business planning, performance goal-setting, pay, and 
benefit cycles. Therefore, the discussion of our compensation programs and our compensation decisions reflects 
this calendar year orientation. Fiscal year information is included in compensation tables, as appropriate.

Our  standard  compensation  program  for  NEOs  includes  six  primary  components:  base  salary,  annual 
incentive  awards,  long-term  incentive  awards,  participation  in  benefit  programs,  eligibility  for  certain  post-
termination employment benefits, and other equity awards as considered appropriate. Each of these compensation 
components is reviewed periodically by our Compensation Committee (the “Committee”). Compensation for 
NEOs other than Mr. Newberry is determined by the Committee. Mr. Newberry’s compensation is recommended 
by the Committee to the independent members of the Board for approval.

We design and operate our executive compensation program to achieve specific objectives including: market 
competitiveness  to  attract,  retain  and  motivate  our  executives;  pay-for-performance;  long-term  effectiveness; 
and cost-effectiveness. These objectives are further described in the section entitled “Compensation Objectives” 
below. In the cyclical environment in which we operate, applying these objectives leads to changes in our programs 
from time to time. For example, prior to the economic downturn, the metrics used for our variable incentive 
programs focused primarily on operating income performance. In response to the downturn, we modified the 
metrics used in those programs to instead focus on on-going operating cash flow objectives in order to better 

19

position the Company for long-term success. As the business climate changes, we will continue to adjust our 
program to reward the management  behaviors that will deliver the best results for our  stockholders  over the 
long-term. Throughout the business cycle, we believe that our compensation programs (1) reward management 
behaviors aligned with our compensation objectives and (2) promote retention of our executive officers.

The  following  bullet  points  highlight  the  key  actions  by  the  Committee  related  to  the  compensation 
of  our  NEOs  in  FY  2010.  Each  of  these  items  is  discussed  in  greater  detail  in  the  applicable  section  of  this 
CD&A report.
• 

Base Salaries. There was a salary reduction in place during most of CY 2009. In light of the improving 
business environment and operating results, the Committee restored base salaries to February 2009 
levels,  effective  December  28,  2009.  Salaries  were  then  reviewed  and  adjusted  in  February  2010, 
effective April 2010.

• 

• 

Annual Incentive Program (“AIP”).
• 

Under the 2009 AIP, the maximum payout under our 2009 AIP was capped at 1.0 times the target 
opportunity, reduced from 2.25 in prior years, to reflect the challenging business environment 
at the time and to enable us to maintain our cash reserves while maximizing financial results for 
our stockholders. As a result of improving business results, for the CY 2010 AIP, the Committee 
restored the maximum payout to 2.25 times the target opportunity.

• 

• 

For the CY 2010 AIP, the performance metrics established under the program were changed, in 
certain cases from the CY 2009 AIP to reflect the improved business environment.

The  Committee  also  modified  the  structure  of  the  CY  2010  AIP.  As  modified,  a  maximum 
payout will be generated based on a corporate metric, and this maximum payout will be used 
to  establish  the  maximum  awards  available  for  payouts  under  the  program.  The  Committee 
may  then  apply  negative  discretion,  to  determine  actual  payouts  to  each  executive  based  on 
corporate and individual performance achievement.

Long-Term Incentive Program (“LTIP”).
• 

In CY 2010, the performance-based equity portion of the LTIP was awarded via performance-
based RSUs rather than via stock options.

• 

For CY 2010, the performance metrics established under the cash portions of the LTIP were 
changed from CY 2009 to reflect the improved business environment.

Governance of the Executive Compensation Program

Role  of  the  Compensation  Committee.  The  Committee  discharges  certain  responsibilities  of  the  Board 
relating  to  executive  compensation  and  oversees  the  incentive,  equity-based  and  other  compensation  plans 
in which our executive officers (including the NEOs) participate, pursuant to a charter that can be viewed at 
http://investor.lamrc.com. The Committee’s key responsibilities with respect to executive compensation include 
the following:
• 

Develop, and from time to time review, compensation policies and practices applicable to our executive 
officers, including the criteria upon which executive compensation is based and the composition of 
executive compensation in terms of base salary, deferred compensation, incentive or equity-based 
compensation and other benefits;

20

• 

• 

• 

Establish and review corporate goals and objectives as relevant to our President and Chief Executive 
Officer  (our  “CEO”)  and  Executive  Chairman,  evaluate  their  performance  in  light  of  these  goals 
and objectives, and, based on this evaluation, recommend the CEO’s and the Executive Chairman’s 
compensation packages for approval by the independent members of the Board1;

Determine  compensation  packages  for  our  other  executive  officers  (including  the  other  NEOs) 
consistent with policies approved by the independent members of the Board;

Review and approve, subject to stockholder or board approval as required, the creation or amendment 
of any of our equity-based compensatory plans; and

Oversee management’s risk assessment of our compensation policies and practices.

• 
Within  this  framework,  the  Committee  receives  and  reviews  information,  analysis,  and  compensation 

proposals provided by our management and by the Committee’s compensation consultant and other advisors.

Role of Executive Officers. Mr. Newberry, assisted by specialists from our Human Resources, Finance, 
and Legal Departments, develops recommendations for the compensation of our executive officers, including 
our  NEOs.  Typically,  these  recommendations  cover  the  base  salaries,  annual  incentive  award  opportunities, 
and long-term incentive award opportunities for our executive officers, as well as the criteria upon which these 
award opportunities may be earned.

The Committee considers Mr. Newberry’s recommendations in light of competitive compensation data, the 
Committee’s pay philosophy and objectives, and current business conditions, and obtains advice from outside 
advisors as discussed below. At the request of the Committee, our Executive Chairman provides input to the 
Committee on Mr. Newberry’s compensation and compensation recommendations.

Mr. Newberry generally attends Compensation Committee meetings as requested by the Committee. He 

leaves the meeting for any discussion of his own compensation.

Role of Committee Advisors. The Committee is authorized to engage its own advisors to assist in carrying 
out  its  responsibilities.  Since  2008,  the  Committee  has  engaged  the  services  of  Compensia,  Inc.,  a  national 
compensation consulting firm (“Compensia”). Compensia provides the Committee with guidance regarding the 
amount and types of compensation that we provide to our executive officers (including the NEOs) and how these 
compare to other companies’ compensation practices.

Representatives of Compensia attend meetings of the Committee as requested and also communicate with 
the Committee’s Chair outside of meetings. Compensia reports to the Committee rather than to our management, 
although Compensia meets with members of management, including Mr. Newberry, for purposes of gathering 
information on proposals that our management or Compensia may make to the Committee. The Committee may 
replace Compensia or hire additional advisors at any time. Compensia has not provided any other services to 
the Committee or to our management, and has received no compensation other than with respect to the services 
described above.

Executive Compensation Philosophy

Compensation  Objectives.  We  design  and  operate  our  executive  compensation  program  to  achieve  the 

following principal objectives:

•  Maintain  programs  to  attract,  retain,  and  motivate  high-caliber  senior  executives  by  developing 
compensation arrangements for our executive officers that are competitive with similarly-situated 
executives in technology companies;

1 

The  independent  members  of  our  Board  of  Directors,  upon  recommendation  from  the  Committee, 
approve the elements of Mr. Newberry’s compensation package. For purposes of this CD&A, a reference 
to  a  compensation  action  or  decision  by  the  Committee  with  respect  to  the  NEOs  means,  in  the  case 
of Mr. Newberry, an action or decision by the independent members of our Board of Directors, unless 
otherwise expressly noted.

21

• 

• 

• 

Provide pay for performance, by appropriately rewarding our senior executives for their achievement 
of both short-term and long-term business objectives;

Establish a long-term orientation by focusing the efforts of our senior executives on our long-term 
financial performance, customer relationships and stockholder value creation; and

Structure cost-effective compensation programs to take into account the accounting treatment and 
tax deductibility of compensation expense.

Compensation  Elements.  Our  executive  compensation  program  consists  of  several  principal  elements 
intended to achieve the objectives described above. We consider each element to be appropriate to meet one or 
more of the principal objectives of our executive compensation philosophy.

Compensation Element
Base salary . . . . . . . . . . . . . . . . . . . . Market competitiveness to attract,

Objective(s)

retain and motivate

Annual incentive awards  . . . . . . . . . Market competitiveness to attract, 

retain and motivate
Pay for performance by rewarding
executives for achieving shorter-term
corporate and individual performance 
objectives

Long-term incentives, including 
cash and equity awards . . . . . . . . . . . Market competitiveness to attract, 

Retirement benefits . . . . . . . . . . . . . .

Deferred compensation benefits . . . .

retain and motivate
Pay-for-performance
Long-term/stockholder orientation
Cost-effectiveness

Provide competitive benefits
Promote executive retention

Provide competitive benefits
Promote executive retention

Target Market Position*
50th – 60th percentile of Peer 
Group

50th – 75th percentile of 
Peer Group, depending on 
performance results

50th – 75th percentile of 
Peer Group, depending on 
performance results

50th percentile of Peer Group

N/A

Severance and change of 
control benefits . . . . . . . . . . . . . . . . . Market competitiveness to attract, 

retain and motivate
Long-term/stockholder orientation

50th – 60th percentile of Peer 
Group

Other benefit programs . . . . . . . . . . . Market competitiveness to attract, 

50th percentile of Peer Group

retain and motivate

* 

See “Peer Group of Comparable Companies” and “Benchmarking and Target Pay Positioning”, below, for 
further explanation of the information in this column.

In  setting  individual  pay  for  an  executive  officer,  the  Committee  considers  a  variety  of  factors,  such 
as  job  performance,  job  scope  and  responsibilities,  skill  set,  prior  experience,  the  executive  officer’s  time  in 
his  or  her  position  with  us,  internal  equity  regarding  pay  levels  for  similar  skill  levels  or  positions,  external 
pressures to attract and retain executive talent, and general market conditions. In general, the differences in total 
compensation, as well as differences in the amounts of individual compensation elements among our executive 
officers, reflect these factors. We believe that these differences are consistent with the pay differentials among 
similar positions at comparable companies.

22

 
Peer  Group  of  Comparable  Companies.  The  Committee  considers  compensation  data  from  a  group  of 
comparably-sized companies in the technology industry (the “Peer Group”) as one element in establishing the 
compensation levels of our executive officers, including the NEOs, as well as the mix and weighting of individual 
compensation elements. The companies constituting our Peer Group are selected for their comparability to us 
based on annual revenues, market capitalization, lines of business, and industry, and because we believe we are 
likely to compete with them for executive talent. Our Peer Group is focused in the semiconductor, semiconductor 
equipment and materials and solar technology industries. We generally use the following criteria for our peer 
group selection:
• 

2009 revenues: Approximately 0.5x to 2x revenues.
• 
•  Median revenue of peers: $1.52 billion.

Average revenues for peers: $1.89 billion.

•  Market  capitalization  (based  on  90-day  average,  calculated  on  July  31,  2009):  $1  billion 

to $5 billion.
• 
Average market capitalization of peers: $4.67 billion.
•  Median market capitalization of peers: $3.49 billion.

Based on the criteria above, the Peer Group may be modified from year to year. For calendar year 2010, no 

changes were made to the 2009 Peer Group and the 2010 Peer Group consisted of the following companies:

• Altera Corporation
• Analog Devices, Inc.
• Applied Materials, Inc.
• Atmel Corporation
• Cypress Semiconductor Corporation
• Fairchild Semiconductor International, Inc.
• First Solar, Inc.
• KLA-Tencor Corporation
• LSI Corporation
• Marvell Technology Group Ltd.
• Maxim Integrated Products, Inc.

• MEMC Electronic Materials, Inc.
• Molex Incorporated
• National Semiconductor Corporation
• Novellus Systems, Inc.
• NVIDIA Corporation
• SanDisk Corporation
• Sun Power Corporation
• Teradyne, Inc.
• Varian Semiconductor Equipment

Associates, Inc.

• Xilinx, Inc.

In addition, in some cases, the Committee also reviews data from a subset of the Peer Group (Applied 
Materials, Inc., KLA-Tencor Corporation, Novellus Systems, Inc., Teradyne, Inc., and Varian Semiconductor 
Equipment Associates, Inc.), focusing specifically on companies in the semiconductor equipment industry.

In addition to this Peer Group data, our Human Resources Department analyzed select survey data on base 
salary, bonus targets, equity awards, and total compensation drawn from the Radford 2009 Executive Survey 
(“Radford Survey”). The Radford Survey includes data from several hundred technology companies; however, 
we focus only on the data for those technology companies comparable in size to the Company.

Benchmarking and Target Pay Positioning. The Compensation Committee reviews compensation practices 
at  Peer  Group  companies  and  selected  data  from  the  Radford  Survey  as  factors  for  determining  whether 
executive officer total compensation is within a competitive range. Generally, the Committee targets the total 
direct compensation (defined as base salary plus target annual incentive awards plus target long-term incentive 
awards) of our executive officers, including the NEOs, near the 50th percentile of the Peer Group. However, 
our programs are designed to provide our executive officers with the opportunity to receive higher levels of 
compensation (up to and above the 75th percentile of the Peer Group) if warranted by superior Company and/or 
individual performance, or lower levels of compensation for below-target Company or individual performance.

23

Calendar Year 2009/2010 Compensation Decisions

Base  Salary.  Base  salaries  represent  one  of  the  primary  non-variable  components  of  our  executive 
compensation program. We believe the purpose of base salary is to fairly and competitively compensate our 
executive officers, including the NEOs, with a fixed amount of salary for the jobs they perform. Accordingly, 
we seek to ensure that our base salary levels are competitive and consistent with Peer Group practice and data 
generally suggested by the Radford Executive Survey. Adjustments to base salary are generally considered by 
the Committee each year in February.

For CY 2009, in view of the prevailing uncertainty in the global economy and potential impact on our 
business, the Committee (upon the recommendation of Mr. Newberry) approved a temporary reduction in the 
base salaries of our NEOs, beginning in February 2009. The reductions ranged from 10% to 17.5% and were 
part of a broader salary reduction program applicable to all of our employees. Based upon improving economic 
conditions  and  Company  performance,  the  Committee  approved  a  restoration  of  base  salaries  for  the  NEOs 
effective December 28, 2009, to the levels in effect prior to the February 2009 reduction.

For  CY  2010,  the  base  salaries  of  the  NEOs  were  determined  by  the  Committee  in  February  2010  and 

became effective in April 2010 based on the factors described above.

The base salaries of the NEOs for CYs 2009 and 2010 are as follows:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CY 2009 (1)
$660,000
$393,750
$385,000
$324,000
$279,000
$283,500

CY 2009/
CY 2010 (2)
$800,000
$450,000
$440,000
$360,000
$310,000
$315,000

CY 2010 (3)
$850,000
$463,500
$453,200
$370,800
$325,000
$325,000

(1) 

(2) 

(3) 

Reduced base salary effective until December 28, 2009.

Base salaries restored to February 2009 levels effective December 28, 2009.

Base salaries effective April 5, 2010.

Annual Incentive Program (“AIP”)

The  AIP  provides  for  annual  cash  incentive  awards  to  our  NEOs  based  on  corporate  and  individual 
performance achievement during the calendar year. For the AIP, the Committee establishes: (i) the corporate and 
individual performance metrics that will apply to each executive officer; (ii) the target levels of performance for 
the corporate and individual metrics which may be 6 or 12 month metrics; and (iii) the individual target award 
opportunities. By reviewing the target levels of performance for certain performance metrics every six-months, 
the Committee retains the ability to make adjustments as necessary to reflect changing business conditions and 
corporate objectives. 

The  specific  metrics  and  their  relative  weightings  are  selected  based  upon  the  recommendations  of 
Mr. Newberry and the determinations of the Committee regarding the important measures of our performance 
during the applicable calendar year.

The Committee establishes the target levels of performance for the corporate and individual metrics so that 
they will be challenging but achievable based on expected levels of performance from our executive officers, 
and so that below-expected performance will reduce the amount of an executive officer’s incentive payments. 
Target levels of performance are set such that very strong performance is required to receive payments above the 
target award opportunity. For example, for CY 2006, AIP payments ranged from 1.9 to 2.05 times target amounts 
and for CY 2007, they ranged from 1.61 to 1.8 times target amounts. In both of these years, our performance 
was exceptional. By contrast, for CY 2008, AIP payments averaged 0.4 times target amounts, reflecting our 

24

performance in the deteriorating economy, and in CY 2009, AIP payments averaged 0.81 times target amounts, 
reflecting difficult economic conditions and corresponding Company performance in the first half of the year 
and improving economic conditions and Company performance in the second half.

The Committee reserves the right to settle any AIP payments in cash, Company shares, or any combination 
of  cash  and  Company  shares,  based  on  the  Company’s  cash  position.  Historically,  AIP  payments  have  been 
settled in cash.

2009 AIP

For CY 2009, AIP awards were determined for the NEOs using the framework of:

Target AIP 
Award
(A)

X (

Corporate 
Performance 
Factor X 50%
(B)

+

Individual 
Performance 
Factor X 50%
(C)

) =

AIP Payment
(D)

where:

(A)  The target AIP award represents a percentage of each executive officer’s annual eligible base earnings 
translated to a dollar amount. The reduced salaries in effect for most of CY 2009 affected eligible base 
salaries. In February 2009, the Committee approved the following target AIP award opportunities for 
CY 2009 for the NEOs:

Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

125%
85%
80%
75%
70%
70%

The maximum potential 2009 AIP payment was capped at 1.0 times target award amount, reduced from 
2.25 in prior years. The differences in target award opportunities among the NEOs were determined 
based on job scope and responsibilities, as well as an assessment of competitive compensation data.

(B)  The  CY  2009  AIP  corporate  performance  factor  was  calculated  based  on  the  actual  level  of 
performance achievement with respect to four performance metrics: ongoing operating cash flow; 
Etch products market share; Clean products market share; and Customer Support Business Group 
(“CSBG”) profit. The Etch products and Clean products market share target levels of performance 
were set in February 2009 for the entire year, and the operating cash flow and CSBG profit target 
levels of performance were set in February 2009 for the first half of the year and adjusted in August 
2009 for the second half of the year. The target levels of performance established with respect to these 
metrics were considered stretch goals; for example, achievement of our operating plan goals would 
result in a 0.5 payout.

The weighting of each metric varied by the executive’s area of responsibility and degree of influence 
with respect to such metric, as follows:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . .

Ongoing 
Operating 
Cash Flow
50%
50%
50%
50%
50%
50%

25

Corporate Metrics
Clean 
Market 
Share
15%
15%
15%
0%
40% 
15%

Etch 
Market 
Share
25%
25%
25%
40%
0% 
25%

CSBG 
Contributed 
Profit
10%
10%
10%
10%
10%
10%

Total
100%
100%
100%
100%
100% 
100%

 
 
 
(C)  CY  2009  AIP  individual  performance  factors  were  calculated  based  on  level  of  performance 
achievement with respect to each NEO’s applicable metrics. Specific NEO performance factors were 
established for each NEO other than Messrs. Newberry and Anstice, whose performance was based 
solely on the corporate performance metric because of their roles as CEO and COO. The specific 
NEO individual performance metrics include: organizational financial performance, business process 
improvement,  market  share,  organizational  capability  and  product  development.  Achievement  of 
individual target levels of performance was measured on the basis of quantitative and qualitative 
metrics that varied by each NEO, with a payment of 0 to 1.2 times target opportunity, based on the 
actual performance level. NEO specific performance metrics and target levels of performance were 
set in February 2009 for the entire year.

(D)  CY 2009 AIP payments were based on the calculated result of performance relative to each specific 

NEO’s performance against the applicable metrics.

For  CY  2009,  the  corporate  performance  factor  was  0.81,  calculated  as  follows  (Dr.  Gottscho’s 
corporate factor was 0.84 due to a higher weighting on Etch market share and Dr. Marks’s corporate 
factor was 0.77 due to the higher weighting on Clean market share):

Corporate Performance Metrics
Ongoing operating cash flow
Etch market share
Clean market share
CSBG Contributed Profits
Corporate Performance  

Factor Result

Weighting  
(A)
50%
25%
15%
10%

1st Half CY 
2009 Factor 
Result
.66

2nd Half CY 
2009 Factor 
Result
.50

1.15
.97

.56

1.20

Annual 
Result (B)
.58
1.15
.97
.88

Corporate 
Performance 
Factor 
Result 
(A x B)
.29
.29
.15
.09

.81

The  corporate  performance  factor  result,  together  with  the  individual  performance  factor  results, 
led to the following AIP payments for our NEOs, as approved by the Committee in February 2010. 
Individual payouts for NEOs with an individual performance factor were reduced by 10% so that 
AIP payments in the aggregate would not exceed the corporate performance factor result.

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . .

Target AIP 
Award ($)
$883,654
$354,916
$326,616
$256,500
$206,150
$209,475

Corporate 
Performance 
Factor Result
0.81
0.81
0.81
0.84
0.77
0.81

Individual 
Performance 
Factor Result
N/A
N/A
1.00
1.09
0.90
1.00

Annual 
Incentive 
Payment
$715,760
$287,482
$266,028
$222,539
$154,551
$170,671

2010 AIP

In February 2010, the Committee reviewed the AIP structure in light of current economic conditions and 

approved several changes to the AIP structure for CY 2010 relative to CY 2009.

First, based on the annual executive compensation review and discussions with its compensation advisor, 

the Committee approved the following target AIP award opportunities for CY 2010:

Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

150%
85%
80%
80%
70%
75%

26

 
 
Second, the Committee approved a maximum payout opportunity for CY 2010 equal to 2.25 times the 
target award. This was the Company’s practice before CY 2009, and reflects the improved economic outlook for 
the Company.

Finally,  a  structural  modification  for  CY  2010  was  made  in  the  determination  of  the  maximum  payout 
amount. Under this modification, a maximum payout will be generated based on ongoing operating income as a 
percentage of revenue. The maximum payout establishes the maximum award payable to each executive under 
the 2010 AIP. The Committee may then apply negative discretion to determine actual payouts to each executive 
based on corporate and individual performance.

Long-Term Incentive Program (“LTIP”)

Long-term incentive awards are an important element of our executive compensation program. From CY 
2006 through CY 2008, we used cash-based awards as our primary long-term incentive compensation vehicle 
under  our  Multi-Year  Incentive  Program  (“MYIP”),  which  is  described  below  under  “Multi-Year  Incentive 
Program”.  Beginning  in  CY  2009,  management  recommended,  and  the  Committee  approved,  a  change  to 
how long-term incentive compensation is delivered to our executives by establishing the Long-Term Incentive 
Program (“LTIP”). Beginning in CY 2009, the LTIP has delivered 50% of the target award in cash, through the 
MYIP, and 50% of the target award through equity awards.

The LTIP is 75% performance-based. The MYIP cash incentive program portion of the award (which is 
50% of the total LTIP award) is earned based on achieving pre-established performance targets, and one-half of 
the equity award portion of the LTIP award (i.e. 25% of the total LTIP award) is delivered through performance-
based  equity.  The  remaining  one-half  of  the  LTIP  equity  award  portion  (i.e.  25%  of  the  total  LTIP  award) 
is  delivered  through  time-vested  RSUs.  The  performance-based  equity  component  of  the  LTIP  is  reviewed 
annually to determine the most appropriate form for the award based on criteria such as the current economic 
environment,  the  perceived  potential  value  to  motivate  and  retain  the  executives,  and  the  accounting  impact 
relative  to  the  potential  value  delivered.  Based  on  these  criteria,  in  CY  2009,  the  performance-based  equity 
award was delivered in stock options, and in CY 2010, it was delivered in performance-based RSUs.

The Committee establishes individual target award opportunities at the beginning of each two-year cycle 
based  on  the  executive’s  position  and  responsibilities,  an  evaluation  of  the  executive’s  performance,  and  an 
assessment of competitive compensation data from the Peer Group. The target amounts for each NEO under the 
various two-year LTIP program cycles (which includes both the MYIP and equity awards) are as follows:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . .

Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . .

Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . .

Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LTIP Program Cycle
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011

Target Amount
$ 4,000,000
$ 4,000,000
$ 4,500,000
$ 1,625,000
$ 1,750,000
$ 2,000,000
$ 1,476,000
$ 1,600,000
$ 1,600,000
$ 1,260,000
$ 1,260,000
$ 1,350,000
$ 930,000
$ 930,000
$ 1,000,000
$ 1,102,500
$ 1,250,000
$ 1,250,000

27

Multi-Year  Incentive  Program.  The  MYIP  is  a  long-term  cash  incentive  program  designed  to  provide 
competitive  levels  of  compensation  to  and  reward  our  senior  executives  for  performance  and  stock  price 
appreciation over a performance period.

The MYIP operates over two-year performance cycles. For example, the 2009/2010 MYIP cycle covers 
performance during CY 2009 and CY 2010. The actual payment amount is determined and payment is made in 
the calendar year following the end of the cycle. For example, the “Award Determination Date” for the 2009/2010 
MYIP cycle will be February 2011. An executive officer generally must be continuously employed by us through 
the Award Determination Date in order to receive payment for a MYIP cycle.

Because  each  MYIP  cycle  covers  performance  in  two  calendar  years,  three  MYIP  cycles  affect  NEO 
compensation during each fiscal year. A new MYIP cycle typically commences at the beginning of each calendar 
year and lasts for two calendar years. The MYIP cycles that affect NEO compensation for fiscal 2010 (which is 
reported in the Summary Compensation Table) are shown in the following chart:

MYIP Performance Periods

Fiscal 2010

2008/2009 MYIP

2009/2010 MYIP

2010/2011 MYIP

1/1/2008 

1/1/2009 

1/1/2010

1/1/2011

1/1/2012 

Award  amounts  under  the  MYIP  may  be  increased  (but  may  not  be  decreased)  through  a  stock  price 
modifier if our stock price exceeds a benchmark level set at the beginning of the MYIP cycle. This is intended 
to allow our executives to participate along with our investors in stock price appreciation resulting from strong 
financial and operating performance results. The specific formula is described in subparagraph (C) below.

The Committee measures actual levels of performance results for the performance metrics on a quarterly 
basis and accrues the potential payment attributable to that fiscal quarter’s performance at the end of each quarter 
during a MYIP cycle, although the Committee may reduce these amounts to determine the actual payouts at the 
end of the cycle.

The structure of a MYIP cycle can be summarized by the following formula:

Target Award 
(A)

X

Performance 
Factor 
(B)

X

Stock Price 
Modifier 
(C)

=

Quarterly 
Accrual 
(D)

where:

(A)  The target award is an amount established for each NEO by the Committee. It is established at the 
start of each two-year MYIP cycle. For purposes of this calculation, the target award is prorated over 
the eight quarters of each MYIP cycle.

(B)  The performance factor is the calculated result based on actual level of performance with respect 
to  the  applicable  metric  during  the  MYIP  cycle.  This  is  described  in  further  detail  below  under 
“Performance Factors.”

28

(C)  The stock price modifier is a ratio of (x) the market price of our common stock over the 50-trading-
day trailing average as of the end of each fiscal quarter to (y) the 200-trading-day trailing average as 
of the end of the December fiscal quarter preceding the beginning of the MYIP cycle, but may not be 
less than 1.0. The stock price modifier allows our executives to participate with our investors in stock 
price appreciation.

(D)  The  quarterly  accrual  is  the  product  of  the  target  award,  the  performance  factor  and  stock  price 
modifier.  This  determination  is  made  each  quarter  of  the  MYIP  cycle,  with  payout  occurring  at 
the Award Determination Date (if approved by the Committee and subject to the NEO’s continued 
employment).

The maximum potential MYIP incentive payment is subject to a cap of 2.5 times the target dollar 
amount.

Target Awards. The target awards for each NEO for the 2008/2009, 2009/2010 and 2010/2011 MYIP cycles are:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYIP Cycle
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011
2008/2009
2009/2010
2010/2011

Target Award for Entire Two- 
Year MYIP Cycle
(prorated equally for each year)
$ 4,000,000
$ 2,000,000
$ 2,250,000
$ 1,625,000
$ 875,000
$ 1,000,000
$ 1,476,000
$ 800,000
$ 800,000
$ 1,260,000
$ 630,000
$ 675,000
$ 930,000
$ 465,000
$ 500,000
$ 1,102,500
$ 625,000
$ 625,000

Performance  Factors.  The  performance  factor  is  the  calculated  result  based  on  the  achievement  of 

performance against the metric and target level of performance.

• 

• 

For the CY 2008 (and earlier) portions of MYIPs, the metric and target level of performance were 
established annually for each year of the MYIP cycle.

For  the  CY  2009  and  subsequent  portions  of  MYIPs,  performance  metrics  and  target  levels  of 
performance  were  established  at  the  beginning  of  the  applicable  period;  performance  metrics  are 
reviewed annually and target levels are reviewed every six months during the applicable cycle, and 
adjusted in the Committee’s discretion.

By reviewing performance metrics and target levels of performance regularly, the Committee retains the 

ability to make adjustments to reflect changing business conditions and corporate objectives. For example:

• 

The performance metric for the CY 2008 portion of the 2008/2009 MYIP cycle was based on ongoing 
operating income.

29

 
• 

• 

The performance metric for the CY 2009 portion of the 2008/2009 and 2009/2010 MYIP cycles was 
changed to ongoing operating cash flow because the Committee believed that this metric represented 
the best indicator of our corporate performance given the economic uncertainties and their impact on 
our business, the Company’s goal of conserving cash reserves and the Committee’s desire to reward 
our executives for achieving objectives in CY 2009 that would position the Company for long-term 
success.

As  business  conditions  improved  for  CY  2010,  the  performance  metric  for  the  CY  2010  portion 
of  the  2009/2010  and  2010/2011  MYIP  cycles  was  returned  to  ongoing  operating  income,  which 
the Committee believes is a stronger indicator of Company performance during improved business 
conditions.

The  ongoing  operating  income  target  level  of  performance  for  CY  2008  was  $528,750,000;  the 
performance factor was actual ongoing operating income divided by this ongoing operating income target level 
of performance.

The ongoing operating cash flow target was a sliding scale from 0% to 120% based on the Company’s 
performance against the ongoing operating cash flow goal. Based on the first half of CY 2009 operating plan 
target of $7 million in ongoing cash from operations (based on $350 million in revenue) and second-half of CY 
2009 operating plan of $11M (based on $628 million in revenue), the performance factor would be 0.5. This 
target performance factor, which is below 1.0 for achieving the operating plan, reflects the difficult economic 
environment in which we operated in CY 2009.

FY 2010 MYIP Payments

The Award Determination Date for the 2008/2009 MYIP cycle occurred in February 2010. The Committee 
reviewed  the  amounts  calculated  under  the  formula  described  under  “Performance  Factors”  and  authorized 
payouts. The average payout under the 2008/2009 MYIP was 58.7% of target, reflecting:

• 

• 

• 

CY 2008 actual ongoing operating income of $313.5 million. This led to a result of zero for the third 
quarter of CY 2008. However, even though an award was potentially awardable for the fourth quarter 
of CY 2008, the Committee exercised negative discretion and reduced the award for that quarter to 
zero, given the difficult economic conditions at that time.

Revenue of $392.3 million and ongoing cash from operations of $29 million for the first half of CY 
2009, resulting in a performance metric result of 0.66 for that period.

Revenue of $805.7 million and ongoing cash from operations of $110.6 million for the second half of 
CY2009, resulting in a performance metric result of 0.50 for that period.

During the 2008/2009 MYIP period, the stock price modifier was positive only for the fourth quarter of 

CY 2009 (1.18 for that quarter). The amounts earned by the NEOs under the 2008/2009 MYIP were:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Target Award 
Opportunity
$ 4,000,000
$ 1,625,000
$ 1,476,000
$ 1,260,000
$ 930,000
$ 1,102,500

Award Payout
$ 2,219,555
$ 963,059
$ 874,868
$ 745,674
$ 550,378
$ 652,463

Award Payout as a 
Percentage of Award 
Opportunity
55.5%
59.3%
59.3%
59.2%
59.2%
59.2%

Mr. Newberry’s award payout percentage was less than the other NEOs’ awards because for purposes of 
determining his 2008/2009 MYIP award, the SEZ Holdings AG business was included in the determination of 
his ongoing operating income results, and for the other NEOs, the SEZ business was excluded.

30

Equity Awards

2009 Equity Awards. Under the LTIP for CY 2009, each NEO received, on February 26, 2009, a grant 
of RSUs and a stock option grant. The number of RSUs granted equaled one-half of the target dollar amount 
shown in the table below divided by $20.21, the closing price of the Company’s common stock on the grant date. 
Each NEO also was granted a stock option covering 2.5 shares of the Company’s common stock for each RSU 
granted. The stock options have an exercise price equal to $20.21, the closing price of the Company’s common 
stock on the grant date, and have a five-year term. The RSUs and options vest on the second anniversary of the 
grant date.

The equity awards for the NEOs were as follows:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Target Dollar 
Amount
$ 2,000,000
$ 875,000
$ 800,000
$ 630,000
$ 465,000
$ 625,000

Stock Option 
Awards
123,700
54,120
49,480
38,965
28,760
38,658

Restricted Stock 
Units Award
49,480
21,648
19,792
15,586
11,504
15,463

2010 Equity Awards. Under the LTIP for CY 2010, each NEO received, on February 5, 2010, a grant of 
performance based and time based RSUs. To determine both the number of time based and performance based 
RSUs, one-half of the NEO’s target dollar amount shown in the table below was divided by $33.29, the closing 
price of our common stock on the grant date. The performance based RSUs vest on the second anniversary of the 
grant date, subject to and based on achievement of ongoing operating profit percentages. The time based RSUs 
vest on the second anniversary of the grant date.

The equity awards for the NEOs were as follows:

Named Executive Officer
Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Other Equity Awards

Target Dollar 
Amount
$ 2,250,000
$ 1,000,000
$ 800,000
$ 675,000
$ 500,000
$ 625,000

Time-based Restricted 
Stock Units Award
33,793
15,019
12,015
10,138
7,509
9,387

Performance-based 
Restricted Stock Units 
Award
33,793
15,019
12,015
10,138
7,509
9,387

In  addition  to  the  LTIP,  certain  executives  are  eligible  to  receive  equity  awards  tied  to  achievement  of 
specific performance goals. In CY 2010, the Committee granted Dr. Gottscho an RSU award covering a total of 
28,000 shares of our common stock, 4,000 shares of which will vest on March 27, 2011, 20,000 shares of which 
will vest on June 26, 2011, and 4,000 shares of which will vest on March 25, 2012, subject to the achievement of 
defined performance criteria relating to Etch products market share, wafer fabrication equipment market share, 
and his continued employment with us through the vesting date. In CY 2010, the Committee granted Dr. Marks 
an RSU award covering a total of 8,000 shares of our common stock, 4,000 of which will vest on March 27, 
2011 and 4,000 of which will vest on March 25, 2012, subject to performance criteria related to wafer fabrication 
equipment market share and his continued employment with us through the vesting date. No other NEO received 
an equity award in calendar year 2010 other than under the LTIP.

31

Employment/Change of Control Arrangements

Effective July 2009, the independent members of our Board of Directors, upon recommendation of the 
Committee,  entered  into  an  employment  agreement  with  Mr.  Newberry  (the  “Newberry  Agreement”)  to: 
(i) document the terms and conditions of Mr. Newberry’s employment and (ii) encourage the retention of our chief 
executive officer. The Committee also approved employment agreements with Messrs. Anstice and Maddock, 
and  change  of  control  agreements  with  our  other  executive  officers,  including  Dr.  Gottscho,  Dr.  Marks,  and 
Mr. Hariri.

Employment Agreements. The Company and Mr. Newberry entered into the Newberry Agreement effective 
July 1, 2009. The Newberry Agreement provides that Mr. Newberry shall serve as the Company’s President and 
Chief Executive Officer for a term commencing on July 1, 2009 and ending on June 30, 2012, subject to the right 
of the Company or Mr. Newberry, under certain circumstances, to terminate the agreement prior to June 30, 
2012, and provided that Mr. Newberry’s employment will terminate immediately upon his death or disability (as 
defined in the Newberry Agreement).

Under the Newberry Agreement, Mr. Newberry will receive a base salary of $800,000 per year, subject 
to  annual  adjustment  at  the  discretion  of  the  independent  members  of  the  Board.  Effective  April  2010,  this 
base salary was adjusted to $850,000. Mr. Newberry is also entitled to participate in any short-term or long-
term  variable  compensation  programs  offered  by  the  Company  to  its  executive  officers  generally,  subject  to 
the  applicable  terms  and  conditions  of  those  programs  and  the  approval  of  the  independent  members  of  the 
Board, and to participate in the Company’s Elective Deferred Compensation Plan. Mr. Newberry receives other 
benefits, such as health insurance, vacation, and benefits under other plans and programs generally applicable 
to executive officers of the Company.

If an Involuntary Termination (as defined in the Newberry Agreement) of Mr. Newberry’s employment 
occurs, other than in connection with a change of control (as defined in the agreement), Mr. Newberry will be 
entitled to:

(1) 

a lump-sum cash payment equal to 18 months of his then-current base salary (without giving effect to 
any salary reduction program currently in effect), plus an amount equal to the average of the last five 
annual payments made to Mr. Newberry under the AIP or any predecessor or successor programs 
(the “Short Term Program,” and such average, the “Short Term Program Average”), plus an amount 
equal to the pro-rata amount he would have earned under the Short Term Program for the calendar 
year  in  which  his  employment  is  terminated  had  his  employment  continued  until  the  end  of  such 
calendar year, such pro-rata portion to be calculated based on the performance results achieved under 
the Short Term Program and the number of full months elapsed prior to the termination date;

(2)  payment  of  any  amounts  accrued  as  of  the  date  of  termination  under  any  long-term  cash-based 
variable-compensation programs of the Company (the “Long Term Cash Programs”), the payment 
of which generally occurs during February  of a calendar year  with  respect to incentive programs 
relating to the prior calendar year;

(3) 

certain medical benefits; and

(4)  vesting, as of the date of termination, of a pro rata portion (based on time of service) of the unvested stock 
option or RSU awards granted to Mr. Newberry at least twelve months prior to the termination date.

If  a  change  of  control  of  the  Company  (as  defined  in  the  agreement)  occurs  during  the  period  of 
Mr. Newberry’s employment, and if there is an Involuntary Termination of Mr. Newberry’s employment either 
in contemplation of or within the 12 months following the change of control, Mr. Newberry will be entitled to:

(1) 

a lump-sum cash payment equal to 18 months of Mr. Newberry’s then-current base salary, plus an 
amount equal to the Short Term Program Average, plus an additional amount equal to the amount he 
would have earned under the Short Term Program for the calendar year in which his employment is 
terminated multiplied by the number of full months worked in that calendar year divided by twelve;

(2) 

certain medical benefits;

32

(3)  vesting,  as  of  the  date  of  termination,  of  the  unvested  stock  option  or  RSU  awards  granted  to 

Mr. Newberry prior to the change of control; and

(4)  payment of any amounts accrued as of the change of control under the Long Term Cash Programs, 

plus an amount equal to the remaining target amount under the Long Term Cash Programs.

If Mr. Newberry’s employment is terminated due to disability or in the event of his death, Mr. Newberry 

(or his estate) will be entitled to:

(1) 

a lump-sum cash payment equal to 12 months of his then-current base salary (without giving effect 
to any salary reduction program currently in effect) less, in the case of his death, certain insurance 
payments,  plus  the  pro-rata  amount  he  would  have  earned  under  the  Short  Term  Program  for  the 
calendar year in which his employment is terminated had his employment continued until the end of 
such calendar year, such pro-rata portion to be calculated based on the performance results achieved 
under the Short Term Program and the number of full months elapsed prior to the termination date;

(2)  payment of any amounts accrued as of the date of termination under the Long Term Cash Programs 
(the payment of which generally occurs during February of a calendar year with respect to incentive 
programs relating to the prior calendar year);

(3) 

certain medical benefits (in the case of Mr. Newberry’s death, benefits to which his dependents are 
entitled); and

(4)  vesting, as of the date of termination, of at least 50% of the unvested stock option or RSU awards 
granted to Mr. Newberry prior to the date of termination (or a pro rata amount, based on period of 
service, if greater than 50%).

If Mr. Newberry voluntarily resigns, he will be entitled to no additional benefits and stock options and 
RSUs will cease to vest on the termination date, and stock options will be cancelled unless they are exercised 
within ninety days after the termination date.

The Newberry Agreement also subjects Mr. Newberry to customary confidentiality and non-competition 
obligations during the term of the agreement, and non-solicitation obligations for a period of six months following 
the termination of his employment. The agreement also requires Mr. Newberry to execute a release in favor of 
the Company to receive the payments described above.

The terms of Mr. Anstice’s agreement are substantively similar to those of the Newberry Agreement, with 
the following material differences: Mr. Anstice shall serve as an Executive Vice President of the Company and will 
receive a base salary of $450,000, subject to annual adjustment at the discretion of the Committee. Effective April 
2010, this base salary was adjusted to $463,500. Mr. Anstice is entitled to payment of twelve months’ COBRA 
premiums in the event that he is not eligible for the Company’s Executive Retiree Medical Benefit Plan.

The severance terms of Mr. Anstice’s agreement are generally similar to those of the Newberry Agreement, 
provided  that  (1)  Mr.  Anstice  will  receive  12  months’  base  salary  instead  of  18  months’  in  the  event  of  his 
Involuntary Termination; (2) instead of a payment of the full Short Term Program Average, he will receive a 
payment of 50% of the Short Term Program Average; and (3) in the event of death or disability, Mr. Anstice will 
not be entitled to any payment based on his base salary. The change of control terms of Mr. Anstice’s agreement 
are generally similar to those of the Newberry Agreement, provided that Mr. Anstice will receive 12 months’ 
base salary instead of 18 months’ in the event of his Involuntary Termination.

The terms of Mr. Maddock’s agreement are substantively similar to those of Mr. Anstice’s agreement, with 
the following material differences: Mr. Maddock shall serve as a Senior Vice President of the Company and will 
receive a base salary of $440,000, subject to annual adjustment at the discretion of the Committee. Effective 
April 2010, this base salary was adjusted to $453,200.

Change of Control Agreements. We entered into change of control agreements with Mr. Hariri, Dr. Marks, 
and  Dr.  Gottscho,  which  provide  that,  if  a  change  of  control  (defined  as  in  the  Newberry  Agreement)  of  the 
Company occurs during the period of employment of the applicable executive officer under the change of control 
agreement, and there is an Involuntary Termination (defined as in the Newberry Agreement) of the executive 
officer’s employment, the executive officer will be entitled to payments and benefits substantively similar to 
those contained in the change of control provisions of Messrs. Anstice and Maddock’s agreements.

33

The  change  of  control  agreements  contain  confidentiality,  non-competition,  and  non-solicitation  terms 
that are substantively similar to those of Messrs. Anstice and Maddock’s agreements, and require Mr. Hariri, 
Dr. Marks, and Dr. Gottscho to execute releases in favor of the Company to receive the payments described in 
the previous paragraph.

Equity Plans. In addition to the above, certain of our stock plans provide for accelerated benefits after 
certain events. While the applicable triggers under each plan vary, these events generally include: (i) a merger 
or  consolidation  in  which  Lam  Research  is  not  the  surviving  entity,  (ii)  a  sale  of  substantially  all  of  Lam’s 
assets, including a liquidation or dissolution of the Company, or (iii) a change in the ownership of more than 
50% of our outstanding securities by tender offer or similar transaction. After a designated event, the vesting 
of some or all of awards granted under these plans may be immediately accelerated in full, or certain awards 
may be assumed, substituted, replaced or settled in cash by a surviving corporation or its parent. The specific 
treatment of awards in a particular transaction will be determined by the Board and/or the terms of the applicable 
transaction documents.

Potential  Payments  to  Named  Executive  Officers  Upon  Termination  or  Change  of  Control.  The  tables 
below summarize the potential payments to our NEOs, assuming a change of control of the Company as of the 
end of FY 2010. These amounts are calculated assuming that the employment termination or change of control 
occurs on the last business day of FY 2010, June 25, 2010. The closing price per share of our common stock on 
June 25, 2010 was $40.25.

Mr. Newberry

Executive Benefits and Payments Upon Termination
Compensation
Severance  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term Incentive (5-year bonus average) . . . . . .
Short-term Incentive (pro rata 2010 bonus) . . . . . . .
Long-term Incentives:

Voluntary 
Termination

Disability or 
Death

For 
Cause

Not for 
Cause

Change of 
Control

Involuntary Termination

$
$
$

— $ 850,000
— $
— $ 637,500

$— $ 1,275,000 $ 1,275,000
974,747
487,373

— $— $ 974,747 $
$— $ 637,500 $

$
2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . .
$
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . .
$
Stock Options (Unvested and Accelerated) . . . . . . .
Restricted Stock Units (Unvested and Accelerated)  $
Benefits and Perquisites
Health Benefit Continuation . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

— $ 1,392,026
— $ 887,851
— $ 1,652,632
— $ 2,687,882

$— $ 1,392,026 $ 1,892,026
$— $ 887,851 $ 2,575,351
$— $ 1,652,632 $ 2,478,948
$— $ 1,327,713 $ 4,711,907

$ 274,000
$ 274,000

$ 274,000
$ 8,381,891

$— $ 274,000 $
274,000
$— $ 8,421,469 $14,669,352

Mr. Anstice

Executive Benefits and Payments Upon Termination

Compensation
Severance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term Incentive (5-year bonus average)  . . . . . . .
Short-term Incentive (pro rata 2010 bonus). . . . . . . . .
Long-term Incentives:

2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Options (Unvested and Accelerated). . . . . . . . .
Restricted Stock Units (Unvested and Accelerated) . .
Benefits and Perquisites
Health Benefit Continuation/COBRA Payment . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Involuntary Termination

Voluntary 
Termination

Disability or 
Death

For
Cause

Not for
Cause

Change of
Control

—   $ — $ 463,500 $ 463,500
$ — $
—   $ — $ 172,322 $ 344,644
$ — $
$ — $ 196,988 $ — $ 196,988 $ 172,322

$ — $ 609,012 $ — $ 609,012 $ 827,762
$ — $ 394,601 $ — $ 394,601 $ 1,144,601
$ — $ 723,043 $ — $ 723,043 $ 1,084,565
$ — $ 1,185,403 $ — $ 580,888 $ 2,080,362

27,886
$ — $
$ — $ 3,136,933 $ — $ 3,168,240 $ 6,145,642

27,886 $ — $

27,886 $

34

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mr. Maddock

Executive Benefits and Payments Upon Termination

Compensation
Severance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term Incentive (5-year bonus average)  . . . . . . .
Short-term Incentive (pro rata 2010 bonus). . . . . . . . .
Long-term Incentives:

2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Options (Unvested and Accelerated). . . . . . . . .
Restricted Stock Units (Unvested and Accelerated) . .
Benefits and Perquisites
Health Benefit Continuation/COBRA Payment . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Involuntary Termination

Voluntary 
Termination

Disability or 
Death

For
Cause

Not for
Cause

Change of 
Control

—   $ — $ 453,200 $ 453,200
$ — $
$ — $
—   $ — $ 177,130 $ 354,259
$ — $ 181,280 $ — $ 181,280 $ 177,130

$ — $ 556,811 $ — $ 556,811 $ 756,811
$ — $ 315,681 $ — $ 315,681 $ 915,681
$ — $ 661,053 $ — $ 661,053 $ 991,579
$ — $ 1,014,689 $ — $ 531,085 $ 1,763,836

$ — $
21,865
$ — $ 2,751,379 $ — $ 2,898,105 $ 5,434,361

21,865 $ — $

21,865 $

Executive Benefits and Payments Upon Termination

Dr. Gottscho

Voluntary 
Termination

Disability or 
Death

For
Cause

Not for 
Cause

Change of 
Control

Involuntary Termination

Compensation
Severance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Short-term Incentive (5-year bonus average)  . . . . . . . $
Short-term Incentive (pro rata 2010 bonus). . . . . . . . . $
Long-term Incentives:

—   $
—   $
—   $

—   $ — $
—   $ — $
—   $ — $

—   $ 370,800
—   $ 286,911
—   $ 143,456

2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . . $
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . . $
Stock Options (Unvested and Accelerated). . . . . . . . . $
Restricted Stock Units (Unvested and Accelerated) . . $
Benefits and Perquisites
Health Benefit Continuation . . . . . . . . . . . . . . . . . . . . $ 270,000
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 270,000

—   $
—   $
—   $
—   $

—   $ — $
—   $ — $
—   $ — $
—   $ — $

—   $ 595,988
—   $ 772,605
—   $ 780,859
—   $ 3,093,696

$ 270,000 $ — $ 270,000
$ 270,000 $ — $ 270,000

$ 270,000
$ 6,314,315

Dr. Marks

Executive Benefits and Payments Upon Termination

Compensation
Severance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term Incentive (5-year bonus average)  . . . . . . .
Short-term Incentive (pro rata 2010 bonus). . . . . . . . .
Long-term Incentives:

2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Options (Unvested and Accelerated). . . . . . . . .
Restricted Stock Units (Unvested and Accelerated) . .
Benefits and Perquisites
Health Benefit Continuation/COBRA Payment . . . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Involuntary Termination

Voluntary 
Termination

Disability or 
Death

For
Cause

Not for 
Cause

Change of 
Control

$ — $ — $ — $ 325,000
$ — $ — $ — $ 212,297
$ — $ — $ — $ 106,148

$ — $ — $ — $ 439,896
$ — $ — $ — $ 572,300
$ — $ — $ — $ 576,350
$ — $ — $ — $ 2,275,011

$ — $ — $ — $
27,886
$ — $ — $ — $ 4,534,888

$ —
$ —
$ —

$ —
$ —
$ —
$ —

$ —
$ —

35

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mr. Hariri

Executive Benefits and Payments Upon Termination

Compensation
Severance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term Incentive (5-year bonus average)  . . . . . . .
Short-term Incentive (pro rata 2010 bonus). . . . . . . . .
Long-term Incentives:

2009-2010 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
2010-2011 MYIP . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Options (Unvested and Accelerated). . . . . . . . .
Restricted Stock Units (Unvested and Accelerated) . .
Benefits and Perquisites
Health Benefit Continuation/COBRA Payment (1) . . .
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Involuntary Termination

Voluntary 
Termination

Disability or 
Death

For
Cause

Not for 
Cause

Change of 
Control

$ —
$ —
$ —

$ —
$ —
$ —
$ —

$ —
$ —

$ — $ — $ — $ 325,000
$ — $ — $ — $ 227,857
$ — $ — $ — $ 113,929

$ — $ — $ — $ 591,258
$ — $ — $ — $ 715,375
$ — $ — $ — $ 774,706
$ — $ — $ — $ 1,378,039

$ — $ — $ — $
42,557
$ — $ — $ — $ 4,168,721

(1)  Mr.  Hariri’s  COBRA  payment  is  based  on  18  months  rather  than  12  months,  since  his  tenure  with  the 

Company exceeds 20 years.

Medical  and  Dental  Coverage.  The  Company  provides  post-retirement  medical  and  dental  insurance 
coverage for eligible former executive officers and members of the Board under our Executive Retirement Medical 
and Dental Plan. We have an independent actuarial valuation of this post-retirement benefit conducted annually 
in accordance with the methodology prescribed by ASC 715. The most recent valuation was conducted in June 
2010 by a new actuarial firm that used different assumptions from the previous firm. As a result, our accumulated 
post-retirement benefit obligation for the NEOs increased significantly, as shown in the table below:

Name

Stephen G. Newberry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FY 2010

$ 274,000
$ 107,000
$ 287,000
$ 270,000
$ 287,000
$ 287,000

In addition, certain of our equity plans provide for accelerated benefits after certain events as discussed 

above.

Other Executive Compensation Plans

Elective Deferred Compensation Plan and 401(k) Plan. We maintain a non-qualified deferred compensation 
plan, the Elective Deferred Compensation Plan (the “EDCP”), which allows eligible employees, including our 
executive officers (and the NEOs), to voluntarily defer receipt of all or a portion of their base salary and all or 
a portion of certain long- or short-term incentive compensation payments until the date or dates elected by the 
participating employee, thereby allowing the employee to defer current taxation on such amounts. The EDCP is 
offered to eligible employees to allow them to defer more compensation than they would otherwise be permitted 
to  defer  under  a  tax-qualified  retirement  plan,  such  as  Lam’s  401(k)  Plan.  Further,  we  offer  the  EDCP  as  a 
competitive practice to enable us to attract and retain top talent.

All of our employees, including the NEOs, are also eligible to receive Company contributions that match 
a certain percentage of their contributions to the 401(k) Plan. In addition, we provide a Company contribution 
to the EDCP to compensate for matching contributions to the 401(k) Plan that would have been received by the 
executive had he not participated in the EDCP.

36

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health and Welfare Benefits.  Except as discussed in this section, our  executive officers, including  the 
NEOs,  are  eligible  to  receive  health  and  welfare  benefits,  including  medical,  disability,  and  life  insurance 
coverage, on the same basis as all of our employees.

We  provide  certain  additional  benefits  to  our  executive  officers,  including  the  NEOs,  which  are  not 
generally  available  to  our  other  employees,  including  the  payment  of  premiums  for  supplemental  long-term 
disability insurance, executive dental insurance coverage, and an executive medical reimbursement program 
that  reimburses  an  executive  officer’s  payment  of  medical  co-insurance  and  co-payments,  and  vision  care 
expenses.

We also provide a program to pay for post-retirement medical and dental insurance coverage for eligible 
former executive officers and members of our Board of Directors (“Executive Retirement Medical and Dental 
Plan”). To be eligible, an individual must have served in the position of vice president or above or as a member of 
the Board, be at least age 55 at the time of his or her retirement, and have at least five years of continuous service 
with Lam Research. An executive officer or director must be enrolled in our United States group medical and 
dental plans at the time of his or her retirement. When the retiree or spouse of a retiree reaches age 65, he or she 
is required to enroll in Medicare (Parts A and B), which would be the primary payer for the participant’s health 
insurance coverage. This benefit also covers the retiree’s spouse at the time of retirement for his or her lifetime, 
as well as dependent children until age of 19 (or 24 if a full-time student). This benefit ceases if the retiree 
becomes employed by one of our competitors after leaving active service with us. We provide this benefit to our 
executive officers and members of our Board to further the long-term retention of their services and provide a 
disincentive to compete against us later.

Perquisites and Other Personal Benefits.  Historically, we have not provided perquisites or other personal 

benefits to our executive officers, including the NEOs, and we did not do so in FY 2010. 

Tax and Accounting Considerations

Deductibility  of  Executive  Compensation.  Section  162(m)  of  the  Internal  Revenue  Code  of  1986,  as 
amended (the “Code”), imposes limitations on the deductibility for federal income tax purposes of compensation 
in excess of $1 million paid to our Chief Executive Officer and any of our three other most highly compensated 
executive  officers  (other  than  our  Chief  Financial  Officer)  in  a  single  tax  year.  Generally,  compensation  in 
excess of $1 million may only be deducted if it is “performance-based compensation” within the meaning of 
the Code.

In determining which components of compensation are to be paid, and how they are weighted, we take 
into account whether a particular form of compensation will be considered “performance-based” compensation 
for purposes of Section 162(m).

In fiscal 2004, we adopted the Executive Incentive Plan (“EIP”) with a structure intended to provide for 
the deductibility of awards granted under the EIP. Accordingly, during fiscal 2010, the annual incentive awards 
and  all  MYIP  awards  to  our  NEOs  were  granted  under  the  EIP  in  order  to  qualify  for  deductibility  under 
Section 162(m).

Compensation income realized upon the exercise of stock options or vesting of RSUs granted under our 
stock incentive plans generally will be deductible if the awards are granted by a committee whose members 
are non-employee directors and certain other conditions are satisfied. However, compensation associated with 
RSUs will not be considered performance-based compensation for the purposes of Section 162(m) unless vesting 
is based on specific performance goals rather than based on continued employment.

The  Committee  monitors  the  application  of  Section  162(m)  and  the  associated  Treasury  regulations 
on  an  ongoing  basis  and  the  advisability  of  qualifying  our  executive  compensation  for  deductibility  of  such 
compensation.  The  Committee’s  policy  is  to  qualify  our  executive  compensation  for  deductibility  under 
applicable  tax  laws  to  the  extent  practicable  and  if  the  Committee  believes  it  is  in  the  best  interests  of  the 
Company and its stockholders.

37

Taxation of “Parachute” Payments.  Sections 280G and 4999 of the Code provide that executive officers 
or directors of a corporation who hold significant equity interests, and certain other service providers, may be 
subject to significant additional taxes if they receive payments or benefits in connection with a change of control 
of  the  corporation  that  exceeds  certain  prescribed  limits.  The  corporation  or  its  successor  may  also  forfeit  a 
deduction on the amounts subject to this additional tax.

We did not provide any of our executive officers, including any NEO, any director, or any other service 
provider with a “gross-up” or other reimbursement payment for any tax liability that the individual might owe 
as a result of the application of Sections 280G or 4999 during fiscal 2010, and we have not agreed and are not 
otherwise obligated to provide any individual with such a “gross-up” or other reimbursement.

Internal Revenue Code Section 409A. Section 409A of the Code imposes significant additional taxes on 
an executive officer, director, or service provider that receives “deferred compensation” that is within the scope 
of Section 409A. Among other things, Section 409A applies to the MYIP, the EDCP, certain equity awards, and 
severance arrangements.

To assist our employees in avoiding additional taxes under Section 409A, we have structured the MYIP, the 

EDCP, and our equity awards in a manner intended to qualify them for exclusion from Section 409A.

Accounting  for  Stock-Based  Compensation.  We  follow  Accounting  Standards  Codification  718, 
Compensation-Stock  Compensation  (“ASC  718”)  for  our  stock  options  and  other  stock-based  awards.  ASC 
718  requires  companies  to  calculate  the  grant  date  “fair  value”  of  their  stock  option  grants  and  other  equity 
awards  using  a  variety  of  assumptions.  This  calculation  is  performed  for  accounting  purposes  and  reported 
in the compensation tables below. ASC 718 also requires companies to recognize the compensation cost of its 
stock option grants and other stock-based awards in their income statements over the period that an employee is 
required to render service in exchange for the option or other equity award. 

 COMPENSATION COMMITTEE REPORT

The Compensation Committee has reviewed and discussed with management the Compensation Discussion 
and Analysis required by Item 402(b) of Regulation S-K. Based on this review and discussion, the Compensation 
Committee  has  recommended  to  the  Board  of  Directors  that  the  Compensation  Discussion  and  Analysis  be 
included in this Proxy Statement and the Company’s Annual Report on Form 10-K.

This Report of the Compensation Committee shall not be deemed “filed” with the SEC for purposes of 
federal securities law, and it shall not, under any circumstances, be incorporated by reference into any of the 
Company’s past or future SEC filings. The Report shall not be deemed soliciting material.

COMPENSATION COMMITTEE
Robert M. Berdahl
Grant M. Inman (Chair)

38

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

None of the Committee members has ever been an officer or employee of Lam Research. No interlocking 
relationship exists or existed during fiscal 2010 between any member of our Compensation Committee and any 
member of any other company’s board of directors or compensation committee.

EXECUTIVE COMPENSATION TABLES

Summary Compensation Table

Non-Equity 
Incentive Plan 
Compensation 
($)

Bonus
($)

Salary
($)

0
0
0
0
0
0
0

Option 
Awards
($) (2)

Stock 
Awards
Fiscal 
($) (1)
Year
0 $3,211,287(3)
$ 2,249,938 $
2010 $ 737,473 $
$ 999,991 $ 969,234 $1,550,036(4)
2009 $ 746,154 $
0 $6,260,949(5)
$
0 $
2008 $ 800,000 $
0 $1,385,442(12)
$ 999,965 $
2010 $ 425,141 $
$ 437,506 $ 424,050 $ 733,090(13)
2009 $ 415,865 $
0 $2,523,046(14)
$
0 $
2008 $ 386,538 $
0 $1,224,780(6)
2010 $ 415,693 $
$ 799,959 $
2009 $ 412,846 $ 102,649(22) $ 399,996 $ 387,694 $ 687,125(7)
0 $2,321,232(8)
0 $
2008 $ 405,231 $
2010 $ 345,363 $ 28,918(23) $ 1,607,108 $
0 $ 995,312(9)
$ 708,913 $ 305,305 $ 495,880(10)
2009 $ 346,154 $
0 $ 699,734(11)
2008 $ 346,538 $
0 $
$
0 $ 725,636(15)
2010 $ 298,492 $ 29,341(23) $ 766,269 $

0
0

0

$

2010 $ 302,298 $ 41,309(23) $ 624,986 $
2009 $ 302,885 $
2008 $ 304,904 $

0 $ 899,574(16)
$ 312,507 $ 302,899 $ 494,275(17)
0 $1,826,383(18)
$

0 $

0
0

Nonqualified 
Deferred 
Compensation 
Earnings
($) (19)
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0

All Other 
Compensation
($) (20)
$11,184
$ 9,876
$ 9,260
$16,857
$15,767
$16,148
$17,987
$10,794
$14,747
$41,719
$14,539
$15,496
$39,312

Total
($)
$ 6,209,882
$ 4,275,291
$ 7,070,209
$ 2,827,405
$ 2,026,278
$ 2,925,732
$ 2,458,419
$ 2,001,104
$ 2,741,210
$ 3,018,420
$ 1,870,791
$ 1,061,768
$ 1,859,050

$0
$0
$0

$48,177
$12,167
$17,959

$ 1,916,344
$ 1,424,733
$ 2,149,246

Name and Principal Position
Stephen G. Newberry  . .
President and Chief
Executive Officer

Martin B. Anstice  . . . . .
Executive Vice President and
 Chief Operating Officer

Ernest E. Maddock  . . . .
Senior Vice President and
Chief Financial Officer

Richard A. Gottscho  . . .
Senior Vice President,
Global Products

Jeffrey Marks. . . . . . . . .

Vice President and
General Manager,
Clean Business

Abdi Hariri (21) . . . . . . . .
Group Vice President,

Global Operations

(1) 

(2) 

(3) 

The amounts shown in this column represent the value of restricted stock unit awards granted during fiscal 
2010 in accordance with ASC 718. However, pursuant to SEC rules, these values are not reduced by an 
estimate for the probability of forfeiture. The assumptions used to calculate the fair value of the restricted 
stock units in fiscal year 2010 are set forth in Note 11 in the Notes to Consolidated Financial Statements 
of the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2010. Amounts for FY 
2009, including the total amounts, were recomputed to conform to the ASC 718 manner of presentation.

The amounts shown in this column represent the grant date fair value of option awards in accordance with 
ASC 718. However, pursuant to SEC rules, these values are not reduced by an estimate for the probability 
of forfeiture. The assumptions used to calculate the fair value of the option awards in fiscal year 2010 are 
set forth in Note 11 in Notes to Consolidated Financial Statements of the Company’s Annual Report on 
Form 10-K for the fiscal year ended June 27, 2010. Amounts for FY 2009, including the total amounts, were 
recomputed to conform to the ASC 718 manner of presentation.

Represents $715,760 earned by Mr. Newberry under the 2009 AIP, $545,650 accrued on Mr. Newberry’s 
behalf  for  performance  during  fiscal  2010  under  the  2008/2009  MYIP,  $1,062,026  accrued  on 
Mr. Newberry’s behalf for performance during fiscal 2010 under the 2009/2010 MYIP, and $887,851 accrued 
on Mr. Newberry’s behalf for performance during fiscal 2010 under the 2010/2011 MYIP. Mr. Newberry 
has received the amounts accrued under the 2008/2009 MYIP, and will be eligible to receive the amounts 
accrued under the 2009/2010 and 2010/2011 MYIPs if he remains employed by the Company through the 
respective award determination dates in February 2011 and February 2012.

39

(4) 

(5) 

Represents $300,000 earned by Mr. Newberry under the 2008 AIP, $122,723 accrued on Mr. Newberry’s 
behalf for performance during fiscal 2009 under the 2007/2008 MYIP, $797,313 accrued on Mr. Newberry’s 
behalf  for  performance  during  fiscal  2009  under  the  2008/2009  MYIP,  and  $330,000  accrued  on 
Mr. Newberry’s behalf for performance during fiscal 2009 under the 2009/2010 MYIP. Mr. Newberry has 
received the amounts accrued under the 2007/2008 MYIP and the 2008/2009 MYIP, and will be eligible to 
receive the amounts accrued under the 2009/2010 MYIP if he remains employed by the Company through 
the payment determination date in February 2011.

Represents  $1,427,690  earned  by  Mr.  Newberry  pursuant  to  the  2007  AIP,  $1,783,440  accrued  on 
Mr. Newberry’s behalf for performance during fiscal 2008 under the 2006/2007 MYIP, $2,173,227 accrued 
on Mr. Newberry’s behalf for performance during fiscal 2008 under the 2007/2008 MYIP, and $876,592 
accrued  on  Mr.  Newberry’s  behalf  for  performance  during  fiscal  2008  under  the  2008/2009  MYIP. 
Mr. Newberry has received the amounts accrued under the 2006/2007, 2007/2008, and 2008/2009 MYIPs.

(6)  Represents  $266,028  earned  by  Mr.  Maddock  pursuant  to  the  2009  AIP,  $218,260  accrued  on 
Mr. Maddock’s behalf for performance during fiscal 2010 under the 2008/2009 MYIP, $424,811 accrued 
on Mr. Maddock’s behalf for performance during fiscal 2010 under the 2009/2010 MYIP, and $315,681 
accrued  on  Mr.  Maddock’s  behalf  for  performance  during  fiscal  2010  under  the  2010/2011  MYIP. 
Mr.  Maddock  has  received  the  amounts  accrued  under  the  2008/2009  MYIP  and  will  be  eligible  to 
receive the amounts accrued under the 2009/2010 and 2010/2011 MYIPs if he remains employed by the 
Company through the respective payment determination dates in February 2011 and February 2012.

(7)  Represents $141,786 earned by Mr. Maddock pursuant to the 2008 AIP, $74,545 accrued on Mr. Maddock’s 
behalf for performance during fiscal 2009 under the 2007/2008 MYIP, $338,794 accrued on Mr. Maddock’s 
behalf  for  performance  during  fiscal  2009  under  the  2008/2009  MYIP,  and  $132,000  accrued  on 
Mr. Maddock’s behalf for performance during fiscal 2009 under the 2009/2010 MYIP. Mr. Maddock has 
received the amounts accrued under the 2007/2008 and 2008/2009 MYIPs and will be eligible to receive 
the  amounts accrued under the 2009/2010 MYIP if he  remains employed by the Company through the 
payment determination date in February 2011.

(8) 

(9) 

Represents  $490,602  earned  by  Mr.  Maddock  pursuant  to  the  2007  AIP,  $672,220  accrued  on 
Mr. Maddock’s behalf for performance during fiscal 2008 under the 2006/2007 MYIP, $840,595 accrued 
on Mr. Maddock’s behalf for performance during fiscal 2008 under the 2007/2008 MYIP, and $317,815 
accrued  on  Mr.  Maddock’s  behalf  for  performance  during  fiscal  2008  under  the  2008/2009  MYIP. 
Mr. Maddock has received the amounts accrued under the 2006/2007, 2007/2008, and 2008/2009 MYIPs.

Represents $222,539 earned by Dr. Gottscho pursuant to the 2009 AIP, $171,880 accrued on Dr. Gottscho’s 
behalf for performance during fiscal 2010 under the 2008/2009 MYIP, $334,538 accrued on Dr. Gottscho’s 
behalf  for  performance  during  fiscal  2010  under  the  2009/2010  MYIP,  and  $266,355  accrued  on 
Dr. Gottscho’s behalf for performance during fiscal 2010 under the 2010/2011 MYIP. Dr. Gottscho has 
received  the  amounts  accrued  under  the  2008/2009  MYIP  and  will  be  eligible  to  receive  the  amounts 
accrued under the 2009/2010 and 2010/2011 MYIPs if he remains employed by the Company through the 
respective payment determination dates in February 2011 and February 2012.

(10)  Represents $114,325 earned by Dr. Gottscho pursuant to the 2008 AIP, $277,605 accrued on Dr. Gottscho’s 
behalf  for  performance  during  fiscal  2009  under  the  2008/2009  MYIP,  and  $103,950  accrued  on 
Dr. Gottscho’s behalf for performance during fiscal 2009 under the 2009/2010 MYIP. Dr. Gottscho has 
received  the  amounts  accrued  under  the  2008/2009  MYIPs  and  will  be  eligible  to  receive  the  amounts 
accrued  under  the  2009/2010  MYIP  if  he  remains  employed  by  the  Company  through  the  payment 
determination date in February 2011.

(11)  Represents  $403,546  earned  by  Dr.  Gottscho  pursuant  to  the  2007  AIP  and  $296,188  accrued  on 
Dr. Gottscho’s behalf for performance during fiscal 2008 under the 2008/2009 MYIP. Dr. Gottscho has 
received the amounts accrued under the 2008/2009 MYIP.

(12)  Represents $287,482 earned by Mr. Anstice pursuant to the 2009 AIP, $238,722 accrued on Mr. Anstice’s 
behalf for performance during fiscal 2010 under the 2008/2009 MYIP, $464,637 accrued on Mr. Anstice’s 
behalf  for  performance  during  fiscal  2010  under  the  2009/2010  MYIP,  and  $394,601  accrued  on 

40

Mr.  Anstice’s  behalf  for  performance  during  fiscal  2010  under  the  2010/2011  MYIP.  Mr.  Anstice  has 
received  the  amounts  accrued  under  the  2008/2009  MYIP  and  will  be  eligible  to  receive  the  amounts 
accrued under the 2009/2010 and 2010/2011 MYIPs if he remains employed by the Company through the 
respective payment determination dates in February 2011 and February 2012.

(13)  Represents $134,831 earned by Mr. Anstice pursuant to the 2008 AIP, $82,152 accrued on Mr. Anstice’s 
behalf for performance during fiscal 2009 under the 2007/2008 MYIP, $371,732 accrued on Mr. Anstice’s 
behalf  for  performance  during  fiscal  2009  under  the  2008/2009  MYIP,  and  $144,375  accrued  on 
Mr.  Anstice’s  behalf  for  performance  during  fiscal  2009  under  the  2009/2010  MYIP.  Mr.  Anstice  has 
received the amounts accrued under the 2007/2008 and 2008/2009 MYIPs and will be eligible to receive 
the amounts accrued under the 2009/2010 MYIP if he remains employed by the Company through the 
payment determination date in February 2011.

(14)  Represents $503,258 earned by Mr. Anstice pursuant to the 2007 AIP, $740,813 accrued on Mr. Anstice’s 
behalf for performance during fiscal 2008 under the 2006/2007 MYIP, $926,370 accrued on Mr. Anstice’s 
behalf  for  performance  during  fiscal  2008  under  the  2007/2008  MYIP,  and  $352,605  accrued  on 
Mr.  Anstice’s  behalf  for  performance  during  fiscal  2008  under  the  2008/2009  MYIP.  Mr.  Anstice  has 
received the amounts accrued under the 2006/2007, 2007/2008, and 2008/2009 MYIPs.

(15)  Represents $154,551 earned by Dr. Marks pursuant to the 2009 AIP, $126,864 accrued on Dr. Marks’ behalf 
for performance during fiscal 2010 under the 2008/2009 MYIP, $246,921 accrued on Dr. Marks’ behalf for 
performance during fiscal 2010 under the 2009/2010 MYIP, and $197,300 accrued on Dr. Marks’ behalf for 
performance during fiscal 2010 under the 2010/2011 MYIP. Dr. Marks has received the amounts accrued 
under the 2008/2009 MYIP and will be eligible to receive the amounts accrued under the 2009/2010 and 
2010/2011 MYIPs if he remains employed by the Company through the respective payment determination 
dates in February 2011 and February 2012.

(16)  Represents $170,671 earned by Mr. Hariri pursuant to the 2009 AIP, $150,395 accrued on Mr. Hariri’s behalf 
for performance during fiscal 2010 under the 2008/2009 MYIP, $331,883 accrued on Mr. Hariri’s behalf for 
performance during fiscal 2010 under the 2009/2010 MYIP, and $246,625 accrued on Mr. Hariri’s behalf 
for performance during fiscal 2010 under the 2010/2011 MYIP. Mr. Hariri has received the amounts accrued 
under the 2008/2009 MYIP and will be eligible to receive the amounts accrued under the 2009/2010 and 
2010/2011 MYIPs if he remains employed by the Company through the respective payment determination 
dates in February 2011 and February 2012.

(17)  Represents $87,392 earned by Mr. Hariri pursuant to the 2008 AIP, $60,853 accrued on Mr. Hariri’s behalf 
for performance during fiscal 2009 under the 2007/2008 MYIP, $242,905 accrued on Mr. Hariri’s behalf for 
performance during fiscal 2009 under the 2008/2009 MYIP, and $103,125 accrued on Mr. Hariri’s behalf for 
performance during fiscal 2009 under the 2009/2010 MYIP. Mr. Hariri has received the amounts accrued under 
the 2007/2008 and 2008/2009 MYIPs and will be eligible to receive the amounts accrued under the 2009/2010 
MYIP if he remains employed by the Company through the payment determination date in February 2011.

(18)  Represents $332,268 earned by Mr. Hariri pursuant to the 2007 AIP, $548,751 accrued on Mr. Hariri’s 
behalf for performance during fiscal 2008 under the 2006/2007 MYIP, $686,200 accrued on Mr. Hariri’s 
behalf for performance during fiscal 2008 under the 2007/2008 MYIP, and $259,164 accrued on Mr. Hariri’s 
behalf for performance during fiscal 2008 under the 2008/2009 MYIP. Mr. Hariri has received the amounts 
accrued under the 2006/2007, 2007/2008, and 2008/2009 MYIPs.

(19)  Reflects interest earned on deferred compensation, to the extent that the interest rate exceeded 120% of the 

applicable federal long-term rate.

(20)  Please refer to the “All Other Compensation” table, which follows this table, for additional information.

(21)  Mr.  Hariri  was  not  an  executive  officer  at  the  end  of  fiscal  2010.  However,  he  is  included  as  a  named 

executive officer in accordance with Regulation S-K Item 402(a)(3)(iv).

(22)  Represents a bonus paid to compensate Mr. Maddock for the increase in exercise price of certain stock options.

(23)  Represents  a  bonus  equal  to  the  additional  income  tax  due  pursuant  to  Section  409A  for  certain  stock 

option awards.

41

All Other Compensation for Fiscal Year 2010

Company 
Matching 
Contribution 
to the 
Company’s 
Section
401(k) Plan

$
0
$7,579
$7,483
$8,376
$7,401
$7,351

Company Paid
Long-Term 
Disability 
Insurance 
Premiums (1)
$ 370
$
0
$ 929
$1,174
0
$
0
$

Fiscal 
Year
2010
2010
2010
2010
2010
2010

Company Paid 
Life Insurance
Premiums (2)
$2,262
$ 991
$1,652
$2,084
$1,481
$1,098

Company Paid 
Healthcare 
Insurance 
Premiums (3)
$8,552
$8,287
$7,923
$8,261
$8,287
$8,552

Tax
Gross-
Up (4)

Total

0 $ 11,184
$
0 $16,857
$
0 $17,987
$
$21,824 $41,719
$22,143 $39,312
$31,176 $48,177

Name
Stephen G. Newberry . . . . .
Martin B. Anstice . . . . . . . .
Ernest E. Maddock . . . . . . .
Richard A. Gottscho . . . . . .
Jeffrey Marks . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . .

(1) 

(2) 

(3) 

Represents the portion of supplemental long-term disability insurance premiums paid by the Company.

Represents the portion of life insurance premiums paid by the Company.

Represents the portion of executive dental and executive medical reimbursement insurance premiums paid 
by the Company.

(4) 

Represents a gross-up for a bonus received due to the additional income tax on certain stock option awards.

42

Grants of Plan-Based Awards for Fiscal Year 2010

Estimated Future 
Payouts Under 
Non-Equity Incentive 
Plan Awards

Target
($) (1)

Maximum
($)

$1,275,000 $2,869,000
$
0
0 $
$2,250,000 $5,625,000
$ 394,000 $ 887,000
0
0 $
$
$1,000,000 $2,500,000
$ 363,000 $ 817,000
$
0
0 $
$ 800,000 $2,000,000
$ 297,000 $ 668,000
$
0
0 $
$ 675,000 $1,687,500
$
0
0 $
$ 228,000 $ 513,000
$
0
0 $
$ 500,000 $1,250,000
$
0
0 $
$ 244,000 $ 549,000
0
0 $
$
$ 625,000 $1,562,500

Approval
Date
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010
2/1/2010

Estimated 
Future 
Payouts 
Under 
Equity 
Incentive 
Plan 
Awards
Target
(#) (3)
0
33,793
0
0
15,019
0
0
12,015
0
0
10,138
0
28,000
0
7,509
0
8,000
0
9,387
0

All 
Other 
Stock 
Awards: 
Number 
of Shares 
of Stock 
or Units
(#) (4)
0
33,793
0
0
15,019
0
0
12,015
0
0
10,138
0
0
0
7,509
0
0
0
9,387
0

All 
Other 
Option 
Awards: 
Number 
of Shares 
of Stock 
or Units
(#)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Grant 
Date Fair 
Value of 
Stock and 
Option 
Awards
($) (5)

0
$
$2,249,938
0
$
$
0
$ 999,965
0
$
$
0
$ 799,959
$
0
0
$
$ 674,988
$
0
$ 932,120
0
$
$ 499,949
$
0
$ 266,320
$
0
$ 624,986
0
$

Name
Stephen G. Newberry . . . Annual Incentive Program N/A

Award Type

Grant
Date

LTIP—Equity Component
LTIP—MYIP Component N/A
Martin B. Anstice . . . . . . Annual Incentive Program N/A

2/5/2010

LTIP—Equity Component
LTIP—MYIP Component N/A
Ernest E. Maddock . . . . . Annual Incentive Program N/A

2/5/2010

LTIP—Equity Component
LTIP—MYIP Component N/A
Richard A. Gottscho . . . . Annual Incentive Program N/A

2/5/2010

LTIP—Equity Component
LTIP—MYIP Component N/A
Performance-Based RSU (2) 2/5/2010

2/5/2010

Jeffrey Marks . . . . . . . . . Annual Incentive Program N/A

LTIP—Equity Component
LTIP—MYIP Component N/A
Performance-Based RSU (2) 2/5/2010

2/5/2010

Abdi Hariri . . . . . . . . . . . Annual Incentive Program N/A

LTIP—Equity Component
LTIP—MYIP Component N/A

2/5/2010

(1) 

(2) 

(3) 

(4) 

(5) 

Base salary used to calculate the AIP target was base salary approved in February 2010. Actual eligible 
base earnings under the AIP could be different.

Represents  a  performance-based  RSU  program  with  a  single  estimated  payout.  Amount  shown  is  for 
performance awards granted during fiscal year 2010.

Represents RSUs with performance-based vesting.

Represents RSUs with time-based vesting.

The amounts shown in this column represent the value of restricted stock unit awards granted during fiscal 
2010 in accordance with ASC 718. However, pursuant to SEC rules, these values are not reduced by an 
estimate for the probability of forfeiture. The assumptions used to calculate the fair value of the restricted 
stock units in fiscal year 2010 are set forth in Note 11 in the Notes to Consolidated Financial Statements of 
the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2010.

43

Outstanding Equity Awards at 2010 Fiscal Year-End

Option Awards

Stock Awards

Name
Stephen G. Newberry (8) . . .

Martin B. Anstice . . . . . . . .

Ernest E. Maddock . . . . . . .

Richard A. Gottscho . . . . . .

Jeffrey Marks . . . . . . . . . . .

Abdi Hariri . . . . . . . . . . . . .

Number of 
Securities 
Underlying 
Unexercised  
Options (#) 
Exercisable

Number of 
Securities 
Underlying 
Unexercised 
Options (#)
Unexercisable

Option 
Exercise  
Price
($)

Option 
Expiration  
Date

Number of  
Shares or 
Units of 
Stock 
That Have 
Not Vested 
(#)

0
0
0
0
0
849(1)
0

2,000(4)

0
0

2,050(1)

0
0

123,700(2)

0
0
0

54,120(2)

0
0
0
0

0

49,480(2)

1,000(3)

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,000(1)
822(1)
0

0
0
0
0
0
0

38,965(2)

0
0
0
0
0
0
0
0

28,760(2)

0
0
0
0

38,658(2)

0

0
0
0

0
0
0
0
0

2/26/2014

N/A 49,480(5)
N/A 33,793(9)

N/A 21,648(5)
N/A 15,019(9)

N/A 19,792(5)
N/A 12,015(9)

10/1/2011
2/26/2014
3/19/2011

0
$
$
0
$ 20.21
0
$
$
0
$ 16.64
$ 20.21
$ 24.25
0
$
$
0
10/1/2011
$ 16.64
$ 20.21
2/26/2014
$ 24.19 12/24/2011
0
N/A
$
0
N/A
$
N/A 10,138(9)
0
$
N/A 5,000(6)
0
$
N/A 15,586(5)
$
0
$ 20.21
0
$
0
$
0
$
0
$
0
$
0
$
0
$
$
0
$ 20.21
0
$
$
0
$ 16.14
$ 16.64
$ 20.21

2/26/2014
N/A
N/A
N/A
N/A
N/A
N/A 7,509(9)
N/A 5,000(6)
N/A 11,504(5)

10/1/2011
10/1/2011
2/26/2014

N/A 15,463(5)
N/A 9,387(9)

2/26/2014

0
0
0
0
0
0

0
0
0

0

Equity 
Incentive 
Plan 
Awards: 
Market or 
Payout 
Value of 
Unearned 
Shares, 
Units or 
Other 
Rights 
That 
Have Not 
Vested 
($) (16)

Equity 
Incentive 
Plan 
Awards: 
Number of 
Unearned 
Shares, 
Units or 
Other 
Rights That
Have Not 
Vested (#)

0

0
$
33,793(10) $ 1,360,168
0
$
0
0
$
0
15,019(10) $
604,515
0
$
0
0
$
0
0
$
0
0
0
12,015(10) $
483,604
0
$
0
0
$
0
0
$
0
8,000(7)
322,000
$
28,000(11) $ 1,127,000
10,138(10) $
408,055
0
$
0
0
$
0
0
0
$
1,000(12) $
40,250
8,000(7)
322,000
$
2,000(13) $
80,500
6,000(14) $
241,500
8,000(15) $
322,000
7,509(10) $
302,237
0
$
0
0
$
0
0
$
0
0
0
$
9,387(10) $
377,827
0
$
0
0
$
0
0
$
0

Market 
Value of 
Shares or  
Units of 
Stock 
That 
Have Not  
Vested 
($) (16)
$ 1,991,570
$ 1,360,168
0
$
871,332
$
604,515
$
0
$
0
$
0
$
796,628
$
483,604
$
0
$
0
$
0
$
0
$
0
$
408,055
201,250
627,337
0
0
0
0
0
0
302,237
201,250
463,036
0
622,386
377,827
0
0
0

$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$

(1)  Options were granted on October 1, 2001. 100% of the options vested on October 1, 2006.

(2)  Options were granted on February 26, 2009. 100% of the options will vest on February 26, 2011 provided 

that the person remains an employee on such date.

(3)  Options were granted on December 24, 2001. 100% of the options vested on December 24, 2006.

44

(4) 

(5) 

(6) 

(7) 

(8) 

(9) 

36,000 options were originally granted on March 19, 2001. The options vested 25% each on March 19, 2002, 
March 19, 2003, March 19, 2004 and March 19, 2005.

RSUs were granted on February 26, 2009. 100% of the RSUs will vest on February 26, 2011 provided that 
the person remains an employee on such date.

RSUs were granted on November 25, 2008. 100% of these RSUs will vest on December 30, 2010 provided 
that the person remains an employee on such date.

Two RSU awards were granted on August 26, 2008 and are subject to performance criteria and service 
period. 50% of the RSUs will vest on August 25, 2010 and 50% of the awards will vest on March 27, 2011, 
provided that the performance criteria have been met and the person remains an employee on such dates.

In accordance with an agreement between the Company and Mr. Newberry, an option for 5,250 shares 
which was granted on October 1, 2001 and reflected in the Company’s 2009 fiscal year proxy statement, 
was cancelled.

RSUs were granted on February 5, 2010. 100% of the RSUs will vest on February 5, 2012 provided that the 
person remains an employee on such date.

(10)  RSUs were granted on February 5, 2010 and are subject to performance criteria and continued service. 
100% of the RSUs will vest on February 5, 2012 provided that the performance criterion has been met and 
the person remains an employee on such date.

(11)  Three RSU awards were granted on February 5, 2010 and are subject to performance criteria and continued 
service. 4,000 RSUs will vest on March 27, 2011, 20,000 RSUs will vest on June 26, 2011 and 4,000 RSUs 
will vest on March 25, 2012, provided that the performance criteria have been met and the person remains 
an employee on such dates.

(12) 

5,000 RSUs were granted on May 12, 2006 and are subject to performance criteria and continued service. 
4,000  RSUs  vested  on  May  12,  2009  and  1,000  RSUs  will  vest  on  May  12,  2011,  provided  that  the 
performance criteria have been met and the person remains an employee on such dates.

(13)  RSUs were granted on August 26, 2008 and are subject to performance criteria and continued service. 
100% of the RSUs will vest on March 27, 2011, provided that the performance criteria have been met and 
the person remains an employee on such date.

(14)  RSUs were granted on October 27, 2008 and are subject to performance criteria and continued service. 
100% of the RSUs will vest on March 27, 2011 provided that the performance criteria have been met and 
the person remains an employee on such date.

(15)  Two RSU awards were granted on February 5, 2010 and are subject to performance criteria and continued 
service. 4,000 RSUs will vest on March 27, 2011 and 4,000 RSUs will vest on March 25, 2012, provided 
that the performance criteria have been met and the person remains an employee on such dates.

(16)  Calculated  by  multiplying  the  number  of  unvested  shares  by  $40.25,  the  closing  price  per  share  of  our 

common stock on June 25, 2010.

Option Exercises and Stock Vested for Fiscal 2010

There were no option exercises or vesting of restricted stock units during fiscal year 2010.

45

Non-Qualified Deferred Compensation for Fiscal 2010

Name
Stephen G. Newberry . . . . . . . . . . . .
Martin B. Anstice . . . . . . . . . . . . . . .
Ernest E. Maddock . . . . . . . . . . . . . .
Richard A. Gottscho . . . . . . . . . . . . .
Jeffrey Marks . . . . . . . . . . . . . . . . . .
Abdi Hariri . . . . . . . . . . . . . . . . . . . .

Executive 
Contributions 
in FY10 ($)
$
0
$ 72,115
$ 87,153
$ 34,892
$
0
$158,373

Registrant 
Contributions 
in FY10 ($) (1)
$0
$0
$0
$0
$0
$0

Aggregate 
Earnings 
in FY10 ($) (2)
$ 58,883
$ 129,103
$ 717,610
$ 67,985
$ 69,777
$ 72,599

Aggregate 
Withdrawals/ 
Distributions 
in FY10 ($)
0
0
0
0
0

Aggregate 
Balance at 
FYE10 ($)
$ 1,167,024
$
$ 1,139,108
$
$ 7,978,764
$
$ 1,435,521
$
$
$ 1,713,263
$(1,764,990) $ 361,407

(1) 

Represents the amount that the Company credited to the Elective Deferred Compensation Plan (“EDCP”), 
which is equal to any matching contribution into the Section 401(k) Plan that an executive would have been 
entitled to but did not receive as a result of compensation deferrals into the EDCP.

(2) 

The NEOs did not receive above-market or preferential earnings in fiscal 2010.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER 
EQUITY COMPENSATION PLANS

The following table provides information as of June 27, 2010, regarding securities authorized for issuance 
under the Company’s equity compensation plans. The equity compensation plans of the Company include the 
1991 Stock Option Plan, the 1997 Stock Incentive Plan, the 1999 Stock Option Plan, the 1999 Employee Stock 
Purchase Plan, and the 2007 Stock Incentive Plan, each as may be amended.

Plan Category

Equity compensation plans approved 

Number of 
Securities 
to be Issued Upon 
Exercise of 
Outstanding 
Options, 
Warrants, and 
Rights
(a)

Weighted- 
Average 
Exercise Price 
of Outstanding 
Options, 
Warrants, and 
Rights (5)
(b)

Number of Securities 
Remaining Available 
for Future Issuance 
Under Equity 
Compensation Plans 
(excluding securities 
reflected in column 
(a)) 
(c)

by security holders  . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,379,187(1)(2)

$21.40

18,086,805(3) 

Equity compensation plans not approved 

by security holders  . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

247,000(4)

3,626,187

$22.16
$21.61

0 
18,086,805 

(1) 

(2) 

(3) 

Includes 165,175 shares issuable under the Company’s 1991 Stock Option Plan and 1997 Stock Incentive 
Plan, both of which expired prior to June 27, 2010. While there are options still outstanding that were issued 
pursuant to those plans, no additional grants may be made under them.

Includes 3,214,012 shares issuable under the Company’s 2007 Stock Incentive Plan, as amended (the “2007 
Plan”). The 2007 Plan was adopted by the Board in August 2006, approved by the Company’s stockholders 
in November 2006, and amended by the Board in November 2006. The term of the 2007 Plan is ten years 
from the latest date of any approval, amendment, or restatement of the Plan by the Company’s stockholders. 
The 2007 Plan reserves for issuance up to 15,000,000 shares of the Company’s common stock.

Includes 8,499,066 shares available for future issuance under the 1999 Employee Stock Purchase Plan, as 
amended (the “1999 ESPP”). This number does not include shares that may be added to the 1999 ESPP 
share reserve in the future in accordance with the terms of the 1999 ESPP. The term of the 1999 ESPP is 
twenty years from its effective date of September 30, 1998, unless otherwise terminated or extended in 
accordance with its terms.

(4) 

Includes shares issuable under the Company’s 1999 Stock Option Plan (the “1999 Option Plan”). The 1999 
Option Plan expired in November 2008.

(5)  Does not include restricted stock units (RSUs).

46

 
PROPOSAL NO. 2
APPROVAL OF 2004 EXECUTIVE INCENTIVE PLAN,
AS AMENDED AND RESTATED

On May 20, 2010, the Compensation Committee amended and restated the Lam 2004 Executive Incentive 
Plan  (as  so  amended  and  restated,  the  “Revised  Plan”).  At  that  time,  the  Compensation  Committee  also 
recommended  that  the  Revised  Plan  be  resubmitted  for  approval  of  the  material  terms  by  our  stockholders 
at  the  2010  stockholders’  meeting  to  qualify  as  deductible  “performance  based  compensation”  for  purposes 
of  Section  162(m)  (“Section  162(m)”)  of  the  Internal  Revenue  Code  (“Code”).  One  of  the  requirements  of 
“performance-based compensation” for purposes of Section 162(m) is that the compensation be paid pursuant to 
a plan that has had its material terms approved by the company’s stockholders, and that the plan be re-approved 
by the company’s stockholders no later than the first stockholders’ meeting that occurs in the fifth year following 
the year in which the stockholders previously approved the material terms of the plan. We are now requesting 
stockholder approval of the terms of the Revised Plan for purposes of compliance with Section 162(m) and to allow 
awards under the Revised Plan to be deductible as “performance based compensation” under Section 162(m).

The  Revised  Plan  provides  for  performance-based  incentive  compensation  that  is  payable  to  selected 
members of the Company’s senior management if the Company achieves specified corporate, financial or other 
business goals. We believe it is in the best interests of the Company and its stockholders for the Company to have 
a stockholder-approved bonus plan such as the Revised Plan that allows the Company both to provide members 
of senior management with a strong incentive to meet or exceed specified financial and business goals and to 
be able to fully deduct amounts paid under the plan for U.S. federal corporate income tax purposes. Without 
stockholder approval, however, Section 162(m) would limit the amount the Company can deduct as compensation 
paid to certain executive officers for awards under the Revised Plan.

If the Revised Plan is approved by stockholders, awards will qualify as performance-based compensation 

under Section 162(m).

BACKGROUND

General Information. The 2004 Executive Incentive Plan (prior to its amendment and restatement in May 
2010, the “Prior Plan”) was initially adopted by Lam’s stockholders in November 2003. In November 2005, the 
Prior Plan was amended by Lam’s stockholders to allow the Company to issue performance-based stock awards 
in addition to cash payments and to revise the business criteria from which the Compensation Committee can 
select in establishing the business goals that must be achieved in order for a participant to earn an award under 
the Prior Plan. In November 2006, Lam’s stockholders also approved an amendment to increase the limit on 
the aggregate amount of cash awards paid under the Prior Plan to any one participant with respect to specified 
performance goals for any twelve-month measurement period from $2 million to $12 million.

Programs.  We  currently  operate  two  incentive  compensation  programs,  the  Annual  Incentive  Program 
(“AIP”) and the Long-Term Incentive Program (“LTIP”) under the Prior Plan. The AIP and LTIP are described 
above under the Compensation Discussion and Analysis.

If we operate more than one compensation program at a time under the Prior Plan or the Revised Plan, as 
we currently do with the AIP and the LTIP, the criteria and the aggregate cash payable to any individual in a 
given twelve-month period under all programs operated under the Prior Plan or the Revised Plan must not exceed 
the applicable plan limits.

DESCRIPTION OF THE AMENDMENTS

The Compensation Committee made two amendments to the Prior Plan in May 2010 when amending and 
restating it to become the Revised Plan. The first amendment increases the maximum aggregate amount of cash 
awards payable under the Revised Plan to any one participant with respect to specified performance goals for 
any  twelve-month  measurement  period  from  $12  million  to  $15  million.  The  second  amendment  revises  the 
business criteria which may be used to establish performance goals for participants in the Plan.

47

Increasing the Revised Plan’s maximum award limit is intended to support and help achieve one of the 
objectives set by the Compensation Committee, specifically to structure cost-effective compensation programs 
to take into account the accounting treatment and tax deductibility of compensation expense. See “Executive 
Compensation  Philosophy”  in  the  Compensation  Discussion  and  Analysis  (“CD&A”)  section  in  Proposal 
No.  1,  above.  The  maximum  award  limit  under  the  Prior  Plan  of  $12,000,000  is  likely  to  remain  adequate 
so  long  as  our  compensation  programs  include  both  cash  and  equity  components  (as  is  the  case  under  our 
current programs). However, the Compensation Committee is concerned that if, for competitive, regulatory or 
other reasons, it becomes advisable to move to an all-cash program, the existing maximum cash award limit 
might not be sufficient to permit the full deductibility of all awards, when considered over the next five-year 
period.  The  Committee  believes  that  it  exercises  appropriate  judgment  in  determining  award  programs  by 
following the principles described under “Executive Compensation Philosophy,” as further articulated by the 
practices  described  throughout  the  CD&A.  Among  these  are  referring  to  competitive  peer  group  practices, 
making performance-based awards under the Annual Incentive Program, making performance-based awards 
for 75% of the target awards under the Long-Term Incentive Program, and seeking the advice of an independent 
compensation adviser. Therefore, the Committee believes that increasing the maximum award limit as provided 
in  the  Revised  Plan,  which  will  enhance  the  tax  deductibility  of  potential  awards,  is  in  the  best  interests  of 
the stockholders.

Revising the business criteria is intended to conform the performance criteria under the Revised Plan to the 
criteria that have been established under the Company’s other compensation and benefit plans and programs. By 
doing so, the Compensation Committee intends to simplify administration of the various plans. The revisions do 
not significantly alter the criteria specified and used for awards under the Prior Plan.

SUMMARY OF THE REVISED PLAN

The  following  is  a  summary  of  material  terms  of  the  Revised  Plan,  and  is  qualified  in  its  entirety  by 

reference to the full text of the Revised Plan, which is attached to this Proxy Statement as Appendix A.

Administration.  The  Compensation  Committee  administers  the  Revised  Plan.  The  Compensation 

Committee is composed solely of at least two “outside directors” as defined under Section 162(m).

Eligible  Employees.  All  members  of  senior  management  of  the  Company  and  its  affiliates  (currently 
approximately 13 persons) are eligible to be selected for participation. For purposes of the Revised Plan, “senior 
management” is defined as any officers who are subject to Section 16(a) of the Securities Exchange Act or who 
are otherwise designated as eligible by the Compensation Committee.

Maximum  Potential  Incentive  Compensation  Awards.  Cash  awards  paid  to  any  one  participant  under 
the Revised Plan in respect of performance goals for any twelve-month measurement period shall not exceed 
$15,000,000; provided, however, that (a) in the event of a measurement period of longer or shorter duration than 
twelve months, the $15,000,000 limit will be increased or decreased, respectively, on a proportionate basis; and 
(b) receipt by a participant of payment of an award amount earned with respect to a measurement period in a later 
period, whether through elective deferral by the participant or a deferral included as part of the award structure, 
does not affect application of the $15,000,000 cash limit to the participant during the later period.

Stock awards or restricted stock unit awards granted to any one participant in any one calendar year (which 
may vest over multiple years) under the Revised Plan shall not exceed 300,000 shares of the Company’s common 
stock. Any stock awards or restricted stock unit awards may be made from and with the terms permitted under 
any stock option, equity incentive or similar plan adopted by the Company’s Board of Directors and approved 
by its stockholders. Currently, equity awards under the Revised Plan are made under the Company’s 2007 Stock 
Incentive Plan.

Performance  Goals.  Payment  under  the  Revised  Plan  will  be  based  on  the  Company’s  attainment  of 
performance goals based on one or more of the business criteria listed below. These goals may be designated 
either individually, alternatively or in any combination; applied to the Company as a whole or to one or more 
business  units,  affiliates  or  business  segments,  either  individually,  alternatively  or  in  any  combination;  and 
measured  either  annually  or  cumulatively  over  a  period  of  years,  on  an  absolute  basis  or  relative  to  a  pre-

48

established target, to previous years’ results or to a designated comparison group; in each case, as specified by 
the Compensation Committee in the applicable award. Goals may include actual, growth, or performance-to-
target goals.

The potential performance goals under the Revised Plan include:

(i) 

cash flow, including free cash flow;

(ii)  earnings  (including  revenue,  gross  margin,  operating  income,  earnings  before  interest  and  taxes, 

earnings before taxes, and net earnings) or earnings per share;

(iii)  stock price;

(iv)  return on equity or average shareholders’ equity;

(v) 

total stockholder return, either actual or relative to share price or market capitalization;

(vi)  return on capital;

(vii)  return on assets or net assets;

(viii) return on investment or invested capital;

(ix)  return on operating revenue;

(x) 

income,  net  income,  operating  income,  net  operating  income,  operating  income,  net  operating 
income, or operating margin (with or without regard to amortization/impairment of goodwill);

(xi)  market share or applications won;

(xii)  operational  performance,  including  orders,  backlog,  deferred  revenues,  revenue  per  employee, 

overhead, days sales outstanding, inventory turns, or other expense levels;

(xiii) stockholder  value  or  return  relative  to  the  moving  average  of  the  S&P  500  Index  or  a  peer 

group index;

(xiv)  asset turns; and

(xv)  strategic plan development and implementation (including individually designed goals and objectives 
that  are  consistent  with  the  participant’s  specific  duties  and  responsibilities  and  that  are  designed 
to improve the organizational performance of the Company, an affiliate, or a specific business unit 
thereof and that are consistent with and derived from the strategic operating plan of the Company, an 
affiliate or any of their business units for the applicable performance period).

Establishment of Award. The Compensation Committee will establish the terms of the awards including 
(i) the length of the measurement period; (ii) the specific business criterion or criteria, or combination thereof, 
that will be used; (iii) the specific performance targets that will be used for the selected business criterion or 
criteria; (iv) any special adjustments that will be applied in calculating whether the performance targets have 
been met to factor out extraordinary items; (v) the formula for calculating compensation eligible for payment 
under the Revised Plan in relation to the performance targets; (vi) the eligible employees who will participate in 
the Revised Plan for that measurement period; and (vii) if applicable, the target amounts for each participant for 
the measurement period.

The Compensation Committee will establish these criteria in writing no later than 90 days after the start 
of each measurement period, on or before 25% of the measurement period has elapsed, and while the outcome 
is substantially uncertain.

Determination  of  Attainment  of  Performance  Goals.  The  Compensation  Committee  will  determine  the 
amounts  to  be  paid  to  each  employee  for  each  measurement  period  or  the  extent  to  which  awards  vest.  The 
Compensation Committee will certify in writing before payments are made the extent to which the goals were 
met and payments amounts. The Compensation Committee does not have discretion to increase the amount of 
an award or accelerate the vesting of an award if such action would cause the award or any part thereof to not be 
deductible under the Internal Revenue Code. The Compensation Committee may exercise negative discretion in 
a manner consistent with Section 162(m).

49

All cash payments for awards will be made on or before March 15th of the year following the year in which 
the measurement period ends, unless a valid deferral election is made which complies with Section  409A of 
the Code.

Amendment and Termination. The Compensation Committee may amend or terminate the Revised Plan on 
a prospective basis at any time although it does not have the power to amend the Revised Plan in any fashion that 
would cause the Revised Plan to fail to qualify as performance-based compensation with respect to any “covered 
employee” under Section 162(m) of the Code.

New Plan Benefits. It is not possible to determine specific amounts of awards that may be granted in the 
future under the Revised Plan because the grant and actual payout of awards will be discretionary and subject 
to Company performance.

FEDERAL INCOME TAX CONSIDERATIONS

The following is a brief summary of the U.S. federal income tax consequences with respect to operation 
of the Revised Plan. It does not purport to be complete and does not discuss the tax consequences arising in 
connection with a participant’s death or under any tax law other than U.S. federal income tax law.

All  cash  amounts  paid  pursuant  to  the  Revised  Plan  constitute  taxable  income  to  the  employee  when 
received. If an employee elects to defer a portion of a Revised Plan bonus, he or she may be entitled to defer 
receipt of the bonus payment year in a manner that complies with Section 409A of the Code and the recognition 
of income to a later year.

If a participant receives unrestricted shares in payment of an award under the Revised Plan (pursuant to 
the 2007 Stock Incentive Plan), the payment generally will be subject to tax at ordinary income rates on the fair 
market value of the shares at such time.

If a participant receives restricted stock units in payment of an award under the Revised Plan (pursuant to 
the 2007 Stock Incentive Plan), no income generally will be recognized upon the award of such restricted stock 
units. The recipient of a restricted stock unit award generally will be subject to tax at ordinary income rates on 
the fair market value of common shares on the date that such shares are transferred to the participant under the 
award, and the capital gains/loss holding period for such shares will also commence on such date.

Generally,  the  Company  will  receive  a  federal  income  tax  deduction  corresponding  to  the  amount  of 

income recognized by a participant in the Plan.

Vote Required to Approve Proposal No. 2; Board Recommendation

Stockholder approval of Proposal No. 2 requires the affirmative vote of a majority of the shares present and 

cast on the matter, in person or by proxy, at the Annual Meeting.

THE BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS A VOTE “FOR” THE 
APPROVAL OF THE 2004 EXECUTIVE INCENTIVE PLAN, AS AMENDED AND RESTATED.

50

PROPOSAL NO. 3 
RATIFICATION OF APPOINTMENT OF  
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Stockholders are being asked to ratify the appointment of Ernst & Young LLP as the Company’s independent 
registered  public  accounting  firm  for  fiscal  2011.  Ernst  &  Young  LLP  has  been  the  Company’s  independent 
registered public accounting firm (independent auditor) since fiscal year 1981.

Approval of Proposal No. 3 will require the affirmative vote of a majority of the outstanding shares of 
Common Stock present or represented and voting on the Proposal at the Annual Meeting. Each proxy received 
by the Proxy Holders will be voted “FOR” the ratification of the appointment of Ernst & Young LLP, unless the 
stockholder provides other instructions.

Ernst  &  Young  LLP’s  audit  services  for  the  Company  during  fiscal  2010  included  examining  Lam’s 
consolidated financial statements and its system of internal control over financial reporting, as well as providing 
services related to Lam’s filings with the SEC and other regulatory bodies. Audit-related services during fiscal 
2010  related  primarily  to  review  of  international  tax  structures  and  the  implementation  of  new  accounting 
pronouncements.

Our Audit Committee meets periodically with Ernst & Young LLP to review both audit and non-audit 
services performed by Ernst & Young LLP, as well as the fees charged for those services. Among other things, 
the  Committee  examines  the  effect  that  the  performance  of  non-audit  services,  if  any,  may  have  upon  the 
independence of the independent registered public accounting firm. All professional services provided by Ernst & 
Young LLP, including non-audit services, if any, are subject to approval by the Audit Committee in accordance 
with applicable securities laws, rules, and regulations. For more information, see the “Audit Committee Report” 
and the “Relationship with Independent Registered Public Accounting Firm” sections elsewhere in this Proxy 
Statement.

A representative of Ernst & Young LLP is expected to be present at the Annual Meeting and will have an 
opportunity to make a statement if he or she so desires. The representative will also be available to respond to 
appropriate questions from the stockholders.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” PROPOSAL NO. 3.

51

 
AUDIT COMMITTEE REPORT

The  Company’s  management,  Audit  Committee  and  independent  registered  public  accounting  firm 
(Ernst & Young LLP) have specific but different responsibilities relating to Lam’s financial reporting. Lam’s 
management is responsible for the financial statements and for the system of internal control and the financial 
reporting process. Ernst & Young LLP has the responsibility to express an opinion on the financial statements 
and the system of internal control over financial reporting, based on the audit they conducted in accordance with 
the standards of the Public Company Accounting Oversight Board (U.S.). The Audit Committee is responsible 
for monitoring and overseeing these processes.

In this context and in connection with the audited financial statements contained in the Company’s Annual 

Report on Form 10-K for the fiscal year ended June 27, 2010, the Audit Committee took the following actions:

• 
• 

• 

• 

Reviewed and discussed the audited financial statements with Company management

Discussed with Ernst & Young LLP the matters required to be discussed by Rule AU380 of the Public 
Company Accounting Oversight Board (“PCAOB”), “Communication with Audit Committees”

Reviewed the written disclosures and the letter from Ernst & Young LLP, required by Rule 3526 of 
the  PCAOB,  “Communication  with  Audit  Committees  Concerning  Independence,”  and  discussed 
with Ernst & Young LLP its independence

Based on the foregoing reviews and discussions, recommended to the Board of Directors that the 
audited financial statements be included in the Company’s 2010 Annual Report on Form 10-K for the 
fiscal year ended June 27, 2010 for filing with the SEC

This Audit Committee Report shall not be deemed “filed” with the SEC for purposes of federal securities 
law, and it shall not, under any circumstances, be incorporated by reference into any of the Company’s past or 
future SEC filings. The Report shall not be deemed soliciting material.

AUDIT COMMITTEE
David G. Arscott
Richard J. Elkus Jr.
Catherine P. Lego (Chair)

52

 
RELATIONSHIP WITH 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Ernst & Young LLP has audited the Company’s consolidated financial statements since the Company’s 

inception.

Fees Billed by Ernst & Young LLP

The table below shows the fees billed by Ernst & Young LLP for audit and other services provided to the 

Company in fiscal years 2010 and 2009.

Services / Type of Fee
Audit Fees(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Audit-Related Fees(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax Fees(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
All Other Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TOTAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Fiscal Year 2010
$2,266,000
84,500
—  
—  
$2,350,500

Fiscal Year 2009
$2,380,000
266,000
12,000
—  
$2,658,000

(1)  Audit  fees  represent  fees  for  professional  services  provided  in  connection  with  the  audits  of  annual 
financial statements, reviews of quarterly financial statements, and audit services related to other statutory 
or regulatory filings or engagements. In addition, audit fees include those fees related to Ernst & Young 
LLP’s  audit  of  the  effectiveness  of  the  Company’s  internal  control  over  financial  reporting  pursuant  to 
Section 404 of the Sarbanes-Oxley Act.

(2)  Audit-related  fees  consist  of  assurance  and  related  services  that  are  reasonably  related  to  the  audit  or 
review of the Company’s financial statements and are not reported above under “Audit Fees.” For fiscal 
2010, these fees related primarily to audit review of international tax structures, review of correspondence 
with the SEC, implementation of new accounting pronouncements, and consultations concerning financial 
accounting  and  reporting  standards  that  are  not  part  of  the  performance  of  the  audit  or  review  of  the 
financial  statements.  For  fiscal  2009,  these  fees  related  primarily  to  audit  review  of  international  tax 
structures, goodwill accounting and implementation of new accounting pronouncements.

(3) 

Tax fees represent fees for services primarily related to international tax compliance.

The Audit Committee reviewed summaries of the services provided by Ernst & Young LLP and the related 
fees during fiscal year 2010 and has determined that the provision of non-audit services was compatible with 
maintaining the independence of Ernst & Young LLP as the Company’s independent registered public accounting 
firm. The Audit Committee approved 100% of the services and related fee amounts for services provided by 
Ernst & Young LLP during fiscal year 2010.

Policy on Audit Committee Pre-Approval of Audit and Non-Audit Services

It is the responsibility of the Audit Committee to approve, in accordance with Sections 10A(h) and (i) of 
the  Exchange  Act  and  the  rules  and  regulations  of  the  SEC,  all  professional  services,  to  be  provided  to  the 
Company  by  its  Independent  Registered  Public  Accounting  Firm,  provided  that  the  Audit  Committee  shall 
not  approve  any  non-audit  services  proscribed  by  Section  10A(g)  of  the  Exchange  Act  in  the  absence  of  an 
applicable exemption.

It is the policy of the Company that the Audit Committee pre-approves all audit and permissible non-audit 
services provided by the Company’s independent registered public accounting firm, consistent with the criteria 
set forth in the Audit Committee Charter and applicable laws and regulations. The Committee has delegated to 
the Chair of the Committee the authority to pre-approve such services, provided that the Chair shall report any 
decisions to pre-approve such services to the full Audit Committee at its next regular meeting. These services 
may include audit services, audit-related services, tax services, and other services. The Company’s independent 
registered public accounting firm and Company management are required to periodically report to the Audit 
Committee regarding the extent of services provided by the Company’s independent registered public accounting 
firm pursuant to any such pre-approval.

53

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

No  family  relationships  exist  or  existed  during  fiscal  2010  among  any  of  the  Company’s  directors  and 

executive officers. No related-party transactions occurred during fiscal 2010.

 OTHER MATTERS

We are not aware of any other matters to be submitted to the Annual Meeting. If any other matters properly 
come before the Annual Meeting, the Proxy Holders intend to vote the shares they represent as the Board of 
Directors may recommend or, if the Board does not make a recommendation, as the Proxy Holders decide in 
their reasonable judgment.

It is important that your stock holdings be represented at the meeting, regardless of the number of shares 
you hold. We urge you to complete and return the accompanying proxy card in the enclosed envelope, or vote 
your shares by telephone or Internet, as described in the materials accompanying this Proxy Statement.

By Order of the Board of Directors,

Fremont, California 
Dated: October 4, 2010

George M. Schisler, Jr.
Secretary

54

 
 
 
 
APPENDIX A

LAM RESEARCH CORPORATION 
2004 EXECUTIVE INCENTIVE PLAN

Amended and Restated
Effective as of May 20, 2010

The Compensation Committee (the “Compensation Committee”) of the Board of Directors of Lam Research 
Corporation (“Company”) hereby adopts this amended and restated version of the 2004 Executive Incentive Plan 
(“Plan”), effective as of May 20, 2010.

1. Purpose.

The  purpose  of  the  Plan  is  to  provide  performance-based  incentive  compensation  in  the  form  of  cash 
payments or stock awards to executive officers and senior management of the Company and any affiliates which 
might subsequently adopt the Plan. The Plan is intended to qualify as performance-based compensation under 
Section 162(m) of the Internal Revenue Code (“Section 162(m)”).

2. Administration.

The  Plan  has  been  established  by,  and  shall  be  administered  by,  the  Compensation  Committee.  The 
Compensation Committee is composed solely of 2 or more outside directors as defined in Section 162(m) and, 
therefore, qualifies as an independent compensation committee under Section 162(m).

3. Stockholder Approval.

The Plan shall initially be effective if, and only if, the Company’s stockholders, by a majority of the votes 
considered present or represented and entitled to vote with respect to this matter, approve the material terms 
of the Plan, specifically, the employees eligible to receive compensation under the Plan; the business criteria 
on which the performance goals may be based; and the maximum amount of compensation that may be paid 
to  any  employee  under  the  Plan  in  any  year.  No  compensation  or  award  will  be  paid  and  vested  under  the 
Plan until after this approval is obtained. To the extent necessary for the Plan to qualify as performance-based 
compensation under Section 162(m) or its successor under then applicable law, these material terms of the Plan 
shall be disclosed to and reapproved by the stockholders no later than the first stockholder meeting that occurs 
in the fifth year following the year in which stockholders previously approved the material terms of the Plan.

4. Participants.

For each measurement period (which may but need not be a fiscal year), the Compensation Committee will 
choose, in its sole discretion, those eligible employees who will participate in the Plan during that measurement 
period and will be eligible to receive payment under the Plan for that measurement period.

a)  Eligible Employees. Persons who are eligible to participate in the Plan are all members of senior 
management of the Company and its affiliates. For purposes of the Plan, senior management is defined 
as any officer who is subject to the reporting rules of Section 16(a) of the Securities Exchange Act of 
1934, or who is designated as eligible for the Plan by the Compensation Committee in its discretion.

b)  Employment Criteria. In general, to participate in the Plan an eligible employee must be continuously 
employed  by  the  Company  or  an  affiliate  for  the  entire  measurement  period.  The  foregoing 
notwithstanding:  (i)  if  an  otherwise  eligible  employee  joins  the  Company  or  an  affiliate  during 
the measurement period, the Compensation Committee may, in its discretion, add the employee to 
the  Plan  for  the  partial  measurement  period,  and  (ii)  if  the  employment  of  an  otherwise  eligible 
employee ends before the end of the measurement period because of death, disability or termination 
of  employment  (as  determined  in  the  discretion  of  the  Compensation  Committee),  the  employee 
shall be paid a pro-rata portion of the compensation, if any, that otherwise would have been payable 
under the Plan based upon the actual achievement of the performance goals applicable during the 

55

measurement period in which termination of employment occurs, unless the Committee determines 
in its sole discretion that payment is not appropriate. If a participant is on unpaid leave status for any 
portion of the measurement period, the Compensation Committee, in its discretion, may reduce the 
participant’s payment on a pro-rata basis.

All determinations under the Plan, including those related to interpretation of the Plan, eligibility, or 
the payment or pro-ration of any payment shall be made by the Compensation Committee pursuant 
to the above terms, and those determinations shall be final and binding on all employees.

5. Awards.

The Compensation Committee shall determine the size and terms of an individual award that can be made 
in cash or stock. Stock awards may be made from and in such forms permitted under any stock option, equity 
incentive or similar plan adopted by the Company’s Board of Directors and approved by its stockholders. The 
stock  awards  shall  be  granted  and/or  vested  based  upon  the  attainment  of  performance  goals  as  set  forth  in 
Section 6.

6. Business Criteria on Which Performance Goals Shall be Based.

Payment under the Plan shall be based on the Company’s attainment of performance goals based on one or 
more of the following business criteria: Either individually, alternatively or in any combination, applied to either 
the Company as a whole or to a business unit, affiliate or business segment, either individually, alternatively or 
in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or 
relative to a pre-established target, to previous years’ results or to a designated comparison group, in each case 
as specified by the Compensation Committee in the award, and may include actual, growth, or performance-to-
target for: (i) cash flow, including free cash flow; (ii) earnings (including revenue, gross margin, operating profit, 
earnings before interest and taxes, earnings before taxes, and net earnings) or earnings per share; (iii) stock price; 
(iv) return on equity or average shareholders’ equity; (v) total stockholder return, either actual or relative to share 
price or market capitalization; (vi) return on capital; (vii) return on assets or net assets; (viii) return on investment 
or invested capital; (ix) return on operating revenue; (x) income, net income, operating income, net operating 
income,  operating  profit,  net  operating  profit,  or  operating  margin  (with  or  without  regard  to  amortization/
impairment of goodwill); (xi) market share or applications won; (xii) operational performance, including orders, 
backlog, deferred revenues, revenue per employee, overhead, days sales outstanding, inventory turns, or other 
expense levels; (xiii) stockholder value or return relative to the moving average of the S&P 500 Index or a peer 
group index; (xiv) asset turns; and (xv) strategic plan development and implementation (including individually 
designed goals and objectives that are consistent with the participant’s specific duties and responsibilities and 
that are designed to improve the organizational performance of the Company, an affiliate, or a specific business 
unit  thereof  and  that  are  consistent  with  and  derived  from  the  strategic  operating  plan  of  the  Company,  an 
affiliate or any of their business units for the applicable performance period). The Compensation Committee may 
appropriately adjust any evaluation of performance under the business criteria to exclude any of the following 
events  that  occurs  during  a  performance  period:  (A)  asset  write-downs;  (B)  litigation  or  claim  judgments  or 
settlements; (C) the effect of changes in tax law, accounting principles or other such laws or provisions affecting 
reported results; (D) accruals for reorganization and restructuring programs; and (E) any extraordinary non-
recurring items as described in Accounting Principles Board Opinion No. 30 and/or in management’s discussion 
and  analysis  of  financial  condition  and  results  of  operations  appearing  in  the  Company’s  annual  report  to 
shareholders for the applicable year.

7. Establishing Performance Goals.

The Compensation Committee shall establish, for each measurement period:

a) 

b) 

c) 

the length of the measurement period;

the specific business criterion or criteria, or combination thereof, that will be used;

the specific performance targets that will be used for the selected business criterion or criteria;

56

 
d) 

e) 

f) 

g) 

any special adjustments that will be applied in calculating whether the performance targets have been 
met to factor out extraordinary items;

the  formula  for  calculating  compensation  eligible  for  payment  under  the  Plan  in  relation  to  the 
performance targets;

the eligible employees who will participate in the Plan for that measurement period; and

if applicable, the target amounts for each participant for the measurement period.

The  Compensation  Committee  shall  make  these  determinations  in  writing  no  later  than  90  days  after 
the  start  of  each  measurement  period,  on  or  before  25%  of  the  measurement  period  has  elapsed,  and  while 
the outcome is substantially uncertain. Cash awards paid to any one participant under the Plan in respect of 
performance goals for any twelve-month measurement period shall not exceed $15,000,000; provided however 
that (a) in the event a measurement period of longer or shorter duration than twelve-months, this limit will be 
increased or decreased, respectively, on a proportionate basis; and (b) receipt by a participant of payment until 
a later period of an award amount earned with respect to a measurement period, either through elective deferral 
by the participant or a deferral included as part of the award structure, shall not affect application of the above 
cash limit to the participant during the later period. Stock awards or restricted stock unit awards granted to any 
one participant in any one calendar year (which may vest over multiple years) under the Plan shall not exceed 
300,000 shares of the Company’s common stock. The 300,000 shares shall be adjusted in the discretion of the 
Compensation Committee in the event of stock dividend, stock split, extraordinary cash dividend, or similar 
recapitalization of the Company.

If  an  employee  joins  the  Company  or  an  affiliate  during  the  measurement  period  and  becomes  an 
eligible employee pursuant to Paragraph 4(b), and if the employee is a “covered employee” within the meaning 
of  Section  162(m),  then  to  the  extent  necessary  for  the  Plan  to  qualify  as  performance-based  compensation 
under Section 162(m) or its successor under then applicable law, all relevant elements of the performance goals 
established pursuant to paragraph 6 of this Plan for that employee must be established on or before the date on 
which 25% of the time from the commencement of employment to the end of the measurement period has elapsed, 
and the outcome under the performance goals for the measurement period must be substantially uncertain at the 
time those elements are established.

8. Determination of Attainment of Performance Goals.

The  Compensation  Committee  shall  determine,  pursuant  to  the  performance  goals  and  other  elements 
established pursuant to section 6 of the Plan, the amounts to be paid to each employee for each measurement 
period or the extent to which awards have vested. The Compensation Committee’s determinations shall be final 
and binding on all participants. However, with respect to the Chief Executive Officer and Executive Chairman, 
the  Company’s  outside  directors  shall  be  entitled  (but  are  not  required)  to  review  and  approve  (by  majority 
vote) the Compensation Committee’s determination. These determinations must be certified in writing before 
payments are made, which requirement may be satisfied by approved minutes of the Compensation Committee 
meeting setting out the determinations made. The Compensation Committee shall not have discretion to increase 
the amount of an award or accelerate the vesting of an award to any employee who is a “covered employee” within 
the meaning of Section 162(m) if such action would cause the award or any part thereof to not be deductible 
under the Internal Revenue Code. The Compensation Committee may exercise negative discretion in a manner 
consistent with Section 162(m).

9. Amendments.

The Compensation Committee may not amend or terminate the Plan so as to increase, reduce or eliminate 
awards under the Plan for any given measurement period retroactively, that is, on any date later than 90 days after 
the start of the measurement period. The Compensation Committee may amend or terminate the Plan at any time 
on a prospective basis and/or in any fashion that does not increase, reduce or eliminate awards retroactively.

57

The foregoing notwithstanding, except as required by applicable law, the Compensation Committee shall 
not have the power to amend the Plan in any fashion that would cause the Plan to fail to qualify as performance-
based compensation with respect to any “covered employee” as defined under Section 162(m) or its successor. 
Without  limiting  the  generality  of  the  foregoing,  to  the  extent  it  would  cause  the  Plan  to  fail  to  qualify  as 
performance-based  compensation  with  respect  to  any  “covered  employee”  as  defined  under  Section  162(m) 
or its successor under then applicable law, the Compensation Committee shall not have the power to change 
the material terms of the performance goals unless (i) the modified performance goals are established by the 
Compensation  Committee  no  later  than  90  days  after  the  start  of  the  applicable  measurement  period,  on  or 
before 25 percent of the measurement period has elapsed, and while the outcome is substantially uncertain; and 
(ii) no payments are made under the modified performance goals until after the material terms of the modified 
performance goals are disclosed to and approved by the Company’s stockholders.

10. Time and Form of Payment.

All payments in respect of awards granted under this Plan shall be made in cash on or before March 15th 
of  the  year  following  the  year  in  which  the  measurement  period  ends.  The  Committee  may  also  provide  for 
payment in the form of shares or share awards as provided in Section 5.

11. Section 409A of the Code.

Awards  under  the  Plan  are  intended  to  comply  with  Section  409A  of  the  Code  and  all  awards  shall  be 
interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other 
interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that 
may be issued after the effective date of the Plan. Notwithstanding any provision of the Plan or any Award to the 
contrary, in the event that the Committee determines that any Award may or does not comply with Section 409A 
of the Code, the Company may adopt such amendments to the Plan and the affected Award (without employee 
consent) or adopt other policies and procedures (including amendments, policies and procedures with retroactive 
effect), or take any other actions, that the Compensation Committee determines are necessary or appropriate 
to  (i)  exempt  the  Plan  and  any  award  from  the  application  of  Section  409A  of  the  Code  and/or  preserve  the 
intended tax treatment of the benefits provided with respect to Award, or (ii) comply with the requirements of 
Section 409A of the Code.

Notwithstanding  any  provisions  of  this  Plan  to  the  contrary,  if  an  employee  is  a  “specified  employee” 
(within the meaning of Section 409A of the Code and determined pursuant to policies adopted by the Company) 
on his or her date of separation from service and if any portion of an award to be received by the employee upon 
his or her separation from service would be considered deferred compensation under Section 409A of the Code, 
amounts of deferred compensation that would otherwise be payable pursuant to this Plan during the six-month 
period immediately following the employee’s separation from service will instead be paid or made available 
on the earlier of (i) the first day of the seventh month following the date of the Participant’s separation from 
service and (ii) the employee’s death. In the event that payments are delayed pursuant to this section, then such 
payments shall be paid at the time specified in this section without interest. The Company shall consult with 
the employee in good faith regarding the implementation of the provisions of this section, provided that neither 
the Company nor any of its employees or representatives shall have any liability to the employee with respect 
thereto.  Any  amount  under  this  program  that  satisfies  the  requirements  of  the  “short-term  deferral”  rule  set 
forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute a deferred payment for purposes 
of  this  Plan.  Any  amounts  scheduled  for  payment  hereunder  when  they  are  ordinarily  paid,  will  nonetheless 
be  paid  to  employee  on  or  before  March  15th  of  the  year  following  the  year  when  the  payment  is  no  longer 
subject  to  a  substantial  risk  of  forfeiture.  For  purposes  of  Section  409A  of  the  Code,  the  right  to  a  series  of 
installment payments shall be treated as a right to a series of separate payments, and references herein to the 
employee’s termination of employment shall refer to employee’s separation of services with the Company within 
the meaning of Section 409A of the Code.

58

12. Rule 10b5-1 Trading Plans; Stock Withholding.

It  is  expected  that  participants  under  the  Plan  will  establish  or  modify  stock  trading  plans  under  Rule 
10b5-1 of the Securities Exchange Act of 1934, as amended, to provide for the sale of Company shares and remit 
to the Company the proceeds to meet the Company’s withholding obligations in connection with stock awards 
hereunder. To the extent participants fail to establish or modify 10b5-1 plans in accordance with the foregoing, 
the Company shall at its election either require the participant to pay cash sufficient to meet the withholding 
obligation or the Company shall withhold the number of shares under a stock award sufficient (based on the fair 
market value of the Shares) to meet such withholding obligation.

13. Effect on Employment/Right to Receive.

Employment with the Company and its affiliates is on an at-will basis. Nothing in the Plan shall interfere 
with or limit in any way the right of the Company to terminate any participant’s employment or service at any 
time, with or without cause or notice. Furthermore, the Company expressly reserves the right, which may be 
exercised at any time and without regard to any measurement period, to terminate any individual’s employment 
with or without cause, and to treat him or her without regard to the effect which such treatment might have 
upon him or her as a participant under this Plan. For purposes of this Plan, transfers of employment between the 
Company and/or its affiliates shall not be deemed a termination of employment. No person shall have the right 
to be selected to receive a Stock Award under the Plan, or, having been so selected, have the right to receive a 
future award.

14. Successors.

All obligations of the Company under the Plan, with respect to awards granted hereunder, shall be binding 
on any successor to the Company, whether the existence of such successor is the result of a direct or indirect 
purchase, merger, consolidation, or otherwise, of all or substantially all the business or assets of the Company.

15. Nontransferability of Awards.

No  award  granted  under  this  Plan  may  be  sold,  transferred,  pledged,  assigned,  or  otherwise  alienated 
or hypothecated, other than by will, by the laws of descent and distribution, or to the extent permitted by the 
Company’s 1997 Stock Incentive Plan, 1999 Stock Incentive Plan or other equity plan, to the extent an award is 
payable from such plans. All rights with respect to an award granted under this Plan shall be available during his 
or her lifetime only to the participant to whom the award under this Plan is granted.

59

(This page intentionally left blank.)

UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

(MARK ONE)

FORM 10-K

(cid:53)  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 27, 2010
OR
(cid:133)  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM __________ TO __________.
Commission file number: 0-12933
LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of 
incorporation or organization)

4650 Cushing Parkway 
Fremont, California 
(Address of principal executive offices)

94-2634797
(I.R.S. Employer 
Identification No.)

94538 
(Zip code)

Registrant’s telephone number, including area code: (510) 572-0200
Securities registered pursuant to Section 12(b) of the Act:

Title of class
Common Stock, Par Value $0.001 Per Share

Name of exchange on which registered
NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes (cid:53)  No (cid:133)
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes (cid:133)  No (cid:53)
Indicate  by  check  mark  whether  the  registrant  (1)  has  filed  all  reports  required  to  be  filed  by  Section  13  or  15(d)  of  the  Securities  Exchange  Act  of 
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing 
requirements for the past 90 days. Yes (cid:53)  No (cid:133)

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required 
to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required 
to submit and post such files). Yes (cid:133)  No (cid:133)

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the 
best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this 
Form 10-K. (cid:133)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See 

the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer (cid:53)

Accelerated filer (cid:133)

Non-accelerated filer (cid:133)
(Do not check if a smaller reporting company)

Smaller reporting company (cid:133)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes (cid:133)  No (cid:53)
The aggregate market value of the Registrant’s Common Stock, $0.001 par value, held by non-affiliates of the Registrant, as of December 27, 2009, the 
last business day of the most recently completed second fiscal quarter with respect to the fiscal year covered by this Form 10-K, was $3,744,253,386. Common 
Stock held by each officer and director and by each person who owns 5% or more of the outstanding Common Stock has been excluded from this computation 
in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination of such status for other 
purposes.

As of August 13, 2010, the Registrant had 124,172,201 outstanding shares of Common Stock.

DOCUMENTS INCORPORATED BY REFERENCE

Parts of the Registrant’s Proxy Statement for the Annual Meeting of Stockholders expected to be held on or about November 4, 2010 are incorporated 
by reference into Part III of this Form 10-K. (However, the Reports of the Audit Committee and Compensation Committee are expressly not incorporated by 
reference herein.)

(This page intentionally left blank.)

LAM RESEARCH CORPORATION

2010 ANNUAL REPORT ON FORM 10-K

 TABLE OF CONTENTS

Part I.

Item 1.

Business  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 1A. Risk Factors  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 1B. Unresolved Staff Comments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 2.

Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 3.

Legal Proceedings  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 4.

Removed and Reserved  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Part II.

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer 

Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 6.

Selected Financial Data  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 7. Management’s Discussion and Analysis of Financial Condition and Results  

of Operations  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 7A. Quantitative and Qualitative Disclosures about Market Risk . . . . . . . . . . . . . . . . . . . . . . . .

Item 8.

Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 9.

Changes in and Disagreements with Accountants on Accounting and  
Financial Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 9A. Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Part III.

Item 10. Directors, Executive Officers, and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 11. Executive Compensation  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related 

Stockholder Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 13. Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . .

Item 14. Principal Accounting Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Part IV.

Item 15. Exhibits, Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signatures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Exhibit Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page

2

10

19

19

19

19

20

22

24

38

41

41

41

42

43

43

43

43

43

44

87

90

1

 
 
PART I

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

With the exception of historical facts, the statements contained in this discussion are forward-looking 
statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform 
Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified 
as forward-looking, by use of phrases and words such as “we believe,” “we anticipate,” “we expect,” “may,” 
“should,” “could,” and other future-oriented terms. The identification of certain statements as “forward-
looking” is not intended to mean that other statements not specifically identified are not forward-looking. 
Forward-looking  statements  include,  but  are  not  limited  to,  statements  that  relate  to  our  future  revenue, 
shipments, cost and margins, product development, demand, acceptance and market share, competitiveness, 
market opportunities, levels of research and development (R&D), the success of our marketing, sales and 
service  efforts,  outsourced  activities  and  operating  expenses,  anticipated  manufacturing,  customer  and 
technical requirements, the ongoing viability of the solutions that we offer and our customers’ success, tax 
expenses, our management’s plans and objectives for our current and future operations and business focus, 
the levels of customer spending or R&D activities, general economic conditions, the sufficiency of financial 
resources  to  support  future  operations,  and  capital  expenditures.  Such  statements  are  based  on  current 
expectations and are subject to risks, uncertainties, and changes in condition, significance, value and effect, 
including without limitation those discussed below under the heading “Risk Factors” within Item 1A and 
elsewhere in this report and other documents we file from time to time with the Securities and Exchange 
Commission (the “SEC”), such as our quarterly reports on Form 10-Q and our current reports on Form 8-K. 
Such risks, uncertainties and changes in condition, significance, value and effect could cause our actual 
results to differ materially from those expressed in this report and in ways we cannot readily foresee. Readers 
are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the 
date hereof and are based on information currently and reasonably known to us. We do not undertake any 
obligation to release the results of any revisions to these forward-looking statements, which may be made to 
reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of 
anticipated or unanticipated events.

Item 1.  Business

Incorporated in 1980, Lam Research Corporation (“Lam Research,” “Lam,” “we,” or the “Company”) is 
headquartered in Fremont, California, and maintains a network of facilities throughout North America, Asia, 
and Europe in order to meet the needs of its global customer base.

Additional information about Lam Research is available on our website at http://www.lamresearch.com.

Our Annual Report on Form 10-K, Quarterly Reports on Forms 10-Q, Current Reports on Forms 8-K, and 
any amendments to those reports are available on our website as soon as reasonably practical after we file them 
with or furnish them to the Securities and Exchange Commission (“SEC”) and are also available online at the 
SEC’s website at http://www.sec.gov.

The Lam Research logo, Lam Research, and all product and service names used in this report are either 
registered trademarks or trademarks of Lam Research Corporation in the United States and/or other countries. 
All other marks mentioned herein are the property of their respective holders.

All  references  to  fiscal  years  apply  to  our  fiscal  years,  which  ended  June  27,  2010,  June  28,  2009,  and 

June 29, 2008.

Lam  Research  is  a  leading  supplier  of  wafer  fabrication  equipment  and  services  to  the  worldwide 
semiconductor  industry.  For  thirty  years,  our  wafer  fabrication  equipment,  services,  and  extensive  technical 
expertise  have  contributed  to  advancing  semiconductor  manufacturing  and  producing  some  of  the  world’s 
most advanced semiconductor devices. We are recognized as the global market share leader in plasma etch and 
maintain the largest installed base of single-wafer wet clean modules in the world.

2

We  design,  manufacture,  market,  refurbish,  and  service  semiconductor  processing  equipment  used  in 
the fabrication of integrated circuits. Semiconductor wafers are subjected to a complex series of process and 
preparation steps that result in the simultaneous creation of many individual integrated circuits. We leverage 
our expertise in the areas of etch and single-wafer clean to develop processing solutions that typically benefit 
our customers through lower defect rates, enhanced yields, faster processing time, and/or reduced cost. Many of 
the technical advances that we introduce in our newest products are also available as upgrades to our installed 
base of equipment; this is a benefit that can provide customers with a cost-effective strategy for extending the 
performance and capabilities of their existing wafer fabrication lines.

Our  innovative  etch  and  clean  technologies  enable  customers  to  build  some  of  the  world’s  highest-
performing integrated circuits. Our etch systems shape the microscopic conductive and dielectric layers into 
circuits that define a chip’s final use and function. Our broad portfolio of single-wafer clean technologies allows 
our customers to implement customized yield-enhancing solutions. With each new technology node, additional 
requirements  and  challenges  drive  the  need  for  advanced  manufacturing  solutions.  We  strive  to  consistently 
deliver these advanced capabilities with cost-effective production performance. Lam Research understands the 
close relationship between customer trust and the timely delivery of new solutions that leads to shared success 
with our customers.

Our Customer Support Business Group (“CSBG”) provides products and services to maximize installed 
equipment performance and operational efficiency. We offer a broad range of services to deliver value throughout 
the lifecycle of our equipment, including customer service, spares, upgrades, and refurbishment of our etch and 
clean products. While most semiconductor device manufacturers have transitioned to 300 mm wafer technology, 
there are still many who utilize 200 mm technology, requiring prior-generation equipment. To address this market 
and to meet customers’ needs for high-performance, low-risk equipment, our Reliant™ Systems Business offers 
a suite of new and refurbished Lam legacy equipment for etch and spin clean.

Etch Process

Etch  processes,  which  are  repeated  numerous  times  during  the  wafer  fabrication  cycle,  are  required  to 
manufacture every type of semiconductor device produced today. Our etch products selectively remove portions 
of various films from the wafer in the creation of semiconductor devices. These products use various plasma-
based technologies to create critical device features at current and future technology nodes. Plasma consists 
of charged and neutral particles that react with exposed portions of the wafer surface to remove dielectric or 
conductive materials and produce the finely delineated features and patterns of an integrated circuit.

Dielectric Etch

Dielectric etch often requires etching multi-layer film stacks. Smaller node sizes increase the complexity 
of the structures being etched, and repeat on-wafer performance remains critical. In addition to the challenges 
introduced by new materials and scaling, device manufacturers’ focus on reducing overall cost per wafer has 
placed an increased emphasis on the ability to etch multiple films in the same chamber (in situ) .

DFC Technology

Production-proven  in  high-volume  manufacturing  for  the  past  15  years,  our  patented  Dual  Frequency 
Confined™  technology  has  been  extended  to  incorporate  multi-frequency  power  with  physically  confined 
plasma.  The  application  of  power  at  different  frequencies  provides  enhanced  process  flexibility  and  allows 
different materials to be etched in the same chamber. Physical confinement of the plasma to an area directly 
above the wafer minimizes chemical interaction with the chamber walls, eliminating potential polymer build-up 
that could lead to defects on the wafer. Confinement also enables our proprietary in situ Waferless Autoclean™ 
(“WAC”)  technology  to  clean  chamber  components  after  each  wafer  has  been  etched.  Used  together,  multi-
frequency and WAC technologies provide a consistent process environment for every wafer, preventing process 
drift and ensuring repeatable process results wafer-to-wafer and chamber-to-chamber.

3

2300® Exelan® Flex™, 2300® Exelan® Flex45™, 2300® Flex™ D Series Dielectric Etch Systems

Our  2300  Flex  dielectric  etch  product  family  represents  a  continuous  evolution  of  the  productivity  and 
performance  benefits  of  DFC  technology.  The  2300  Flex  family  allows  a  single  chamber  design  to  meet  the 
requirements of a wide range of applications at multiple nodes. Advances in system design, such as multiple 
frequencies, higher power capabilities and tunable wafer temperature, meet the more demanding uniformity and 
profile requirements for applications at the 32 nm node and beyond.

Conductor Etch

As the semiconductor industry continues to shrink critical feature sizes and improve device performance, 
a variety of new etch challenges have emerged. For conductor etch, these challenges include processing smaller 
features, new materials, and new transistor structures on the wafer. Due to decreasing feature sizes, the etch 
process can now require atomic-level control across a 300 mm wafer. The incorporation of new metal gates and 
high-k dielectric materials in the device  stack  requires advanced multi-film etching capability. Furthermore, 
the adoption of double patterning techniques to address lithography challenges at the 45 nm node and beyond is 
driving the etch process to define the feature on the wafer as well as to transfer the pattern into the film. All of 
these challenges require today’s conductor etch systems to provide advanced capabilities, while still providing 
high productivity.

TCP Technology

Introduced  in  1992,  our  Transformer  Coupled  Plasma™  technology  continues  to  provide  leading-edge 
capability for advanced conductor etch applications at the 32 nm node and beyond. By efficiently coupling radio 
frequency (“RF”) power into plasma at low pressures, the TCP technology provides capability to etch nanoscale 
features into silicon and metal films. The advanced TCP source design ensures a uniform, high-density plasma 
across the wafer, without requiring magnetic enhancements that could cause device damage. With a wide process 
window over a range of power, chemistry, and pressure combinations, TCP technology provides the flexibility 
required to perform multiple etch steps in the same chamber.

2300® Versys® Kiyo®, 2300® Versys® Kiyo45™, 2300® Kiyo® C Series, 2300® Versys® Metal, 2300® Versys® 
Metal45™, 2300® Versys® Metal L Conductor Etch Systems

Now in its third generation, the 2300 Kiyo product family combines iterative advances in technology to 
provide critical dimension (“CD”) uniformity and productivity for a wide range of conductor etch applications. 
The  2300  Versys  Metal  product  family  leverages  Lam’s  proprietary  TCP  technology  to  provide  a  flexible 
platform for back-end-of-line metal etch processes. Our etch products perform production-proven in situ etches 
of complex features. In addition, proprietary pre-coat and post-etch chamber clean techniques provide the same 
environment for superior repeatability, as well as high uptime and yield wafer after wafer.

MEMS and Deep Silicon Etch

Deep  silicon  etch  is  an  enabling  process  for  several  emerging  technologies,  including  micro-
electromechanical  systems  (“MEMS”)  devices,  CMOS  image  sensors,  and  power  devices.  Many  of  these 
technologies are increasingly being used in consumer applications, such as ink jet printer heads, accelerometers, 
and inertial sensors. This is driving a number of deep silicon etch applications to transition into high-volume 
manufacturing,  which  requires  the  high  levels  of  cost-effective  production  typically  seen  in  commodity 
semiconductor memory devices. To achieve high yield in mass production, the deep silicon etch process requires 
wafer-to-wafer repeatability.

TCP ® 9400DSiE™ Deep Silicon Etch System

The TCP 9400DSiE system is based on our production-proven TCP 9400 silicon etch series. The system’s 
patented high-density TCP plasma source provides a configuration to meet the challenges of silicon deep reactive 
ion  etch,  offering  broad  process  capability  and  flexibility  for  a  wide  range  of  MEMS,  advanced  packaging, 
and power semiconductor applications. Incorporation of our proprietary in situ chamber cleaning technology 
provides etch rate stability.

4

Three-Dimensional Integrated Circuit Etch

The  semiconductor  industry  is  developing  advanced,  three-dimensional  integrated  circuits  (“3-D  ICs”) 
using  through-silicon  vias  (“TSVs”)  to  provide  interconnect  capability  for  die-to-die  and  wafer-to-wafer 
stacking. In addition to a reduced form factor, 3-D ICs can enhance device performance through increased speed 
and decreased power consumption. Manufacturers are currently considering a wide variety of 3-D integration 
schemes that present an equally broad range of TSV etch requirements. Plasma etch technology, which has been 
used  extensively  for  deep  silicon  etching  in  memory  devices  and  MEMS  production,  is  well  suited  for  TSV 
creation.

2300® Syndion® Through-Silicon Via Etch System

The 2300 Syndion etch system is based on our patented TCP technology and the production-proven 2300 
Versys Kiyo conductor etch system. The Syndion system can etch multiple film stacks in the same chamber, 
including silicon, dielectric, and conducting materials, thereby addressing multiple TSV etch requirements.

Clean Process

The manufacture of semiconductor devices involves a series of processes such as etch, deposition, and 
implantation, which leave particles and residues on the surface of the wafer. The wafer must generally be cleaned 
after these steps to remove particles and residues that could adversely impact the processes that immediately 
follow them and degrade device performance. Common wafer cleaning steps include post-etch and post-strip 
cleans and pre-diffusion and pre-deposition cleans, among others.

Specific  challenges  at  the  45  nm  node  and  beyond  include  efficient  particle  and  residue  removal  while 
minimizing substrate material loss, protecting structures with fragile new materials and smaller feature sizes, 
and efficient drying. In addition, management of potential defect sources at the wafer edge becomes increasingly 
challenging as new materials are introduced in the process flow.

Single-Wafer Wet Clean

As device geometries shrink and new materials are introduced, device flows become more complex, and 
the number of wafer cleaning steps increases. The need to have better control of the cleaning process, to increase 
overall clean efficiency, and to clean fragile structures without causing damage are reasons why chipmakers are 
turning to single-wafer wet clean processing technology for next-generation devices.

Over the past decade, a transition from batch to single-wafer processing has occurred for back-end-of-line wet 
clean applications and a similar migration is now taking place for front-end-of-line wet clean applications as the 
need for higher particle removal efficiency without device structure damage becomes more critical. Single-wafer 
wet processing is particularly advantageous for those applications where improved defect performance (removing 
particles without damaging the wafer pattern) or enhanced selectivity and CD control can improve yield.

Spin Clean Products: SP Series, Da Vinci®, DV-Prime™

Introduced  over  20  years  ago,  SEZ®  spin  technology  for  cleaning  and  removing  films  has  assisted  the 
industry transition from batch to single-wafer wet processing. This proven technology provides the productivity 
and  flexibility  needed  for  both  high-volume  manufacturing  and  leading-edge  development  across  multiple 
technology nodes and for all device types. By offering advanced dilute chemistry and solvent solutions in our 
systems, our spin wet clean systems address certain defectivity and material integrity requirements.

Linear Clean Product: 2300® Serene®

To meet the challenges of smaller critical dimensions, increasing aspect ratios, and new materials integration, 
our 2300 Serene wet clean system is targeted at applications requiring high-selectivity residue removal without 
damaging sensitive device structures. The system’s C3™ (Confined Chemical Cleaning™) technology combines 
linear wafer motion with chemically-driven single-wafer cleaning to remove residues with chemical exposure 
times as short as a few seconds. The cleaning exposure time is optimized for efficient removal of the target 
materials, while limiting the impact on critical materials. This technology addresses applications that require 
high-selectivity cleaning, such as high-k metal gate post-etch clean.

5

Plasma-Based Bevel Clean

Semiconductor manufacturers are paying increasing attention to the wafer edge as a source of yield limiting 
defects. New materials like porous low-k and organic films often do not adhere as well as traditional silicon or 
polymer-based films and have the potential to be significant defect sources. By including cleaning steps that 
target the bevel region, the number of good die at the wafer’s edge can be increased to maximize yield.

2300® Coronus® Plasma Bevel Clean System

The 2300 Coronus plasma bevel clean system incorporates plasma technology to remove yield limiting 
defect  sources.  The  system  combines  the  ability  of  plasma  to  selectively  remove  a  wide  variety  of  materials 
with a proprietary confinement technology that protects the die area. Incorporating our Dynamic Alignment 
technology  on  the  production-proven  2300  platform,  the  Coronus  system  provides  highly  accurate  wafer 
placement for repeatable process results and superior encroachment control and is designed to remove a wide 
range of material types, in multiple applications, throughout the manufacturing process flow.

Research and Development

The  market  for  semiconductor  capital  equipment  is  characterized  by  rapid  technological  change  and 
product  innovation.  Our  ability  to  achieve  and  maintain  our  competitive  advantage  depends  in  part  on  our 
continued and timely development of new products and enhancements to existing products. Accordingly, we 
devote a significant portion of our personnel and financial resources to R&D programs and seek to maintain 
close and responsive relationships with our customers and suppliers.

Our  R&D  expenses  during  fiscal  years  2010,  2009,  and  2008  were  $320.9  million,  $288.3  million,  and 
$323.8 million, respectively. The majority of R&D spending over the past three years has been targeted at etch and other 
plasma-based technologies, single-wafer clean, and other semiconductor manufacturing products. We believe current 
challenges for customers at various points in the semiconductor manufacturing process present opportunities for us.

We expect to continue to make substantial investments in R&D to meet our customers’ product needs, 

support our growth strategy, and enhance our competitive position.

Marketing, Sales, and Service

Our marketing, sales, and service efforts are focused on building long-term relationships with our customers 
and targeting product and service solutions designed to meet their needs. These efforts are supported by a team 
of  product  marketing  and  sales  professionals  as  well  as  equipment  and  process  engineers  who  work  closely 
with individual customers to develop solutions for their wafer processing needs. We maintain ongoing service 
relationships with our customers and have an extensive network of service engineers in place throughout the 
United States, Europe, Taiwan, Korea, Japan, and Asia Pacific. We believe that comprehensive support programs 
and close working relationships with customers are essential to maintaining high customer satisfaction and our 
competitiveness in the marketplace.

We provide standard warranties for our systems that generally run for a period of 12 months from system 
acceptance. The warranty provides that systems shall be free from defects in material and workmanship and 
conform to agreed-upon specifications. The warranty is limited to repair of the defect or replacement with new 
or  like-new  equivalent  goods  and  is  valid  when  the  buyer  provides  prompt  notification  within  the  warranty 
period of the claimed defect or non-conformity and also makes the items available for inspection and repair. We 
also offer extended warranty packages to our customers to purchase as desired.

International Sales

A significant portion of our sales and operations occur outside the United States and, therefore, may be 
subject to certain risks, including but not limited to tariffs and other barriers, difficulties in staffing and managing 
non-U.S. operations, adverse tax consequences, foreign currency exchange rate fluctuations, changes in currency 

6

controls, compliance with U.S. and international laws and regulations, including U.S. export restrictions, and 
economic  and  political  conditions.  Any  of  these  factors  may  have  a  material  adverse  effect  on  our  business, 
financial position, and results of operations and cash flows. Revenue by region was as follows:

Revenue:

United States  . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Korea  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Taiwan  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total revenue  . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

$ 186,036
133,685
318,641
539,312
703,854
252,248
$ 2,133,776

Year Ended
June 28, 
2009
(in thousands)

$ 171,359
121,178
234,070
239,911
208,053
141,375
$ 1,115,946

June 29, 
2008

$ 417,807
235,191
455,322
554,924
502,683
308,984
$ 2,474,911

Customers

Our customers include many of the world’s leading semiconductor manufacturers. Customers continue to 
establish joint ventures, alliances and licensing arrangements which have the potential to positively or negatively 
impact our competitive position and market opportunities. In fiscal year 2010, revenues from Samsung Electronics 
Company, Ltd., Taiwan Semiconductor Manufacturing Company, Ltd., and Toshiba Corporation accounted for 
approximately 24%, 15%, and 11%, respectively, of total revenues. In fiscal year 2009, revenues from Samsung 
Electronics Company, Ltd. and Toshiba Corporation accounted for approximately 19% and 11%, respectively, of 
total revenues. In fiscal year 2008, revenues from Samsung Electronics Company, Ltd. and Toshiba Corporation 
accounted for approximately 19% and 13%, respectively, of total revenues.

A material reduction in orders from our customers in the semiconductor industry could adversely affect 
our  results  of  operations  and  projected  financial  condition.  Our  business  depends  upon  the  expenditures  of 
semiconductor  manufacturers.  Semiconductor  manufacturers’  businesses,  in  turn,  depend  on  many  factors, 
including their economic capability, the current and anticipated market demand for integrated circuits and the 
availability of equipment capacity to support that demand.

Backlog

In general, we schedule production of our systems based upon our customers’ delivery requirements. In 
order for a system to be included in our backlog, the following conditions must be met: 1) a written customer 
request that has been accepted, 2) agreement on prices and product specifications, and 3) scheduled shipment 
within the next 12 months. The spares and services backlog includes customer orders where written customer 
requests have been accepted and the delivery of products or provision of services is anticipated within the next 
12 months. Where specific spare parts and customer service purchase contracts do not contain discrete delivery 
dates, we use volume estimates at the contract price and over the contract period, not exceeding 12 months, in 
calculating backlog amounts. Our policy is to revise our backlog for order cancellations and to make adjustments 
to  reflect,  among  other  things,  changes  in  spares  volume  estimates  and  customer  delivery  date  changes.  At 
June 27, 2010 and June 28, 2009, our backlog was approximately $667 million and $391 million, respectively. 
Generally, orders for our products and services are subject to cancellation by our customers with limited penalties. 
Because some orders are received and shipped in the same quarter and because customers may change delivery 
dates and cancel orders, our backlog at any particular date is not necessarily indicative of business volumes or 
actual revenue levels for succeeding periods.

Manufacturing

Our manufacturing operations consist mainly of assembling and testing components, sub-assemblies, and 
modules that are then integrated into finished systems prior to shipment to or at the location of our customers. 
Most of the assembly and testing of our products is conducted in cleanroom environments.

7

We  have  agreements  with  third  parties  to  outsource  certain  aspects  of  our  manufacturing,  production 
warehousing, and logistics functions. We believe that these outsourcing contracts provide us more flexibility 
to scale our operations up or down in a timely and cost effective manner, enabling us to respond to the cyclical 
nature of our business. We believe that we have selected reputable providers and have secured their performance 
on terms documented in written contracts. However, it is possible that one or more of these providers could fail to 
perform as we expect, and such failure could have an adverse impact on our business and have a negative effect 
on our operating results and financial condition. Overall, we believe we have effective mechanisms to manage 
risks associated with our outsourcing relationships. Refer to Note 13 of our Consolidated Financial Statements, 
included in Item 15 of this report, for further information concerning our outsourcing commitments.

Certain  components  and  sub-assemblies  that  we  include  in  our  products  may  only  be  obtained  from  a 
single supplier. We believe that, in many cases, we could obtain and qualify alternative sources to supply these 
products. Nevertheless, any prolonged inability to obtain these components could have an adverse effect on our 
operating results and could unfavorably impact our customer relationships.

Environmental Matters

We are subject to a variety of governmental regulations related to the management of hazardous materials 
that we use in our business operations. We are currently not aware of any pending notices of violation, fines, 
lawsuits, or investigations arising from environmental matters that would have a material effect on our business. 
We believe that we are generally in compliance with these regulations and that we have obtained (or will obtain or 
are otherwise addressing) all necessary environmental permits to conduct our business. Nevertheless, the failure 
to comply with present or future regulations could result in fines being imposed on us, require us to suspend 
production  or  cease  operations  or  cause  our  customers  to  not  accept  our  products.  These  regulations  could 
require us to alter our current operations, to acquire significant additional equipment, or to incur substantial 
other  expenses  to  comply  with  environmental  regulations.  Our  failure  to  control  the  use,  sale,  transport  or 
disposal of hazardous substances could subject us to future liabilities.

Employees

As of August 13, 2010, we had approximately 3,232 regular employees. Although we have employment-related 
agreements with a number of key employees, these agreements do not guarantee continued service. Each of our employees 
is required to comply with our policies relating to maintaining the confidentiality of our non-public information.

In the semiconductor and semiconductor equipment industries, competition for highly skilled employees 
is intense. Our future success depends, to a significant extent, upon our continued ability to attract and retain 
qualified employees particularly in the R&D and customer support functions.

Competition

The semiconductor capital equipment industry is characterized by rapid change and is highly competitive 
throughout the world. To compete effectively, we invest significant financial resources to continue to strengthen 
and enhance our product and services portfolio and to maintain customer service and support locations globally. 
Semiconductor manufacturers evaluate capital equipment suppliers in many areas, including, but not limited to, 
process performance, productivity, customer support, defect control, and overall cost of ownership, which can be 
affected by many factors such as equipment design, reliability, software advancements, etc. Our ability to succeed 
in the marketplace depends upon our ability to maintain existing products and introduce product enhancements 
and new products that meet customer requirements on a timely basis. In addition, semiconductor manufacturers 
must make a substantial investment to qualify and integrate new capital equipment into semiconductor production 
lines. As a result, once a semiconductor manufacturer has selected a particular supplier’s equipment and qualified 
it for production, the manufacturer generally maintains that selection for that specific production application and 
technology node as long as the supplier’s products demonstrate performance to specification in the installed base. 
Accordingly, we may experience difficulty in selling to a given customer if that customer has qualified a competitor’s 
equipment. We must also continue to meet the expectations of our installed base of customers through the delivery 
of high-quality and cost-efficient spare parts in the presence of third-party spare parts provider competition.

8

We face significant competition with all of our products and services. Our primary competitors in the etch 
market are Tokyo Electron, Ltd. and Applied Materials, Inc. Our primary competitor in the single-wafer wet 
clean market is Dainippon Screen Manufacturing Co. Ltd.

Certain of our existing and potential competitors have substantially greater financial resources and larger 
engineering, manufacturing, marketing, and customer service and support organizations than we do. In addition, 
we  face  competition  from  a  number  of  emerging  companies  in  the  industry.  We  expect  our  competitors  to 
continue to improve the design and performance of their current products and processes and to introduce new 
products and processes with enhanced price/performance characteristics. If our competitors make acquisitions or 
enter into strategic relationships with leading semiconductor manufacturers, or other entities, covering products 
similar to those we sell, our ability to sell our products to those customers could be adversely affected. There can 
be no assurance that we will continue to compete successfully in the future.

Patents and Licenses

Our policy is to seek patents on inventions relating to new or enhanced products and processes developed as part 
of our ongoing research, engineering, manufacturing, and support activities. We currently hold a number of United 
States and foreign patents covering various aspects of our products and processes. We believe that the duration of 
our patents generally exceeds the useful life of the technologies and processes disclosed and claimed in them. Our 
patents, which cover material aspects of our past and present core products, have current durations ranging from 
approximately one to twenty years. We believe that, although the patents we own and may obtain in the future will be 
of value, they alone will not determine our success. Our success depends principally upon our engineering, marketing, 
support, and delivery skills. However, in the absence of patent protection, we may be vulnerable to competitors who 
attempt to imitate our products, manufacturing techniques, and processes. In addition, other companies and inventors 
may receive patents that contain claims applicable or similar to our products and processes. The sale of products 
covered by patents of others could require licenses that may not be available on terms acceptable to us, or at all. For 
further discussion of legal matters, see Item 3, “Legal Proceedings,” of this report.

EXECUTIVE OFFICERS OF THE COMPANY

As of August 20, 2010, the executive officers of Lam Research were as follows:

Name
Stephen G. Newberry
Martin B. Anstice
Ernest E. Maddock

Jeffrey Marks
Richard A. Gottscho
Thomas J. Bondur
Sarah A. O’Dowd

Age
56
43
52

52
58
42
60

Title

President and Chief Executive Officer
Executive Vice President and Chief Operating Officer
Senior Vice President, Chief Financial Officer 

and Chief Accounting Officer

Vice President and General Manager, Clean Business
Group Vice President and General Manager, Etch Business
Vice President and General Manager, Sales and Marketing
Group Vice President, Human Resources and Chief Legal Officer

Stephen  G.  Newberry  was  appointed  President  and  Chief  Executive  Officer  of  Lam  Research  in 
June 2005. He joined Lam Research in August 1997 as Executive Vice President and Chief Operating Officer 
and was promoted to the position of President and Chief Operating Officer in July 1998. Mr. Newberry currently 
serves  as  a  director  of  Lam  Research,  Amkor  Technology,  and  Semiconductor  Equipment  and  Materials 
International (SEMI), the industry’s trade association. He also serves as a member of the Haas Advisory Board, 
Haas School of Business, University of California at Berkeley and as a member of the Dean’s Advisory Council, 
University of California at Davis Graduate School of Management. Prior to joining Lam Research, Mr. Newberry 
was Group Vice President of Global Operations and Planning at Applied Materials, Inc. Mr. Newberry served 
five years in naval aviation prior to joining Applied Materials. He is a graduate of the U.S. Naval Academy and 
the Harvard Graduate School of Business, Program for Management Development.

Martin  B.  Anstice  joined  Lam  Research  in  April  2001  as  Senior  Director,  Operations  Controller,  was 
promoted to the position of Managing Director and Corporate Controller in May 2002, and was promoted to 
Group Vice President, Chief Financial Officer, and Chief Accounting Officer in June 2004, was named Senior 
Vice  President,  Chief  Financial  Officer  and  Chief  Accounting  Officer  in  March  2007,  and  was  promoted  to 

9

Executive Vice President, Chief Operating Officer, in September 2008. Mr. Anstice began his career at Raychem 
Corporation where, during his 13-year tenure, he held numerous finance roles of increasing responsibility in 
Europe and North America. Subsequent to Tyco International’s acquisition of Raychem in 1999, he assumed 
responsibilities supporting mergers and acquisition activities of Tyco Electronics. Mr. Anstice is an associate 
member of the Chartered Institute of Management Accountants in the United Kingdom.

Ernest  E.  Maddock  was  appointed  Senior  Vice  President  and  Chief  Financial  Officer  of  Lam  Research  in 
September 2008. Additionally, Mr. Maddock oversees Information Technology and heads Silfex Incorporated (formerly 
Bullen  Semiconductor  Corporation),  a  division  of  Lam  Research.  From  October  2003  through  September  2008, 
Mr. Maddock held the position of Senior Vice President of Global Operations at Lam Research, overseeing Information 
Technology,  Global  Supply  Chain,  Production  Operations,  Corporate  Quality,  Global  Security,  and  Global  Real 
Estate & Facilities. Mr. Maddock also held the position of Vice President of the Customer Support Business Group 
(CSBG) with the Company. Mr. Maddock joined the Company in November 1997. Prior to his employment with 
Lam Research, Mr. Maddock was Managing Director, Global Logistics and Repair Services Operations, and Chief 
Financial Officer, Software Products Division, of NCR Corporation. He has also held a variety of executive roles in 
finance and operations in several industries ranging from commercial real estate to telecommunications.

Jeffrey Marks has spent the past 20 years in the semiconductor industry, focusing on advanced process 
equipment development and business growth. He joined Lam Research Corporation in 1999, and has been the 
Vice President and General Manager of the Clean Product Group since March 2007. He is responsible for the 
Company’s spin, linear and bevel clean products. Before assuming responsibility for wet and plasma-based bevel 
clean, Dr. Marks managed the dielectric etch business at Lam Research. He worked for Applied Materials from 
1988 until 1999 and was responsible for several key technology and business activities, including flat panel etch, 
CMP,  dielectric  etch,  and  dielectric  CVD.  He  received  his  Ph.D.  in  chemistry  from  Stanford  University  and 
his B.S. degree in chemistry from the University of California, San Diego. He holds numerous patents and has 
authored several technical publications in the areas of semiconductor processing and thin-film applications.

Richard A. Gottscho, Group Vice President and General Manager, Etch Businesses since March 2007, joined 
the  Company  in  January  1996  and  has  served  at  various  Director  and  Vice  President  levels  in  support  of  etch 
products, CVD products, and corporate research. Prior to joining Lam Research, Dr. Gottscho was a member of Bell 
Laboratories for 15 years where he started his career working in plasma processing. During his tenure at Bell, he 
headed research departments in electronics materials, electronics packaging, and flat panel displays. Dr. Gottscho 
is the author of numerous papers, patents, and lectures in plasma processing and process control. He is a recipient 
of the American Vacuum Society’s Peter Mark Memorial Award and is a fellow of the American Physical and 
American Vacuum Societies, has served on numerous editorial boards of refereed technical publications, program 
committees for major conferences in plasma science and engineering, and was vice-chair of a National Research 
Council study on plasma science in the 1980s. Dr. Gottscho earned Ph.D. and B.S. degrees in physical chemistry 
from the Massachusetts Institute of Technology and the Pennsylvania State University, respectively.

Thomas  J.  Bondur,  Vice  President  and  General  Manager,  Sales  and  Marketing,  since  April  2009  and 
previously Vice President, Global Field Operations since March 2007, joined Lam Research in August 2001 and 
has served in various roles in business development and field operations in Europe and the United States. Prior 
to joining Lam Research, Mr. Bondur spent eight years in the semiconductor industry with Applied Materials 
in  various  roles  in  Santa  Clara  and  France  including  Sales,  Business  Management  and  Process  Engineering. 
Mr. Bondur holds a degree in Business from the State University of New York.

Sarah  A.  O’Dowd  joined  Lam  Research  in  September  2008  as  Group  Vice  President  and  Chief  Legal 
Officer, and was appointed Group Vice President, Human Resources and Chief Legal Officer in April 2009. 
Prior to joining Lam Research, Ms. O’Dowd served as Vice President and General Counsel for FibroGen, Inc. 
from February 2007 until September 2008. Until February 2007, Ms. O’Dowd was a shareholder in the law firm 
of Heller Ehrman LLP for more than twenty years.

Item 1A.  Risk Factors

In addition to the other information in this 2010 Form 10-K, the following risk factors should be carefully 
considered  in  evaluating  the  Company  and  its  business  because  such  factors  may  significantly  impact  our 
business,  operating  results,  and  financial  condition.  As  a  result  of  these  risk  factors,  as  well  as  other  risks 

10

discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-
looking statements. No priority or significance is intended, nor should be attached, to the order in which the risk 
factors appear.

The Semiconductor Industry is Subject to Major Fluctuations and, as a Result, We Face Risks Related to Our 
Strategic Resource Allocation Decisions

The business cycle in the semiconductor equipment industry has historically been characterized by frequent 
periods  of  rapid  change  in  demand  that  challenge  our  management  to  adjust  spending  and  other  resources 
allocated  to  operating  activities.  During  periods  of  rapid  growth  or  decline  in  demand  for  our  products  and 
services, we face significant challenges in maintaining adequate financial and business controls, management 
processes, information systems, procedures for training, managing, and appropriately sizing our supply chain, 
our work force, and other components of our business on a timely basis.

If  we  do  not  adequately  meet  these  challenges  during  periods  of  demand  decline,  our  gross  margins 
and earnings may be impaired. In late 2008 and throughout 2009, the semiconductor industry experienced a 
general decline in demand, leading to a steep decline in demand for our products and services. In response to 
that industry demand decline and in an effort to minimize the disruptive effects of the deteriorating economic 
conditions on our business operating results, we made difficult resource allocation decisions, including layoffs 
and restructurings.

During fiscal year 2010 we transitioned into what we believe to be a period of demand growth, although 
the duration and intensity of the growth period is uncertain. This is fueled in large part by increased investment 
by customers who, during the downturn, reduced or eliminated their spending on our products. We continuously 
reassess our strategic resource allocation choices in response to the changing business environment. If we do not 
adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up 
our business to meet customer expectations and compete successfully during this period of growth; or, we may 
expand our capacity too rapidly and/or beyond what is appropriate for the actual demand environment.

Especially during transitional periods, resource allocation decisions can have a significant impact on our 
future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, 
to a significant extent, on the ability of our executive officers and other members of our senior management to 
identify and respond to these challenges effectively.

Future Decline in the Semiconductor Equipment Industry, and the Overall World Economic Conditions on 
Which it is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations 
and Financial Condition

Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in 
turn depend on the current and anticipated market demand for integrated circuits. The semiconductor industry 
is cyclical in nature and historically experiences periodic downturns. Global economic and business conditions, 
which  are  often  unpredictable,  have  historically  impacted  customer  demand  for  our  products  and  normal 
commercial  relationships  with  our  customers,  suppliers,  and  creditors.  Additionally,  in  times  of  economic 
uncertainty, some of our customers’ budgets for our products, or their ability to access credit to purchase them, 
could be adversely affected. This would limit their ability to purchase our products and services. As a result, 
economic downturns can cause material adverse changes to our results of operations and financial condition 
including, but not limited to:

• 
• 
• 

• 
• 

a decline in demand for our products;

an increase in reserves on accounts receivable due to our customers’ inability to pay us;

an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our 
inability to sell such inventory;

valuation allowances on deferred tax assets;

restructuring charges;

11

• 
• 
• 

• 

• 

asset impairments including the potential impairment of goodwill and other intangible assets;

a decline in the value of our investments;

exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of 
customer purchases that do not come to fruition;

a  decline  in  value  of  certain  facilities  we  lease  to  less  than  our  residual  value  guarantee  with  the 
lessor; and

challenges maintaining reliable and uninterrupted sources of supply.

Fluctuating  levels  of  investment  by  semiconductor  manufacturers  may  materially  affect  our  aggregate 
shipments, revenues and operating results. Where appropriate, we will attempt to respond to these fluctuations 
with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which 
sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in 
research and development and maintain extensive ongoing worldwide customer service and support capabilities 
to remain competitive, which may temporarily harm our profitability and other financial results.

Our Quarterly Revenues and Operating Results Are Unpredictable

Our revenues and operating results may fluctuate significantly from quarter to quarter due to a number of 
factors, not all of which are in our control. We manage our expense levels based in part on our expectations of 
future revenues. Because our operating expenses are based in part on anticipated future revenues, and a certain 
amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of 
gross profit from a small number of transactions can unfavorably affect operating results in a particular quarter. 
Factors that may cause our financial results to fluctuate unpredictably include, but are not limited to:

• 

economic conditions in the electronics and semiconductor industries in general and specifically the 
equipment industry;

the size and timing of orders from customers;

procurement shortages;

• 
• 
• 

customer cancellations or delays in shipments, installations, and/or customer acceptances;

the failure of our suppliers or outsource providers to perform their obligations in a manner consistent 
with our expectations;
•  manufacturing difficulties;
• 
• 
• 
• 

our  ability  in  a  timely  manner  to  develop,  introduce  and  market  new,  enhanced,  and  competitive 
products;

the extent that customers continue to purchase and use our products and services in their business;

changes in average selling prices, customer mix, and product mix;

• 
• 
• 

• 

• 

• 
• 

our competitors’ introduction of new products;

legal or technical challenges to our products and technology;

transportation,  communication,  demand,  information  technology  or  supply  disruptions  based  on 
factors outside our control such as acts of God, wars, terrorist activities, and natural disasters;

natural, physical, logistical or other events or disruptions affecting our principal facilities (including 
labor disruptions, earthquakes, and power failures)

legal, tax, accounting, or regulatory changes (including but not limited to change in import/export 
regulations) or changes in the interpretation or enforcement of existing requirements;

changes in our estimated effective tax rate; and

foreign currency exchange rate fluctuations.

12

We Derive Our Revenues Primarily from a Relatively Small Number of High-Priced Systems

System sales constitute a significant portion of our total revenue. Our systems are priced up to approximately 
$6 million per unit, and our revenues in any given quarter are dependent upon the acceptance of a limited number 
of systems. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse 
impact on our revenues for that quarter.

We Have a Limited Number of Key Customers

Sales to a limited number of large customers constitute a significant portion of our overall revenue, new 
orders and profitability. As a result, the actions of even one customer may subject us to revenue swings that are 
difficult to predict. Similarly, significant portions of our credit risk may, at any given time, be concentrated among 
a limited number of customers, so that the failure of even one of these key customers to pay its obligations to us 
could significantly impact our financial results. As of June 27, 2010, two customers accounted for approximately 
24% and 22 % of accounts receivable. As of June 28, 2009, three customers accounted for approximately 17%, 
15%, and 14% of accounts receivable.

Variations in the Amount of Time it Takes for Our Customers to Accept Our Systems May Cause Fluctuation 
in Our Operating Results

We  generally  recognize  revenue  for  new  system  sales  on  the  date  of  customer  acceptance  or  the  date 
the  contractual  customer  acceptance  provisions  lapse.  As  a  result,  the  fiscal  period  in  which  we  are  able  to 
recognize new systems revenues is typically subject to the length of time that our customers require to evaluate 
the performance of our equipment after shipment and installation, which may vary from customer to customer 
and tool to tool. Such variations could cause our quarterly operating results to fluctuate.

We Depend on New Products and Processes for Our Success. Consequently, We are Subject to Risks Associated 
with Rapid Technological Change

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure 
to develop technological advances that enable those processes. We believe that our future success depends in 
part upon our ability to develop and offer new products with improved capabilities and to continue to enhance 
our existing products. If new products have reliability, quality, or design problems, our performance may be 
impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, 
and additional service and warranty expenses. We may be unable to develop and manufacture new products 
successfully, or new products that we introduce may fail in the marketplace. Our failure to commercialize these 
new products in a timely manner could result in unanticipated costs and inventory obsolescence, which would 
adversely affect our financial results.

In order to develop new products and processes, we expect to continue to make significant investments in 
R&D and to pursue joint development relationships with customers, suppliers or other members of the industry. 
We  must  manage  product  transitions  and  joint  development  relationships  successfully,  as  the  introduction  of 
new products could adversely affect our sales of existing products. Moreover, future technologies, processes 
or product developments may render our current product offerings obsolete, leaving us with non-competitive 
products, or obsolete inventory, or both.

We are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification

We derive a substantial percentage of our revenues from a limited number of products, and we expect our 
etch and clean products to continue to account for a large percentage of our revenues in the near term. Continued 
market acceptance of these products is, therefore, critical to our future success. Our business, operating results, 
financial condition, and cash flows could therefore be adversely affected by:

• 
• 

a decline in demand for even a limited number of our products;

a failure to achieve continued market acceptance of our key products;

13

• 

• 

• 
• 
• 

export restrictions or other regulatory or legislative actions that could limit our ability to sell those 
products to key customer or market segments;

an  improved  version  of  products  being  offered  by  a  competitor  in  the  market  in  which  we 
participate;

increased pressure from competitors that offer broader product lines;

technological changes that we are unable to address with our products; or

a failure to release new or enhanced versions of our products on a timely basis.

In addition, the fact that we offer limited product lines creates the risk that our customers may view us as 
less important to their business than our competitors that offer additional products as well. This may impact our 
ability to maintain or expand our business with certain customers. Such product concentration may also subject 
us to additional risks associated with technology changes. Since we are a provider of etch and clean equipment, 
our business is affected by our customers’ use of etching and clean steps in their processes. Should technologies 
change so that the manufacture of semiconductor chips requires fewer etching or clean steps, this could have a 
larger impact on our business than it would on the business of our less concentrated competitors.

Strategic Alliances May Have Negative Effects on Our Business

Increasingly, semiconductor companies are entering into strategic alliances with one another to expedite the 
development of processes and other manufacturing technologies. Often, one of the outcomes of such an alliance 
is the definition of a particular tool set for a certain function or a series of process steps that use a specific set of 
manufacturing equipment. While this could work to our advantage if our equipment becomes the basis for the 
function or process, it could work to our disadvantage if a competitor’s tools or equipment become the standard 
equipment for such function or process. In the latter case, even if our equipment was previously used by a customer, 
that equipment may be displaced in current and future applications by the tools standardized by the alliance.

Similarly, our customers may team with, or follow the lead of, educational or research institutions that 
establish  processes  for  accomplishing  various  tasks  or  manufacturing  steps.  If  those  institutions  utilize  a 
competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same 
equipment in setting up their own manufacturing lines. These actions could adversely impact our market share 
and financial results.

We are Dependent On a Limited Number of Key Suppliers

We  obtain  certain  components  and  sub-assemblies  included  in  our  products  from  a  single  supplier  or 
a  limited  group  of  suppliers.  We  have  established  long-term  contracts  with  many  of  these  suppliers.  These 
long-term  contracts  can  take  a  variety  of  forms.  We  may  renew  these  contracts  periodically.  In  some  cases, 
these suppliers have sold us products during at least the last five years, and we expect that we will continue to 
renew these contracts in the future or that we will otherwise replace them with competent alternative suppliers. 
However, certain of our suppliers are relatively new providers to us so that our experience with them and their 
performance is limited. Where practical, we intend to establish alternative sources to mitigate the risk that the 
failure of any single supplier will adversely affect our business. Nevertheless, a prolonged inability to obtain 
certain  components  could  impair  our  ability  to  ship  products  and  generate  revenues,  which  could  adversely 
affect our operating results and damage to our customer relationships.

Our Outsource Providers May Fail to Perform as We Expect

Outsource providers have played and will continue to play a key role in our manufacturing operations and in 
many of our transactional and administrative functions, such as information technology, facilities management, 
and certain elements of our finance organization. Although we attempt to select reputable providers and secure 
their performance on terms documented in written contracts, it is possible that one or more of these providers 
could fail to perform as we expect and such failure could have an adverse impact on our business.

14

In addition, the expansive role of our outsource providers has required and may continue to require us 
to  implement  changes  to  our  existing  operations  and  to  adopt  new  procedures  to  deal  with  and  manage  the 
performance of these outsource providers. Any delay or failure in the implementation of our operational changes 
and  new  procedures  could  adversely  affect  our  customer  and/or  employee  relationships,  which  could  have  a 
negative effect on our operating results.

Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing 
Equipment,  the  Manufacturer  Typically  Continues  to  Purchase  that  Competitor’s  Equipment,  Making  it 
More Difficult for Us to Sell Our Equipment to that Customer

Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing 
equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects 
a  particular  supplier’s  processing  equipment,  the  manufacturer  generally  relies  upon  that  equipment  for  that 
specific production line application for an extended period of time. Accordingly, we expect it to be more difficult 
to sell to a given customer if that customer initially selects a competitor’s equipment.

We Face a Challenging and Complex Competitive Environment

We face significant competition from multiple competitors. Other companies continue to develop systems 
and products that are competitive to ours and may introduce new products, which may affect our ability to sell 
our existing products. We face a greater risk if our competitors enter into strategic relationships with leading 
semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely 
affect our ability to sell products to those manufacturers.

We believe that to remain competitive we must devote significant financial resources to offer a broad range 
of products, to maintain customer service and support centers worldwide, and to invest in product and process 
R&D. Certain of our competitors, especially those that are created and financially backed by foreign governments, 
have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and 
customer service and support resources than we do and therefore have the potential to increasingly dominate 
the semiconductor equipment industry. These competitors may deeply discount or give away products similar to 
those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening 
our ability to sell those products. We also face competition from our own customers, who in some instances 
have established affiliated entities that manufacture equipment similar to ours. For these reasons, we may fail to 
continue to compete successfully worldwide.

In addition, our competitors may be able to develop products comparable or superior to those we offer 
or  may  adapt  more  quickly  to  new  technologies  or  evolving  customer  requirements.  In  particular,  while  we 
continue to develop product enhancements that we believe will address future customer requirements, we may 
fail in a timely manner to complete the development or introduction of these additional product enhancements 
successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, 
competition may intensify and we may be unable to continue to compete successfully in our markets, which 
could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.

Our Future Success Depends on International Sales and the Management of Global Operations

Non-U.S. sales accounted for approximately 91% of total revenue in fiscal year 2010, 85% of total revenue 
in fiscal year 2009, and 83% in fiscal year 2008. We expect that international sales will continue to account for 
a substantial portion of our total revenue in future years.

We are subject to various challenges related to international sales and the management of global operations 

including, but not limited to:

• 
• 
• 
• 

trade balance issues;

global economic and political conditions;

changes in currency controls;

differences in the enforcement of intellectual property and contract rights in varying jurisdictions;

15

• 

• 

• 
• 
• 

our ability to respond to customer demands for locally sourced systems, spare parts and services and 
develop the necessary relationships with local suppliers;

compliance with U.S. and international laws and regulations affecting foreign operations, including 
U.S. export restrictions;

fluctuations in interest and foreign currency exchange rates;

the need for technical support resources in different locations; and

our ability to secure and retain qualified people in all necessary locations for the successful operation 
of our business.

Certain  international  sales  depend  on  our  ability  to  obtain  export  licenses  from  the  U.S.  government. 
Our failure or inability to obtain such licenses would substantially limit our markets and severely restrict our 
revenues. Many of the challenges noted above are applicable in China, which is a fast developing market for the 
semiconductor equipment industry and therefore an area of potential significant growth for our business. As the 
business volume between China and the rest of the world grows, there is inherent risk, based on the complex 
relationships between China, Taiwan, Japan, and the United States that political and diplomatic influences might 
lead to trade disruptions; this would adversely affect our business with China and/or Taiwan and perhaps the 
entire Asia Pacific region. A significant trade disruption in these areas could have a materially adverse impact 
on our future revenue and profits.

We are potentially exposed to adverse as well as beneficial movements in foreign currency exchange rates. 
The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign 
currency exchange rate fluctuations related to certain of our revenues denominated in Japanese yen and Euros, 
as well as certain of our spares and service contracts, Euro denominated expenses, and expenses related to our 
non-U.S. sales and support offices that are denominated in the related countries’ local currency.

We currently enter into foreign exchange forward contracts to minimize the short-term impact of the 
foreign  currency  exchange  rate  fluctuations  on  Japanese  yen-denominated  revenue  and  monetary  assets 
and liabilities, as well as monetary assets and liabilities denominated in Swiss francs, Euros and Taiwanese 
dollars.  We  currently  believe  these  are  our  primary  exposures  to  currency  rate  fluctuation.  We  expect  to 
continue  to  enter  into  hedging  transactions,  for  the  purposes  outlined,  in  the  foreseeable  future.  However, 
these hedging transactions may not achieve their desired effect because differences between the actual timing 
of customer acceptances and our forecasts of those acceptances may leave us either over- or under-hedged on 
any given transaction. Moreover, by hedging these foreign currency denominated revenues, monetary assets 
and liabilities with foreign exchange forward contracts, we may miss favorable currency trends that would 
have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency 
exchange rate fluctuations on non-U.S. dollar-denominated assets and liabilities (other than those currency 
exposures  previously  discussed)  and  currently  we  do  not  enter  into  foreign  exchange  forward  contracts  to 
hedge these other foreign currency exposures. Therefore, we are subject to both favorable and unfavorable 
foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany 
transactions) in other currencies.

Our Ability To Attract, Retain and Motivate Key Employees Is Critical To Our Success.

Our  ability  to  compete  successfully  depends  in  large  part  on  our  ability  to  attract,  retain  and  motivate 
key employees. This is an ongoing challenge due to intense competition for top talent, as well as fluctuations in 
industry economic conditions that may require cycles of hiring activity and workforce reductions. Our success 
in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs 
and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall 
compensation programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. 
If we are not able to successfully attract, retain and motivate key employees, we may be unable to capitalize on 
market opportunities and our operating results may be materially and adversely affected.

16

We Rely Upon Certain Critical Information Systems for the Operation of Our Business

We maintain and rely upon certain critical information systems for the effective operation of our business. 
These information systems include telecommunications, the internet, our corporate intranet, various computer 
hardware and software applications, network communications, and e-mail. These information systems may be 
owned and maintained by us, our outsource providers or third parties such as vendors and contractors. These 
information  systems  are  subject  to  attacks,  failures,  and  access  denials  from  a  number  of  potential  sources 
including  viruses,  destructive  or  inadequate  code,  power  failures,  and  physical  damage  to  computers,  hard 
drives,  communication  lines,  and  networking  equipment.  To  the  extent  that  these  information  systems  are 
under our control, we have implemented security procedures, such as virus protection software and emergency 
recovery processes, to mitigate the outlined risks. However, security procedures for information systems cannot 
be guaranteed to be failsafe and our inability to use or access these information systems at critical points in time 
could unfavorably impact the timely and efficient operation of our business.

Our  Financial  Results  May  be  Adversely  Impacted  by  Higher  Than  Expected  Tax  Rates  or  Exposure  to 
Additional Tax Liabilities

As  a  global  company,  our  effective  tax  rate  is  highly  dependent  upon  the  geographic  composition  of 
worldwide earnings and tax regulations governing each region. We are subject to income taxes in the United States 
and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. 
Our effective tax rate could be adversely affected by changes in the split of earnings between countries with 
differing statutory tax rates, in the valuation of deferred tax assets, in tax laws, or by material audit assessments. 
These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are 
predominantly in the United States, is dependent on our ability to generate future taxable income in the United 
States. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions, and 
a material assessment by a governing tax authority could affect our profitability.

A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results

We are subject to a variety of governmental regulations related to the discharge or disposal of toxic, volatile 
or otherwise hazardous chemicals. We believe that we are generally in compliance with these regulations and that 
we have obtained (or will obtain or are otherwise addressing the need for) all environmental permits necessary to 
conduct our business. These permits generally relate to the disposal of hazardous wastes. Nevertheless, the failure 
to comply with present or future regulations could result in fines being imposed on us, require us to suspend 
production,  or  cease  operations  or  cause  our  customers’  to  not  accept  our  products.  These  regulations  could 
require us to alter our current operations, to acquire significant additional equipment or to incur substantial other 
expenses to comply with environmental regulations. Our failure to control the use, sale, transport or disposal of 
hazardous substances could subject us to future liabilities.

If  We  Choose  to  Acquire  or  Dispose  of  Product  Lines  and  Technologies,  We  May  Encounter  Unforeseen 
Costs and Difficulties That Could Impair Our Financial Performance

An important element of our management strategy is to review acquisition prospects that would complement 
our  existing  products,  augment  our  market  coverage  and  distribution  ability,  or  enhance  our  technological 
capabilities. As a result, we may make acquisitions of complementary companies, products or technologies, such 
as our March 2008 acquisition of SEZ Holding AG (“SEZ”), or we may reduce or dispose of certain product lines 
or technologies that no longer fit our long-term strategies. Managing an acquired business, disposing of product 
technologies  or  reducing  personnel  entail  numerous  operational  and  financial  risks,  including  difficulties  in 
assimilating acquired operations and new personnel or separating existing business or product groups, diversion 
of management’s attention away from other business concerns, amortization of acquired intangible assets and 
potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that 
we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of 
product lines or technologies, or reduction in personnel or that our management, personnel, or systems will be 
adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse 
effect on our business, operating results, financial condition, and cash flows.

17

In  addition,  any  acquisition  could  result  in  changes  such  as  potentially  dilutive  issuances  of  equity 
securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and 
goodwill impairment charges, any of which could materially adversely affect our business, financial condition, 
and results of operations and/or the price of our Common Stock.

The  Market  for  Our  Common  Stock  is  Volatile,  Which  May  Affect  Our  Ability  to  Raise  Capital  or  Make 
Acquisitions

The market price for our Common Stock is volatile and has fluctuated significantly over the past years. 
The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response 
to a variety of factors, many of which are not within our control or influence. These factors include but are not 
limited to the following:

• 
• 
• 
• 

• 

• 
• 
• 
• 
• 

general market, semiconductor, or semiconductor equipment industry conditions;

economic or political events and trends occurring globally or in any of our key sales regions;

variations in our quarterly operating results and financial condition, including our liquidity;

variations in our revenues, earnings or other business and financial metrics from forecasts by us or 
securities analysts, or from those experienced by other companies in our industry;

announcements  of  restructurings,  reductions  in  force,  departure  of  key  employees,  and/or 
consolidations of operations;

government regulations;

developments in, or claims relating to, patent or other proprietary rights;

technological innovations and the introduction of new products by us or our competitors;

commercial success or failure of our new and existing products; or

disruptions of relationships with key customers or suppliers.

In  addition,  the  stock  market  experiences  significant  price  and  volume  fluctuations.  Historically,  we 
have witnessed significant volatility in the price of our Common Stock due in part to the actual or anticipated 
movement in interest rates and the price of and markets for semiconductors. These broad market and industry 
factors have and may again adversely affect the price of our Common Stock, regardless of our actual operating 
performance.  In  the  past,  following  volatile  periods  in  the  price  of  their  stock,  many  companies  became  the 
object of securities class action litigation. If we are sued in a securities class action, we could incur substantial 
costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial 
performance and the price for our Common Stock.

Intellectual Property, Indemnity and Other Claims Against Us Can be Costly and We Could Lose Significant 
Rights That are Necessary to Our Continued Business and Profitability

Third parties may assert infringement, unfair competition, product liability, breach of contract, or other 
claims  against  us.  From  time  to  time,  other  parties  send  us  notices  alleging  that  our  products  infringe  their 
patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges 
relating to intellectual property issues. We also face risks of claims from commercial and other relationships. In 
addition, our Bylaws and indemnity obligations provide that we will indemnify officers and directors against 
losses that they may incur in legal proceedings resulting from their service to Lam Research. In such cases, it is 
our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable 
terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other 
settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other 
parties may materially adversely affect our business and financial results. Moreover, although we seek to obtain 
insurance to protect us from claims and cover losses to our property, there is no guarantee that such insurance 
will fully compensate us for any losses that we may incur.

18

We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business

Our success depends in part on our proprietary technology and our ability to protect key components of that 
technology through patents, copyrights and trade secret protection. Protecting our key proprietary technology helps 
us to achieve our goals of developing technological expertise and new products and systems that give us a competitive 
advantage; increasing market penetration and growth of our installed base; and providing comprehensive support 
and service to our customers. As part of our strategy to protect our technology we currently hold a number of United 
States and foreign patents and pending patent applications. However, other parties may challenge or attempt to 
invalidate or circumvent any patents the United States or foreign governments issue to us or these governments may 
fail to issue patents for pending applications. Additionally, even when patents are issued, the legal systems in certain 
of the countries in which we do business do not enforce patents and other intellectual property rights as rigorously 
as the United States. The rights granted or anticipated under any of our patents or pending patent applications may 
be narrower than we expect or, in fact, provide no competitive advantages. Any of these circumstances could have 
a material adverse impact on our business if they relate to critical technologies.

Compliance with Federal Securities Laws, Rules and Regulations, as well As NASDAQ Requirements, has 
Become Increasingly Complex, and the Significant Attention and Expense We Must Devote to those Areas 
May Have an Adverse Impact on Our Business

Federal securities laws, rules and regulations, as well as NASDAQ rules and regulations, require companies to 
maintain extensive corporate governance measures, impose comprehensive reporting and disclosure requirements, 
set  strict  independence  and  financial  expertise  standards  for  audit  and  other  committee  members  and  impose 
civil and criminal penalties for companies and their chief executive officers, chief financial officers and directors 
for  securities  law  violations.  These  laws,  rules  and  regulations  have  increased,  and  in  the  future  are  expected 
to  continue  to  increase,  the  scope,  complexity  and  cost  of  our  corporate  governance,  reporting  and  disclosure 
practices, which could harm our results of operations and divert management’s attention from business operations. 
A failure to comply with these regulations could also have a material adverse effect on our business.

Item 1B.  Unresolved Staff Comments

None.

Item 2.  Properties

Our executive offices and principal operating and R&D facilities are located in Fremont, California, and 
are held under operating leases expiring from fiscal years 2012 to 2015. These leases generally include options 
to renew or purchase the facilities. In addition, we lease properties for our service, technical support and sales 
personnel throughout the United States, Europe, Taiwan, Korea, Japan, and Asia Pacific and own manufacturing 
facilities  located  in  Eaton,  Ohio  and  Villach,  Austria.  Our  fiscal  years  2010,  2009,  and  2008  rental  expense 
for the space occupied during those periods aggregated approximately $6 million, $9 million, and $11 million 
respectively.  Our  facilities  lease  obligations  are  subject  to  periodic  increases.  We  believe  that  our  existing 
facilities are well-maintained and in good operating condition.

Item 3.  Legal Proceedings

From time to time, we have received notices from third parties alleging infringement of their patent or 
other intellectual property rights. In such cases it is our policy to defend the claims, or negotiate licenses on 
commercially  reasonable  terms  as  appropriate.  However,  no  assurance  can  be  given  that  we  will  be  able  to 
negotiate  necessary  licenses  on  commercially  reasonable  terms,  or  at  all.  Any  litigation  resulting  from  such 
claims could have a materially adverse effect on our consolidated financial position, liquidity, operating results, 
or our consolidated financial statements taken as a whole.

Item 4.  Removed and Reserved

19

PART II

Item 5. 

 Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases 
of Equity Securities

Our  Common  Stock  is  traded  on  the  Nasdaq  Global  Select  Market  under  the  symbol  LRCX.  As  of 
August 13, 2010 we had 358 stockholders of record. In fiscal years 2010 and 2009 we did not declare or pay cash 
dividends to our stockholders. We currently have no plans to declare or pay cash dividends. The table below 
sets forth the high and low prices of our common stock as reported by The NASDAQ Stock Market, Inc. for the 
period indicated:

First Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth Quarter  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

First Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth Quarter  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2010

High
$35.21
$39.16
$41.43
$42.90

Low
$25.44
$32.50
$32.25
$36.58

2009

High
$40.42
$31.98
$25.47
$29.23

Low
$30.00
$14.72
$18.24
$22.01

On September 8, 2008, the Company announced that its Board of Directors had authorized the repurchase 
of  up  to  $250  million  of  Company  common  stock  from  the  public  market  or  in  private  purchases,  using  the 
Company’s available cash. While the repurchase program does not have a defined termination date, it may be 
suspended, discontinued or reinstated at any time.

The  Company  temporarily  suspended  repurchases  under  the  Board-authorized  program  prior  to  the 
end of the December 2008 quarter. Subsequently, on February 2, 2010, the Board of Directors authorized the 
resumption of the repurchase program. Repurchases were expected to be made only in the amounts necessary to 
offset anticipated dilution resulting from the Company’s equity compensation plans.

Share repurchases under the repurchase program were as follows (in thousands except per share data):

Period

As of June 28, 2009  . . . . . . . . . . . . . . . . . . . . . .
Quarter Ending September 27, 2009  . . . . . . . . .
Quarter Ending December 27, 2009 . . . . . . . . . .
Quarter Ending March 28, 2010 . . . . . . . . . . . . .
March 29, 2010 — April 25, 2010 . . . . . . . . . . . .
April 26, 2010 — May 23, 2010 . . . . . . . . . . . . .
May 24, 2010 — June 27, 2010 . . . . . . . . . . . . . .

Total Number 
of Shares 
Repurchased (1)

Average Price 
Paid Per Share

Total Number of 
Shares Purchased as 
Part of Publicly 
Announced Plans or 
Programs

Amount 
Available 
Under 
Repurchase 
Program

(in thousands, except per share data)

—
79
14
2,096
2
90
701
2,982

$ —
$30.19
$34.91
$34.46
$38.82
$41.04
$39.56
$35.74

—
—
—
2,000
—
—
697
2,697

$226,942
$226,942
$226,942
$158,268
$158,268
$158,268
$130,693
$130,693

(1) 

Included in the 2,982,000 shares indicated in the table above are 285,000 shares that the Company withheld 
through net share settlements to cover tax withholding obligations upon the vesting of restricted stock unit 
awards under the Company’s equity compensation plans.

20

The  graph  below  compares  Lam  Research  Corporation’s  cumulative  5-year  total  shareholder  return  on 
common stock with the cumulative total returns of the NASDAQ Composite index and the Research Data Group, 
Incorporated (“RDG”) Semiconductor Composite index. The graph tracks the performance of a $100 investment 
in our common stock and in each of the indices (with the reinvestment of all dividends) from June 30, 2005 to 
June 30, 2010.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*  
AMONG LAM RESEARCH CORPORATION , THE NASDAQ COMPOSITE INDEX 
AND THE RDG SEMICONDUCTOR COMPOSITE INDEX

$250

$200

$150

$100

$50

$0

6/05

6/06

6/07

6/08

6/09

6/10

Lam Research Corporation

NASDAQ Composite

RDG Semiconductor Composite

* 

$100 invested on 6/30/05 in stock or index, including reinvestment of dividends.

Fiscal year ending June 30.

Lam Research Corporation . . . . . . . . . . . . . . .
NASDAQ Composite . . . . . . . . . . . . . . . . . . . . .
RDG Semiconductor Composite . . . . . . . . . . .

6/05
100.00
100.00
100.00

6/06
161.38
107.08
99.04

6/07
177.55
130.99
117.18

6/08
124.87
114.02
99.83

6/09
89.81
90.79
74.03

6/10
131.47
105.54
89.20

21

 
Item 6. 

Selected Financial Data (derived from audited financial statements)

June 27, 
2010 (1)

Year Ended
June 24, 
June 29, 
June 28, 
2009 (1)
2007
2008 (1)
(in thousands, except per share data)

June 25, 
2006

OPERATIONS:
Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,133,776 $1,115,946 $2,474,911 $2,566,576 $1,642,171
827,012
969,935
Gross margin . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill impairment (2) . . . . . . . . . . . . . . . . .
—
—
Restructuring charges and asset  

1,305,054
—

1,173,406
—

388,734
96,255

impairments, net (3) . . . . . . . . . . . . . . . . . .
409A expense (4) . . . . . . . . . . . . . . . . . . . . . . .
Legal judgment  . . . . . . . . . . . . . . . . . . . . . . . .
In-process research and development . . . . . . .
Operating income (loss). . . . . . . . . . . . . . . . . .
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . .
Net income (loss) per share:

21,314
(38,590) 

—
—
425,410
346,669

44,513
3,232
4,647
—

(281,243) 
(302,148) 

6,366
44,494
—
2,074
509,431
439,349

—
—
—
—
778,660
685,816

—
—
—
—
404,768
335,210

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

2.73 $
2.71 $

(2.41)  $
(2.41)  $

3.52 $
3.47 $

4.94 $
4.85 $

2.42
2.33

BALANCE SHEET:
Working capital . . . . . . . . . . . . . . . . . . . . . . . . $1,198,004 $ 855,064 $1,280,028 $ 743,563 $1,138,720
2,327,382
Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . .
350,969
Long-term obligations, less current portion . .

2,487,392
160,600

2,101,605
252,487

1,993,184
158,019

2,806,755
385,132

(1)  Fiscal year 2010, 2009 and 2008 amounts include the operating results of SEZ from the acquisition date 
of March 11, 2008. The acquisition was accounted for as a business combination in accordance with the 
applicable accounting guidance. See Note 15 of Notes to Consolidated Financial Statements for additional 
information.

(2)  During  fiscal  year  2009,  a  combination  of  factors,  including  the  economic  environment,  a  sustained 
decline in our market valuation and a decline in our operating results indicated possible impairment of 
our goodwill. We conducted an analysis and concluded that the fair value of our Clean Product Group had 
been reduced below its carrying value. As a result, we recorded a non-cash goodwill impairment charge of 
approximately $96.3 million during fiscal year 2009.

(3)  Restructuring charges and asset impairments, net exclude restructuring charges included in cost of goods 
sold and reflected in gross margin of $3.4 million, $21.0 million, and $12.6 million for fiscal years 2010, 
2009, and 2008, respectively. Restructuring and asset impairment amounts included in cost of goods sold 
and reflected in gross margin during fiscal year 2010 primarily related to asset impairments for production 
efficiencies and shifts in product demands partially offset by the recovery of expenses related to previously 
impaired inventory. Restructuring amounts included in cost of goods sold and reflected in gross margin 
during fiscal year 2009 primarily relate to the Company’s alignment of its cost structure with the outlook 
for the current economic environment and future business opportunities. The restructuring amounts in 
fiscal year 2008 primarily related to the integration of SEZ.

(4)  409A expense excludes a credit included in cost of goods sold and reflected in gross margin of $5.8 million 
in fiscal year 2010 related to a reversal of accrued liabilities due to final settlement of matters associated 
with our Internal Revenue Code Section 409A (“409A”) expenses from the 2007 voluntary independent 
stock option review. 409A expense excludes an expense included in cost of goods sold and reflected in 
gross  margin  of  $6.4  million  during  fiscal  year  2008.  Following  a  voluntary  independent  review  of  its 
historical stock option granting process, the Company considered whether Section 409A of the Internal 
Revenue Code of 1986, as amended (“IRC”), and similar provisions of state law, applied to certain stock 
option grants as to which, under the applicable accounting guidance, intrinsic value was deemed to exist at 

22

the time of the options’ measurement dates. If, under applicable tax principles, an employee stock option 
is not considered as granted with an exercise price equal to the fair market value of the underlying stock 
on the grant date, then the optionee may be subject to federal and state penalty taxes under Section 409A 
(collectively,  “Section  409A  liabilities”).  On  March  30,  2008,  the  Board  of  Directors  authorized  the 
Company (i) to assume potential Section 409A Liabilities, inclusive of applicable penalties and interest, of 
current and past employees arising from the exercise in 2006 or 2007 of Company stock options that vested 
after 2004, and (ii) if necessary, to compensate such employees for additional tax liability associated with 
that assumption.

UNAUDITED SELECTED QUARTERLY FINANCIAL DATA

Three Months Ended (1)

June 27, 
2010

March 28, 
2010

December 27, 
2009 (2)

September 27, 
2009 (2)

(in thousands, except per share data)

QUARTERLY FISCAL YEAR 2010:
Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $695,289
Restructuring and asset impairments —  

cost of goods sold. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
409A expense — cost of goods sold . . . . . . . . . . . . . . . . .
Gross margin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring and asset impairments —  

operating expenses. . . . . . . . . . . . . . . . . . . . . . . . . . . .
409A expense — operating expenses . . . . . . . . . . . . . . . .
Operating income  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share

3,438
—
321,442

13,302
—
155,717
139,997

$ 632,763

$487,176

$318,548

—
—
292,871

—
—
149,093
120,301

—
(2,696) 

—
(3,120) 

221,187

134,435

5,919
(18,362) 
91,348
69,574

2,093
(20,228) 
29,252
16,797

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

1.11
1.10

$
$

0.94
0.94

$
$

0.55
0.54

$
$

0.13
0.13

Number of shares used in per share calculations:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

126,339
127,786

127,307
128,587

127,296
128,829

126,774
127,890

Three Months Ended (1)

June 28, 
2009

March 29, 
2009

December 28, 
2008

September 28, 
2008

(in thousands, except per share data)

QUARTERLY FISCAL YEAR 2009:
Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $217,764
Restructuring and asset impairments —  

$ 174,412

$283,409

$440,361

cost of goods sold. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross margin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill impairment — operating expenses . . . . . . . . . .
Restructuring and asset impairments —  

operating expenses. . . . . . . . . . . . . . . . . . . . . . . . . . . .
409A expense — operating expenses . . . . . . . . . . . . . . . .
Legal judgment — operating expenses . . . . . . . . . . . . . . .
Operating income  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share

—
67,757
7,179

5,396
982
4,647
(65,186) 
(88,490) 

10,217
36,515
89,076

13,028
646
—

(195,184) 
(198,359) 

7,728
101,352
—

10,121
843
—

(37,392) 
(24,172) 

3,048
183,110
—

15,968
761
—
16,519
8,873

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

(0.70)  $
(0.70)  $

(1.58) 
(1.58) 

$
$

(0.19) 
(0.19) 

$
$

0.07
0.07

Number of shares used in per share calculations:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

126,273
126,273

125,566
125,566

125,084
125,084

125,527
126,819

23

(1)  Our reporting period is a 52/53-week fiscal year. The fiscal years ended June 27, 2010 and June 28, 2009 

both included 52 weeks. All quarters presented above included 13 weeks.

(2)  Certain amounts as reported in the Condensed Consolidated Financial Statements for the three months 
ended September 27, 2009 and December 27, 2009 have been revised to correct the allocation of 409A 
expense between cost of goods sold and operating expenses.

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations contains forward-looking 
statements, which are subject to risks, uncertainties and changes in condition, significance, value and effect. 
Our actual results could differ materially from those anticipated in the forward-looking statements as a result 
of certain factors, including but not limited to those discussed in “Risk Factors” and elsewhere in this 2010 
Form 10-K and other documents we file from time to time with the Securities and Exchange Commission. 
(See “Cautionary Statement Regarding Forward-Looking Statements” in Part I of this 2010 Form 10-K).

Management’s  Discussion  and  Analysis  of  Financial  Condition  and  Results  of  Operations  (“MD&A”) 
provides  a  description  of  our  results  of  operations  and  should  be  read  in  conjunction  with  our  Consolidated 
Financial  Statements  and  accompanying  Notes  to  Consolidated  Financial  Statements  included  in  this  2010 
Form 10-K. MD&A consists of the following sections:

Executive  Summary  provides  a  summary  of  the  key  highlights  of  our  results  of  operations  and  our 

management’s assessment of material trends and uncertainties relevant to our business

Results of Operations provides an analysis of operating results

Critical Accounting Policies and Estimates discusses accounting policies that reflect the more significant 

judgments and estimates used in the preparation of our consolidated financial statements

Liquidity and Capital Resources provides an analysis of cash flows, contractual obligations and financial 

position

Executive Summary

We design, manufacture, market, refurbish, and service semiconductor processing equipment used in the 
fabrication of integrated circuits and are recognized as a major provider of such equipment to the worldwide 
semiconductor industry. Our customers include semiconductor memory and foundry manufacturers that make 
DRAM, flash memory, and logic integrated circuits for a wide range of consumer and industrial electronics. 
Semiconductor  wafers  are  subjected  to  a  complex  series  of  process  and  preparation  steps  that  result  in  the 
simultaneous creation of many individual integrated circuits. We leverage our expertise in the areas of etch and 
single-wafer  clean  to  develop  processing  solutions  that  typically  benefit  our  customers  through  lower  defect 
rates, enhanced yields, faster processing time, and/or reduced cost as well as by facilitating their ability to meet 
more stringent performance and design standards.

The semiconductor industry is cyclical in nature and has historically experienced periodic and pronounced 
downturns and upturns. Today’s leading indicators of change in customer investment patterns may not be any 
more reliable than in prior years. Demand for our equipment can vary significantly from period to period as a 
result of various factors, including, but not limited to, economic conditions (both general and in the semiconductor 
and  electronics  industries),  supply,  demand,  prices  for  semiconductors,  customer  capacity  requirements,  and 
our  ability  to  develop,  acquire,  and  market  competitive  products.  For  these  and  other  reasons,  our  results  of 
operations for fiscal years 2010, 2009, and 2008 may not necessarily be indicative of future operating results.

Adverse conditions in the global economy during 2008 and 2009 severely reduced customer demand for 
our products, resulting in reduced revenue and profits throughout fiscal 2009. After three quarters of net losses, 
we returned to profitability in the September 2009 quarter as worldwide demand for wafer fabrication equipment 
began to recover. Our shipments, revenue and net income increased significantly in fiscal year 2010 compared to 
2009, as both industry and global economic conditions continued to improve. We expect the same to be true for 
calendar year 2010 versus calendar year 2009 given our current view of wafer fabrication equipment spending.

24

We believe that, over the long term, demand for our products will continue to increase as our customers’ 
capital expenditures increase to meet growing demand for semiconductor devices. However, historically, any 
improvement in demand for semiconductor manufacturing equipment occurs at an uneven pace. Accordingly, 
any forecasts about demand for wafer fabrication equipment in the near term are subject to uncertainty, and we 
could experience significant volatility in our quarterly results of operations over the next several quarters.

The following summarizes certain key annual financial information for the periods indicated below:

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

FY10 vs. FY09

FY09 vs. FY08

Revenue. . . . . . . . . . . . . . . .  $2,133,776
Gross margin  . . . . . . . . . . .
969,935
Gross margin as a  
percent of total  
revenue . . . . . . . . . . . . .
Total operating expenses  . .
Net income (loss)  . . . . . . . .
Diluted net income  

544,525
346,669

45.5% 

(in thousands, except per share data and percentages)

$ 1,115,946
388,734

$ 2,474,911
1,173,406

$1,017,830
$ 581,201

91.2 %  $(1,358,965) 
149.5 %  $ (784,672) 

-54.9% 
-66.9% 

34.8% 

47.4 % 

669,977
(302,148) 

663,975
439,349

10.7% 
$ (125,452) 
$ 648,817

-12.6% 
6,002

-18.7 %  $
214.7 %  $ (741,497) 

0.9% 
-168.8% 

(loss) per share . . . . . . . $

2.71

$

(2.41)  $

3.47

$

5.12

212.4 %  $

(5.88) 

-169.5% 

Fiscal  year  2010  results  compared  with  fiscal  year  2009  results  reflect  continued  improvement  in  the 
global business environment and in the semiconductor industry, improved foundry fabrication utilization and 
an  increase  in  the  rate  of  next-generation  DRAM  and  NAND  technology  conversions  by  leading  memory 
companies. This comparison is in sharp contrast to the decline in revenue in fiscal year 2009 compared to fiscal 
year 2008, and the resulting net loss in 2009.

Throughout calendar year 2009 and the first half of calendar year 2010, we maintained our investments in new 
product R&D to defend our market share and win new application share. Our activities also focused on improving 
customer productivity in our installed base by delivering continuously improved performance and lower cost of 
ownership.  We  continued  to  develop  the  operational  capability  to  rapidly  respond  to  short  lead-time  customer 
orders, and believe that these activities will allow us to maintain and grow our cash position over time.

We believe that the total market for wafer-fabrication equipment will increase substantially in calendar 
year 2010 as compared to 2009 and currently anticipate year-on-year growth in our customer shipments as a 
result of both expansion of the market as a whole and increases in our market share.

While conditions in our industry have clearly improved and we currently anticipate industry and market 
share growth in calendar year 2010, we cannot predict the robustness or pace of any macroeconomic recovery. 
The  electronics  and  semiconductor  industries  remain  significantly  linked  to  growth  in  worldwide  GDP  and 
consumer spending.

Fiscal  year  2010  revenues  increased  91%  compared  to  fiscal  year  2009,  primarily  reflecting  increased 
system  shipments  driven  by  growth  in  customer  demand.  Fiscal  year  2010  shipments  were  approximately 
$2.3 billion and increased 136% as compared to fiscal year 2009. The increase in gross margin as a percentage 
of revenue for the fiscal year 2010 compared to fiscal year 2009 was due primarily to increased revenue along 
with improved factory utilization and a more favorable product mix as well as a decrease in restructuring and 
asset impairment charges recorded in cost of goods sold.

Operating  expenses  in  fiscal  year  2010  decreased  as  compared  to  fiscal  year  2009.  This  decrease  was 
primarily due to a decrease in restructuring charges and asset and goodwill impairments from approximately 
$141 million in fiscal year 2009 to $21 million in fiscal year 2010 and a credit in fiscal year 2010 of approximately 
$39  million  related  to  a  reversal  of  accrued  liabilities  due  to  final  settlement  of  matters  associated  with  our 
Internal  Revenue  Code  Section  409A  expenses  from  the  2007  voluntary  independent  stock  option  review  as 
compared to a charge of $3 million in fiscal year 2009. These factors were partially offset by the restoration of 
employee salaries and benefits, as well as higher variable compensation expense associated with our improved 
profitability.

25

Our cash and cash equivalents, short-term investments, and restricted cash and investments balances totaled 
approximately $992 million as of June 27, 2010 compared to $758 million as of June 28, 2009. We generated 
approximately $351 million in net cash provided by operating activities during fiscal year 2010, compared to net 
use of cash by operating activities of $78 million in fiscal year 2009.

Results of Operations

Shipments and Backlog

Shipments (in millions) . . . . . . . . . . . . . . . . . . . . . . . .
North America  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Korea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Taiwan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010 
$2,304

Year Ended
June 28, 
2009 
$ 976

June 29, 
2008 
$2,367

8% 
7% 
15% 
27% 
32% 
11% 

16% 
11% 
20% 
21% 
20% 
12% 

16% 
9% 
20% 
22% 
20% 
13% 

Shipments for fiscal year 2010 increased by 136% compared to fiscal year 2009, reflecting improvements 
in the industry and economic environment as noted above. Shipments for fiscal year 2009 decreased sequentially 
from fiscal year 2008 by 59% reflecting declines in customer demand, consistent with the deterioration in the 
general economy and, specifically, the downturn in the semiconductor industry which had been impacted by a 
decline in consumer spending for electronic goods.

During  fiscal  year  2010,  300  millimeter  applications  represented  approximately  96%  of  total  systems 
shipments and 96% of total systems shipments were for applications at less than or equal to the 65 nanometer 
technology  node.  During  fiscal  year  2009,  300  millimeter  applications  represented  approximately  90%  of 
total  systems  shipments  and  87%  of  total  systems  shipments  were  for  applications  at  less  than  or  equal  to 
the 65 nanometer technology node. Fiscal year 2010 shipments consisted of: Memory at approximately 61%, 
Foundry at 29% and Integrated Device Manufacturers and Logic at 10%. Fiscal year 2009 shipments consisted 
of: Memory at approximately 58%, Foundry at 21%, and Integrated Device Manufacturers and Logic at 21%.

Unshipped  orders  in  backlog  as  of  June  27,  2010  were  approximately  $667  million  and  increased  from 
approximately  $391  million  as  of  June  28,  2009  consistent  with  improved  spending  commitments  from  our 
customers.  Our  unshipped  orders  backlog  includes  orders  for  systems,  spares,  and  services.  Please  refer 
to  “Backlog”  in  Part  I  Item  1,  “Business”  of  this  report  for  a  description  of  our  policies  for  adding  to  and 
adjusting backlog.

Revenue

Revenue (in thousands) . . . . . . . . . . . . . . . . . . . . .
North America  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Korea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Taiwan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010 

Year Ended
June 28, 
2009 

June 29, 
2008 

$2,133,776

$1,115,946

$2,474,911

9% 
6% 
15% 
25% 
33% 
12% 

15% 
11% 
21% 
21% 
19% 
13% 

17% 
10% 
18% 
22% 
20% 
13% 

26

The revenue increase during fiscal year 2010 compared to fiscal year 2009 reflected improvements in the 
industry and economic environments as noted above. The revenue decline during fiscal year 2009 compared 
to fiscal year 2008 reflected adverse conditions in the global economy and semiconductor industry as noted 
above.  Our  revenue  levels  are  generally  correlated  to  the  amount  of  shipments  and  our  installation  and 
acceptance timelines. The overall Asia region continues to account for a predominant portion of our revenues as 
a substantial amount of the worldwide capacity additions for semiconductor manufacturing continues to occur 
in this region, and the concentration of revenue within the overall Asia region increased in fiscal year 2010 as it 
had in fiscal year 2009. Our deferred revenue balance increased to $207.4 million as of June 27, 2010 compared 
to $64.7 million as of June 28, 2009, consistent with increased customer spending levels during fiscal year 2010. 
Our deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer 
until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time 
of acceptance. The anticipated future revenue value from shipments to Japanese customers was approximately 
$52 million as of June 27, 2010 compared to $13 million as of June 28, 2009.

Gross Margin

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

FY10 vs. FY09
(in thousands, except percentages)

FY09 vs. FY08

Gross margin  . . . . . . . . .
Percent of total revenue . .

$969,935

$388,734

$1,173,406

$581,201

149.5%  $(784,672) 

-66.9% 

45.5% 

34.8% 

47.4% 

10.7% 

-12.6% 

The increase in gross margin as a percentage of revenue for fiscal year 2010 compared to fiscal year 2009 
was due primarily to improved product mix and more favorable absorption from the factories. Additionally, there 
was a decrease in restructuring and asset impairments included in gross margin from approximately $21 million 
in fiscal year 2009 to $3 million in fiscal year 2010 and a credit in fiscal year 2010 of approximately $6 million 
related to a reversal of accrued liabilities due to final settlement of matters associated with our Internal Revenue 
Code Section 409A expenses from the 2007 voluntary independent stock option review.

The  decrease  in  gross  margin  as  a  percent  of  revenue  for  fiscal  year  2009  compared  with  fiscal  year 
2008 was primarily due to decreased factory and field utilization as a result of reduced shipment volumes on 
declining customer demand, changes in our product mix, customer concentration, and $21 million of one-time 
restructuring and asset impairment expenses, partially offset by favorable warranty performance.

Research and Development

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

FY10 vs. FY09

FY09 vs. FY08

(in thousands, except percentages)

Research & development  . . . . . $320,859
Percent of total revenue  . . . . . .

15.0% 

$288,269

$323,759

$32,590

25.8% 

13.1% 

-10.8% 

11.3%  $(35,490) 
12.7% 

-11.0% 

We continue to make significant investments in R&D focused on plasma etch, single-wafer clean and other 
semiconductor manufacturing products. The increase in R&D spending during fiscal year 2010 compared to 
fiscal year 2009 was due primarily to higher other employee compensation, salaries, and benefits of $25 million, 
mainly as a result of stronger company profitably, and higher outside services and supplies of $5 million related 
to customer penetration activities.

Approximately 24% and 79% of fiscal years 2010 and 2009 systems revenues, respectively, were derived 
from products introduced over the previous two years, which is reflective of our continued investment in new 
products and technologies.

27

The decline in R&D spending during fiscal year 2009 compared to fiscal year 2008, included approximately 
$8 million of lower salary and benefits related to cost savings measures, $11 million in lower other employee 
compensation  on  lower  profits  and  a  $26  million  decrease  in  outside  services  and  supplies,  partially  offset 
by  $5  million  in  depreciation  and  amortization  mainly  related  to  the  inclusion  of  the  acquisition  of  SEZ  in 
March 2008.

Selling, General and Administrative

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

FY10 vs. FY09
(in thousands, except percentages)

FY09 vs. FY08

Selling, general & administrative  

(“SG&A”)  . . . . . . . . . . . . . . . . . $240,942

$233,061

$287,282

$7,881

3.4%  $ (54,221) 

-18.9% 

Percent of total revenue  . . . . . . . . .

11.3% 

20.9% 

11.6% 

-9.6% 

9.3% 

The growth in SG&A expense during fiscal year 2010 compared to fiscal year 2009 was driven by increases 
of approximately $26 million in other employee compensation as a result of increased company profitability 
offset by a $9 million decline in depreciation, rent and utilities expenses primarily as a result of restructuring 
activities, and $7 million due to a non-recurring accounts receivable reserve recorded for specific distressed 
customers in fiscal year 2009.

The  decrease  in  SG&A  expenses  during  fiscal  year  2009  compared  to  fiscal  year  2008  was  driven 
by  a  reduction  of  approximately  $34  million  in  other  employee  compensation  as  a  result  of  lower  company 
profitability, a reduction of $7 million in salaries and benefits related to cost savings measures, a reduction of 
$19 million in costs incurred as a result of the voluntary independent stock option review that was completed in 
fiscal year 2008, and a reduction of $5 million in outside services and supplies, partially offset by a $7 million 
charge to increase the reserves against our receivables balance for distressed customers.

Goodwill Impairment

During  fiscal  year  2009,  a  combination  of  factors,  including  the  economic  environment,  a  sustained 
decline  in  our  market  valuation,  and  a  decline  in  our  operating  results  indicated  possible  impairment  of  our 
goodwill. We performed an impairment analysis and concluded that the fair value of our Clean Product Group 
had been reduced below its carrying value. As a result, we recorded a non-cash goodwill impairment charge of 
approximately $96.3 million during fiscal year 2009. No indicators of impairment resulted from our fiscal 2010 
assessment.

The calculation of the goodwill impairment charge is based on estimates of future operating results. If 
our future operating results do not meet current forecasts or if we experience a sustained decline in our market 
capitalization that is determined to be indicative of a reduction in fair value of our businesses, an additional 
impairment analysis may be required which may result in further impairment charges.

Restructuring and Asset Impairments

During  fiscal  year  2008,  we  incurred  expenses  for  restructuring  and  asset  impairment  charges 
of  $19.0  million  related  to  the  integration  of  SEZ  and  overall  streamlining  of  our  combined  Clean  Product 
Group (“June 2008 Plan”). We incurred additional expenses of $19.0 million under the June 2008 Plan during 
fiscal  year  2009.  The  charges  during  fiscal  year  2008  included  severance  and  related  benefits  costs,  excess 
facilities-related costs and certain asset impairments associated with our initial product line integration road 
maps. The charges during fiscal year 2009 primarily included severance and related benefits costs and certain 
asset impairments associated with our product line integration road maps. During fiscal year 2010, we recorded 
a recovery of $2.2 million related primarily to inventory previously restructured in connection with our initial 
product line integration road maps.

28

During  fiscal  year  2009,  we  incurred  expenses  of  $17.8  million  for  restructuring  and  asset  impairment 
charges designed to better align our cost structure with our business opportunities in consideration of market 
and economic uncertainties (“December 2008 Plan”). The charges consisted primarily of severance and related 
benefits costs as well as certain facilities related costs and asset impairments.

During fiscal year 2009, we also incurred expenses of $28.6 million for restructuring and asset impairment 
charges  designed  to  align  our  cost  structure  with  our  outlook  for  the  current  economic  environment  and 
future business opportunities (“March 2009 Plan”). The charges during fiscal year 2009 consisted primarily 
of severance and related benefits costs as well as certain facilities related costs and asset impairments. The 
Company  incurred  additional  expenses  of  $20.9  million  during  fiscal  2010  under  the  March  2009  Plan 
consisting primarily of certain facilities charges related to the reassessment of future obligations for previously 
restructured leases, severance and related benefits costs, and asset impairments.

In addition to charges incurred under specific restructuring plans, during fiscal year 2010 we incurred 

$6.0 million of asset impairment charges related to production efficiencies and shifts in product demands.

For further details related to restructuring and asset impairment, see Note 18 of the Notes to Consolidated 

Financial Statements.

409A Expense

Following the voluntary independent review of our historical option grant process, we considered whether 
Section 409A of the Internal Revenue Code and similar provisions of state law would apply to stock options 
that were found, under applicable accounting guidance, to have intrinsic value at the time of their respective 
measurement dates. If a stock option is not considered as issued with an exercise price of at least the fair market 
value of the underlying stock, it may be subject to penalty taxes under Section 409A and similar provisions of 
state law. In such a case, taxes may be assessed not only on the intrinsic value increase, but on the entire stock 
option gain as measured at various times. On March 30, 2008, our Board of Directors authorized us to assume 
potential tax liabilities of certain employees, including our Chief Executive Officer and certain executive officers, 
relating to options that might be subject to Section 409A and similar provisions of state law. Those liabilities 
totaled $50.9 million; $44.5 million was recorded in operating expenses and $6.4 million in cost of goods sold in 
our consolidated statements of operations for fiscal year 2008. We incurred $3.2 million of expense during fiscal 
year 2009 consisting of interest and legal fees. During fiscal year 2010, we reached final settlement of matters 
associated with our 409A expenses with the Internal Revenue Service (“IRS”) and California Franchise Tax 
Board (“FTB”) resulting in a credit of $44.4 million due to the reversal of 409A liabilities. The determinations 
from  the  voluntary  independent  stock  option  review  are  more  fully  described  in  Note  3,  “Restatement  of 
Consolidated Financial Statements” to Consolidated Financial Statements and “Management’s Discussion and 
Analysis of Financial Condition and Results of Operations” in Item 7 of our 2007 Form 10-K.

Legal Judgment

Aspect Systems, Inc. (“Aspect”) sued us for breach of contract and various business torts arising out of a 
transaction in which we licensed Aspect to sell certain of our legacy Autoetch and Drytek products. The case 
went to trial in the United States District Court for the District of Arizona in December of 2008, resulting in 
a jury verdict in favor of Aspect. We filed an appeal from the ensuing judgment, which is now pending. We 
recorded the amount of the legal judgment of $4.6 million in our consolidated statement of operations for the 
year ended June 28, 2009.

29

Other Income (Expense), Net

Other income (expense), net, consisted of the following:

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

FY10 vs. FY09

FY09 vs. FY08

(in thousands, except percentages)

Interest income . . . . . . . . . . . . . . . . . .
Interest expense  . . . . . . . . . . . . . . . . .
Foreign exchange gain (loss)  . . . . . . .
Other, net  . . . . . . . . . . . . . . . . . . . . . .

-64.6%  $(26,911)  -52.6% 
$ 8,598 $24,283 $ 51,194 $(15,685) 
(12,674)  $ (5,503) 
-84.7%  $ (6,177)  -48.7% 
31,070 $ (1,025)  -111.2%  $(30,148)  -97.0% 
72.7% 
(2,045)  $ (2,212)  -396.4%  $ 1,487

(994) 
(103) 
(2,770) 

(6,497) 
922
(558) 

$ 4,731 $18,150 $ 67,545

The decrease in interest income during fiscal year 2010 compared with fiscal year 2009 was primarily due 
to decreases in our average cash and investment balances and decreases in interest rate yields. The decrease in 
average balances was primarily due to treasury stock repurchases, capital expenditures, and principal payments 
on  long-term  debt.  The  decrease  in  interest  income  during  fiscal  year  2009  compared  with  fiscal  year  2008 
was primarily due to a decrease in our average balances of cash, cash equivalents, short-term investments, and 
restricted cash and investments throughout fiscal year 2009 and, to a lesser extent, decreases in interest rate 
yields. The decrease in average balances was primarily related to payment of the outstanding principal balance 
of $250.0 million of our existing long-term debt with ABN AMRO Bank N.C. (“ABN AMRO”) during fiscal 
year 2009.

The decrease in interest expense during fiscal years 2010 and 2009 as compared with the prior year was 
due to our $250.0 million loan payment to ABN AMRO during fiscal year 2009, principal payments on long-
term debt and capital leases, and to a lesser extent, decreases in interest rate yields.

Foreign  exchange  gains  in  fiscal  year  2009  were  related  to  un-hedged  portions  of  the  balance  sheet 
exposures, primarily in the Japanese yen, Taiwanese dollar and Euro and were partially offset by $4.0 million 
of  deferred  net  losses  associated  with  ineffectiveness  related  to  forecasted  transactions  that  were  no  longer 
considered  probable  of  occurring  and  were  recognized  in  “Other  income  (expense),  net”  in  the  Company’s 
Consolidated Statements of Operations during fiscal year 2009. Included in foreign exchange gains during fiscal 
year 2008 were gains associated with the acquisition of SEZ of $42.7 million relating primarily to the settlement 
of  a  hedge  of  the  Swiss  franc.  These  acquisition-related  net  foreign  exchange  gains  were  partially  offset  by 
other foreign exchange losses of approximately $11.6 million during fiscal year 2008; these offsetting losses 
were primarily due to our foreign currency denominated liabilities with non-U.S. dollar functional subsidiaries 
where the U.S. dollar weakened against certain currencies, primarily the Euro and Taiwan dollar resulting in 
the foreign exchange loss. In fiscal year 2009, we implemented a balance sheet hedging program to manage 
Swiss franc, Euro and Taiwanese dollar foreign currency exchange rate fluctuations and the impact of those 
fluctuations on our Consolidated Statements of Operations. These exposures are related to monetary assets and 
liabilities in these currencies. A description of our exposure to foreign currency exchange rates can be found in 
the Risk Factors section of this report under the heading “Our Future Success Depends on International Sales 
and Management of Global Operations” and in Note 2 of the Consolidated Financial Statements.

Other expenses increased during fiscal year 2010 as compared with 2009 as the result of increased charitable 
contributions and the recognition of a $0.9 million realized loss on investments due to an other-than-temporary 
impairment charge.

Income Tax Expense

Our annual income tax expense was $83.5 million, $39.1 million, and $137.6 million in fiscal years 2010, 
2009, and 2008, respectively. Our effective tax rate for fiscal years 2010, 2009, and 2008 was 19.4%, (14.8%), 
and 23.9%, respectively. The increase in the effective tax rate in fiscal year 2010 is primarily due to the increase 
in the Company’s income, the change in geographical mix of income between higher and lower tax jurisdictions, 
adjustments for previously estimated tax liabilities upon the filing of our U.S. tax return and decrease in Federal 
R&D credit due to the expiration of the credit on December 31, 2009.

30

The fiscal year 2009 effective tax rate was (14.8%), compared to the fiscal year 2008 effective tax rate 
of 23.9%. The decrease in the effective tax rate in fiscal year 2009 was primarily due to the Company’s loss 
position. In fiscal year 2009 there were certain events that resulted in a net tax expense. These events included 
favorable  adjustments  for  previously  estimated  tax  liabilities  upon  the  filing  of  our  U.S.  and  certain  foreign 
income tax returns and the R&D credit reinstatement offset by tax expense for a change in California law, and a 
valuation allowance placed on certain foreign deferred tax assets.

Deferred Income Taxes

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of 
assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as 
the tax effect of carryforwards. Our gross deferred tax assets, composed primarily of reserves and accruals that 
are not currently deductible and tax credit carryforwards, were $137.4 million and $157.0 million at the end of 
fiscal years 2010 and 2009, respectively. These gross deferred tax assets were offset by deferred tax liabilities of 
$36.3 million and $41.9 million at the end of fiscal years 2010 and 2009, respectively, and a valuation allowance 
of $37.0 million and $35.5 million at the end of fiscal years 2010 and 2009, respectively.

We record a valuation allowance to reduce our deferred tax assets to the amount that is more-likely-than-
not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe 
it  is  more  likely  than  not  that  such  assets  will  be  realized;  however,  ultimate  realization  could  be  negatively 
impacted by market conditions and other variables not known or anticipated at this time. In the event that we 
determine that we would not be able to realize all or part of our net deferred tax assets, an adjustment would be 
charged to earnings in the period such determination is made. Likewise, if we later determine that it is more-
likely-than-not that the deferred tax assets would be realized, then the previously provided valuation allowance 
would be reversed. Our fiscal years 2010 and 2009 valuation allowance of $37.0 million and $35.5 million relate 
to certain California and foreign deferred tax assets.

During fiscal year 2010, we recorded an additional valuation allowance on certain California deferred tax 
assets reflecting the potential impacts of the California law related to the repeal of the cost of performance sales 
factor sourcing rule and the single sales factor apportionment election. We also recorded a reduction of valuation 
allowance against certain foreign deferred tax assets due to an increase in the forecasted income for certain 
foreign entities.

We evaluate the realizability of the deferred tax assets quarterly and will continue to assess the need for 

additional valuation allowances, if any.

Uncertain Tax Positions

We reevaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, 
but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, 
and new audit activity. Such a change in recognition or measurement would result in the recognition of a tax 
benefit or an additional charge to the tax provision.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles 
(“GAAP”) requires management to make certain judgments, estimates and assumptions that could affect the 
reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of 
revenue  and  expenses  during  the  reporting  period.  We  based  our  estimates  and  assumptions  on  historical 
experience and on various other assumptions we believed to be applicable and evaluate them on an ongoing 
basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from 
those estimates.

31

The significant accounting policies used in the preparation of our financial statements are described in 
Note 2 of our Consolidated Financial Statements. Some of these significant accounting policies are considered 
to be critical accounting policies. A critical accounting policy is defined as one that has both a material impact 
on our financial condition and results of operations and requires us to make difficult, complex and/or subjective 
judgments, often regarding estimates about matters that are inherently uncertain.

We  believe  that  the  following  critical  accounting  policies  reflect  the  more  significant  judgments  and 

estimates used in the preparation of our consolidated financial statements.

Revenue Recognition: We recognize all revenue when persuasive evidence of an arrangement exists, delivery 
has  occurred  and  title  has  passed  or  services  have  been  rendered,  the  selling  price  is  fixed  or  determinable, 
collection of the receivable is reasonably assured, and we have completed our system installation obligations, 
received customer acceptance or are otherwise released from our installation or customer acceptance obligations. 
If terms of the sale provide for a lapsing customer acceptance period, we recognize revenue upon the expiration 
of the lapsing acceptance period or customer acceptance, whichever occurs first. If the practices of a customer 
do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, we 
recognize  revenue  when  it  can  be  reliably  demonstrated  that  the  delivered  system  meets  all  of  the  agreed-to 
customer  specifications.  In  situations  with  multiple  deliverables,  we  recognize  revenue  upon  the  delivery  of 
the  separate  elements  to  the  customer  and  when  we  receive  customer  acceptance  or  are  otherwise  released 
from our customer acceptance obligations. We allocate revenue from multiple-element arrangements among the 
separate elements based on their relative fair values, provided the elements have value on a stand-alone basis, 
there is objective and reliable evidence of fair value, the arrangement does not include a general right of return 
relative  to  the  delivered  item  and  delivery,  or  performance  of  the  undelivered  item(s)  is  considered  probable 
and substantially in our control. The maximum revenue we recognize on a delivered element is limited to the 
amount that is not contingent upon the delivery of additional items. We generally recognize revenue related to 
sales of spare parts and system upgrade kits upon shipment. We generally recognize revenue related to services 
upon completion of the services requested by a customer order. We recognize revenue for extended maintenance 
service contracts with a fixed payment amount on a straight-line basis over the term of the contract.

Inventory  Valuation:  Inventories  are  stated  at  the  lower  of  cost  or  market  using  standard  costs  which 
generally approximate actual costs on a first-in, first-out basis. We maintain a perpetual inventory system and 
continuously record the quantity on-hand and standard cost for each product, including purchased components, 
subassemblies, and finished goods. We maintain the integrity of perpetual inventory records through periodic 
physical counts of quantities on hand. Finished goods are reported as inventories until the point of title transfer to 
the customer. Generally, title transfer is documented in the terms of sale. When the terms of sale do not specify 
title transfer, we assume title transfers when we complete physical transfer of the products to the freight carrier 
unless other customer practices prevail. Transfer of title for shipments to Japanese customers generally occurs 
at the time of customer acceptance.

We reassess standard costs as needed but annually at a minimum, and reflect achievable acquisition costs. 
Acquisition costs are generally based on the most recent vendor contract prices for purchased parts, normalized 
assembly and test labor utilization levels, methods of manufacturing, and normalized overhead. Manufacturing 
labor and overhead costs are attributed to individual product standard costs at a level planned to absorb spending 
at  average  utilization  volumes.  We  eliminate  all  intercompany  profits  related  to  the  sales  and  purchases  of 
inventory between our legal entities from our consolidated financial statements.

Management  evaluates  the  need  to  record  adjustments  for  impairment  of  inventory  at  least  quarterly. 
Our  policy  is  to  assess  the  valuation  of  all  inventories  including  manufacturing  raw  materials,  work-in-
process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess 
of management’s estimated usage requirements over the next 12 to 36 months is written down to its estimated 
market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts 
related  to  our  future  manufacturing  schedules,  customer  demand,  technological  and/or  market  obsolescence, 
general semiconductor market conditions, and possible alternative uses. If future customer demand or market 
conditions are less favorable than our projections, additional inventory write-downs may be required and would 
be reflected in cost of goods sold in the period in which we make the revision.

32

Warranty:  Typically,  the  sale  of  semiconductor  capital  equipment  includes  providing  parts  and  service 
warranty to customers as part of the overall price of the system. We provide standard warranties for our systems 
that generally run for a period of 12 months from system acceptance. When appropriate, we record a provision 
for estimated warranty expenses to cost of sales for each system when we recognize revenue. We do not maintain 
general or unspecified reserves; all warranty reserves are related to specific systems. The amount recorded is 
based on an analysis of historical activity which uses factors such as type of system, customer, geographic region, 
and any known factors such as tool reliability trends. All actual or estimated parts and labor costs incurred in 
subsequent periods are charged to those established reserves on a system-by-system basis.

Actual warranty expenses are accounted for on a system-by-system basis and may differ from our original 
estimates. While we periodically monitor the performance and cost of warranty activities, if actual costs incurred 
are  different  than  our  estimates,  we  may  recognize  adjustments  to  provisions  in  the  period  in  which  those 
differences arise or are identified. In addition to the provision of standard warranties, we offer customer-paid 
extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment 
amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded either as 
incurred or when related liabilities are determined to be probable and estimable.

Equity-based  Compensation  —  Employee  Stock  Purchase  Plan  (“ESPP”)  and  Employee  Stock  Plans: 
GAAP requires us to recognize the fair value of equity-based compensation in net income. We determine the 
fair value of our restricted stock units based upon the fair market value of Company stock at the date of grant. We 
estimate the fair value of our stock options and ESPP awards using the Black-Scholes option valuation model. 
This model requires us to input highly subjective assumptions, including expected stock price volatility and the 
estimated life of each award. We amortize the fair value of equity-based awards over the vesting periods of the 
awards, and we have elected to use the straight-line method of amortization.

We make quarterly assessments of the adequacy of our tax credit pool related to equity-based compensation 
to determine if there are any deficiencies that we are required to recognize in our consolidated statements of 
operations. We will only recognize a benefit from stock-based compensation in paid-in-capital if we realize an 
incremental tax benefit after all other tax attributes currently available to us have been utilized. In addition, 
we  have  elected  to  account  for  the  indirect  benefits  of  stock-based  compensation  on  the  research  tax  credit 
through the income statement (continuing operations) rather than through paid-in-capital. We have also elected 
to  net  deferred  tax  assets  and  the  associated  valuation  allowance  related  to  net  operating  loss  and  tax  credit 
carryforwards for the accumulated stock award tax benefits for income tax footnote disclosure purposes. We will 
track these stock award attributes separately and will only recognize these attributes through paid-in-capital.

Income  Taxes:  Deferred  income  taxes  reflect  the  net  tax  effect  of  temporary  differences  between  the 
carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax 
purposes, as well as the tax effect of carryforwards. We record a valuation allowance to reduce our deferred 
tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets 
is dependent on future taxable income. We believe it is more-likely-than-not that such assets will be realized; 
however, ultimate realization could be negatively impacted by market conditions and other variables not known 
or anticipated at the time. In the event that we determine that we would not be able to realize all or part of our 
net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. 
Likewise, if we later determine that it is more-likely-than-not that the deferred tax assets would be realized, then 
the previously provided valuation allowance would be reversed.

We calculate our current and deferred tax provision based on estimates and assumptions that can differ 
from the actual results reflected in income tax returns filed during the subsequent year. Adjustments based on 
filed returns are recorded when identified.

We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be 
sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and 
penalties related to unrecognized tax benefits as a component of income tax expense. Please refer to Note 14 of 
these Notes to the Consolidated Financial Statements for additional information.

33

In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of 
complex  tax  regulations.  We  recognize  liabilities  for  uncertain  tax  positions  based  on  the  two-step  process 
prescribed within the interpretation. The first step is to evaluate the tax position for recognition by determining 
if the weight of available evidence indicates that it is more-likely-than-not that the position will be sustained on 
audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate 
and measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate 
settlement. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the 
probability of various possible outcomes. We reevaluate these uncertain tax positions on a quarterly basis. This 
evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax 
law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement 
would result in the recognition of a tax benefit or an additional charge to the tax provision in the period such 
determination is made.

Goodwill  and  Intangible  Assets:  Goodwill  represents  the  amount  by  which  the  purchase  price  in  each 
business combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. We 
allocate the carrying value of goodwill to our reporting units. We test goodwill and identifiable intangible assets 
with indefinite useful lives for impairment at least annually. We amortize intangible assets with estimable useful 
lives over their respective estimated useful lives to their estimated residual values, and we review for impairment 
whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not 
be recoverable and the carrying amount exceeds its fair value.

We review goodwill at least annually for impairment. If certain events or indicators of impairment occur 
between annual impairment tests, we would perform an impairment test of goodwill at that date. In testing for a 
potential impairment of goodwill, we: (1) allocate goodwill to our reporting units to which the acquired goodwill 
relates; (2) estimate the fair value of our reporting units; and (3) determine the carrying value (book value) of 
those reporting units, as some of the assets and liabilities related to those reporting units are not held by those 
reporting units but by a corporate function. Prior to this allocation of the assets to the reporting units, we are 
required to assess long-lived assets for impairment. Furthermore, if the estimated fair value of a reporting unit 
is less than the carrying value, we must estimate the fair value of all identifiable assets and liabilities of that 
reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require 
independent valuations of certain internally generated and unrecognized intangible assets such as in-process 
research and development and developed technology. Only after this process is completed can the amount of 
goodwill impairment, if any, be determined.

The  process  of  evaluating  the  potential  impairment  of  goodwill  is  subjective  and  requires  significant 
judgment  at  many  points  during  the  analysis.  We  determine  the  fair  value  of  our  reporting  units  by  using  a 
weighted combination of both market and an income approach, as this combination is deemed to be the most 
indicative of fair value in an orderly transaction between market participants.

Under the market approach, we use information regarding the reporting unit as well as publicly available 
industry information to determine various financial multiples to value our reporting units. Under the income 
approach, we determine fair value based on estimated future cash flows of each reporting unit, discounted by 
an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit 
and the rate of return an outside investor would expect to earn.

In estimating the fair value of a reporting unit for the purposes of our annual or periodic analyses, we make 
estimates and judgments about the future cash flows of our reporting units, including estimated growth rates and 
assumptions about the economic environment. Although our cash flow forecasts are based on assumptions that 
are consistent with the plans and estimates we are using to manage the underlying businesses, there is significant 
judgment involved in determining the cash flows attributable to a reporting unit. In addition, we make certain 
judgments about allocating shared assets to the estimated balance sheets of our reporting units. We also consider 
our market capitalization and that of our competitors on the date we perform the analysis. Changes in judgment 
on these assumptions and estimates could result in a goodwill impairment charge.

34

As a result, several factors could result in impairment of a material amount of our goodwill balance in 
future periods, including, but not limited to: (1) weakening of the global economy, weakness in the semiconductor 
equipment industry, or failure of the Company to reach its internal forecasts, which could impact our ability to 
achieve our forecasted levels of cash flows and reduce the estimated discounted cash flow value of our reporting 
units; and (2) a decline in our stock price and resulting market capitalization, if we determine that the decline is 
sustained and indicates a reduction in the fair value of our reporting units below their carrying value. In addition, 
the value we assign to intangible assets, other than goodwill, is based on our estimates and judgments regarding 
expectations such as the success and life cycle of products and technology acquired. If actual product acceptance 
differs significantly from our estimates, we may be required to record an impairment charge to write down the 
asset to its realizable value.

Recent Accounting Pronouncements

In December 2007, the Financial Accounting Standard Board (“FASB”) revised the applicable accounting 
guidance  for  business  combinations,  which  establishes  principles  and  requirements  for  how  an  acquirer 
recognizes  and  measures  in  its  financial  statements  the  identifiable  assets  acquired,  the  liabilities  assumed, 
any noncontrolling interest in the acquiree and the goodwill acquired. The revised guidance also establishes 
disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. 
The accounting treatment of tax benefits from acquired companies has changed under the revised guidance. Any 
changes to the tax benefits associated with the valuation allowances related to business combinations will be 
recorded through income tax expense. We adopted the revised guidance on June 29, 2009, and the adoption did 
not have a significant impact on our results of operations or financial condition.

In December 2007, the FASB issued guidance that establishes accounting and reporting standards for the 
treatment of noncontrolling interests in a subsidiary. Noncontrolling interests in a subsidiary are to be reported 
as  a  component  of  equity  in  the  consolidated  financial  statements  and  any  retained  noncontrolling  equity 
investment upon deconsolidation of a subsidiary is initially measured at fair value. We adopted the guidance 
on June 29, 2009, and the adoption did not have a significant impact on our results of operations or financial 
condition.

In April 2009, the FASB issued guidance to require publicly-traded companies to disclose on the fair value 
of financial instruments in interim financial statements. We adopted this guidance on June 29, 2009, and the 
adoption resulted in expanded disclosures, and the adoption did not have a significant impact on our consolidated 
results of operations or financial condition.

In  June  2009,  the  FASB  issued  the  FASB  Accounting  Standards  Codification  (“Codification”).  The 
Codification is the single source for all authoritative GAAP recognized by the FASB to be applied for financial 
statements issued for periods ending after September 15, 2009. The Codification does not change GAAP and did 
not have a significant impact on our financial statements.

In September 2009, the FASB ratified guidance from the Emerging Issues Task Force (“EITF”) regarding 
revenue arrangements with multiple deliverables. This guidance addresses criteria for separating the consideration 
in  multiple-element  arrangements  and  will  require  companies  to  allocate  the  overall  consideration  to  each 
deliverable  by  using  a  best  estimate  of  the  selling  price  of  individual  deliverables  in  the  arrangement  in  the 
absence of vendor-specific objective evidence or other third-party evidence of the selling price. This guidance 
will  be  effective  for  revenue  arrangements  entered  into  or  materially  modified  in  fiscal  years  beginning  on 
or after June 15, 2010. We will adopt this guidance in the beginning of fiscal year 2011 and do not believe the 
adoption will have a significant impact on our results of operations or financial condition.

In September 2009, the FASB also ratified guidance from the EITF regarding certain revenue arrangements 
that include software elements. This guidance modifies the scope of the software revenue recognition rules to 
exclude (a) non-software components of tangible products and (b) software components of tangible products that 
are sold, licensed, or leased with tangible products when the software components and non-software components 
of the tangible product function together to deliver the tangible product’s essential functionality. This guidance 
will  be  effective  for  revenue  arrangements  entered  into  or  materially  modified  in  fiscal  years  beginning  on 
or after June 15, 2010. We will adopt this guidance in the beginning of fiscal year 2011 and do not believe the 
adoption will have a significant impact on our results of operations or financial condition.

35

Liquidity and Capital Resources

Total gross cash, cash equivalents, short-term investments, and restricted cash and investments balances 
were $991.7 million at the end of fiscal year 2010 compared to $757.8 million at the end of fiscal year 2009. 
This increase was primarily due to cash provided by operations, which was partially offset by treasury stock 
purchases.

Cash Flows from Operating Activities

Net cash provided by operating activities of $351 million during fiscal year 2010 consisted of (in millions):

Net income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash charges:

Depreciation and amortization . . . . . . . . . . . . . . . . . . . . .
Equity-based compensation . . . . . . . . . . . . . . . . . . . . . . .
Restructuring charges, net  . . . . . . . . . . . . . . . . . . . . . . . .
Net tax benefit on equity-based compensation plans . . . . . .
Deferred income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in operating asset and liability accounts  . . . . . . . .
Other  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 346.7

71.4
50.5
24.7
0.4
13.7
(159.9) 
3.2
$ 350.7

Significant changes in operating asset and liability accounts included the following uses of cash: increases 
in  accounts  receivable  of  $246.7  million,  inventories  of  $79.7  million,  and  prepaid  and  other  expenses  of 
$23.6  million.  These  uses  of  cash  were  partially  offset  by  the  following  sources  of  cash:  increases  in  trade 
accounts payable of $71.6 million, deferred profit of $77.4 million, and accrued expenses and other liabilities of 
$41.1 million. These changes in overall cash were all consistent with increased business volumes.

Cash Flows from Investing Activities

Net cash used for investing activities during fiscal year 2010 was $103.4 million which was primarily due 
to net purchases of investments of $78.0 million and capital expenditures of $35.6 million. These uses of cash 
were partially offset by transfer of restricted cash and investments of $13.2 million.

Cash Flows from Financing Activities

Net  cash  used  for  financing  activities  during  fiscal  year  2010  was  $72.7  million  which  was  due  to 
stock repurchases of $93.0 million and principal payments on long-term debt and capital lease obligations of 
$21.0 million. These uses were partially offset by the following sources of cash: proceeds from the reissuance of 
treasury stock of $17.5 million, proceeds from the issuance of common stock of $13.4 million, and the excess tax 
benefit on equity-based compensation plans of $10.2 million.

Given the cyclical nature of the semiconductor equipment industry, we believe that maintaining sufficient 
liquidity  reserves  is  important  to  support  sustaining  levels  of  investment  in  R&D  and  capital  infrastructure. 
Based upon our current business outlook, our levels of cash, cash equivalents, and short-term investments at 
June 27, 2010 are expected to be sufficient to support our presently anticipated levels of operations, investments, 
debt service requirements, and capital expenditures through at least the next 12 months.

In  the  longer  term,  liquidity  will  depend  to  a  great  extent  on  our  future  revenues  and  our  ability  to 
appropriately manage our costs based on demand for our products. If we should require additional funding we 
may need to raise the required funds through borrowings or public or private sales of debt or equity securities. 
We believe that if we require additional funds, we will be able to access the capital markets on terms and in 
amounts  adequate  to  meet  our  objectives.  However,  given  the  possibility  of  changes  in  market  conditions  or 
other occurrences, there can be no certainty that any funding will be available in needed quantities or on terms 
favorable to us.

36

Off-Balance Sheet Arrangements and Contractual Obligations

We have certain obligations to make future payments under various contracts. Consistent with GAAP, some 
of these are recorded on our balance sheet and some are not. Obligations that are recorded on our balance sheet 
include our long-term debt and capital lease obligations. Our off-balance sheet arrangements include contractual 
relationships for operating leases, purchase obligations, and guarantees. Our contractual cash obligations and 
commitments relating to long-term debt, capital leases, and off-balance sheet agreements are included in the 
following table. These amounts exclude $110.5 million of liabilities related to uncertain tax benefits because we 
are unable to reasonably estimate the ultimate amount or time of settlement. See Note 14, of Notes to Consolidated 
Financial Statements for further discussion.

Operating 
Leases

Capital 
Leases

Purchase 
Obligations

Long-term 
Debt and 
Interest Expense

Total

(in thousands)

Payments due by period:

Less than 1 year . . . . . . . . . . . . . . . . . . . . . . . $
1-3 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3-5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Over 5 years . . . . . . . . . . . . . . . . . . . . . . . . . .

8,012 $ 1,671
3,337
9,160
2,746
146,045
9,206
7,875
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $171,092 $16,960

$128,469
59,676
26,649
7,715
$222,509

$3,672
3,394
—
—
$7,066

$141,824
75,567
175,440
24,796
$417,627

Operating Leases

We lease most of our administrative, R&D and manufacturing facilities, regional sales/service offices and 
certain equipment under non-cancelable operating leases, which expire at various dates through fiscal year 2016. 
Certain of our facility leases for buildings located at our Fremont, California headquarters and certain other 
facility leases provide us with an option to extend the leases for additional periods or to purchase the facilities. 
Certain of our facility leases provide for periodic rent increases based on the general rate of inflation.

Included  in  the  Operating  Leases  3-5  years  section  of  the  table  above  is  $141.7  million  in  guaranteed 
residual  values  for  lease  agreements  relating  to  certain  properties  at  our  Fremont,  California  campus  and 
properties in Livermore, California. The remaining operating lease balances primarily relate to non-cancelable 
facility-related operating leases.

Capital Leases

Capital  leases  reflect  building  lease  obligations  assumed  from  our  acquisition  of  SEZ  and  an  office 

equipment lease. The amounts in the table above include the interest portion of payment obligations.

Purchase Obligations

Purchase obligations consist of significant contractual obligations either on an annual basis or over multi-
year periods related to our outsourcing activities or other material commitments, including vendor-consigned 
inventories. We continue to enter into new agreements and maintain existing agreements to outsource certain 
activities,  including  elements  of  our  manufacturing,  warehousing,  logistics,  facilities  maintenance,  certain 
information  technology  functions,  and  certain  transactional  general  and  administrative  functions.  The  table 
presented above contains our purchase obligations at June 27, 2010 under these arrangements and others. Actual 
expenditures  will  vary  based  on  the  volume  of  transactions  and  length  of  contractual  service  provided.  In 
addition to these obligations, certain of these agreements include early termination provisions and/or cancellation 
penalties that could increase or decrease amounts actually paid.

Consignment inventories, which are owned by vendors but located in our storage locations and warehouses, 
are not reported as our inventory until title is transferred to us or our purchase obligation is determined. At June 27, 
2010, vendor-owned inventories held at our locations and not reported as our inventory were $33.7 million.

37

Long-Term Debt

During fiscal year 2010 we made $21.0 million in principal payments on long-term debt and capital leases. 
During fiscal year 2009, we paid the outstanding principal balance of $250.0 million of our existing long-term 
debt with ABN AMRO using existing cash balances. There were no penalties associated with the payment. In 
connection with the payment, the parties agreed to terminate the ABN AMRO Credit Agreement and related 
Collateral  Documents.  ABN  AMRO  continues  to  be  a  participant  in  our  operating  leases  with  BNP  Paribas 
Leasing Corporation and continues to provide banking services to us for customary fees.

Our remaining total long-term debt, excluding interest, of $7.0 million as of June 27, 2010 is the result 
of  obligations  we  assumed  in  connection  with  our  acquisition  of  SEZ,  consisting  of  various  bank  loans  and 
government subsidized technology loans supporting operating needs.

Guarantees

We  have  issued  certain  indemnifications  to  our  lessors  for  taxes  and  general  liability  under  some  of 
our lease agreements. We have entered into certain insurance contracts that may limit our exposure to these 
indemnification obligations. As of June 27, 2010, we have not recorded any liability on our consolidated financial 
statements in connection with these indemnifications, as we do not believe, based on information available, that 
it is probable that any amounts will be paid under these guarantees.

Generally,  we  indemnify  our  customers  for  infringement  of  third-party  intellectual  property  rights  by 
our products or services under pre-determined conditions and limitations. We seek to limit our liability for any 
indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification 
obligations. We do not believe, based on information available, that it is probable that any material amounts will 
be paid under these indemnities.

Warranties

We provide standard warranties on our systems that generally run for a period of 12 months from system 
acceptance. The liability amount is based on actual historical warranty spending activity by type of system, 
customer, and geographic region, modified for any known considerations such as the impact of system reliability 
improvements.

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

Investments

We maintain an investment portfolio of various holdings, types, and maturities. As of June 27, 2010, the 
Company’s  mutual  funds  are  classified  as  trading  securities.  Investments  classified  as  trading  securities  are 
recorded at fair value based upon quoted market prices. Any material differences between the cost and fair value 
of trading securities is recognized as “Other income (expense)” in the Consolidated Statement of Operations. 
All  of  the  Company’s  other  short-term  investments  are  classified  as  available-for-sale  and  consequently  are 
recorded in the Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate 
component of accumulated other comprehensive income, net of tax.

Fixed Income Securities

Our investments in various interest earning securities carry a degree of market risk for changes in interest 
rates. At any time, a sharp rise in interest rates could have a material adverse impact on the fair value of our 
fixed income investment portfolio. Conversely, declines in interest rates could have a material adverse impact 
on interest income for our investment portfolio. We target to maintain a conservative investment policy, which 
focuses on the safety and preservation of our invested funds by limiting default risk, market risk, reinvestment 
risk,  and  the  amount  of  credit  exposure  to  any  one  issuer.  The  following  table  presents  the  hypothetical  fair 

38

values of fixed income securities that would result from selected potential decreases and increases in interest 
rates. Market changes reflect immediate hypothetical parallel shifts in the yield curve of plus or minus 50 basis 
points (“BPS”), 100 BPS, and 150 BPS. The hypothetical fair values as of June 27, 2010 were as follows:

Valuation of Securities 
Given an Interest Rate 
Decrease of X Basis Points
(100 BPS)

(50 BPS)

(150 BPS)

Municipal Notes and Bonds . . . . . $106,397 $105,565 $104,733
US Treasury & Agencies  . . . . . . .
3,459
Government-Sponsored 

3,472

3,484

Enterprises  . . . . . . . . . . . . . . .
Foreign Government . . . . . . . . . . .
Bank and Corporate Notes . . . . . .
Mortgage Backed Securities — 

6,168
1,010

6,096
1,009
292,289 291,338 290,388

6,132
1,009

Fair Value as of 
June 27, 2010
0.00%
(in thousands)
$103,903
3,447

6,060
1,008
289,437

Valuation of Securities 
Given an Interest Rate 
Increase of X Basis Points
100 BPS

50 BPS

150 BPS

$103,070 $102,238 $101,407
3,411

3,423

3,435

6,025
1,007

5,953
1,005
288,487 287,536 286,586

5,989
1,006

Residential . . . . . . . . . . . . . . . .

6,198

6,167

6,137

6,106

6,076

6,046

6,016

Mortgage Backed Securities — 

Commercial . . . . . . . . . . . . . . .

43,257
Total  . . . . . . . . . . . . . . . . . . . . . . . $459,390 $457,234 $455,079

43,844

43,551

42,964
$452,925

42,671

42,084
$450,771 $448,615 $446,462

42,377

We  mitigate  default  risk  by  investing  in  high  credit  quality  securities  and  by  positioning  our  portfolio 
to  respond  appropriately  to  a  significant  reduction  in  a  credit  rating  of  any  investment  issuer  or  guarantor. 
The portfolio includes only marketable securities with active secondary or resale markets to achieve portfolio 
liquidity and maintain a prudent amount of diversification.

Publicly Traded Securities

The values of our investments in publicly traded securities are subject to market price risk. The following 
table  presents  the  hypothetical  fair  values  of  our  publicly  traded  securities  that  would  result  from  selected 
potential decreases and increases in the price of each security in the portfolio. Potential fluctuations in the price 
of each security in the portfolio of plus or minus 10%, 15%, or 25% were selected based on potential near-term 
changes in those security prices. The hypothetical fair values as of June 27, 2010 were as follows:

Valuation of Securities 
Given an X% Decrease 
in Security Price
(15%)

(10%)

(25%)

Mutual Funds . . . . . . . . . . . . . . . . . . . . . $13,593 $15,406 $16,312
Publicly Traded Equity Securities . . . . . $ 5,739 $ 6,504 $ 6,886

Foreign Currency Derivatives

Fair Value as of 
June 27, 2010
0.00%
(in thousands)
$18,124
$ 7,636

Valuation of Securities 
Given an X% Increase 
in Security Price
15%

25%

10%

$19,937 $20,843 $22,655
$ 8,417 $ 8,799 $ 9,565

We conduct business on a global basis in several major international currencies. As such, we are potentially 
exposed to adverse as well as beneficial movements in foreign currency exchange rates. The majority of our 
revenues and expenses are denominated in U.S. dollars except for certain revenues denominated in Japanese 
yen, certain revenues and expenses denominated in the Euro, certain spares and service contracts denominated 
in various currencies, and expenses related to our non-U.S. sales and support offices denominated in the related 
countries’ local currency. We currently enter into foreign exchange forward contracts to minimize the short-
term impact of foreign currency exchange rate fluctuations on Japanese yen-denominated revenue and monetary 
asset and liability exposure, as well as monetary assets and liabilities denominated in Swiss francs, Euros and 
Taiwanese dollars. We currently believe these are our primary exposures to currency rate fluctuation.

39

To protect against the reduction in value of forecasted Japanese yen-denominated revenue, we enter into 
foreign  currency  forward  exchange  rate  contracts  that  generally  expire  within  12  months,  and  no  later  than 
24 months. These foreign currency forward exchange rate contracts are designated as cash flow hedges and are 
carried on our balance sheet at fair value, with the effective portion of the contracts’ gains or losses included in 
accumulated other comprehensive income (loss) and subsequently recognized in earnings in the same period 
the hedged revenue is recognized. We also enter into foreign currency forward contracts to hedge the gains and 
losses  generated  by  the  remeasurement  of  Japanese  yen-denominated  monetary  assets  and  liabilities  against 
the U.S. dollar and monetary assets and liabilities denominated in Swiss francs, Euros and Taiwanese dollars. 
The change in fair value of these balance sheet hedge contracts is recorded into earnings as a component of 
other income (expense), net and offsets the change in fair value of the foreign currency denominated monetary 
assets and liabilities also recorded in other income (expense), net, assuming the hedge contract fully covers the 
intercompany and trade receivable balances.

The notional amount and unrealized gain of our outstanding forward contracts that are designated as cash 
flow hedges, as of June 27, 2010 are shown in the table below. This table also shows the change in fair value 
of these cash flow hedges assuming a hypothetical foreign currency exchange rate movement of plus-or-minus 
10 percent and plus-or-minus 15 percent.

Notional 
Amount

Unrealized 
FX Loss/(Gain) 
June 27, 2010

Valuation of Fx Contracts 
Given an X% Increase (+)/ 
Decrease(-) in Each Fx Rate
+ /-(15%) 
+ /-(10%) 

(in $ Millions)

Cash Flow Hedge
Forward Contracts Sold . . . . . . . . . .

JPY/USD

$73.3

($ 0.0) 

$7.3

$11.0

The notional amount and unrealized loss of our outstanding foreign currency forward contracts that are 
designated as balance sheet hedges, as of June 27, 2010 are shown in the table below. This table also shows the 
change  in  fair  value  of  these  balance  sheet  hedges,  assuming  a  hypothetical  foreign  currency  exchange  rate 
movement of plus-or-minus 10 percent and plus-or-minus 15 percent. These changes in fair values would be 
offset in other income (expense), net, by corresponding change in fair values of the foreign currency denominated 
monetary assets and liabilities, assuming the hedge contract fully covers the intercompany and trade receivable 
balances.

Notional 
Amount

Unrealized 
FX Loss/(Gain) 
June 27, 2010

Valuation of Fx Contracts 
Given an X% Increase (+)/ 
Decrease(-) in Each Fx Rate
+ /-(15%) 
+ /-(10%) 

(in $ Millions)

JPY/USD
USD/CHF
USD/TWD
USD/EUR

$ 75.3
$(188.6) 
$ (66.0) 
$ (38.2) 
$(217.5) 

$ 1.3
$ (0.4) 
$ 0.9
$ (0.0) 
$ 1.8

$ 7.5
$18.9
$ 6.6
$ 3.8
$36.8

$11.3
$28.3
$ 9.9
$ 5.7
$55.2

Balance Sheet Hedge

Forward Contracts Sold . . . . .

Long-Term Debt

Our long-term debt includes $1.8 million of variable rate debt based on LIBOR plus a spread of 0.875 and 

is subject to adverse as well as beneficial changes in interest expense due to fluctuation in interest rates.

We  believe  that  maintaining  sufficient  liquidity  reserves  is  important  to  support  sustaining  levels 
of  investment  in  our  business  activities.  Based  upon  our  current  business  outlook,  our  levels  of  cash,  cash 
equivalents, and short-term investments at June 27, 2010 are expected to be sufficient to support our anticipated 
levels of operations, investments, debt service requirements, and capital expenditures, through at least the next 
12 months. In the longer term, liquidity will depend to a great extent on our future revenues and our ability to 

40

appropriately manage our costs based on demand for our products. Should additional funding be required, we 
may need to raise the required funds through borrowings or public or private sales of debt or equity securities. 
We believe that, in the event of such requirements, we will be able to access the capital markets on terms and 
in amounts adequate to meet our objectives. However, given the possibility of changes in market conditions or 
other occurrences, there can be no certainty that such funding will be available in needed quantities or on terms 
favorable to us.

Item 8.  Financial Statements and Supplementary Data

The Consolidated Financial Statements required by this Item are set forth on the pages indicated in Item 
15(a). The unaudited quarterly results of our operations for our two most recent fiscal years are incorporated in 
this Item by reference under Item 6, “Selected Financial Data” above.

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.  Controls and Procedures

Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange 
Act”), as of June 27, 2010, we carried out an evaluation, under the supervision and with the participation of 
our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness 
of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon 
that evaluation, our Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure 
controls and procedures are effective at the reasonable assurance level.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures 
on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our 
senior management has timely access to material information that could affect our business.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal 
quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial 
reporting.

Management’s Report on Internal Control Over Financial Reporting

Management  is  responsible  for  establishing  and  maintaining  adequate  “internal  control  over  financial 
reporting”,  as  that  term  is  defined  in  Exchange  Act  Rules  13a-15(f)  and  15d-15(f).  Management  has  used 
the  framework  set  forth  in  the  report  entitled  “Internal  Control  —  Integrated  Framework”  published  by  the 
Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission  to  evaluate  the  effectiveness  of  the 
Company’s internal control over financial reporting. Based on that evaluation, management has concluded that 
the Company’s internal control over financial reporting was effective as of June 27, 2010 at providing reasonable 
assurance regarding the reliability of financial reporting and the preparation of financial statements for external 
purposes in accordance with GAAP.

Ernst  &  Young  LLP,  an  independent  registered  public  accounting  firm,  has  audited  the  Company’s 
internal control over financial reporting, as stated in their report, which is included in Part IV, Item 15 of this 
2010 Form 10-K.

41

Effectiveness of Controls

While we believe the present design of our disclosure controls and procedures and internal control over 
financial  reporting  is  effective  at  the  reasonable  assurance  level,  future  events  affecting  our  business  may 
cause  us  to  modify  our  disclosure  controls  and  procedures  or  internal  control  over  financial  reporting.  The 
effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors 
or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would 
likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% 
effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide 
only reasonable, not absolute, assurance that the control system’s objectives will be met.

Item 9B.  Other Information

None.

42

PART III

We have omitted from this 2010 Form 10-K certain information required by Part III because we, as the 
Registrant, will file a definitive proxy statement with the Securities and Exchange Commission (SEC) within 
120 days after the end of our fiscal year, pursuant to Regulation 14A, as promulgated by the SEC, for our Annual 
Meeting of Stockholders expected to be held on or about November 4, 2010 (the “Proxy Statement”), and certain 
information included in the Proxy Statement is incorporated into this report by reference. (However, the Reports 
of the Audit Committee and Compensation Committee in the Proxy Statement are expressly not incorporated by 
reference into this report.)

Item 10.  Directors, Executive Officers, and Corporate Governance

For  information  regarding  our  executive  officers,  see  Part  I,  Item  1  of  this  2010  Form  10-K  under  the 

caption “Executive Officers of the Company,” which information is incorporated into Part III by reference.

The information concerning our directors required by this Item is incorporated by reference to our Proxy 

Statement under the heading “Proposal No. 1 — Election of Directors.”

The information concerning our audit committee and audit committee financial experts required by this 

Item is incorporated by reference to our Proxy Statement under the heading “Corporate Governance.”

The information concerning compliance by our officers, directors and 10% shareholders with Section 16 
of the Exchange Act required by this Item is incorporated by reference to our Proxy Statement under the heading 
“Section 16(a) Beneficial Ownership Reporting Compliance.”

The  Company  has  adopted  a  Corporate  Code  of  Ethics  that  applies  to  all  employees,  officers,  and 
directors of the Company. Our Code of Ethics is publicly available on the investor relations page of our website 
at  http://investor.lamresearch.com.  To  the  extent  required  by  law,  any  amendments  to,  or  waivers  from,  any 
provision of the Code of Ethics will promptly be disclosed to the public. To the extent permitted by applicable 
legal requirements, we intend to make any required public disclosure by posting the relevant material on our 
website in accordance with SEC rules.

Item 11.  Executive Compensation

The  information  required  by  this  Item  is  incorporated  by  reference  to  our  Proxy  Statement  under  the 

heading “Executive Compensation and Other Information.”

Item 12. 

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder 
Matters

The information required by this Item is incorporated by reference to our Proxy Statement under the headings 
“Proposal  No.  1  —  Election  of  Directors,”  “Compensation  Committee  Interlocks  and  Insider  Participation,” 
“Compensation Committee Report,” “Security Ownership of Certain Beneficial Owners and Management” and 
“Securities Authorized for Issuance Under Equity Compensation Plans.”

Item 13.  Certain Relationships and Related Transactions, and Director Independence

The  information  required  by  this  Item  is  incorporated  by  reference  to  our  Proxy  Statement  under  the 

heading “Certain Relationships and Related Transactions.”

Item 14.  Principal Accounting Fees and Services

The  information  required  by  this  Item  is  incorporated  by  reference  to  our  Proxy  Statement  under  the 

heading “Relationship with Independent Registered Public Accounting Firm.”

43

PART IV

Item 15.  Exhibits, Financial Statement Schedules

(a) 

   The following documents are filed as part of this Annual Report on Form 10-K

   1. Index to Financial Statements

Consolidated Balance Sheets — June 27, 2010 and June 28, 2009 . . . . . . . . . . . . . . . . . . 
Consolidated Statements of Operations — Years Ended June 27, 2010, 

June 28, 2009, and June 29, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Consolidated Statements of Cash Flows — Years Ended June 27, 2010, 

June 28, 2009, and June 29, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Consolidated Statements of Stockholders’ Equity — Years Ended June 27, 2010, 

June 28, 2009, and June 29, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Reports of Independent Registered Public Accounting Firm  . . . . . . . . . . . . . . . . . . . . . . 

Page
45

46

47

48
50
85

   2. Index to Financial Statement Schedules

Schedule II —Valuation and Qualifying Accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

89

  Schedules, other than those listed above, have been omitted since they are not applicable/

not required, or the information is included elsewhere herein.

   3. See (c) of this Item 15, which is incorporated herein by reference.

(c) 

    The  list  of  Exhibits  follows  page  88  of  this  2010  Form  10-K  and  is  incorporated  herein  by  this 

reference.

44

 
 
 
 
 
 
LAM RESEARCH CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)

ASSETS
Cash and cash equivalents  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Short-term investments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Accounts receivable, less allowance for doubtful accounts of 

$10,609 as of June 27, 2010 and $10,719 as of June 28, 2009 . . . . . . . . . . . . . 
Inventories  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Total current assets  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Property and equipment, net  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Restricted cash and investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Intangible assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

June 27, 
2010

June 28, 
2009

$

545,767  
280,690  

$

374,167 
205,221 

499,890  
318,479  
46,158  
65,677  
  1,756,661  
200,336  
165,234  
26,218  
169,182  
67,724  
102,037  
$ 2,487,392  

253,585 
233,410 
69,043 
101,714 
  1,237,140 
215,666 
178,439 
17,007 
169,182 
91,605 
84,145 
$ 1,993,184 

LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Accrued expenses and other current liabilities  . . . . . . . . . . . . . . . . . . . . . . . . . . 
Deferred profit  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Current portion of long-term debt and capital leases . . . . . . . . . . . . . . . . . . . . . . 
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Long-term debt and capital leases  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Income taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Other long-term liabilities  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

$

121,099  
309,397  
123,194  
4,967  
558,657  
17,645  
110,462  
32,493  
719,257  

$

49,606 
281,335 
45,787 
5,348 
382,076 
40,886 
102,999 
14,134 
540,095 

Commitments and contingencies
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized — 

5,000 shares, none outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

—  

— 

Common stock, at par value of $0.001 per share; authorized — 
400,000 shares; issued and outstanding — 125,946 shares 
at June 27, 2010 and 126,532 shares at June 28, 2009  . . . . . . . . . . . . . . . . . . 
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Treasury stock, at cost, 36,884 shares at June 27, 2010 and 34,679 shares 

at June 28, 2009  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Total stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

126  
  1,452,939  

127 
  1,377,231 

  (1,581,417)  
(69,849)  
  1,966,336  
  1,768,135  
$ 2,487,392  

  (1,495,693) 
(52,822) 
  1,624,246 
  1,453,089 
$ 1,993,184 

See Notes to Consolidated Financial Statements

45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cost of goods sold  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cost of goods sold — restructuring and asset impairments . . .  
Cost of goods sold — 409A expense . . . . . . . . . . . . . . . . . . . .  
Total costs of goods sold  . . . . . . . . . . . . . . . . . . . . . . . . . .  
    Gross margin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Research and development  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Selling, general and administrative. . . . . . . . . . . . . . . . . . . . . . . .  
Goodwill impairment  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Restructuring and asset impairments . . . . . . . . . . . . . . . . . . . . . .  
409A expense. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Legal judgment  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
In-process research and development . . . . . . . . . . . . . . . . . . . . . .  
Total operating expenses  . . . . . . . . . . . . . . . . . . . . . . . . . .  
Operating income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . .  

Other income (expense), net:
Interest income  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Foreign exchange gains (losses)  . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Income (loss) before income taxes . . . . . . . . . . . . . . . . . . .  
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  

Net income (loss) per share:

June 27, 
2010
$2,133,776  
  1,166,219  
3,438  
(5,816)  
  1,163,841  
969,935  
320,859  
240,942  
—  
21,314  
(38,590)  
—  
—  
544,525  
425,410  

8,598  
(994)  
(103)  
(2,770)  
430,141  
83,472  
$ 346,669  

YEAR ENDED
June 28, 
2009
$1,115,946  
706,219  
20,993  
—  
727,212  
388,734  
288,269  
233,061  
96,255  
44,513  
3,232  
4,647  
—  
669,977  
(281,243)  

June 29, 
2008
$2,474,911 
  1,282,494 
12,610 
6,401 
  1,301,505 
  1,173,406 
323,759 
287,282 
— 
6,366 
44,494 
— 
2,074 
663,975 
509,431 

24,283  
(6,497)  
922  
(558)  
(263,093)  
39,055  
$ (302,148)  

51,194 
(12,674) 
31,070 
(2,045) 
576,976 
137,627 
$ 439,349 

Basic net income (loss) per share. . . . . . . . . . . . . . . . . . . . . . .  
Diluted net income (loss) per share . . . . . . . . . . . . . . . . . . . . .  

$
$

2.73  
2.71  

$
$

(2.41)  
(2.41)  

$
$

3.52 
3.47 

Number of shares used in per share calculations:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  

126,933  
128,126  

125,595  
125,595  

124,647 
126,504 

See Notes to Consolidated Financial Statements

46

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

YEAR ENDED
June 28, 
2009

June 27, 
2010

June 29, 
2008

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $ 346,669    $(302,148)   $ 439,349 
Adjustments to reconcile net income (loss) to net cash provided by (used for) by operating activities:

Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Deferred income taxes  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Restructuring charges, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Equity-based compensation expense  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Income tax benefit on equity-based compensation plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Excess tax benefit on equity-based compensation plans  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Net gain on settlement of call option  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Goodwill impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Changes in operating asset accounts:

71,401   
13,718   
24,752   
50,463   
10,635   
(10,234)  
—   
—   
3,190   

72,417   
30,545   
65,506   
53,042   
(14,294)  
6,273   
—   
96,255   
9,353   

54,704 
(26,661) 
18,976 
42,516 
83,472 
(58,904) 
(33,839) 
— 
(3,319) 

Accounts receivable, net of allowance  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Prepaid expenses and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Trade accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Deferred profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Accrued expenses and other liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
  Net cash provided by (used for) operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  

  (246,653)  
(79,701)  
(23,647)  
71,600   
77,407   
41,113   
  350,713   

  152,086   
46,052   
5,888   
(39,381)  
(82,464)  
  (177,259)  
(78,129)  

99,887 
19,684 
(21,972) 
(40,125) 
(64,007) 
80,558 
  590,319 

CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acquisitions of businesses, net of cash acquired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Purchases of available-for-sale securities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sales and maturities of available-for-sale securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Purchase of call option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Proceeds from settlement of call option . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Purchase of other investments  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Loans made . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Transfer of restricted cash and investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
  Net cash provided by (used for) investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  

(35,590)  
—   
  (192,755)  
  114,768   
—   
—   
(2,184)  
(800)  
13,205   
  (103,356)  

(44,282)  
(19,457)  
  (209,298)  
  383,062   
—   
—   
(3,439)  
(8,375)  
(92,206)  
6,005   

(76,803) 
  (482,574) 
  (310,873) 
  329,695 
(13,506) 
47,345 
(4,560) 
— 
15,471 
  (495,805) 

CASH FLOWS FROM FINANCING ACTIVITIES:
  (251,714) 
Principal payments on long-term debt and capital lease obligations  . . . . . . . . . . . . . . . . . . . . . . . . . .  
  251,915 
Net proceeds from issuance of long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
58,904 
Excess tax benefit on equity-based compensation plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(14,552) 
Treasury stock purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
8,563 
Reissuances of treasury stock. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
12,694 
Proceeds from issuance of common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
65,810 
  Net cash provided by (used for) financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
(1,754) 
Effect of exchange rate changes on cash  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
  158,570 
Net increase (decrease) in cash and cash equivalents  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cash and cash equivalents at beginning of year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
  573,967 
Cash and cash equivalents at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $ 545,767    $ 374,167    $ 732,537 
Schedule of noncash transactions

  (256,047)  
625   
(6,273)  
(30,946)  
19,797   
12,014   
  (260,830)  
(25,416)  
  (358,370)  
  732,537   

(21,040)  
336   
10,234   
(93,032)  
17,452   
13,386   
(72,664)  
(3,093)  
  171,600   
  374,167   

—    $
Acquisition of leased equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $
Accrued payables for stock repurchases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $ 13,500    $

454    $ 21,784 
— 
—    $

Supplemental disclosures:

Cash payments for interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $
7,808    $ 10,900 
Cash payments for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $ 16,261    $ 33,583    $ 74,243 

878    $

See Notes to Consolidated Financial Statements

47

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

COMMON 
STOCK 
SHARES   
123,535
1,703
(287)
—

COMMON 
STOCK 
$124
1
—
—

ADDITIONAL 
PAID-IN 
CAPITAL 
$1,194,215
12,695
—
(2,282)

TREASURY 
STOCK 
$(1,483,169)
—
(14,552)
—

ACCUMULATED 
OTHER 
COMPREHENSIVE 
INCOME (LOSS) 
$ (4,302)
—
—
—

RETAINED 
EARNINGS   TOTAL 
$1,176,320
$1,469,452
12,696
—
(14,552)
—
(2,282)
—

Balance at June 24, 2007. . . . . . . . . . . . . . .  
Sale of common stock . . . . . . . . . . . . . . . . .  
Purchase of treasury stock  . . . . . . . . . . . . .  
Tender offer . . . . . . . . . . . . . . . . . . . . . . . . .  
Income tax benefit on equity-based 

compensation plans  . . . . . . . . . . . . . . .  
Reissuance of treasury stock  . . . . . . . . . . .  
Equity-based compensation expense . . . . .  
Adoption of interpretive guidance on 

uncertainties in income taxes  . . . . . . .  

Components of comprehensive income:

Net income . . . . . . . . . . . . . . . . . . . . . .  
Foreign currency translation 

adjustment . . . . . . . . . . . . . . . . . . .  

Unrealized gain on fair value of 

derivative financial 
instruments, net . . . . . . . . . . . . . . .  

Unrealized gain on financial 

instruments, net . . . . . . . . . . . . . . .  

Less: Reclassification adjustment for 

gains included in earnings . . . . . . .  
Change in retiree medical benefit . . . . .  
Total comprehensive income . . . . .  
Balance at June 29, 2008. . . . . . . . . . . . . . .  
Sale of common stock . . . . . . . . . . . . . . . . .  
Purchase of treasury stock  . . . . . . . . . . . . .  
Income tax benefit on equity-based 

compensation plans  . . . . . . . . . . . . . . .  
Reissuance of treasury stock  . . . . . . . . . . .  
Equity-based compensation expense . . . . .  
Components of comprehensive loss:

Net loss . . . . . . . . . . . . . . . . . . . . . . . . .  
Foreign currency translation 

adjustment . . . . . . . . . . . . . . . . . . .  

Unrealized loss on fair value of 

derivative financial 
instruments, net . . . . . . . . . . . . . . .  

Unrealized gain on financial 

instruments, net . . . . . . . . . . . . . . .  

—
236
—

—

—

—

—

—

—
—
—

—

—

—

—

—

74,865
1,543
42,516

8,607

—

—

—

—

—
7,020
—

—

—

—

—

—

—
—
—
125,187
1,806
(1,367)

—
—
—
$ 125
2
(1)

—
—
—
$ 1,332,159
12,012
—

—
—
—
$(1,490,701)
—
(30,945)

—
906
—

—

—

—

—

—
1
—

—

—

—

—

(14,294)
(6,157)
53,511

—
25,953
—

—

—

—

—

—

—

—

—

Less: Reclassification adjustment for 

losses included in earnings  . . . . . .  
Change in retiree medical benefit . . . . .  
Total comprehensive loss. . . . . . . .  
Balance at June 28, 2009. . . . . . . . . . . . . . .  

—
—
—
126,532

—
—
—
$127

—
—
—
$1,377,231

—
—
—
$(1,495,693)

48

—
—
—

—

—

12,557

398

2,787

(461)
(359)
—
$ 10,620
—
—

—
—
—

—

(58,587)

(6,633)

1,192

501
85
—
$(52,822)

—
—
—

74,865
8,563
42,516

17,593

26,200

439,349

439,349

—

—

—

12,557

398

2,787

—
—
—
$ 1,926,394
—
—

(461)
(359)
454,271
$1,778,597
12,014
(30,946)

—
—
—

(14,294)
19,797
53,511

(302,148)

(302,148)

—

—

—

(58,587)

(6,633)

1,192

—
—
—
$1,624,246

501
85
(365,590)
$1,453,089

 
 
 
 
 
 
 
LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY – (continued)
(in thousands)

Sale of common stock . . . . . . . . . . . . . . . . .  
Purchase of treasury stock  . . . . . . . . . . . . .  
Income tax benefit on equity-based 

compensation plans  . . . . . . . . . . . . . . .  
Reissuance of treasury stock  . . . . . . . . . . .  
Equity-based compensation expense . . . . .  
Components of comprehensive income:

Net income . . . . . . . . . . . . . . . . . . . . . .  
Foreign currency translation 

adjustment . . . . . . . . . . . . . . . . . . .  

Unrealized loss on fair value of 

derivative financial 
instruments, net . . . . . . . . . . . . . . .  

Unrealized gain on financial 

instruments, net . . . . . . . . . . . . . . .  

Less: Reclassification adjustment for 

gains included in earnings . . . . . . .  
Change in retiree 

medical benefit . . . . . . . . . . . .  
Total comprehensive income . . . . .  
Balance at June 27, 2010 . . . . . . . . . . . . . . .  

— 
— 
125,946 

COMMON 
STOCK 
SHARES
1,619 
(2,982)   

COMMON 
STOCK

1 
(3) 

ADDITIONAL 
PAID-IN 
CAPITAL
13,386

TREASURY 
STOCK

— 

—  

(106,531)   

— 
777 
— 

— 

— 

— 

— 

— 

  — 
1 
  — 

  — 

  — 

  — 

  — 

  — 

  — 
  — 
$126 

10,635
1,224
50,463

— 
20,807 
— 

—  

—  

—  

—  

—  

—  
—  

— 

— 

— 

— 

— 

— 
— 

$1,452,939

  $(1,581,417)   

ACCUMULATED 
OTHER 
COMPREHENSIVE 
INCOME (LOSS)

— 
— 

— 
— 
— 

— 

RETAINED 
EARNINGS
— 
— 

TOTAL

13,386 
(106,532) 

— 
(4,579)     
— 

10,635 
17,452 
50,463 

346,669 

346,669 

  (13,868) 

— 

(13,868) 

(414) 

2,062 

(645) 

—     

(414) 

—     

2,062 

— 

(645) 

(4,162) 
— 
$(69,849) 

(4,162) 
329,642 
  $1,966,336    $1,768,135 

— 
— 

See Notes to Consolidated Financial Statements

49

 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
JUNE 27, 2010

Note 1: Company and Industry Information

The  Company  designs,  manufactures,  markets,  refurbishes  and  services  semiconductor  processing 
equipment  used  in  the  fabrication  of  integrated  circuits.  Semiconductor  wafers  are  subjected  to  a  complex 
series of process and preparation steps that result in the simultaneous creation of many individual integrated 
circuits. The Company leverages its expertise in the areas of etch and single-wafer clean to develop processing 
solutions that typically benefit its customers through lower defect rates, enhanced yields, faster processing time, 
or reduced cost. The Company sells its products and services primarily to companies involved in the production 
of semiconductors in North America, Europe, Taiwan, Korea, Japan, and Asia Pacific.

The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and 
upturns. Today’s leading indicators of changes in customer investment patterns may not be any more reliable 
than in prior years. Demand for the Company’s equipment can vary significantly from period to period as a 
result  of  various  factors,  including,  but  not  limited  to,  economic  conditions,  supply,  demand,  and  prices  for 
semiconductors, customer capacity requirements, and the Company’s ability to develop and market competitive 
products. For these and other reasons, the Company’s results of operations for fiscal years 2010, 2009, and 2008 
may not necessarily be indicative of future operating results.

Note 2: Summary of Significant Accounting Policies

The preparation of financial statements, in conformity with U.S. Generally Accepted Accounting Principles 
(“GAAP”), requires management to make judgments, estimates, and assumptions that could affect the reported 
amounts  of  assets  and  liabilities  at  the  date  of  the  financial  statements  and  the  reported  amounts  of  revenue 
and  expenses  during  the  reporting  period.  The  Company  based  its  estimates  and  assumptions  on  historical 
experience and on various other assumptions we believed to be applicable, and evaluated them on an on-going 
basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from 
those estimates.

Revenue Recognition: The Company recognizes all revenue when persuasive evidence of an arrangement 
exists,  delivery  has  occurred  and  title  has  passed  or  services  have  been  rendered,  the  selling  price  is  fixed 
or  determinable,  collection  of  the  receivable  is  reasonably  assured,  and  the  Company  has  completed  its 
system installation obligations, received customer acceptance or is otherwise released from its installation or 
customer  acceptance  obligations.  If  terms  of  the  sale  provide  for  a  lapsing  customer  acceptance  period,  the 
Company  recognizes  revenue  upon  the  expiration  of  the  lapsing  acceptance  period  or  customer  acceptance, 
whichever occurs first. If the practices of a customer do not provide for a written acceptance or the terms of 
sale do not include a lapsing acceptance provision, the Company recognizes revenue when it can be reliably 
demonstrated that the delivered system meets all of the agreed-to customer specifications. In situations with 
multiple deliverables, revenue is recognized upon the delivery of the separate elements to the customer and when 
the Company receives customer acceptance or is otherwise released from its customer acceptance obligations. 
Revenue from multiple-element arrangements is allocated among the separate elements based on their relative 
fair values, provided the elements have value on a stand-alone basis, there is objective and reliable evidence of 
fair value, the arrangement does not include a general right of return relative to the delivered item and delivery 
or performance of the undelivered item(s) is considered probable and substantially in our control. The maximum 
revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of 
additional items. Revenue related to sales of spare parts and system upgrade kits is generally recognized upon 
shipment. Revenue related to services is generally recognized upon completion of the services requested by a 
customer order. Revenue for extended maintenance service contracts with a fixed payment amount is recognized 
on a straight-line basis over the term of the contract.

Inventory  Valuation:  Inventories  are  stated  at  the  lower  of  cost  or  market  using  standard  costs  which 
generally approximate actual costs on a first-in, first-out basis. The Company maintains a perpetual inventory 
system and continuously records the quantity on-hand and standard cost for each product, including purchased 
components, subassemblies, and finished goods. The Company maintains the integrity of perpetual inventory 

50

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

records through periodic physical counts of quantities on hand. Finished goods are reported as inventories until 
the point of title transfer to the customer. Generally, title transfer is documented in the terms of sale. When the 
terms of sale do not specify title transfer, the Company assumes title transfers when it completes physical transfer 
of the products to the freight carrier unless other customer practices prevail. Transfer of title for shipments to 
Japanese customers generally occurs at time of customer acceptance.

Standard costs are reassessed as needed but annually at a minimum, and reflect achievable acquisition 
costs.  Acquisition  costs  are  generally  based  on  the  most  recent  vendor  contract  prices  for  purchased  parts, 
normalized  assembly  and  test  labor  utilization  levels,  methods  of  manufacturing,  and  normalized  overhead. 
Manufacturing labor and overhead costs are attributed to individual product standard costs at a level planned to 
absorb spending at average utilization volumes. All intercompany profits related to the sales and purchases of 
inventory between the Company’s legal entities are eliminated from its consolidated financial statements.

Management evaluates the need to record adjustments for impairment of inventory at least quarterly. The 
Company’s policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-
process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess 
of management’s estimated usage requirements over the next 12 to 36 months is written down to its estimated 
market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts 
related  to  the  Company’s  future  manufacturing  schedules,  customer  demand,  technological  and/or  market 
obsolescence,  general  semiconductor  market  conditions,  possible  alternative  uses,  and  ultimate  realization 
of  excess  inventory.  If  future  customer  demand  or  market  conditions  are  less  favorable  than  the  Company’s 
projections, additional inventory write-downs may be required and would be reflected in cost of sales in the 
period the revision is made.

Warranty:  Typically,  the  sale  of  semiconductor  capital  equipment  includes  providing  parts  and  service 
warranty to customers as part of the overall price of the system. The Company provides standard warranties 
for our systems that generally run for a period of 12 months from system acceptance. When appropriate, the 
Company records a provision for estimated warranty expenses to cost of sales for each system upon revenue 
recognition. The Company does not maintain general or unspecified reserves; all warranty reserves are related 
to specific systems. The amount recorded is based on an analysis of historical activity which uses factors such 
as type of system, customer, geographic region, and any known factors such as tool reliability trends. All actual 
or estimated parts and labor costs incurred in subsequent periods are charged to those established reserves on a 
system-by-system basis.

Actual  warranty  expenses  are  accounted  for  on  a  system-by-system  basis  and  may  differ  from  the 
Company’s original estimates. While the Company periodically monitors the performance and cost of warranty 
activities, if actual costs incurred are different than its estimates, the Company may recognize adjustments to 
provisions in the period in which those differences arise or are identified. In addition to the provision of standard 
warranties, the Company offers customer-paid extended warranty services. Revenues for extended maintenance 
and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the 
contract. Related costs are recorded either as incurred or when related liabilities are determined to be probable 
and estimable.

Equity-based  Compensation  —  Employee  Stock  Purchase  Plan  (“ESPP”)  and  Employee  Stock  Plans: 
GAAP requires the recognition of the fair value of equity-based compensation in net income. The fair value 
of  the  Company’s  restricted  stock  units  was  calculated  based  upon  the  fair  market  value  of  Company  stock 
at the date of grant. The fair value of the Company’s stock options and ESPP awards was estimated using a 
Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including 
expected stock price volatility and the estimated life of each award. The fair value of equity-based awards is 
amortized over the vesting period of the award and the Company has elected to use the straight-line method 
of amortization.

51

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The Company makes quarterly assessments of the adequacy of its tax credit pool related to equity-based 
compensation to determine if there are any deficiencies that require recognition in its consolidated statements 
of operations. The Company will only recognize a benefit from stock-based compensation in paid-in-capital if 
an incremental tax benefit is realized after all other tax attributes currently available to us have been utilized. 
In addition, the Company has elected to account for the indirect benefits of stock-based compensation on the 
research tax credit through the income statement (continuing operations) rather than through paid-in-capital. 
The Company has also elected to net deferred tax assets and the associated valuation allowance related to net 
operating loss and tax credit carryforwards for the accumulated stock award tax benefits for income tax footnote 
disclosure purposes. The Company will track these stock award attributes separately and will only recognize 
these attributes through paid-in-capital.

Income Taxes: Deferred income taxes reflect the net effect of temporary differences between the carrying 
amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, 
as well as the tax effect of carryforwards. The Company records a valuation allowance to reduce its deferred tax 
assets to the amount that is more-likely-than-not to be realized. Realization of the Company’s net deferred tax 
assets is dependent on future taxable income. The Company believes it is more-likely-than-not that such assets 
will  be  realized;  however,  ultimate  realization  could  be  negatively  impacted  by  market  conditions  and  other 
variables not known or anticipated at the time. In the event that the Company determines that it would not be 
able to realize all or part of its net deferred tax assets, an adjustment would be charged to earnings in the period 
such determination is made. Likewise, if the Company later determined that it is more-likely-than-not that the 
deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.

The Company calculates its current and deferred tax provision based on estimates and assumptions that 
can differ from the actual results reflected in income tax returns filed during the subsequent year. Adjustments 
based on filed returns are recorded when identified.

In July 2006, the FASB issued guidance which defines the threshold for recognizing the benefits of tax 
return positions in the financial statements as “more-likely-than-not” to be sustained by the taxing authority. 
The Company adopted this guidance on June 25, 2007. It provides guidance on the de-recognition, measurement 
and classification of income tax uncertainties, along with any related interest and penalties. This guidance also 
includes information concerning accounting for income tax uncertainties in interim periods and increases the 
level of disclosures associated with any recorded income tax uncertainties. We must make certain estimates and 
judgments in determining income tax expense for financial statement purposes. These estimates and judgments 
occur in the calculation of tax credits, benefits, and deductions, and in the calculation of certain tax assets and 
liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial 
statement purposes, as well as the interest and penalties relating to these uncertain tax positions. Significant 
changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.

In  addition,  the  calculation  of  the  Company’s  tax  liabilities  involves  dealing  with  uncertainties  in  the 
application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based 
on the two-step process prescribed within the interpretation. The first step is to evaluate the tax position for 
recognition by determining if the weight of available evidence indicates that it is more-likely-than-not that the 
position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The 
second step requires the Company to estimate and measure the tax benefit as the largest amount that is more 
than  50%  likely  to  be  realized  upon  ultimate  settlement.  It  is  inherently  difficult  and  subjective  to  estimate 
such  amounts,  as  this  requires  us  to  determine  the  probability  of  various  possible  outcomes.  The  Company 
reevaluates these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but 
not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and 
new audit activity. Such a change in recognition or measurement would result in the recognition of a tax benefit 
or an additional charge to the tax provision in the period such determination is made.

52

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Goodwill and Intangible Assets: Goodwill represents the amount by which purchase price in each business 
combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. The carrying 
value of goodwill is allocated to our reporting units. Goodwill and identifiable intangible assets with indefinite 
useful lives are tested for impairment at least annually. Intangible assets with estimable useful lives are amortized 
over  their  respective  estimated  useful  lives  to  their  estimated  residual  values  and  reviewed  for  impairment 
whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not 
be recoverable and the carrying amount exceeds its fair value.

The Company reviews goodwill at least annually for impairment. Should certain events or indicators of 
impairment occur between annual impairment tests, the Company would perform an impairment test of goodwill 
at that date. In testing for a potential impairment of goodwill, the Company: (1) allocates goodwill to our reporting 
units to which the acquired goodwill relates; (2) estimates the fair value of its reporting units; and (3) determines 
the carrying value (book value) of those reporting units, as some of the assets and liabilities related to those 
reporting units are not held by those reporting units but by a corporate function. Prior to this allocation of the 
assets to the reporting units, the Company is required to assess long-lived assets for impairment. Furthermore, 
if the estimated fair value of a reporting unit is less than the carrying value, the Company must estimate the 
fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price 
allocation for an acquired business. This can require independent valuations of certain internally generated and 
unrecognized intangible assets such as in-process research and development and developed technology. Only 
after this process is completed can the amount of goodwill impairment, if any, be determined.

The  process  of  evaluating  the  potential  impairment  of  goodwill  is  subjective  and  requires  significant 
judgment at many points during the analysis. The Company determines the fair value of its reporting units by 
using a weighted combination of both a market and an income approach, as this combination is deemed to be the 
most indicative of our fair value in an orderly transaction between market participants.

Under  the  market  approach,  the  Company  utilizes  information  regarding  the  reporting  unit  as  well  as 
publicly available industry information to determine various financial multiples to value our reporting units. 
Under the income approach, the Company determines fair value based on estimated future cash flows of each 
reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of 
inherent risk of a reporting unit and the rate of return an outside investor would expect to earn.

In  estimating  the  fair  value  of  a  reporting  unit  for  the  purposes  of  the  Company’s  annual  or  periodic 
analyses,  the  Company  makes  estimates  and  judgments  about  the  future  cash  flows  of  its  reporting  units, 
including estimated growth rates and assumptions about the economic environment. Although the Company’s 
cash flow forecasts are based on assumptions that are consistent with the plans and estimates it is using to manage 
the  underlying  businesses,  there  is  significant  judgment  involved  in  determining  the  cash  flows  attributable 
to  a  reporting  unit.  In  addition,  the  Company  makes  certain  judgments  about  allocating  shared  assets  to  the 
estimated balance sheets of our reporting units. The Company also considers its market capitalization and that 
of its competitors on the date it performs the analysis. Changes in judgment on these assumptions and estimates 
could result in a goodwill impairment charge.

As a result, several factors could result in impairment of a material amount of the Company’s goodwill 
balance in future periods, including, but not limited to: (1) weakening of the global economy, weakness in the 
semiconductor equipment industry, or failure of the Company to reach its internal forecasts, which could impact 
the Company’s ability to achieve its forecasted levels of cash flows and reduce the estimated discounted cash flow 
value of its reporting units; and (2) a decline in the Company’s stock price and resulting market capitalization, if 
the Company determines that the decline is sustained and indicates a reduction in the fair value of the Company’s 
reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, 
is based on estimates and judgments regarding expectations such as the success and life cycle of products and 
technology acquired. If actual product acceptance differs significantly from the estimates, the Company may be 
required to record an impairment charge to write down the asset to its realizable value.

53

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Fiscal Year: The Company follows a 52/53-week fiscal reporting calendar and its fiscal year ends on the 
last  Sunday  of  June  each  year.  The  Company’s  most  recent  fiscal  year  ended  on  June  27,  2010  and  included 
52  weeks.  The  fiscal  year  ended  June  28,  2009  included  52  weeks  and  the  fiscal  year  ended  June  29,  2008 
included 53 weeks. The Company’s next fiscal year, ending on June 26, 2011 will include 52 weeks.

Principles of Consolidation: The consolidated financial statements include the accounts of the Company 
and  its  wholly-owned  subsidiaries.  All  intercompany  accounts  and  transactions  have  been  eliminated 
in consolidation.

Cash Equivalents and Short-Term Investments: All investments purchased with an original final maturity 
of three months or less are considered to be cash equivalents. The Company’s mutual funds are classified as 
trading securities as of the respective balance sheet dates. All of the Company’s other short-term investments are 
classified as available-for-sale at the respective balance sheet dates. The Company accounts for its investment 
portfolio at fair value. Investments classified as trading securities are recorded at fair value based upon quoted 
market  prices.  Any  material  differences  between  the  cost  and  fair  value  of  trading  securities  is  recognized 
as  “Other  income  (expense)”  in  the  Consolidated  Statement  of  Operations.  The  investments  classified  as 
available-for-sale  are  recorded  at  fair  value  based  upon  quoted  market  prices,  and  any  material  temporary 
difference between the cost and fair value of available-for-sale securities is presented as a separate component of 
accumulated other comprehensive income (loss). Unrealized losses on available-for-sale securities are charged 
against “Other income (expense)” when a decline in fair value is determined to be other-than-temporary. The 
Company considers several factors to determine whether a loss is other-than-temporary. These factors include 
but are not limited to: (i) the extent to which the fair value is less than cost basis, (ii) the financial condition and 
near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the 
Company’s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair 
value. The Company’s ongoing consideration of these factors could result in additional impairment charges in the 
future, which could adversely affect its results of operation. An other-than-temporary impairment is triggered 
when there is an intent to sell the security, it is more-likely-than-not that the security will be required to be sold 
before recovery, or the security is not expected to recover the entire amortized cost basis of the security. Other-
than-temporary impairments attributed to credit losses are recognized in the income statement. The specific 
identification method is used to determine the realized gains and losses on investments.

Allowance  for  Doubtful  Accounts:  We  evaluate  our  allowance  for  doubtful  accounts  based  on  a 
combination of factors. In circumstances where specific invoices are deemed to be uncollectible, we provide a 
specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount 
we reasonably believe will be collected. We also provide allowances based on our write-off history. We charge 
accounts receivable balances against our allowance for doubtful accounts once we have concluded our collection 
efforts  are  unsuccessful.  Accounts  receivable  is  considered  past  due  when  not  paid  in  accordance  with  the 
contractual terms of the related arrangement.

Property and Equipment: Property and equipment is stated at cost. Equipment is depreciated by the straight-
line method over the estimated useful lives of the assets, generally three to eight years. Furniture and fixtures 
are depreciated by the straight-line method over the estimated useful lives of the assets, generally five years. 
Software is depreciated by the straight-line method over the estimated useful lives of the assets, generally three 
to five years. Buildings are depreciated by the straight-line method over the estimated useful lives of the assets, 
generally twenty-five to thirty-three years. Leasehold improvements are generally amortized by the straight-line 
method over the shorter of the life of the related asset or the term of the underlying lease. Amortization of capital 
leases is included with depreciation expense.

Impairment  of  Long-Lived  Assets  (Excluding  Goodwill):  The  Company  routinely  considers  whether 
indicators of impairment of long-lived assets are present. If such indicators are present, the Company determines 
whether  the  sum  of  the  estimated  undiscounted  cash  flows  attributable  to  the  assets  in  question  is  less  than 
their  carrying  value.  If  the  sum  is  less,  the  Company  recognizes  an  impairment  loss  based  on  the  excess  of 
the  carrying  amount  of  the  assets  over  their  respective  fair  values.  Fair  value  is  determined  by  discounted 

54

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

future cash flows, appraisals or other methods. If the assets determined to be impaired are to be held and used, 
the  Company  recognizes  an  impairment  charge  to  the  extent  the  present  value  of  anticipated  net  cash  flows 
attributable to the asset are less than the asset’s carrying value. The fair value of the asset then becomes the 
asset’s new carrying value, which the Company depreciates over the remaining estimated useful life of the asset. 
Assets to be disposed of are reported at the lower of the carrying amount or fair value less cost to sell.

Derivative Financial Instruments: The Company’s policy is to attempt to minimize short-term business 
exposure to foreign currency exchange rate risks using an effective and efficient method to eliminate or reduce 
such exposures. In the normal course of business, the Company’s financial position is routinely subjected to 
market  risk  associated  with  foreign  currency  exchange  rate  fluctuations.  The  Company  carries  derivative 
financial instruments (derivatives) on the balance sheet at their fair values. The Company has a policy that allows 
the use of derivative financial instruments, specifically foreign currency forward exchange rate contracts, to 
hedge foreign currency exchange rate fluctuations on forecasted revenue transactions denominated in Japanese 
yen and net monetary assets or liabilities denominated in various foreign currencies. The Company does not 
use derivatives for trading or speculative purposes. The Company does not believe that it is or was exposed to 
more than a nominal amount of credit risk in its interest rate and foreign currency hedges, as counterparties 
are established and well-capitalized financial institutions. The Company’s exposures are in liquid currencies 
(Japanese yen, Swiss francs, Euros, and Taiwanese dollars), so there is minimal risk that appropriate derivatives 
to maintain the Company’s hedging program would not be available in the future.

To hedge foreign currency risks, the Company uses foreign currency exchange forward contracts, where 
possible and practical. These forward contracts are valued using standard valuation formulas with assumptions 
about future foreign currency exchange rates derived from existing exchange rates and interest rates observed 
in the market.

The Company considers its most current outlook in determining the level of foreign currency denominated 
intercompany revenue to hedge as cash flow hedges. The Company combines these forecasts with historical 
trends to establish the portion of its expected volume to be hedged. The revenue is hedged and designated as cash 
flow hedges to protect the Company from exposures to fluctuations in foreign currency exchange rates. If the 
underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge 
gains and losses on the cash flow hedge are reclassified from accumulated other comprehensive income (loss) to 
interest and other income (expense) on the consolidated statement of operations at that time.

For  further  details  related  to  the  Company’s  derivatives,  see  Note  4  of  the  Notes  to  the  Consolidated 

Financial Statements.

Guarantees: The Company accounts for guarantees in accordance with applicable accounting guidance. 
Accordingly,  the  Company  evaluates  its  guarantees  to  determine  whether  (a)  the  guarantee  is  specifically 
excluded from the scope of such guidance, (b) the guarantee is subject to disclosure requirements only, but not 
subject to the initial recognition and measurement provisions, or (c) the guarantee is required to be recorded 
in the financial statements at fair value. The Company has recorded a liability for certain guaranteed residual 
values related to specific facility lease agreements. The Company has evaluated its remaining guarantees and 
has  concluded  that  they  do  not  require  disclosure  or  do  not  require  recognition  in  the  financial  statements. 
These guarantees generally include certain indemnifications to its lessors under operating lease agreements for 
environmental matters, potential overdraft protection obligations to financial institutions related to one of the 
Company’s subsidiaries, indemnifications to the Company’s customers for certain infringement of third-party 
intellectual property rights by its products and services, and the Company’s warranty obligations under sales of 
its products.

Foreign  Currency  Translation:  The  Company’s  non-U.S.  subsidiaries  that  operate  in  a  local  currency 
environment, where that local currency is the functional currency, primarily generate and expend cash in their 
local currency. Billings and receipts for their labor and services are primarily denominated in the local currency, 
and the workforce is paid in local currency. Their individual assets and liabilities are primarily denominated 
in the local foreign currency and do not materially impact the Company’s cash flows. Accordingly, all balance 
sheet accounts of these local functional currency subsidiaries are translated at the fiscal period-end exchange 

55

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

rate, and income and expense accounts are translated using average rates in effect for the period, except for costs 
related to those balance sheet items that are translated using historical exchange rates. The resulting translation 
adjustments  are  recorded  as  cumulative  translation  adjustments  and  are  a  component  of  accumulated  other 
comprehensive income (loss). Translation adjustments are recorded in other income (expense), net, where the 
U.S. dollar is the functional currency.

Reclassifications: Certain amounts presented in the comparative financial statements for prior years have 

been reclassified to conform to the fiscal year 2010 presentation.

Note 3: Recent Accounting Pronouncements

In December 2007, the Financial Accounting Standards Board (“FASB”) revised the applicable accounting 
guidance for business combinations. The guidance establishes principles and requirements for how an acquirer 
recognizes  and  measures  in  its  financial  statements  the  identifiable  assets  acquired,  the  liabilities  assumed, 
any noncontrolling interest in the acquiree and the goodwill acquired. The revised guidance also establishes 
disclosure requirements to enable readers to evaluate the nature and financial effects of the business combination. 
The accounting treatment of tax benefits from acquired companies has changed under the revised guidance. 
Any changes to the tax benefits associated with valuation allowances related to business combinations will be 
recorded through income tax expense. The Company adopted the revised guidance on June 29, 2009, and the 
adoption did not have a significant impact on its results of operations or financial condition.

In  December  2007,  the  FASB  issued  guidance  that  establishes  accounting  and  reporting  standards  for 
the treatment of noncontrolling interests in a subsidiary. Noncontrolling interests in a subsidiary are reported 
as  a  component  of  equity  in  the  consolidated  financial  statements  and  any  retained  noncontrolling  equity 
investment when a subsidiary is deconsolidated is initially measured at fair value. The Company adopted the 
guidance on June 29, 2009, and the adoption did not have a significant impact on its results of operations or 
financial condition.

In April 2009, the FASB issued guidance that requires publicly-traded companies to disclose the fair value 
of financial instruments in interim financial statements. The Company adopted this guidance on June 29, 2009, 
and the adoption resulted in expanded disclosures, and the adoption did not have a significant impact on the 
Company’s consolidated results of operations or financial condition.

In  June  2009,  the  FASB  issued  the  FASB  Accounting  Standards  Codification  (“Codification”).  The 
Codification is the single source for all authoritative GAAP recognized by the FASB to be applied for financial 
statements issued for periods ending after September 15, 2009. The Codification does not change GAAP and did 
not have a significant impact on the Company’s financial statements.

In  September  2009,  the  FASB  ratified  guidance  from  the  Emerging  Issues  Task  Force  (“EITF”) 
regarding revenue arrangements with multiple deliverables. This guidance addresses criteria for separating the 
consideration in multiple-element arrangements and requires companies to allocate the overall consideration to 
each deliverable by using a best estimate of the selling price of individual deliverables in the arrangement in the 
absence of vendor-specific objective evidence or other third-party evidence of the selling price. This guidance 
will be effective for revenue arrangements entered into or materially modified in fiscal years beginning on or 
after June 15, 2010. The Company will adopt this guidance in the beginning of fiscal year 2011 and does not 
believe the adoption will have a significant impact on its results of operations or financial condition.

In September 2009, the FASB also ratified guidance from the EITF regarding certain revenue arrangements 
that include software elements. This guidance modifies the scope of the software revenue recognition rules to 
exclude (a) non-software components of tangible products and (b) software components of tangible products that 
are sold, licensed, or leased with tangible products when the software components and non-software components 
of the tangible product function together to deliver the tangible product’s essential functionality. This guidance 
will be effective for revenue arrangements entered into or materially modified in fiscal years beginning on or 
after June 15, 2010. The Company will adopt this guidance in the beginning of fiscal year 2011 and does not 
believe the adoption will have a significant impact on its results of operations or financial condition.

56

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Note 4: Financial Instruments

Fair Value

Pursuant to the accounting guidance for fair value measurement and its subsequent updates, the Company 
defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an 
orderly  transaction  between  market  participants  at  the  measurement  date.  When  determining  the  fair  value 
measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers 
the principal or most advantageous market in which it would transact, and it considers assumptions that market 
participants would use when pricing the asset or liability.

The FASB has established a fair value hierarchy that prioritizes the inputs to valuation techniques used 
to measure fair value. An asset or liability’s level in the hierarchy is based on the lowest level of input that is 
significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed 
in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient 

volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar 
assets  or  liabilities,  quoted  prices  in  markets  that  are  not  active,  or  model-derived  valuations  techniques  for 
which all significant inputs are observable in the market or can be corroborated by, observable market data for 
substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the 
measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and 
may not have been corroborated by observable market data.

The following table sets forth the Company’s financial assets and liabilities measured at fair value on a 

recurring basis as of June 27, 2010:

Total

Fair Value Measurement at June 27, 2010

Quoted Prices in 
Active Markets for 
Identical Assets 
(Level 1)

Significant Other 
Observable Inputs 
(Level 2)

Significant 
Unobservable 
Inputs 
(Level 3)

(In thousands)

Assets
Fixed Income

Money Market Funds . . . . . . . . . . . . . . . . . . . .   $ 470,936
Municipal Notes and Bonds . . . . . . . . . . . . . . .     103,903
3,447
US Treasury & Agencies  . . . . . . . . . . . . . . . . .    
6,060
Government-Sponsored Enterprises. . . . . . . . .    
Foreign Governments. . . . . . . . . . . . . . . . . . . .    
1,008
Bank and Corporate Notes . . . . . . . . . . . . . . . .     289,437
Mortgage Backed Securities — Residential. . .    
6,106
Mortgage Backed Securities — Commercial. .     42,964
Total Fixed Income. . . . . . . . . . . . . . . . . . .   $ 923,861
7,636
Equities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   
Mutual Funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    18,124
Derivatives Assets  . . . . . . . . . . . . . . . . . . . . . . . . .   
2,063
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 951,684
Liabilities
Derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . .  $

470

$ 470,936
—
—
6,060
—
169,723
—
—
$ 646,719
7,636
18,124
—
$ 672,479

$

—
103,903
3,447
—
1,008
119,636
6,106
42,964
$ 277,064
—
—
2,063
$279,127

$

—

$

470

$ —
—
—
—
—
78
—
—
$ 78
—
—
—
$ 78

$ —

57

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The  amounts  in  the  table  above  are  reported  in  the  consolidated  balance  sheet  as  of  June  27,  2010 

as follows:

Reported As:

Total

(Level 1)

(Level 2)

(Level 3)

Cash Equivalents  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Short-Term Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Restricted cash and investments . . . . . . . . . . . . . . . . . . . . . . . 
Prepaid expenses and other current assets . . . . . . . . . . . . . . . 
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Accrued expenses and other current liabilities  . . . . . . . . . . . 

(In thousands)

$ 478,286 
  280,690 
  164,885 
2,063 
  25,760 
$ 951,684 
470 
$

$ 477,279 
4,555 
  164,885 
— 
  25,760 
$ 672,479 
— 
$

$
1,007 
  276,057 
— 
2,063 
— 
$ 279,127 
470 
$

$—
  78
  —
  —
  —
$78
$—

At  June  27,  2010  the  fair  value  of  Level  3  assets  measured  on  a  recurring  basis  was  $0.1  million  and 
consisted of a corporate note security. Fair values were based on non-binding, broker-provided price quotes and 
may not have been corroborated by observable market data.

The following table sets forth the Company’s financial assets and liabilities measured at fair value on a 

recurring basis as of June 28, 2009:

Total

Fair Value Measurement at June 28, 2009

Quoted Prices in 
Active Markets for 
Identical Assets 
(Level 1)

Significant Other 
Observable 
Inputs (Level 2)

Significant 
Unobservable 
Inputs 
(Level 3)

(In thousands)

Assets
Fixed Income

Money Market Funds . . . . . . . . . . . . . . . . . . . .   $ 273,439 
Municipal Notes and Bonds . . . . . . . . . . . . . . .     103,618 
US Treasury & Agencies  . . . . . . . . . . . . . . . . .     24,184 
6,323 
Government-Sponsored Enterprises. . . . . . . . .    
Foreign Governments. . . . . . . . . . . . . . . . . . . .    
1,024 
Bank and Corporate Notes . . . . . . . . . . . . . . . .     228,171 
Mortgage Backed Securities — Residential. . .     11,630 
Mortgage Backed Securities — Commercial. .     13,442 
Total Fixed Income. . . . . . . . . . . . . . . . . . .   $ 661,831 
4,961 
Equities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   
— 
Mutual Funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   
Derivatives Assets  . . . . . . . . . . . . . . . . . . . . . . . . .   
74 
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 666,866 
Liabilities
Derivative liabilities . . . . . . . . . . . . . . . . . . . . . . . .  $

69 

$ 273,439

—  

  24,184

—  

$
  103,618

—  

—  
—  

  183,171

—  
—  

$ 480,794
4,961

—  
—  

$ 485,755

6,323
1,024
  45,000
  11,630
  13,442
$181,037

—  
—  
74
$ 181,111

$

—  

$

69

$ —
  —
  —
  —
  —
  —
  —
  —
$ —
  —
  —
  —
$ —

$ —

58

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The  amounts  in  the  table  above  are  reported  in  the  consolidated  balance  sheet  as  of  June  28,  2009 

as follows:

Reported As:

Total

Level 1

Level 2

Level 3

Cash Equivalents  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Short-Term Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Restricted cash and investments . . . . . . . . . . . . . . . . . . . . . . . 
Prepaid expenses and other current assets . . . . . . . . . . . . . . . 
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Accrued expenses and other current liabilities  . . . . . . . . . . . 

(In thousands)

$ 278,304 
  205,221 
  178,306 
74 
4,961 
$ 666,866 
69 
$

$ 278,304 
  24,184 
  178,306 
— 
4,961 
$ 485,755 
— 
$

$
— 
  181,037 
— 
74 
— 
$ 181,111 
69 
$

$—
  —
  —
  —
  —
$—
$—

The Company’s primary financial instruments include its cash, cash equivalents, short-term investments, 
restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and 
capital leases, and foreign currency related derivatives. The estimated fair value of cash, accounts receivable and 
accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated 
fair  values  of  long-term  debt  and  capital  lease  obligations  approximate  their  carrying  value  as  the  substantial 
majority of these obligations have interest rates that adjust to market rates on a periodic basis. The fair value of cash 
equivalents, short-term investments, restricted cash and investments, long-term investments, and foreign currency 
related derivatives are based on quotes from brokers using market prices for similar instruments.

Investments

The following tables summarize the Company’s investments (in thousands):

June 27, 2010

Cash  . . . . . . . . . . . . . . . . . . . . . . . .   $
Fixed Income Money  

Cost

67,830

Unrealized 
Gain
$ —

Unrealized 
(Loss) 
$ — $

  Fair Value  Cost

67,830 $ 95,996

June 28, 2009

Unrealized 
Gain
$ —

Unrealized 
(Loss) 
$ — $ 95,996

Fair 
Value

Market Funds . . . . . . . . . . . . . .  

470,936

—

—

470,936

273,439

—

—

273,439

Municipal Notes and  

Bonds . . . . . . . . . . . . . . . . . . . .  
US Treasury & Agencies . . . . . . . .  
Government-Sponsored  

Enterprises . . . . . . . . . . . . . . . .  
Foreign Governments . . . . . . . . . . .  
Bank and Corporate  

102,130
3,437

1,784
10

5,976
1,007

84
1

(11)
—

—
—

103,903
3,447

101,587
23,828

6,060
1,008

6,177
1,024

2,069
387

146
—

(38)
(31)

—
—

103,618
24,184

6,323
1,024

Notes  . . . . . . . . . . . . . . . . . . . .  

287,922

1,608

(93)

289,437

227,244

1,025

(98)

228,171

Mortgage Backed  

Securities — Residential . . . . .  

5,825

Mortgage Backed  

Securities — Commercial . . . .  
Total Cash and 

42,765

Short -Term  
Investments . . . . . . . . . . .   $ 987,828

323

275

(42)

(76)

6,106

11,328

42,964

13,465

385

166

(83)

11,630

(189)

13,442

$ 4,085

$ (222) $ 991,691 $ 754,088

$ 4,178

$ (439)

$ 757,827

Publicly traded equity  

securities . . . . . . . . . . . . . . . . .   $

Mutual Funds . . . . . . . . . . . . . . . . .  
Total Financial  

9,471
19,043

$ —
—

$(1,835) $
(919)

7,636 $

18,124

8,359
—

$ —
—

$(3,398)
—

$

4,961
—

Instruments  . . . . . . .   $1,016,342

$ 4,085

$(2,976) $1,017,451 $ 762,447

$ 4,178

$(3,837)

$ 762,788

As Reported
Cash and Cash  

Equivalents  . . . . . . . . . . . . . . .   $ 545,766

$

1

$ — $ 545,767 $ 374,167

$ —

$ — $ 374,167

Short-Term 

Investments . . . . . . . . . . . . . . .  

276,828

4,084

(222)

280,690

201,482

4,178

(439)

205,221

Restricted cash and  

investments . . . . . . . . . . . . . . .  
Other Assets . . . . . . . . . . . . . . . . . .  

165,234
28,514
Total. . . . . . . . . . . . . .    $1,016,342

—
—
$ 4,085

—
(2,754)

178,439
8,359
$(2,976) $1,017,451 $ 762,447

165,234
25,760

—
—
$ 4,178

—
(3,398)
$(3,837)

178,439
4,961
$ 762,788

59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investments 
sold are specifically identified. Management assesses the fair value of investments in debt securities that are not 
actively traded through consideration of interest rates and their impact on the present value of the cash flows 
to be received from the investments. The Company also considers whether changes in the credit ratings of the 
issuer could impact the assessment of fair value. Net realized gains (losses) on investments included other-than-
temporary impairment charges of $0.9 million, $0.3 million and $1.0 million in fiscal years 2010, 2009 and 2008, 
respectively.  Additionally,  realized  gains  (losses)  from  sales  of  investments  were  approximately  $0.8  million 
and $(0.2) million in fiscal year 2010, $2.2 million and $(1.9) million in fiscal year 2009 and $3.3 million and 
$(1.3) million in fiscal year 2008, respectively.

The following is an analysis of the Company’s fixed income securities in unrealized loss positions as of 

June 27, 2010 (in thousands):

June 27, 2010 

UNREALIZED LOSSES 
LESS THAN 12 MONTHS   

UNREALIZED LOSSES 
12 MONTHS OR GREATER  

TOTAL 

Gross 
Unrealized 
Loss 

  Fair Value

Gross 
Unrealized 
Loss

  Gross 
Unrealized 
Loss 

  Fair Value

   Fair Value  

  $ 6,567 
    24,996 

$ (11) 
(92) 

  $ —  
  204

$ — 
(1) 

  $ 6,567  $ (11) 
(93) 
    25,200 

Fixed Income Securities

Municipal Notes and Bonds . . . . .
Bank and Corporate Bonds  . . . . .
Mortgage Backed Securities — 

Residential  . . . . . . . . . . . . . . .

— 

  — 

  395

  (42) 

395 

(42) 

Mortgage Backed Securities — 

Commercial  . . . . . . . . . . . . . .
Total Fixed Income  . . . . . . . . . . . . .

    15,558 
  $ 47,121 

(76) 
$ (179) 

  —  

  $ 599

  — 
$(43) 

(76) 
    15,558 
  $47,720  $ (222) 

The amortized cost and fair value of cash equivalents and short-term investments and restricted cash and 

investments with contractual maturities are as follows:

Due in less than one year . . . . . . . . . . . . . . . . . . . . . . .  
Due in more than one year . . . . . . . . . . . . . . . . . . . . . .  

June 27, 2010

June 28, 2009

Cost

Estimated 
Fair Value

Cost

Estimated 
Fair Value

(in thousands)

$ 723,143 
  196,855 
$ 919,998 

$ 723,707 
  200,154 
$ 923,861 

$ 504,359 
153,732 
$ 658,091 

$ 504,597
157,233
$ 661,830

Management has the ability, if necessary, to liquidate any of its investments in order to meet the Company’s 
liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 
one year from the date of purchase nonetheless are classified as short-term on the accompanying consolidated 
balance sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments (“derivatives”) on its consolidated balance sheets at 
their fair values. The Company enters into foreign exchange forward contracts with financial institutions with 
the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate 
fluctuations.  The  counterparties  to  these  foreign  exchange  forward  contracts  are  creditworthy  multinational 
financial institutions; therefore, we do not consider the risk of counterparty nonperformance to be material.

60

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Cash Flow Hedges

The Company’s policy is to attempt to minimize short-term business exposure to foreign currency exchange 
rate fluctuations using an effective and efficient method to eliminate or reduce such exposures. In the normal 
course of business, the Company’s financial position is routinely subjected to market risk associated with foreign 
currency  exchange  rate  fluctuations.  To  protect  against  a  reduction  in  value  of  Japanese  yen-denominated 
revenues,  the  Company  has  instituted  a  foreign  currency  cash  flow  hedging  program.  The  Company  enters 
into foreign exchange forward contracts that generally expire within 12 months and no later than 24 months. 
These foreign exchange forward contracts are designated as cash flow hedges and are carried on the Company’s 
balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated 
other  comprehensive  income  (loss)  and  subsequently  recognized  in  revenue  in  the  same  period  the  hedged 
revenue is recognized.

At inception and at each quarter end, hedges are tested for effectiveness using regression testing. Changes 
in  the  fair  value  of  foreign  exchange  forward  contracts  due  to  changes  in  time  value  are  excluded  from  the 
assessment of effectiveness and are recognized in revenue in the current period. The change in forward time 
value was not material for all reported periods. There were no gains or losses during the twelve months ended 
June  27,  2010  associated  with  ineffectiveness  or  forecasted  transactions  that  failed  to  occur.  There  were 
$4.0 million of deferred net losses associated with ineffectiveness related to forecasted transactions that were no 
longer considered probable of occurring and were recognized in “Other income (expense), net” in the Company’s 
consolidated statements of operations during twelve months ended June 28, 2009. There were no gains or losses 
during the twelve months ended June 29, 2008 associated with ineffectiveness or forecasted transactions that 
failed to occur. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the 
derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the 
hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting 
the exposure to changes in the hedged item’s fair value or cash flows will be measured.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception 
of  the  hedge  and  the  hedges  must  be  highly  effective  in  offsetting  changes  to  future  cash  flows  on  hedged 
transactions.  When  derivative  instruments  are  designated  and  qualify  as  effective  cash  flow  hedges,  the 
Company  is  able  to  defer  effective  changes  in  the  fair  value  of  the  hedging  instrument  within  accumulated 
other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of 
excluded time value and hedge ineffectiveness recognized, the Company’s results of operations are not subject 
to  fluctuation  as  a  result  of  changes  in  the  fair  value  of  the  derivative  instruments.  If  hedges  are  not  highly 
effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the 
Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, 
future  changes  in  the  fair  values  of  the  Company’s  derivative  instruments  would  be  recognized  in  earnings. 
Additionally, related amounts previously recorded in “Other comprehensive income” would be reclassified to 
income immediately. At June 27, 2010, the Company had a de minimis amount of losses accumulated in other 
comprehensive income.

Balance Sheet Hedges

The  Company  also  enters  into  foreign  exchange  forward  contracts  to  hedge  the  effects  of  foreign 
currency fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily 
intercompany receivables and payables. These foreign exchange forward contracts are not designated for hedge 
accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other 
income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, 
recorded in other income (expense).

61

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

As of June 27, 2010, the Company had the following outstanding foreign currency forward contracts that 

were entered into to hedge forecasted revenues and purchases:

Derivatives Designated as 
ASC 815 Hedging Instruments:

Derivatives Not Designated as 
ASC 815 Hedging Instruments:

(in thousands)

Foreign Currency Forward 

Contracts
Sell JPY  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sell JPY  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Buy CHF  . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Buy EUR  . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sell EUR. . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Buy TWD . . . . . . . . . . . . . . . . . . . . . . . . . . .  

$ 73,349

$ 73,349

$

—
76,624
  189,158
48,046
9,882
65,384
$ 389,094

The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 27, 2010 

was as follows:

Fair Value of Derivative Instruments 

Asset Derivatives

Liability Derivatives 

Balance Sheet 
Location

Fair Value

(in thousands) 

Balance Sheet 
Location

  Fair Value 

Derivatives designated as ASC 815 

hedging instruments:
Foreign exchange forward contracts . . .

Derivatives not designated as hedging 

instruments under ASC 815:
Foreign exchange forward contracts . . .

Total derivatives . . . . . . . . . . . . . . . . . . . . 

Prepaid expense and 
other assets

Prepaid expense and 
other assets

$

30

  Accrued liabilities   $ (52) 

$2,033
$2,063

  Accrued liabilities   $ (418) 
  $ (470) 

The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 28, 2009 

was as follows:

Fair Value of Derivative Instruments

Asset Derivatives

Liability Derivatives

Balance Sheet 
Location

Fair Value

Balance Sheet 
Location

Fair Value

(in thousands)

Derivatives designated as ASC 815 

hedging instruments:
Foreign exchange forward contracts  . . . . Prepaid expense and 

other assets

$ 6

Accrued liabilities

$ 0

Derivatives not designated as hedging 

instruments under ASC 815:
Foreign exchange forward contracts  . . . . Prepaid expense and 

Total derivatives . . . . . . . . . . . . . . . . . . . . . .

other assets

$ 68
$ 74

Accrued liabilities

$ (69)
$ (69)

62

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The  effect  of  derivative  instruments  designated  as  cash  flow  hedges  on  the  Company’s  consolidated 

statements of operations for the twelve months ended June 27, 2010 and June 28, 2009 was as follows:

Twelve Months Ended June 27, 2010

Gain (Loss) Recognized 
(Effective Portion) (1)  

Gain (Loss) Recognized 
(Effective Portion) (2)  

Gain (Loss) Recognized 
(Ineffective Portion) (3)  

Gain (Loss) Recognized 
(Excluded from 
Effectiveness Testing) (4)

(in thousands)

Derivatives 

Designated 
as ASC 815 
Hedging 
Instruments:
Foreign exchange 

forward 
contracts  . . .

Derivatives 

Designated 
as ASC 815 
Hedging 
Instruments:
Foreign exchange 

forward 
contracts  . . .

$388

$404

$ —

$59

Twelve Months Ended June 28, 2009

Gain (Loss) Recognized 
(Effective Portion) (1)

Gain (Loss) Recognized 
(Effective Portion) (2)

Gain (Loss) Recognized 
(Ineffective Portion) (3)

(in thousands)

Gain (Loss) Recognized 
(Excluded from 
Effectiveness Testing) (4)

$(11,840)

$ (3,485)

$(4,085)

$1,462

(1)  Amount recognized in other comprehensive income (loss) (effective portion).

(2)  Amount  of  gain  (loss)  reclassified  from  accumulated  other  comprehensive  income  into  income  (loss) 

(effective portion) located in revenue.

(3)  Amount of gain (loss) recognized in income on derivative (ineffective portion) located in other income 

(expense), net.

(4)  Amount of gain (loss) recognized in income on derivative (amount excluded from effectiveness testing) 

located in other income (expense), net.

The effect of derivative instruments not designated as cash flow hedges on the Company’s consolidated 

statement of operations for the twelve months ended June 27, 2010 and June 28, 2009 was as follows:

Derivatives Not Designated as ASC 815 Hedging Instruments:

Foreign exchange forward contracts  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  

$(17,367) 

$(953) 

(5)  Amount of gain (loss) recognized in income located in other income (expense), net.

Twelve Months Ended 

June 27, 2010 
Gain (Loss) 
Recognized (5)   

  June 28, 2009 
Gain (Loss) 
Recognized (5) 

(in thousands) 

63

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Concentrations of Credit Risk

Financial  instruments  that  potentially  subject  the  Company  to  concentrations  of  credit  risk  consist 
principally of cash equivalents, short term investments, restricted cash and investments, loans receivable, trade 
accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit in 
major financial institutions in various countries throughout the world. Such deposits may be in excess of insured 
limits. Management believes that the financial institutions that hold the Company’s cash are financially sound 
and, accordingly, minimal credit risk exists with respect to these balances.

The  Company’s  available-for-sale  securities,  which  are  invested  in  taxable  financial  instruments,  must 
have a minimum rating of A2 / A, as rated by two of the following three rating agencies: Moody’s, Standard & 
Poor’s (S&P), or Fitch. Available-for-sale securities that are invested in tax-exempt financial instruments must 
have a minimum rating of A2 / A, as rated by any one of the same three rating agencies. The Company’s policy 
limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign 
currency forward contracts that are used to mitigate the effect of exchange rate changes. These counterparties 
are large international financial institutions and to date no such counterparty has failed to meet its financial 
obligations to the Company. The Company does not anticipate nonperformance by these counterparties.

As of June 27, 2010, two customers accounted for approximately 24% and 22 % of accounts receivable. As 

of June 28, 2009, three customers accounted for approximately 17%, 15%, and 14% of accounts receivable.

Credit  risk  evaluations,  including  trade  references,  bank  references  and  Dun  &  Bradstreet  ratings,  are 
performed on all new customers and the Company monitors its customers’ financial statements and payment 
performance. In general, the Company does not require collateral on sales.

Note 5: Inventories

Inventories  are  stated  at  the  lower  of  cost  (first-in,  first-out  method)  or  market.  Shipments  to  Japanese 
customers, to whom title does not transfer until customer acceptance, are classified as inventory and carried at 
cost until title transfers. Inventories consist of the following:

Raw materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Work-in-process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Finished goods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Note 6: Property and Equipment

Property and equipment, net, consist of the following:

Manufacturing, engineering and  

office equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Computer equipment and software  . . . . . . . . . . . . . . . . . . . . . . .
Land  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Leasehold improvements  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Furniture and fixtures  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Less: accumulated depreciation  

and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

64

June 27, 
2010

June 28, 
2009

(in thousands)

$ 159,574
67,114
91,791
$318,479

$145,421
35,487
52,502
$233,410

June 27, 
2010

June 28, 
2009

(in thousands)

$ 252,771
77,249
15,788
62,085
55,300
14,095
477,288

$ 254,397
69,567
16,550
64,488
52,115
13,295
470,412

(276,952)
$ 200,336

(254,746)
$ 215,666

 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Depreciation expense, including amortization of capital leases, recognized during fiscal years 2010, 2009, 

and 2008 was $47.8 million, $48.4 million, and $36.8 million, respectively.

Note 7: Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

Accrued compensation . . . . . . . . . . . . . . . . . . . . . . . .
Warranty reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income and other taxes payable . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

June 28, 
2009

(in thousands)

$164,579
31,756
54,874
58,188
$309,397

$171,609
21,185
31,970
56,571
$281,335

Following  a  voluntary  independent  review  of  the  Company’s  historical  employee  stock  option  grant 
process,  the  Company  considered  whether  Section  409A  (“Section  409A”)  of  the  Internal  Revenue  Code  of 
1986, as amended (“IRC”) and similar provisions of state law would apply to certain stock option grants that 
were found to have intrinsic value at the time of their respective measurement dates. If a stock option is not 
considered as issued with an exercise price of at least the fair market value of the underlying stock on the date 
of grant, it may be subject to penalty taxes under Section 409A and similar provisions of state law. In such a 
case, such taxes may be assessed not only on the intrinsic value increase, but on the entire stock option gain as 
measured at various times. On March 30, 2008, the Board of Directors of the Company authorized the Company 
to assume potential tax liabilities of certain employees, including the Company’s Chief Executive Officer and 
certain other executive officers, relating to options that might be subject to Section 409A and similar provisions 
of state law. The assumed Section 409A liability was $53.7 million as of June 28, 2009 and is included in accrued 
compensation in the table above.

During fiscal year 2010, the Company reached a final settlement with respect to its Section 409A liabilities, 
which  resulted  in  a  reduction  of  the  liability  and  net  credits  recognized  in  the  statements  of  operations  of 
$(5.8) million recorded in cost of goods sold and $(38.6) million recorded in operating expenses.

Note 8: Other Income (Expense), Net

The significant components of other income (expense), net, are as follows:

Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign exchange gains (losses) . . . . . . . . . . . . . . . . . . . . . . .
Other, net  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

$ 8,598
(994)
(103)
(2,770)
$ 4,731

Year Ended
June 28, 
2009

(in thousands)
$24,283
(6,497)
922
(558)
$ 18,150

June 29, 
2008

$ 51,194
(12,674)
31,070
(2,045)
$ 67,545

Included in foreign exchange gains during the year ended June 29, 2008 are gains of $42.7 million relating 

primarily to the settlement of a hedge of the Swiss franc associated with the acquisition of SEZ.

65

 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Note 9: Net Income (Loss) Per Share

Basic  net  income  (loss)  per  share  is  computed  by  dividing  net  income  (loss)  by  the  weighted-average 
number  of  common  shares  outstanding  during  the  period.  Diluted  net  income  (loss)  per  share  is  computed, 
using  the  treasury  stock  method,  as  though  all  potential  common  shares  that  are  dilutive  were  outstanding 
during  the  period.  There  are  no  dilutive  shares  included  during  fiscal  year  2009  due  to  the  net  loss  for  the 
period. The following table provides a reconciliation of the numerators and denominators of the basic and diluted 
computations for net income per share.

Year Ended
June 29, 
June 28, 
June 27, 
2010
2008
2009
(in thousands, except per share data)

Numerator:

Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . .

$346,669

$(302,148)

$ 439,349

Denominator:

Basic average shares outstanding. . . . . . . . . . . . .
Effect of potential dilutive securities:

126,933

125,595

124,647

Employee stock plans . . . . . . . . . . . . . . . .
Diluted average shares outstanding  . . . . . . . .
Net income (loss) per share — Basic. . . . . . . . . . . . .
Net income (loss) per share — Diluted . . . . . . . . . . .

1,193
128,126
2.73
2.71

$
$

—
125,595
(2.41)
(2.41)

$
$

1,857
126,504
3.52
3.47

$
$

For purposes of computing diluted net income (loss) per share, weighted-average common shares do not 
include  potentially  dilutive  securities  that  are  anti-dilutive  under  the  treasury  stock  method.  The  following 
potentially dilutive securities were excluded:

June 27, 
2010

Year Ended
June 28, 
2009

June 29, 
2008

Number of potentially dilutive securities excluded . . . . . . . . . . . . .

577

(in thousands)
2,699

250

Note 10: Comprehensive Income (Loss)

The components of comprehensive income (loss), on an after-tax basis where applicable, are as follows:

Net income (loss)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $346,669
Foreign currency translation adjustment . . . . . . . . . . . . . . . . . . . . . . . . . .
(13,868)
Unrealized gain (loss) on fair value of  

June 27, 
2010

Year Ended
June 28, 
2009
(in thousands)
$(302,148)
(58,587)

June 29, 
2008

$439,349
12,557

(414)
derivative financial instruments, net  . . . . . . . . . . . . . . . . . . . . . . . . . .
2,062
Unrealized gain on financial instruments, net . . . . . . . . . . . . . . . . . . . . . .
(645)
Reclassification adjustment for loss (gain) included in earnings. . . . . . . .
Postretirement benefit plan adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . .
(4,162)
Comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 329,642

(6,633)
1,192
501
85
$ (365,590)

398
2,787
(461)
(359)
$454,271

66

 
 
 
 
 
 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The  balance  of  accumulated  other  comprehensive  loss,  on  an  after-tax  basis  where  applicable,  is  as 

follows:

Accumulated foreign currency translation adjustment  . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated unrealized gain (loss) on derivative financial instruments . . . . . . . . . .
Accumulated unrealized gain on financial instruments  . . . . . . . . . . . . . . . . . . . . . . .
Postretirement benefit plan adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

June 28, 
2009

(in thousands)

$(65,843)
(1)
1,225
(5,230)
$ (69,849)

$(51,975)
15
206
(1,068)
$ (52,822)

Note 11: Equity-Based Compensation Plans

The Company has adopted stock plans that provide for the grant to employees of equity-based awards, 
including stock options and restricted stock units, of Lam Research Common Stock. In addition, these plans 
permit the grant of nonstatutory equity-based awards to consultants and outside directors. Pursuant to the plans, 
the equity-based award price is determined by the Board of Directors or its designee, the plan administrator, but 
in no event will the exercise price for any option be less than the fair market value of the Company’s Common 
Stock  on  the  date  of  grant.  Equity-based  awards  granted  under  the  plans  vest  over  a  period  determined  by 
the  Board  of  Directors  or  the  plan  administrator.  The  Company  also  has  an  ESPP  that  allows  employees  to 
purchase shares of its Common Stock through payroll deduction at a discounted price. A summary of stock plan 
transactions is as follows:

Options Outstanding

Available 
For Grant
23,999,837
(960,157)

84,124
(7,283,998)

15,839,806
(2,592,679)

981,297
(3,516,323)

10,712,101
(1,383,941)

259,579

Number of 
Shares
3,285,140
—
(663,681)
(14,765)

2,606,694
476,094
(731,934)
(760,538)

1,590,316
—
(642,861)
(62,030)

Weighted- 
Average 
Exercise Price
$20.37
$ —
$19.13
$23.23

$21.60
$20.21
$16.42
$24.97

$22.10
$ —
$20.91
$41.36

9,587,739

885,425

$ 21.61

Restricted Stock Units 
Outstanding

Number of 
Shares
1,843,675
960,157

Weighted- 
Average 
FMV at Grant
$43.14
$43.41

(69,359)

$47.97

(1,038,249)
1,696,224
2,116,585

$37.56
$46.51
$27.29

(220,759)

$43.98

(1,071,987)
2,520,063
1,383,941

(197,549)
(965,693)
2,740,762

$47.26
$30.32
$34.71

$33.23
$35.29
$30.50

June 24, 2007  . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . .
Exercised . . . . . . . . . . . . . . . . . . .
Canceled . . . . . . . . . . . . . . . . . . .
Expired . . . . . . . . . . . . . . . . . . . .
Vested restricted stock . . . . . . . .
June 29, 2008  . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . .
Exercised . . . . . . . . . . . . . . . . . . .
Canceled . . . . . . . . . . . . . . . . . . .
Expired . . . . . . . . . . . . . . . . . . . .
Vested restricted stock . . . . . . . .
June 28, 2009  . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . .
Exercised . . . . . . . . . . . . . . . . . . .
Canceled . . . . . . . . . . . . . . . . . . .
Vested restricted stock . . . . . . . .
June 27, 2010 . . . . . . . . . . . . . . . .

67

 
 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Outstanding and exercisable options presented by price range at June 27, 2010 are as follows:

Range of
Exercise
Prices 

$14.38-$14.81
$16.14-$16.88
$17.50-$18.75
$19.25-$20.71
$21.26-$22.79
$23.03-$23.99
$24.19-$24.72
$25.25-$27.79
$28.00-$29.47
$31.40-$36.88
$14.38-$36.88

Options Outstanding

Options Exercisable

Number of 
Options 
Outstanding
39,595
53,111
7,725
494,044
12,475
39,665
107,600
41,350
85,750
4,110
885,425

Weighted- 
Average 
Remaining 
Life 
(Years)
0.49
1.13
0.39
3.58
1.14
1.21
1.36
0.93
4.05
0.44
2.76

Weighted- 
Average 
Exercise 
Price
$14.61
$16.40
$18.15
$20.22
$21.84
$23.60
$24.52
$26.42
$29.03
$31.55
$ 21.61

Number of 
Options 
Exercisable
39,595
53,111
7,725
17,950
12,475
39,665
107,600
41,350
85,750
4,110
409,331

Weighted- 
Average 
Exercise 
Price
$14.61
$16.40
$18.15
$20.44
$21.84
$23.60
$24.52
$26.42
$29.03
$31.55
$23.24

The Company awarded a total of 1,383,941 and 2,116,585 restricted stock units during fiscal years 2010 
and 2009, respectively. Certain of the unvested restricted stock units at June 27, 2010 include Company-specific 
performance targets as vesting criteria. As of June 27, 2010, a total of 2,740,762 restricted stock units remained 
subject to vesting requirements. The Company did not award any stock options during fiscal year 2010. The 
Company  awarded  476,094  stock  options  during  fiscal  year  2009,  all  of  which  remain  subject  to  vesting 
requirements as of June 27, 2010.

The  2007  Stock  Incentive  Plan  provides  for  the  grant  of  non-qualified  equity-based  awards  to  eligible 
employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. Additional 
shares are reserved for issuance pursuant to awards previously granted under the Company’s 1997 Stock Incentive 
Plan and its 1999 Stock Option Plan. As of June 27, 2010 there were a total of 3,626,187 shares subject to options 
and restricted stock units issued and outstanding under the Company’s Stock Plans. As of June 27, 2010, there 
were a total of 9,587,739 shares available for future issuance under the 2007 Stock Incentive Plan.

The ESPP allows employees to designate a portion of their base compensation to be deducted and used 
to purchase the Company’s Common Stock at a purchase price per share of the lower of 85% of the fair market 
value of the Company’s Common Stock on the first or last day of the applicable purchase period. Typically, each 
offering period lasts 12 months and comprises three interim purchase dates. In fiscal year 2004, the Company’s 
stockholders  approved  an  amendment  to  the  1999  ESPP  to  (i)  each  year  automatically  increase  the  number 
of  shares  available  for  issuance  under  the  plan  by  a  specific  amount  on  a  one-for-one  basis  with  shares  of 
Common Stock that the Company will redeem in public market and private purchases for such purpose and (ii) to 
authorize the Plan Administrator (the Compensation Committee of the Board) to set a limit on the number of 
shares a plan participant can purchase on any single plan exercise date. The automatic annual increase provides 
that the number of shares in the plan reserve available for issuance shall be increased on the first business day 
of each calendar year commencing with 2004, on a one-for-one basis with each share of Common Stock that the 
Company redeems, in public-market or private purchases, and designates for this purpose, by a number of shares 
equal to the lesser of (i) 2,000,000, (ii) one and one-half percent (1.5%) of the number of shares of all classes 
of Common Stock of the Company outstanding on the first business day of such calendar year, or (iii) a lesser 
number determined by the Plan Administrator. During fiscal years 2010, 2009, and 2008, the number of shares 
of Lam Research Common Stock reserved for issuance under the 1999 ESPP increased by 1.9 million each year, 
subject to the Company’s repurchase of an equal number of shares in public market or private purchases.

68

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

During fiscal year 2010, a total of 777,448 shares of the Company’s Common Stock were sold to employees 
under the 1999 ESPP. A total of 12,164,242 shares of the Company’s Common Stock have been issued under 
the  1999  ESPP  through  June  27,  2010,  at  prices  ranging  from  $4.11  to  $46.25  per  share.  At  June  27,  2010, 
8,499,066 shares were available for purchase under the 1999 ESPP.

The Company recognized equity-based compensation expense of $50.5 million during fiscal year 2010, 
$53.0 million during fiscal year 2009, and $42.5 million during fiscal year 2008. The income tax benefit recognized 
in  the  consolidated  statements  of  operations  related  to  equity-based  compensation  expense  was  $8.3  million 
during fiscal 2010, $9.1 million during fiscal year 2009, and $7.0 million during fiscal year 2008. The tax benefit 
realized from the exercise and vesting of stock options and restricted stock was $11.1 million during fiscal year 
2010, $8.1 million during fiscal year 2009, and $18.2 million during fiscal year 2008. The estimated fair value 
of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting period on 
a straight-line basis.

Stock Options and Restricted Stock Units

Stock Options

The  Company  did  not  grant  any  stock  options  during  fiscal  years  2010  or  2008.  The  fair  value  of  the 
Company’s stock options granted during fiscal year 2009 was estimated using a Black-Scholes option valuation 
model. This model requires the input of highly subjective assumptions, including expected stock price volatility 
and the estimated life of each award. The Company assumed no expected dividends and the following assumptions 
were used to value these stock options:

Expected term . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . .

4.0 years
46.9%
2.07%

The year-end intrinsic value relating to stock options for fiscal years 2010, 2009, and 2008 is presented 

below:

Intrinsic value — options outstanding . . . . . . . . . . . . . .
Intrinsic value — options exercisable  . . . . . . . . . . . . . .
Intrinsic value — options exercised . . . . . . . . . . . . . . . .

June 27, 
2010

$16.50
$ 6.96
$ 9.98

Year Ended
June 28, 
2009
(millions)
$6.70
$4.50
$7.20

June 29, 
2008

$41.20
$40.74
$22.18

As of June 27, 2010, there was $1.2 million of total unrecognized compensation cost related to unvested 
stock options granted and outstanding; that cost is expected to be recognized through the March 2011 quarter. 
Cash received from stock option exercises was $13.4 million, $12.0 million, and $12.7 million during fiscal years 
2010, 2009, and 2008, respectively.

Restricted Stock Units

The fair value of the Company’s restricted stock units was calculated based upon the fair market value 
of the Company’s stock at the date of grant. As of June 27, 2010, there was $59.5 million of total unrecognized 
compensation cost related to unvested restricted stock units granted; that cost is expected to be recognized over 
a weighted average remaining vesting period of 1.6 years.

69

 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

ESPP

ESPP rights were valued using the Black-Scholes model. During fiscal years 2010, 2009, and 2008 ESPP 

was valued assuming no expected dividends and the following weighted-average assumptions:

Expected life (years) . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected stock price volatility . . . . . . . . . . . . . . . . . .
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . .

Year Ended
June 28, 
June 27, 
2009
2010
0.68
0.78
59.07% 74.00% 42.60 %
2.00 %
0.41%
0.61%

June 29, 
2008
0.82

As of June 27, 2010, there was $3.6 million of total unrecognized compensation cost related to the ESPP 

that is expected to be recognized over a remaining vesting period of 6 months.

Note 12: Profit Sharing and Benefit Plans

Profit Sharing

Profit  sharing  is  awarded  to  certain  employees  based  upon  performance  against  specific  corporate 
financial  and  operating  goals.  Distributions  to  employees  by  the  Company  are  based  upon  a  percentage  of 
earned  compensation,  provided  that  a  threshold  level  of  the  Company’s  financial  and  performance  goals  are 
met. In addition to profit sharing the Company has other bonus plans based on achievement of profitability and 
other specific performance criteria. Charges to expense under these plans were $72.5 million, $16.2 million, and 
$93.1 million during fiscal years 2010, 2009, and 2008, respectively.

Employee Savings and Retirement Plan

The Company maintains a 401(k) retirement savings plan for its full-time employees in North America. 
Each participant in the plan may elect to contribute from 1% to 75% of his or her annual eligible earnings to the 
plan, subject to statutory limitations. The Company makes matching employee contributions in cash to the plan at 
the rate of 50% of the first 6% of earnings contributed. Employees participating in the 401(k) retirement savings 
plan are 100% vested in the Company matching contributions, and investments are directed by participants. The 
Company made matching contributions of approximately $4.3 million, $4.7 million, and $5.0 million in fiscal 
years 2010, 2009, and 2008, respectively.

Additionally, outside of North America, the Company provides long term savings plans for its employees 

consistent with local practice and market competitiveness.

Deferred Compensation Arrangements

The  Company  has  an  unfunded,  non-qualified  deferred  compensation  plan  whereby  certain  executives 
may  defer  a  portion  of  their  compensation.  Participants  earn  a  return  on  their  deferred  compensation  based 
on their allocation of their account balance among measurement funds. The Company controls the investment 
of these funds and the participants remain general creditors of the Company. Participants are able to elect the 
payment of benefits on a specified date at least three years after the opening of a of deferral subaccount or upon 
retirement. Distributions are made in the form of lump sum or annual installments over a period of up to 20 years 
as elected by the participant. If no alternate election has been made, a lump sum payment will be made upon 
termination of a participant’s employment with the Company. As of June 27, 2010 and June 28, 2009 the liability 
of the Company to the plan participants was $55.1 million and $52.4 million, respectively, which was recorded 
in accrued expenses and other current liabilities on the Consolidated Balance Sheets. As of June 27, 2010 and 
June 28, 2009 the Company invested in certain assets in the form of retail mutual funds and company owned 
life insurance policies that correlate to the deferred compensation obligations of $53.0 million and $26.8 million, 
respectively, which was recorded in other assets on the consolidated balance sheets.

70

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Postretirement Healthcare Plan

The  Company  maintains  a  postretirement  healthcare  plan  for  certain  executive  and  director  retirees. 
Coverage continues through the duration of the lifetime of the retiree or the retiree’s spouse, whichever is longer. 
The benefit obligation was $8.9 million and $2.6 million as of June 27, 2010 and June 28, 2009, respectively.

Note 13: Commitments

The Company has certain obligations to make future payments under various contracts. Consistent with 
GAAP, some of these are recorded on its balance sheet and some are not. Obligations that are recorded on the 
Company’s balance sheet include the Company’s long-term debt and capital lease obligations. The Company’s 
off-balance sheet arrangements include contractual relationships for operating leases, purchase obligations, and 
guarantees. The Company’s contractual cash obligations and commitments relating to long-term debt and off-
balance sheet agreements are included in the table below. These amounts exclude $110.5 million of liabilities 
related to uncertain tax benefits because the Company is unable to reasonably estimate the ultimate amount or 
time of settlement. See Note 14, of Notes to Consolidated Financial Statements for further discussion.

Capital Leases

Capital leases reflect building lease obligations assumed from the Company’s acquisition of SEZ and an 

office equipment lease. The amounts in the table below include the interest portion of payment obligations.

Long-Term Debt

During fiscal year 2010 the Company made $21.0 million in principal payments on long-term debt and 
capital leases. During fiscal year 2009, the Company paid the outstanding principal balance of $250.0 million 
of  its  existing  long-term  debt  with  ABN  AMRO  Bank  N.V.  (“ABN  AMRO”)  using  existing  cash  balances. 
There were no penalties associated with the payment. In connection with the payment, the parties agreed to 
terminate the ABN AMRO Credit Agreement and related Collateral Documents. ABN AMRO continues to be 
a participant in our operating leases with BNP Paribas Leasing Corporation and continues to provide banking 
services to the Company for customary fees.

The  Company’s  remaining  total  long-term  debt  of  $7.0  million  as  of  June  27,  2010  is  the  result  of 
obligations the Company assumed in connection with the acquisition of SEZ, consisting of various bank loans 
and government subsidized technology loans supporting operating needs.

The Company’s contractual cash obligations relating to its existing capital leases and long-term debt as of 

June 27, 2010 were as follows:

Payments due by period:
One year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Two years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Three years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Four years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Five years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Over 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest on capital leases . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of long-term debt and capital leases . . .
Long-term debt and capital leases  . . . . . . . . . . . . . . . . .

Capital 
Leases

Long-term 
Debt

Total

(in thousands)

$ 1,671
1,682
1,655
1,373
1,373
9,206
16,960
1,311
1,369
$ 14,280

$3,598
2,789
576
—
—
—
6,963

3,598
$3,365

$ 5,269
4,471
2,231
1,373
1,373
9,206
23,923
1,311
4,967
$ 17,645

71

 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Operating Leases

The Company leases most of its administrative, R&D and manufacturing facilities, regional sales/service 
offices and certain equipment under non-cancelable operating leases, which expire at various dates through fiscal 
year 2016. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters 
and certain other facility leases provide the Company with an option to extend the leases for additional periods 
or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based 
on the general rate of inflation. The Company’s rental expense for facilities occupied during fiscal years 2010, 
2009, and 2008 was approximately $6 million, $9 million, and $11 million, respectively.

Included  in  the  Operating  Leases  five  years  section  of  the  table  below  is  $141.7  million  in  guaranteed 
residual values for lease agreements relating to certain properties at the Company’s Fremont, California campus 
and properties in Livermore, California.

On  December  18,  2007,  the  Company  entered  into  two  operating  leases  regarding  certain  improved 
properties  in  Livermore,  California.  These  leases  were  amended  on  April  3,  2008  and  July  9,  2008  (as  so 
amended, the “Livermore Leases”). On December 21, 2007, the Company entered into a series of four amended 
and  restated  operating  leases  (the  “New  Fremont  Leases,”  and  collectively  with  the  Livermore  Leases,  the 
“Operating  Leases”)  with  regard  to  certain  improved  properties  at  the  Company’s  headquarters  in  Fremont, 
California.  Each  of  the  Operating  Leases  is  an  off-balance  sheet  arrangement.  The  Operating  Leases  (and 
associated documents for each Operating Lease) were entered into by the Company and BNP Paribas Leasing 
Corporation (“BNPPLC”).

Each Operating Lease facility has a term of approximately seven years ending on the first business day in 
January 2015. Under each Operating Lease, the Company may, at its discretion and with 30 days’ notice, elect to 
purchase the property that is the subject of the Operating Lease for an amount approximating the sum required to 
prepay the amount of BNPPLC’s investment in the property and any accrued but unpaid rent. Any such amount 
may also include an additional make-whole amount for early redemption of the outstanding investment, which 
will vary depending on prevailing interest rates at the time of prepayment.

The Company is required, pursuant to the terms of the Operating Leases and associated documents, to 
maintain  collateral  in  an  aggregate  of  approximately  $164.9  million  in  separate  interest-bearing  accounts  as 
security  for  the  Company’s  obligations  under  the  Operating  Leases.  As  of  June  27,  2010,  the  Company  had 
$164.9  million  recorded  as  restricted  cash  in  its  consolidated  balance  sheet  as  collateral  required  under  the 
Operating Leases related to the amounts currently outstanding on the facilities.

When  the  term  of  an  Operating  Lease  expires,  the  property  subject  to  that  Operating  Lease  may  be 
remarketed. The Company has guaranteed to BNPPLC that each property will have a certain minimum residual 
value, as set forth in the applicable Operating Lease. The aggregate guarantee made by the Company under 
the Operating Leases is generally no more than approximately $141.7 million; however, under certain default 
circumstances, the guarantee with regard to an Operating Lease may be 100% of BNPPLC’s aggregate investment 
in the applicable property. The amounts payable under such guarantees will be no more than $164.9 million plus 
related indemnification or other obligations.

The lessor under the Operating Leases is a substantive independent leasing company that does not have the 

characteristics of a variable interest entity (VIE) and is therefore not consolidated by the Company.

72

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The Company’s contractual cash obligations with respect to operating leases as of June 27, 2010 were as 

follows:

Payments due by period:
One year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Two years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Three years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Four years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Five years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Over 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Operating 
Leases

(in thousands)

$

8,012
5,068
4,092
2,883
143,162
7,875
$ 171,092

Purchase Obligations

Purchase obligations consist of significant contractual obligations either on an annual basis or over multi-year 
periods related to the Company’s outsourcing activities or other material commitments, including vendor-consigned 
inventories. The Company continues to enter into new agreements and maintain existing agreements to outsource 
certain activities, including elements of its manufacturing, warehousing, logistics, facilities maintenance, certain 
information technology functions, and certain transactional general and administrative functions. The contractual 
cash obligations and commitments table presented below contains the Company’s obligations at June 27, 2010 under 
these arrangements and others. Actual expenditures will vary based on the volume of transactions and length of 
contractual service provided. In addition to these obligations, certain of these agreements include early termination 
provisions and/or cancellation penalties that could increase or decrease amounts actually paid.

Consignment inventories, which are owned by vendors but located in the Company’s storage locations and 
warehouses, are not reported as the Company’s inventory until title is transferred to the Company or its purchase 
obligation is determined. At June 27, 2010, vendor-owned inventories held at the Company’s locations and not 
reported as its inventory were $33.7 million.

The  Company’s  contractual  cash  obligations  and  commitments  related  to  these  agreements  as  of 

June 27, 2010 are as follows:

Payments due by period:
One year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Two years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Three years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Four years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Five years  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Over 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Purchase 
Obligations

(in thousands)

$ 218,469
33,370
26,306
14,798
11,851
7,715
$ 222,509

73

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some 
of its lease agreements. The Company has entered into certain insurance contracts that may limit its exposure 
to these indemnification obligations. As of June 27, 2010, the Company has not recorded any liability on its 
consolidated financial statements in connection with these indemnifications, as it does not believe, based on 
information available, that it is probable that any amounts will be paid under these guarantees.

Generally, the Company indemnifies its customers for infringement of third-party intellectual property 
rights by the Company’s products or services, under pre-determined conditions and limitations. The Company 
seeks to limit its liability for any indemnity to an amount not to exceed the sales price of the products or services 
subject to its indemnification obligations. The Company does not believe, based on information available, that it 
is probable that any material amounts will be paid under these indemnities.

The Company recognized at lease inception $0.6 million in estimated liabilities related to the Operating 
Leases, which represents the fair value guarantee premium that would be required had the guarantee been issued 
in a standalone transaction. These liabilities are recorded in other long-term liabilities with the offsetting entry 
recorded as prepaid rent in other assets. The balances in prepaid rent and the guarantee liability are amortized 
to  the  statement  of  operations  on  a  straight  line  basis  over  the  life  of  the  leases.  If  it  becomes  probable  that 
the  Company  will  be  required  to  make  a  payment  under  the  residual  guarantee,  the  Company  will  increase 
its  liability  with  a  corresponding  increase  to  prepaid  rent  and  amortize  the  increased  prepaid  rent  over  the 
remaining lease term with no corresponding reduction in the liability. As of June 27, 2010, the unamortized 
portion of the fair value of the residual value guarantees remaining in other long-term liabilities and prepaid rent 
was $0.3 million.

During fiscal year 2010, the Company recognized a restructuring charge of $13.0 million related to the 
reassessment  of  the  residual  value  guarantee  for  previously  restructured  leases;  the  liability  was  recorded  in 
other long-term liabilities.

Warranties

The Company provides standard warranties on our systems that generally run for a period of 12 months 
from system acceptance. The liability amount is based on actual historical warranty spending activity by type 
of system, customer, and geographic region, modified for any known differences such as the impact of system 
reliability improvements.

Changes in the Company’s product warranty reserves were as follows:

Year Ended

June 27, 
2010

June 28, 
2009

(in thousands)

Balance at beginning of period. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Warranties assumed upon acquisitions  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warranties issued during the period. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Settlements made during the period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expirations and change in liability for pre-existing warranties during the period . . .
Changes in foreign currency exchange rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 21,185
—
36,875
(18,673)
(7,301)
(330)
$ 31,756

$ 61,308
878
13,613
(31,553)
(20,805)
(2,256)
$ 21,185

74

 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Note 14: Income Taxes

The components of income (loss) before income taxes are as follows:

United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

$ 140,309
289,832
$ 430,141

Year Ended
June 28, 
2009
(in thousands)
$ 26,200
(289,293)
$ (263,093)

June 29, 
2008

$263,489
313,487
$ 576,976

Significant components of the provision (benefit) for income taxes attributable to income before income 

taxes are as follows:

Federal:

Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

State:

Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

Year Ended
June 28, 
2009
(in thousands)

June 29, 
2008

$38,221
11,438
$ 49,659

$ (6,523)
11,668
$ 5,145

$116,788
(18,635)
$ 98,153

$ 6,126
5,009
$ 11,135

$ (487)
8,047
$ 7,560

$

$

5,603
930
6,533

Foreign:

Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total Provision for Income Taxes. . . . . . . . . . . . . . . . . . .

$22,813
(135)
$ 22,678
$ 83,472

$15,017
11,333
$26,350
$ 39,055

$ 38,294
(5,353)
$ 32,941
$ 137,627

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of 
assets and liabilities for financial reporting purposes, and the amounts used for income tax purposes, as well as the 
tax effect of carryforwards. Significant components of the Company’s net deferred tax assets are as follows:

Deferred tax assets:

Tax carryforwards  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowances and reserves  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventory valuation differences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized R&D expenses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred tax assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax liabilities:

Fixed assets depreciation and intangibles amortization . . . . . . . . . . . . . . . . . . . .
State cumulative temporary differences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred tax assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

75

June 27, 
2010

June 28, 
2009

(in thousands)

$ 50,182
63,143
7,764
6,202
5,027
5,088
137,406
(36,957)
100,449

(20,188)
(10,118)
(6,026)
(36,332)
$ 64,117

$ 57,350
72,037
11,656
6,200
5,677
4,095
157,015
(35,518)
121,497

(25,632)
(11,917)
(4,326)
(41,875)
$ 79,622

 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Realization  of  the  Company’s  net  deferred  tax  assets  is  based  upon  the  weight  of  available  evidence, 
including such factors as the recent earnings history and expected future taxable income. The Company believes 
it is more likely than not that such assets will be realized with the exception of $37.0 million related to certain 
California and foreign deferred tax assets. To the extent realization of the deferred tax assets becomes more-
likely-than-not, the Company would recognize such deferred tax asset as an income tax benefit during the period 
the realization occurred. However, ultimate realization of deferred tax assets could be negatively impacted by 
market conditions and other variables not known or anticipated at this time.

The  provisions  related  to  the  tax  accounting  for  stock-based  compensation  prohibit  the  recognition  of 
a deferred tax asset for an excess benefit that has not yet been realized. As a result, we will only recognize a 
benefit from stock-based compensation in additional paid-in-capital if an incremental tax benefit is realized or 
realizable after all other tax attributes currently available to us have been utilized. In addition, we have elected 
to account for the indirect benefits of stock-based compensation on the R&D tax credit through the consolidated 
statement of income (continuing operations) rather than through additional paid-in-capital.

As  of  June  27,  2010,  the  Company  had  California  net  operating  loss  carry-forwards  of  approximately 
$2.3 million. Unused net operating loss carry-forwards will expire in the year 2030. When recognized these net 
operating losses will result in a benefit to additional paid-in capital of approximately $0.1 million.

At  June  27,  2010,  the  Company  had  federal  and  state  tax  credit  carryforwards  of  approximately 
$182.5 million, of which approximately $66.8 million will expire in varying amounts between fiscal years 2026 
and 2031. The remaining balance of $115.7 million of tax carryforwards may be carried forward indefinitely. The 
tax benefits relating to approximately $57.0 million of the tax credit carryforwards will be credited to additional 
paid-in-capital when recognized.

At June 27, 2010, the Company had foreign net operating loss carryforwards of approximately $68.9 million, 
of which approximately $25.9 million may be carried forward indefinitely and $43.0 million will begin to expire 
in fiscal year 2012.

A reconciliation of income tax expense provided at the federal statutory rate (35% in fiscal years 2010, 

2009 and 2008) to actual income expense is as follows:

Income tax expense computed at federal statutory rate . . . . . . . . . . . .
State income taxes, net of federal tax benefit  . . . . . . . . . . . . . . . . . . .
Foreign income taxes at different rates  . . . . . . . . . . . . . . . . . . . . . . . .
Tax credits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation Allowance, net of federal tax benefit . . . . . . . . . . . . . . . . . .
Equity-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other, net  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

$150,549
4,754
(84,081)
(4,410)
4,627
11,847
186
$ 83,472

Year Ended
June 28, 
2009
(in thousands)
$ (92,083)
(4,550)
125,124
(9,273)
12,109
10,985
(3,257)
$ 39,055

June 29, 
2008

$201,942
3,712
(84,077)
(6,745)
—
10,717
12,078
$ 137,627

Effective from fiscal year 2003 through June 2013, the Company has negotiated a tax holiday in Switzerland 
for  one  of  its  foreign  subsidiaries,  which  is  conditional  upon  the  Company  meeting  certain  employment  and 
investment thresholds. The impact of the tax holiday decreased income taxes by approximately $45.9 million 
and $18.9 million for fiscal years 2010 and 2008, respectively. The Company did not record a tax benefit related 
to the tax holiday in 2009. The benefit of the tax holiday on diluted earnings per share was approximately $0.36 
in fiscal year 2010, $0.00 in fiscal year 2009, and $0.15 in fiscal year 2008.

76

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Unremitted  earnings  of  the  Company’s  foreign  subsidiaries  included  in  consolidated  retained  earnings 
aggregated to approximately $1.01 billion at June 27, 2010. These earnings, which reflect full provisions for foreign 
income taxes, are indefinitely reinvested in foreign operations. If these earnings were remitted to the United States, 
they would be subject to U.S. and foreign withholding taxes of approximately $250.9 million at current statutory 
rates. The Company’s federal income tax provision includes U.S. income taxes on certain foreign-based income.

Accounting standards prescribe a minimum recognition threshold that a tax position is required to meet before 
being recognized in the financial statements. These accounting standards also provide guidance on de-recognition, 
measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.

As of June 27, 2010, the total gross unrecognized tax benefits were $190.5 million compared to $178.4 million 
as of June 28, 2009, and $143.8 million as of June 29, 2008. During fiscal year 2010, gross unrecognized tax 
benefits increased by approximately $12 million. The amount of unrecognized tax benefits that, if recognized, 
would impact the effective tax rate was $153.8 million, $125.5 million, and $101.8 million as of June 27, 2010, 
June 28, 2009, and June 29, 2008, respectively. The aggregate changes in the balance of gross unrecognized tax 
benefits were as follows:

Beginning balance as of June 25, 2007 (date of adoption)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlements and effective settlements with tax authorities and related remeasurements . . . . . . . .
Lapse of statute of limitations  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . . .
Decreases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during current period . . . . . . . . . . . . . . . . . . .
Balance as of June 29, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlements and effective settlements with tax authorities and related remeasurements . . . . . . . .
Lapse of statute of limitations  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . . .
Decreases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during current period . . . . . . . . . . . . . . . . . . .
Balance as of June 28, 2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Settlements and effective settlements with tax authorities and related remeasurements . . . . . . . .
Lapse of statute of limitations  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . . .
Decreases in balances related to tax positions taken during prior periods . . . . . . . . . . . . . . . . . . .
Increases in balances related to tax positions taken during current period . . . . . . . . . . . . . . . . . . .
Balance as of June 27, 2010  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in millions)
$119.2
(11.7)
(0.7)
—
—
37.0
$143.8
—
(0.7)
13.9
(2.5)
23.9
$178.4
(1.3)
(8.1)
5.5
(2.0)
18.0
$190.5

During fiscal year 2008, the Company completed its unilateral advanced pricing agreement (“APA”) with 
certain foreign tax authorities. As a result of the APA, the Company reduced its balance of gross unrecognized 
tax benefits by approximately $11.7 million, of which $8.1 million relates to years prior to fiscal year 2008.

The Company recognizes interest expense and penalties related to the above unrecognized tax benefits within 
income tax expense. The Company had accrued $18.5 million, $19.1 million, and $12.6 million, cumulatively, for 
gross interest and penalties as of June 27, 2010, June 28, 2009 and June 29, 2008, respectively.

The Company files U.S. federal, U.S. state, and foreign income tax returns. As of June 27, 2010, tax years 

2001-2009 remain subject to examination in the jurisdictions where the Company operates.

77

 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The Internal Revenue Service (“IRS”) is examining the Company’s U.S. income tax return for fiscal year 
2007.  The  California  Franchise  Tax  Board  (“FTB”)  is  examining  the  Company’s  tax  returns  for  fiscal  years 
2005 and 2006. It is anticipated that the IRS audit will be completed in fiscal year 2011. As of June 27, 2010, no 
significant adjustments have been proposed by the IRS or FTB. The Company is unable to make a reasonable 
estimate as to when cash settlements, if any, with the relevant taxing authorities will occur.

The French tax authorities have examined the Company’s tax returns for the fiscal years 2004 through 
2006 and have proposed certain adjustments to its transfer pricing. The Company believes it has made adequate 
tax payments and accrued adequate amounts such that the outcome of these audits will have no material adverse 
effects on its results of operations or financial condition. It is reasonably possible that certain examinations may 
be concluded in the next twelve months.

The Company does not anticipate that the total unrecognized tax benefits will significantly change due to 

the settlement of audits or the expiration of statute of limitations in the next 12 months.

Note 15: Acquisitions

During fiscal year 2008, the Company acquired approximately 99% of the outstanding shares of SEZ, a 
major supplier of single-wafer wet clean technology and products to the global semiconductor manufacturing 
industry. The acquisition was an all-cash transaction. The Company acquired the remaining outstanding shares 
during the six months ended December 28, 2008. The acquisition of the shares was conducted pursuant to the 
terms of a Transaction Agreement entered into on December 10, 2007 by and between the Company and SEZ. 
SEZ’s Spin-Process single-wafer clean technology is part of a broad equipment portfolio for wafer cleaning and 
decontamination that is a key process adjacent to the etch process.

The  acquisition  was  accounted  for  as  a  business  combination  and  the  purchase  price  at  the  time  of 
acquisition was allocated based on the estimated fair value of net tangible and intangible assets acquired, and 
liabilities assumed.

The purchase price was allocated to the fair value of assets acquired and liabilities assumed as follows, 

in thousands:

Cash consideration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Transaction costs  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net tangible assets  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 628,092
11,115
$ 639,207

$ 345,494
67,743
225,970
$ 639,207

Unaudited pro forma financial information for the Company is presented below as if the acquisition of 
SEZ occurred at the beginning of the fiscal 2008. The pro forma information presented below is not necessarily 
indicative  of  the  consolidated  financial  position  or  results  of  operations  in  future  periods  or  the  results  that 
actually  would  have  been  realized  had  the  acquisition  in  fact  occurred  at  the  beginning  of  fiscal  year  2008. 
The pro forma results below reflect certain adjustments to exclude one-time transaction costs incurred with the 
acquisition, to amortize intangible assets and to transition to an acceptance-based revenue recognition model 
with respect to the acquisition of SEZ.

Pro forma results of operations are as follows for the twelve months ended June 29, 2008:

Pro forma revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pro forma net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pro forma basic earnings per share  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pro forma diluted earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 29, 
2008
$ 2,687,846
445,621
3.58
3.52

$
$

78

 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Note 16: Goodwill and Intangible Assets

Goodwill

There  were  no  changes  in  goodwill  or  accumulated  impairment  during  the  twelve  months  ended 
June 27, 2010. Gross goodwill and accumulated impairment losses as of both June 27, 2010 and June 28, 2009 
were  $265.5  million  and  $96.3  million,  respectively.  Changes  in  the  balance  of  goodwill  during  the  twelve 
months ended June 28, 2009 were as follows: 

Balance as of June 29, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additional share purchases / acquisitions  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax adjustments  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effect of changes in foreign currency exchange rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of June 28, 2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in thousands)
$ 281,298
10,960
(1,303)
(96,255)
(25,518)
$ 169,182

During fiscal year 2009, a combination of factors, including the economic environment, a sustained decline 
in the Company’s market valuation and a decline in the Company’s operating results were indicators of possible 
impairment of the Company’s goodwill. The Company conducted an analysis and concluded that the fair value 
of the Company’s Clean Product Group had been reduced below its carrying value. As a result, the Company 
recorded a non-cash goodwill impairment charge of approximately $96.3 million during fiscal year 2009.

The calculation of the goodwill impairment charge was based on estimates of future operating results. If the 
Company’s future operating results do not meet current forecasts or if the Company experiences a sustained decline in 
its market capitalization that is determined to be indicative of a reduction in fair value of the Company’s Clean Product 
Group, an additional impairment analysis may be required which may result in additional impairment charges.

Goodwill attributable to the SEZ acquisition of approximately net $104 million is not tax deductible due to 

foreign jurisdiction law. The remaining goodwill balance of approximately $65 million is tax deductible.

Intangible Assets

The  following  table  provides  details  of  the  Company’s  intangible  assets  subject  to  amortization  as  of 

June 27, 2010 (in thousands, except years):

Customer relationships . . . . . . . . . . . . . . . . . . . . . . . . . . .
Existing technology  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
Patents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Gross
$ 35,226
61,598
35,216
20,270
$ 152,310

Accumulated 
Amortization
$(18,512)
(27,084)
(27,783)
(11,207)
$(84,586)

Net
$16,714
34,514
7,433
9,063
$ 67,724

Weighted- 
Average 
Useful Life 
(years)
6.90
6.70
4.10
6.13
6.07

The  following  table  provides  details  of  the  Company’s  intangible  assets  subject  to  amortization  as  of 

June 28, 2009 (in thousands, except years):

Customer relationships . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Existing technology  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Patents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

79

Gross
$ 35,226
61,598
35,216
20,270
$ 152,310

Accumulated 
Amortization
$(13,557)
(19,003)
(20,222)
(7,923)
$ (60,705)

Net
$21,669
42,595
14,994
12,347
$ 91,605

Weighted- 
Average 
Useful Life 
(years)
6.90
6.70
4.10
6.13
6.07

 
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

The Company recognized $23.9 million, $24.0 million, and $17.9 million in intangible asset amortization 

expense during fiscal years 2010, 2009, and 2008, respectively.

The  estimated  future  amortization  expense  of  purchased  intangible  assets  as  of  June  27,  2010  was  as 

follows (in thousands):

Fiscal Year
2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amount
20,911
17,802
16,156
10,269
2,074
512
$ 67,724

Note 17: Segment, Geographic Information and Major Customers

The Company operates in one reportable business segment: manufacturing and servicing of front-end wafer 
processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for 
aggregation due to their identical customer base and similarities in economic characteristics, nature of products 
and services, and processes for procurement, manufacturing and distribution.

The Company operates in six geographic regions: North America, Europe, Japan, Korea, Taiwan, and Asia 
Pacific. For geographical reporting, revenue is attributed to the geographic location in which the customers’ 
facilities  are  located  while  long-lived  assets  are  attributed  to  the  geographic  locations  in  which  the  assets 
are located.

Revenue:

North America  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Korea  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Taiwan  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total revenue  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Long-lived assets:

North America  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Korea  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Taiwan  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asia Pacific  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total long-lived assets  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 27, 
2010

$ 186,036
133,685
318,641
539,312
703,854
252,248
$ 2,133,776

June 27, 
2010

$ 178,055
77,839
1,377
12,379
2,627
4,335
276,612

$

Year Ended
June 28, 
2009
(in thousands)

$ 171,359
121,178
234,070
239,911
208,053
141,375
$ 1,115,946

June 28, 
2009
(in thousands)

$ 183,372
90,608
1,776
11,478
2,687
4,077
$ 293,998

June 29, 
2008

$ 417,807
235,191
455,322
554,924
502,683
308,984
$ 2,474,911

June 29, 
2008

$ 188,432
113,020
1,982
3,511
5,420
1,797
$ 314,162

80

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

In fiscal year 2010, revenues from Samsung Electronics Company, Ltd., Taiwan Semiconductor Manufacturing 
Company, Ltd., and Toshiba Corporation accounted for approximately 24%, 15%, and 11%, respectively, of total 
revenues. In fiscal year 2009, revenues from Samsung Electronics Company, Ltd. and Toshiba Corporation accounted 
for approximately 19% and 11%, respectively, of total revenues. In fiscal year 2008, revenues from Samsung Electronics 
Company, Ltd. and Toshiba Corporation accounted for approximately 19% and 13%, respectively of total revenues.

Note 18: Restructuring and Asset Impairments

Prior  to  the  end  of  each  of  the  June  2008,  December  2008,  and  March  2009  quarters,  the  Company 
initiated the announced restructuring activities and management, with the proper level of authority, approved 
specific actions under the June 2008, December 2008, and March 2009 Plans (as defined below in this Note 
18). Severance packages to affected employees were communicated in enough detail such that the employees 
could determine their type and amount of benefit. The termination of the affected employees occurred as soon 
as practical after the restructuring plans were announced. The amount of remaining future lease payments and 
certain contractual obligations for facilities the Company ceased to use and included in the restructuring charges 
is based on management’s estimates using known prevailing real estate market conditions at that time based, 
in  part,  on  the  opinions  of  independent  real  estate  experts.  Leasehold  improvements  relating  to  the  vacated 
buildings were written off, as it was determined that these items would have no future economic benefit to the 
Company and have been abandoned.

Accounting  for  restructuring  activities,  as  compared  to  regular  operating  cost  management  activities, 
requires an evaluation of formally committed and approved plans. Restructuring activities have comparatively 
greater strategic significance and materiality and may involve exit activities, whereas regular cost containment 
activities are more tactical in nature and are rarely characterized by formal and integrated action plans or exiting 
a particular product, facility, or service.

The  following  table  summarizes  restructuring  and  asset  impairment  charges  (recoveries)  during  fiscal 

years 2010, 2009, and 2008 for each restructuring Plan:

June 2008 Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 2008 Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
March 2009 Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total restructuring and asset impairment charges  

June 27, 
2010

$ (2,217)
92
20,891

Year Ended
June 28, 
2009
(in thousands)
$19,016
17,849
28,641

June 29, 
2008

$18,976
—
—

incurred under restructuring plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 18,766

$ 65,506

$ 18,976

The amounts in the table above were reported in the Company’s consolidated statement of operations for 

fiscal years ended 2010, 2009, and 2008 as follows:

Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expense  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total restructuring and asset impairment charges  

June 27, 
2010

$ (2,175)
20,941

Year Ended
June 28, 
2009
(in thousands)
$20,993
44,513

June 29, 
2008

$12,610
6,366

incurred under restructuring plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 18,766

$ 65,506

$ 18,976

In addition to charges incurred under specific restructuring plans, as detailed in the above tables, during 
fiscal  year  2010  the  Company  incurred  an  additional  $6.0  million  of  asset  impairment  charges  related  to 
production efficiencies and shifts in product demands. Of the total $6.0 million, $5.6 million was recorded in 
cost of sales and $0.4 million was recorded in operating expenses.

81

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

June 2008 Plan

During the June 2008 quarter, the Company incurred restructuring expenses and asset impairment charges 
related to the integration of SEZ and overall streamlining of the Company’s combined Clean Product Group 
(“June 2008 Plan”). Restructuring and asset impairment charges during fiscal years 2010, 2009, and 2008 under 
the June 2008 Plan were as follows:

Severance and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Facilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abandoned assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total restructuring and asset impairment charges . . . . . . . . . . . . . . . . . . . .

Below is a table summarizing activity relating to the June 2008 Plan:

June 27, 
2010

$

(42)
—
—
(2,175)
$ (2,217)

Year Ended
June 28, 
2009

(in thousands)
$12,554
—
3,395
3,067
$19,016

June 29, 
2008

$ 5,513
899
1,893
10,671
$18,976

Fiscal year 2008 expense . . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . . .
Balance at June 29, 2008  . . . . . . . . . . . . .
Fiscal year 2009 expense . . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . . .
Balance at June 28, 2009  . . . . . . . . . . . . .
Fiscal year 2010 expense  . . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . . .
Balance at June 27, 2010 . . . . . . . . . . . . . .

Severance 
and 
 Benefits

$ 5,513
(927)
—
4,586
12,554
(13,155)
(3,418)
567
(42)
(525)
—
—

$

Facilities

$ 899
—
—
899
—
(873)
—
26
—
(26)
—
$ —

Abandoned 
 Assets

(in thousands)
$ 1,893
—
(1,893)
—
3,395
—
(3,395)
—
—
—
—
$ —

Inventory

Total

$ 10,671
—
(10,671)
—
3,067
—
(3,067)
—
(2,175)
—
2,175

$ 18,976
(927)
(12,564)
5,485
19,016
(14,028)
(9,880)
593
(2,217)
(551)
2,175
—

$

— $

Total charges incurred as of June 27, 2010 under the June 2008 Plan were $35.8 million.

December 2008 Plan

During the December 2008 quarter, the Company incurred restructuring expenses and asset impairment 
charges designed to better align the Company’s cost structure with its business opportunities in consideration 
of market and economic uncertainties (“December 2008 Plan”). There were no charges under this plan prior 
to fiscal year 2009. Restructuring and asset impairment charges during fiscal years 2010 and 2009 under the 
December 2008 Plan were as follows:

Severance and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Facilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total restructuring and asset impairment charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

82

Year Ended

June 27, 
2010

June 28, 
2009

(in thousands)

$ 92
—
—
$ 92

$16,412
618
819
$ 17,849

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Below is a table summarizing activity relating to the December 2008 Plan:

Fiscal year 2009 expense . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at June 28, 2009  . . . . . . . . . . . . . . . . . . . . . . . . . .
Fiscal year 2010 expense  . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance at June 27, 2010 . . . . . . . . . . . . . . . . . . . . . . . . . . .

Severance 
and 
 Benefits

$ 16,412
(15,728)
—
684
92
(497)
279

$

Facilities

Inventory

Total

(in thousands)

$ 618
—
(618)
—
—
—
$ —

$ 819
—
(819)
—
—
—
$ —

$ 17,849
(15,728)
(1,437)
684
92
(497)
279

$

Total charges incurred as of June 27, 2010 under the December 2008 Plan were $17.9 million. The severance 

and benefits-related balances are anticipated to be paid by the end of fiscal year 2011.

March 2009 Plan

During  the  March  2009  quarter,  the  Company  incurred  restructuring  expenses  and  asset  impairment 
charges designed to align the Company’s cost structure with its outlook for the current economic environment 
and future business opportunities (“March 2009 Plan”). There were no charges under this plan prior to fiscal 
year 2009. Restructuring and asset impairment charges during fiscal years 2010 and 2009 under the March 2009 
Plan were as follows:

Year Ended

June 27, 
2010

June 28, 
2009

Severance and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Facilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abandoned assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total restructuring and asset impairment charges . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Below is a table summarizing activity relating to the March 2009 Plan:

$

(in thousands)
472
19,832
587
—
$ 20,891

$23,038
2,265
3,008
330
$ 28,641

Fiscal year 2009 expense . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . .
Balance at June 28, 2009  . . . . . . . . . . . .
Fiscal year 2010 expense  . . . . . . . . . . . .
Cash payments  . . . . . . . . . . . . . . . . . . . .
Non-cash charges . . . . . . . . . . . . . . . . . .
Balance at June 27, 2010 . . . . . . . . . . . . .

Severance 
and 
 Benefits

$ 23,038
(18,647)
(466)
3,925
472
(4,132)
—
265

$

Facilities

$ 2,265
(1,828)
—
437
19,832
(3,417)
—
$ 16,852

Abandoned 
Assets

(in thousands)
$ 3,008
—
(3,008)
—
587
—
(587)
$ —

Inventory

Total

$ 330
—
(330)
—
—
—
—
$ —

$ 28,641
(20,475)
(3,804)
4,362
20,891
(7,549)
(587)
$ 17,117

Total charges incurred as of June 27, 2010 under the March 2009 Plan were $49.5 million. The severance 
and benefits-related balances are anticipated to be paid by the end of fiscal year 2011. The facilities balance 
consists primarily of lease payments, net of sublease income, on vacated buildings and is expected to be paid by 
the end of fiscal year 2015.

83

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) 
JUNE 27, 2010

Note 19: Stock Repurchase Program

On September 8, 2008, the Company announced that its Board of Directors had authorized the repurchase 
of  up  to  $250  million  of  Company  common  stock  from  the  public  market  or  in  private  purchases,  using  the 
Company’s available cash. While the repurchase program does not have a defined termination date, it may be 
suspended or discontinued at any time.

The Company temporarily suspended repurchases under the program during the December 2008 quarter. 
Subsequently on February 2, 2010, the Board of Directors authorized the resumption of the repurchase program. 
Repurchases  were  expected  to  be  made  only  in  the  amounts  necessary  to  offset  dilution  resulting  from  the 
Company’s equity compensation plans.

Repurchases under the repurchase program were as follows during the periods indicated (in thousands, 

except per-share data):

Period

Total 
Number of 
Shares 
Repurchased

Total Cost  
of Repurchase
(in thousands, except per share data)

Average Price 
Paid Per Share

Quarter ended September 27, 2009  . . . . . . . . .
Quarter ended December 27, 2009 . . . . . . . . . .
Quarter ended March 28, 2010 . . . . . . . . . . . . .
Quarter ended June 27, 2010. . . . . . . . . . . . . . . 

—
—
2,000
697

$ —
$ —
$68,674
$27,575

$ —
$ —
$34.34
$39.56

Amount  
Available 
Under 
Repurchase 
Program

$226,942
$226,942
$158,268
$130,693

In addition to shares repurchased under Board authorized repurchase programs shown above, during the 
twelve  months  ended  June  27,  2010  the  Company  withheld  285,000  shares  through  net  share  settlements  to 
cover tax withholding obligations upon the vesting of restricted stock unit awards under the Company’s equity 
compensation plans.

Note 20: Legal Proceedings

From time to time,  the Company has received notices  from third parties alleging infringement of such 
parties’ patent or other intellectual property rights by the Company’s products. In such cases it is the Company’s 
policy to defend the claims, or if considered appropriate, negotiate licenses on commercially reasonable terms. 
However, no assurance can be given that the Company will be able in the future to negotiate necessary licenses 
on commercially reasonable terms, or at all, or that any litigation resulting from such claims would not have a 
material adverse effect on the Company’s consolidated financial position or operating results.

84

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of Lam Research Corporation

We  have  audited  the  accompanying  consolidated  balance  sheets  of  Lam  Research  Corporation  as  of 
June 27, 2010 and June 28, 2009, and the related consolidated statements of operations, stockholders’ equity, 
and  cash  flows  for  each  of  the  three  years  in  the  period  ended  June  27,  2010.  Our  audits  also  included  the 
financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the 
responsibility  of  the  Company’s  management.  Our  responsibility  is  to  express  an  opinion  on  these  financial 
statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight 
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance 
about whether the financial statements are free of material misstatement. An audit includes examining, on a 
test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes 
assessing the accounting principles used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In  our  opinion,  the  financial  statements  referred  to  above  present  fairly,  in  all  material  respects,  the 
consolidated  financial  position  of  Lam  Research  Corporation  at  June  27,  2010  and  June  28,  2009,  and  the 
consolidated results of its operations and its cash flows for each of the three years in the period ended June 27, 
2010, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial 
statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly 
in all material respects the information set forth therein.

As discussed in Note 2 to the Notes to the Consolidated Financial Statements, under the heading Income 
Taxes,  Lam  Research  Corporation  changed  its  method  of  accounting  for  income  tax  uncertainties  in  fiscal 
year 2008.

We  also  have  audited,  in  accordance  with  the  standards  of  the  Public  Company  Accounting  Oversight 
Board (United States), Lam Research Corporation’s internal control over financial reporting as of June 27, 2010, 
based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring 
Organizations  of  the  Treadway  Commission  and  our  report  dated  August  20,  2010  expressed  an  unqualified 
opinion thereon.

San Jose, California
August 20, 2010

85

 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of Lam Research Corporation

We have audited Lam Research Corporation’s internal control over financial reporting as of June 27, 2010, 
based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring 
Organizations  of  the  Treadway  Commission  (the  COSO  criteria).  Lam  Research  Corporation’s  management 
is responsible for maintaining effective internal control over financial reporting and for its assessment of the 
effectiveness of internal control over financial reporting included in the accompanying Management’s Report 
on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s 
internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight 
Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance 
about whether effective internal control over financial reporting was maintained in all material respects. Our 
audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a 
material weakness exists, testing and evaluating the design and operating effectiveness of internal control based 
on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We 
believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance 
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in 
accordance with generally accepted accounting principles. A company’s internal control over financial reporting 
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, 
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable 
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance 
with  generally  accepted  accounting  principles,  and  that  receipts  and  expenditures  of  the  company  are  being 
made  only  in  accordance  with  authorizations  of  management  and  directors  of  the  company;  and  (3)  provide 
reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of 
the company’s assets that could have a material effect on the financial statements.

Because  of  its  inherent  limitations,  internal  control  over  financial  reporting  may  not  prevent  or  detect 
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that 
controls may become inadequate because of changes in conditions, or that the degree of compliance with the 
policies or procedures may deteriorate.

In our opinion, Lam Research Corporation maintained, in all material respects, effective internal control 

over financial reporting as of June 27, 2010, based on the COSO criteria.

We  also  have  audited,  in  accordance  with  the  standards  of  the  Public  Company  Accounting  Oversight 
Board (United States), the consolidated balance sheets of Lam Research Corporation as of June 27, 2010 and 
June 28, 2009, and the related consolidated statements of operations, stockholders’ equity and cash flows for 
each of the three years in the period ended June 27, 2010 of Lam Research Corporation and our report dated 
August 20, 2010 expressed an unqualified opinion thereon.

San Jose, California
August 20, 2010

86

 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the 
Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

LAM RESEARCH CORPORATION

By  /s/ Stephen G. Newberry                  

  Stephen G. Newberry,
  President and Chief Executive Officer

Dated: August 20, 2010

87

 
 
 
 
 
 
 
 
 
 
POWER OF ATTORNEY AND SIGNATURES

By signing this Annual Report on Form 10-K below, I hereby appoint each of Stephen G. Newberry and 
Ernest E. Maddock, jointly and severally, as my attorney-in-fact to sign all amendments to this Form 10-K on 
my behalf, and to file this Form 10-K (including all exhibits and other related documents) with the Securities 
and Exchange Commission. I authorize each of my attorneys-in-fact to (1) appoint a substitute attorney-in-fact 
for himself and (2) perform any actions that he believes are necessary or appropriate to carry out the intention 
and purpose of this Power of Attorney. I ratify and confirm all lawful actions taken directly or indirectly by my 
attorneys-in-fact and by any properly appointed substitute attorneys-in-fact.

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act  of  1934,  as  amended,  this  Report  has 
been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates 
indicated.

Signatures

Title

Date

Principal Executive Officer
/s/ Stephen G. Newberry
Stephen G. Newberry

Principal Financial Officer and 
Principal Accounting Officer
/s/ Ernest E. Maddock
Ernest E. Maddock

Other Directors
/s/ James W. Bagley
James W. Bagley

/s/ David G. Arscott
David G. Arscott

/s/ Robert M. Berdahl
Robert M. Berdahl

/s/ Richard J. Elkus, Jr.
Richard J. Elkus, Jr.

/s/ Grant M. Inman
Grant M. Inman

/s/ Catherine P. Lego
Catherine P. Lego

President and Chief Executive Officer,
Director

August 20, 2010

Senior Vice President, Chief Financial
Officer, and Chief Accounting Officer

Executive Chairman

Director

Director

Director

Director

Director

August 20, 2010

August 20, 2010

August 20, 2010

August 20, 2010

August 20, 2010

August 20, 2010

August 20, 2010

88

LAM RESEARCH CORPORATION

 SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

Additions

Balance 
at 
Beginning 
of 
Period

Charged 
to 
Costs 
and 
Expenses

Balance 
at 
End 
of 
Period

Deductions 
(Describe) (1)

(in thousands)

Description

YEAR ENDED JUNE 27, 2010
Deducted from asset accounts:

Allowance for doubtful accounts . . . . . . . . . .

$10,719,000

$

45,000

$155,000

$10,609,000

YEAR ENDED JUNE 28, 2009
Deducted from asset accounts:

Allowance for doubtful accounts . . . . . . . . . .

$ 4,102,000

$6,794,000

$177,000

$10,719,000

YEAR ENDED JUNE 29, 2008
Deducted from asset accounts:

Allowance for doubtful accounts . . . . . . . . . .

$ 3,851,000

$ 255,000

$

4,000

$ 4,102,000

(1)  $0.2 million of specific customer accounts were written-off in each of fiscal years 2010 and 2009, and less 

than $0.1 million was written-off in fiscal 2008.

89

Exhibit

3.1(4)

3.2(19)

3.3(4)

4.4(2)*

4.8(7)*

4.11(3)*

4.12(6)*

4.13*

4.14*

4.15(9)*

10.3(1)*

10.99(5)*

10.102(8)

10.103(8)

10.106(11)*

10.107(12)

10.108(12)

10.111(13)

10.112(13)

10.113(13)

10.114(13)

10.115(13)

LAM RESEARCH CORPORATION

ANNUAL REPORT ON FORM 10-K 
FOR THE FISCAL YEAR ENDED JUNE 27, 2010 
EXHIBIT INDEX

Description

Certificate of Incorporation of the Registrant, dated September 7, 1989; as amended by the 
Agreement and Plan of Merger, Dated February 28, 1990; the Certificate of Amendment 
dated  October  28,  1993;  the  Certificate  of  Ownership  and  Merger  dated  December  15, 
1994; the Certificate of Ownership and Merger dated June 25, 1999 and the Certificate of 
Amendment effective as of March 7, 2000; and the Certificate of Amendment effective as 
of November 5, 2009.

Bylaws of the Registrant, as amended, dated November 5, 2009.

Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred 
Stock dated January 27, 1997.

Amended 1991 Stock Option Plan and Forms of Stock Option Agreements.

Amended and restated 1997 Stock Incentive Plan.

Amended and restated 1996 Performance-Based Restricted Stock Plan.

Amended and restated 1999 Stock Option Plan.

Lam Research Corporation 1999 Employee Stock Purchase Plan, as amended.

Lam Research Corporation 2004 Executive Incentive Plan, as amended.

Lam Research Corporation 2007 Stock Incentive Plan, as amended.

Form of Indemnification Agreement.

Form of Nonstatutory Stock Option Agreement — Lam Research Corporation 1997 Stock 
Incentive Plan.

Form of Restricted Stock Unit Award Agreement (U.S. Agreement A) — Lam Research 
Corporation 1997 Stock Incentive Plan.

Form  of  Restricted  Stock  Unit  Award  Agreement  (non-U.S.  Agreement  I-A)  —  Lam 
Research Corporation 1997 Stock Incentive Plan.

Form  of  Restricted  Stock  Unit  Award  Agreement  (U.S.  Agreement)  —  Lam  Research 
Corporation 2007 Stock Incentive Plan.

Form of Restricted Stock Unit Award Agreement — Outside Directors (U.S. Agreement) 
— Lam Research Corporation 2007 Stock Incentive Plan.

Form of Restricted Stock Unit Award Agreement — Outside Directors (non-U.S. Agreement) 
— Lam Research Corporation 2007 Stock Incentive Plan.

Credit  Agreement  dated  as  of  March  3,  2008  among  Lam  Research  Corporation,  as 
the  Borrower,  ABN  Amro  Bank  N.V.,  as  Administrative  Agent,  and  the  other  Lenders 
Party thereto.

Unconditional Guaranty dated as of March 3, 2008 by Bullen Semiconductor Corporation 
to ABN AMRO Bank N.V.

Security Agreement dated as of March 3, 2008 between Lam Research Corporation and 
ABN AMRO Bank N.V.

Security Agreement dated as of March 3, 2008 between Bullen Semiconductor Corporation 
and ABN AMRO Bank N.V.

Pledge Agreement dated as of March 3, 2008 among Lam Research Corporation and ABN 
AMRO Bank N.V.

90

Exhibit

Description

10.116(10)*

10.117(14)

10.118(14)

10.119(14)

10.120(14)

10.121(14)

10.122(14)

10.123(14)

10.124(14)

10.125(14)

10.126(14)

10.127(14)

10.128(14)

10.129(14)

10.130(14)

10.131(14)

10.132(14)

10.133(14)

10.134(14)

10.135(14)

Employment Agreement between James W. Bagley and Lam Research Corporation, dated 
December 11, 2006.

Lease  Agreement  (Fremont  Building  #1)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Pledge  Agreement  (Fremont  Building  #1)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Closing  Certificate  and  Agreement  (Fremont  Building  #1)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

Agreement  Regarding  Purchase  and  Remarketing  Options  (Fremont  Building  #1) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 21, 2007.

Lease  Agreement  (Fremont  Building  #2)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Pledge Agreement (Fremont Building #2) between Lam Research Corporation and BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Closing  Certificate  and  Agreement  (Fremont  Building  #2)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

Agreement  Regarding  Purchase  and  Remarketing  Options  (Fremont  Building  #2) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 21, 2007.

Lease  Agreement  (Fremont  Building  #3)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Pledge Agreement (Fremont Building #3) between Lam Research Corporation and BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Closing  Certificate  and  Agreement  (Fremont  Building  #3)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

Agreement  Regarding  Purchase  and  Remarketing  Options  (Fremont  Building  #3) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 21, 2007.

Lease  Agreement  (Fremont  Building  #4)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Pledge Agreement (Fremont Building #4) between Lam Research Corporation and BNP 
Paribas Leasing Corporation, dated December 21, 2007.

Closing  Certificate  and  Agreement  (Fremont  Building  #4)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

Agreement  Regarding  Purchase  and  Remarketing  Options  (Fremont  Building  #4) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 21, 2007.

Lease  Agreement  (Livermore/Parcel  6)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 18, 2007.

Pledge  Agreement  (Livermore/Parcel  6)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 18, 2007.

Closing  Certificate  and  Agreement  (Livermore/Parcel  6)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

91

Exhibit

Description

10.136(14)

10.137(14)

10.138(14)

10.139(14)

10.140(14)

10.141(14)

10.142(14)

10.143(15)

10.144(15)

10.145(15)

10.146(15)

10.147(16)

10.148(17)*

10.149(17)*

10.150(18)*

10.151(20)*

10.152(20)*

10.153(20)*

10.154(20)*

21

23.1

24

31.1

31.2

32.1

32.2

(1) 

(2) 

Agreement  Regarding  Purchase  and  Remarketing  Options  (Livermore/Parcel  6) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 18, 2007.

Construction  Agreement  (Livermore/Parcel  6)  between  Lam  Research  Corporation  and 
BNP Paribas Leasing Corporation, dated December 18, 2007.

Lease  Agreement  (Livermore/Parcel  7)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 18, 2007.

Pledge  Agreement  (Livermore/Parcel  7)  between  Lam  Research  Corporation  and  BNP 
Paribas Leasing Corporation, dated December 18, 2007.

Closing  Certificate  and  Agreement  (Livermore/Parcel  7)  between  Lam  Research 
Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

Agreement  Regarding  Purchase  and  Remarketing  Options  (Livermore/Parcel  7) 
between  Lam  Research  Corporation  and  BNP  Paribas  Leasing  Corporation,  dated 
December 18, 2007.

Construction  Agreement  (Livermore/Parcel  7)  between  Lam  Research  Corporation  and 
BNP Paribas Leasing Corporation, dated December 18, 2007.

First Modification Agreement (Fremont Buildings #1, #2, #3, #4) between Lam Research 
Corporation and BNP Paribas Leasing Corporation, dated April 3, 2008.

First Modification Agreement (Livermore Parcel 6) between Lam Research Corporation 
and BNP Paribas Leasing Corporation, dated April 3, 2008.

Second Modification Agreement (Livermore Parcel 6) between Lam Research Corporation 
and BNP Paribas Leasing Corporation, dated July 9, 2008.

First Modification Agreement (Livermore Parcel 7) between Lam Research Corporation 
and BNP Paribas Leasing Corporation, dated July 9, 2008.

First Amendment to Credit Agreement between Lam Research Corporation, ABN AMRO 
B.V. and the Lenders party thereto, dated September 29, 2008.

Form of Indemnification Agreement.

Reformation of Stock Option Agreement.

Stock Option Amendment and Special Bonus Agreement.

Employment Agreement with Stephen G. Newberry, dated July 1, 2009.

Employment Agreement with Martin B. Anstice, dated July 1, 2009.

Form of Change in Control Agreement.

Employment Agreement with Ernest Maddock, dated July 1, 2009.

Subsidiaries of the Registrant.

Consent of Independent Registered Public Accounting Firm.

Power of Attorney (See Signature page)

Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Executive Officer)

Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Financial Officer)

Section 1350 Certification — (Principal Executive Officer)

Section 1350 Certification — (Principal Financial Officer)

Incorporated  by  reference  to  the  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 
April 3, 1988.

Incorporated  by  reference  to  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 
December 31, 1995.

92

(3) 

(4) 

(5) 

(6) 

Incorporated  by  reference  to  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 
December 26, 1999.

Incorporated by reference to Registrant’s Amendment No. 2 to its Annual Report on Form 10K/A for the 
fiscal year ended June 25, 2000, and Registrant’s Current Report on Form 8-K dated November 5, 2009.

Incorporated  by  reference  to  Registrant’s  Annual  Report  on  Form  10-K  for  the  fiscal  year  ended 
June 27, 2004.

Incorporated by reference to Registrant’s Registration Statement on Form S-8 (No. 33-127936) filed with 
the Securities and Exchange Commission on August 28, 2005.

(7) 

Incorporated by reference to Registrant’s Current Report on Form 8-K dated November 8, 2005.

(8) 

Incorporated by reference to Registrant’s Current Report on Form 8-K dated February 6, 2006.

(9) 

Incorporated by reference to Registrant’s Registration Statement of Form S-8 (No. 333-138545) filed with 
the Securities and Exchange Commission on November 9, 2006.

(10)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated December  15, 2006. This 

exhibit was originally filed with the 8-K as Exhibit Number 10.1.

(11)  Incorporated  by  reference  to  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 

December 24, 2006.

(12)  Incorporated  by  reference  to  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 

March 25, 2007.

(13)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated March 7, 2008.

(14)  Incorporated  by  reference  to  Registrant’s  Annual  Report  on  Form  10-K  for  the  fiscal  year  ended 

June 24, 2007.

(15)  Incorporated  by  reference  to  Registrant’s  Annual  Report  on  Form  10-K  for  the  fiscal  year  ended 

June 29, 2008.

(16)  Incorporated  by  reference  to  Registrant’s  Quarterly  Report  on  Form  10-Q  for  the  quarter  ended 

September 28, 2008.

(17)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated November 13, 2008.

(18)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated May 8, 2008.

(19)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated November 5, 2009.

(20)  Incorporated by reference to Registrant’s Current Report on Form 8-K dated July 31, 200

* 

Indicates management contract or compensatory plan or arrangement in which executive officers of the 
Company are eligible to participate.

93

(This page intentionally left blank.)

EXHIBIT 4.13

LAM RESEARCH CORPORATION 
1999 EMPLOYEE STOCK PURCHASE PLAN

Amended and Restated Effective as of May 20, 2010

1.  Purpose. 

This Amended and Restated Lam Research Corporation 1999 Employee Stock Purchase Plan (“Plan”) is 
amended and restated as of May 20, 2010. The Plan is intended to provide employees of the Company and its 
Designated Subsidiaries with an opportunity to purchase Common Stock of the Company through accumulated 
payroll deductions. The Company’s intention is to have the Plan qualify as an “employee stock purchase plan” 
under Section 423 of the Code (the “423(b) Plan”), although the Company makes no undertaking or representation 
to maintain such qualification. The provisions of the 423(b) Plan, accordingly, will be construed so as to extend 
and limit Plan participation in a uniform and nondiscriminatory basis consistent with the requirements of Section 
423(b) of the Code. In addition, this Plan document authorizes the grant of rights to purchase stock pursuant to 
rules, procedures or sub-plans adopted by the Board or Administrator that are designed to achieve tax, securities 
law or other Company compliance objectives in particular locations outside the United States.

All grants made to participants outside of the United States shall be deemed to be made under a Non-U.S. 

Sub-Plan, unless otherwise designated at the time of grant.

2.  Definitions.

(a)  “Administrator” means the Board, the Compensation Committee of the Board or any committee the 
Board may subsequently appoint to administer the Plan pursuant to Section 14 hereof, if one is appointed. If at 
any time or to any extent the Board shall not administer the Plan, then the functions of the Board specified in 
the Plan shall be exercised by the Administrator. The VP of Human Resources shall administer the Non-U.S. 
Sub-Plans of the Plan and shall be the “Administrator” for such purposes.

(b)  “Annual Increase” means the number of shares of Common Stock that, pursuant to Section 13, may 

annually be added to the number of shares issuable under the Plan.

(c)  “Board” means the Board of Directors of the Company.

(d)  “Code” means the Internal Revenue Code of 1986, as amended.

(e)  “Common Stock” means the Common Stock of the Company.

(f)  “Company” means Lam Research Corporation, a Delaware corporation.

(g)  “Compensation” means all regular, straight-time gross earnings, exclusive of payments for overtime, 

shift premium, incentive compensation, incentive payments, bonuses, commissions, or other compensation.

(h)  “Continuous Status as an Employee” means the absence of any interruption or termination of service 
as an Employee. Continuous Status as an Employee shall not be considered interrupted in the case of a leave of 
absence agreed to in writing by the Company, provided that such leave is for a period of not more than 90 days 
or re-employment upon the expiration of such leave is guaranteed by contract or statute.

(i)  “Designated  Subsidiaries”    means  the  Subsidiaries  that  have  been  designated  by  the  Board  or 

Administrator from time to time in its sole discretion as eligible to participate in this Plan.

(j)  “Employee” means any person, including an officer or an employee member of the Board of Directors, 
who is customarily employed for at least 20 hours per week by the Company or one of its Designated Subsidiaries. 
For purposes of the 423(b) Plan, whether an individual qualifies as an Employee shall be determined by the 
Administrator, in its sole discretion, by reference to Section 3401(c) of the Code and the regulations promulgated 
thereunder. Unless the Administrator makes a contrary determination, the Employees of the Company shall, for 
all purposes of the 423(b) Plan, be those individuals who satisfy the customary employment criteria set forth 
above and are carried as employees by the Company or a Designated Subsidiary for regular payroll purposes. 

For purposes of a Non U.S. Sub-Plan, the Administrator may determine that Employees are eligible to participate 
even if they are employed for less than twenty (20) hours per week if, in the Administrator’s sole judgment, 
applicable laws require such a determination.

(k)  “Exercise  Date”  means  such  business  days  during  each  Offering  Period  of  this  Plan  as  may  be 

identified by the Administrator pursuant to Section 8 of this Plan.

(l)  “Interim Offering Date” means the first business day following an Exercise Date other than the last 

Exercise Date of an Offering Period.

(m) “Maximum Share Amount” means the maximum number of shares of Common Stock that a Participant 

can purchase during any single Offering Period as set forth in Section 3(d)(ii) of this Plan.

(n)  “Non-U.S. Sub-Plan” shall mean a sub-plan of the Plan that does not necessarily meet the requirements 

set forth in Section 423(b) of the Code, as amended.

(o)  “Offering Date” means the first business day of an Offering Period.

(p)  “Offering  Period”  means  a  period  established  by  the  Administrator  pursuant  to  Section  4  of  this 
Plan  during  which  payroll  deductions  are  accumulated  from  Participants  and  applied  to  the  purchase  of 
Common Stock.

(q)  “Participant”  means  an  Employee  who  has  elected  to  participate  in  this  Plan  pursuant  to 

Section 5 hereof.

(r)  “Plan” means this Amended and Restated Lam Research Corporation 1999 Employee Stock Purchase 

Plan, including both the 423(b) Plan and any Non-U.S. Sub-Plan unless otherwise indicated.

(s)  “Purchase  Right”  means  a  right  to  purchase  Common  Stock  granted  pursuant  to  Section  7  of 

this Plan.

(t)  “Subsidiary”  means  a  corporation,  domestic  or  foreign,  of  which  not  less  than  50%  of  the  voting 
shares  are  held  by  the  Company  or  a  Subsidiary,  whether  or  not  such  corporation  now  exists  or  is  hereafter 
organized or acquired by the Company or a Subsidiary.

(u)  “423(b)  Plan”  means  an  employee  stock  purchase  plan  that  is  designed  to  meet  the  requirements 
set forth in Section 423(b) of the Code, as amended. The provisions of this 423(b) Plan should be construed, 
administered and enforced in accordance with Section 423(b) of the Code.

3.  Eligibility; Accrual and Purchase Limits.

(a)  Regular Participation. Any person who is, or will be, an Employee on the Offering Date of a given 
Offering Period shall be eligible to participate in this Plan during such Offering Period, subject to the requirements 
of Section 5(a) of this Plan.

(b)  Interim Participation. Any person who becomes an Employee after the Offering Date of an Offering 
Period and before an Interim Offering Date shall be eligible to participate in this Plan during such Offering 
Period, but only on and beginning with the first Interim Offering Date on or before which such person becomes 
an Employee, and subject to the requirements of Section 5(a) of this Plan.

(c)  Exclusion of Five Percent Stockholders. Notwithstanding paragraphs (a) and (b) of this Section 3, an 
Employee shall not be eligible to participate in this Plan during an Offering Period to the extent that immediately 
after the grant of a Purchase Right on an Offering Date or Interim Offering Date, the Employee (or any other 
person whose stock would be attributed to the Employee under Section 424(d) of the Code) would own stock 
and/or hold outstanding purchase rights to purchase stock possessing five percent or more of the total combined 
voting power or value of all classes of stock of the Company or of any Subsidiary.

(d)  Accrual and Purchase Limits. Notwithstanding any other provisions of this Plan or any subscription 
agreement or other offering documents, no Participant may (i) accrue rights to purchase stock under all employee 
stock purchase plans of the Company and its Subsidiaries at a rate that exceeds $25,000 of fair market value of 
such stock (determined at the date of grant of those purchase rights) for each calendar year in which the purchase 

2

rights would be outstanding at any time; or (ii) purchase more than 10,000 shares of the Company’s Common 
Stock during any Offering Period. Notwithstanding the share limit described in clause 3(d)(ii), the Administrator 
may designate an alternative shares limit (other than zero) in its sole discretion, prior to the commencement of 
any Offering Period to which the alternative limit applies. If the Administrator establishes an alternative limit, 
all participants shall be notified of the alternative limit prior to the commencement of the Offering Period to 
which the limit first applies. Any alternative limit set by the Administrator shall continue to apply with respect 
to all succeeding Exercise Dates and Offering Periods unless revised by the Administrator as provided in this 
clause 3(d)(ii).

4.  Offering Periods.

The duration of each Offering Period shall be determined by the Administrator, provided that an Offering 
Period shall be no shorter than 3 months and no longer than 24 months (measured from the first business day 
of  the  first  month  to  the  last  business  day  of  the  last  month)  and  succeeding  Offering  Periods  shall  be  the 
same  duration  unless  otherwise  determined  by  the  Administrator  pursuant  to  this  Section.  Unless  otherwise 
determined by the Administrator:

(a)  a  new  Offering  Period  shall  begin  on  the  first  business  day  after  the  last  Exercise  Date  of  an 

Offering Period;

(b)  a new Offering Period shall begin, and the old Offering Period shall terminate, on the first business 
day after an Exercise Date (other than the last Exercise Date of an Offering Period) if the fair market value (as 
defined in Section 7(b)(i) of this Plan) of a share of Common Stock is less than the fair market value of a share 
of Common Stock on the Offering Date of the Offering Period; and

(c)  an Offering Period shall terminate on the date that there are no Participants enrolled in it.

5.  Participation.

(a)  An Employee may become a Participant in this Plan by completing a subscription agreement, in such 
form or forms as the Administrator may approve from time to time, and filing it with the Company’s payroll 
office within 15 days before the applicable Offering Date or Interim Offering Date, unless another time for filing 
the subscription agreement is set by the Administrator for all Employees with respect to a given Offering Period. 
The subscription agreement shall authorize payroll deductions pursuant to this Plan and shall have such other 
terms as the Administrator may specify from time to time.

(b)  At the end of an Offering Period, each Participant in the Offering Period who remains an Employee 
shall be automatically enrolled in the next succeeding Offering Period (a “Re-enrollment”) unless, in a manner 
and  at  a  time  specified  by  the  Administrator,  but  in  no  event  later  than  the  day  before  the  Offering  Date  of 
such succeeding Offering Period, the Participant notifies the Administrator in writing that the Participant does 
not wish to be re-enrolled. Re-enrollment shall be at the withholding percentage specified in the Participant’s 
most recent subscription agreement unless the Participant changes that percentage by timely written notice. No 
Participant shall be automatically re-enrolled whose participation has terminated by operation of Section 10 of 
this Plan.

(c)  If an Offering Period commences pursuant to Section 4(b) of this Plan, each Employee on the Offering 
Date  of  that  Offering  Period  shall  automatically  become  a  Participant  in  the  commencing  Offering  Period. 
Participation  shall  be  at  the  withholding  percentage  specified  in  the  Participant’s  most  recent  subscription 
agreement,  unless  the  Participant  notice  changes  that  percentage  by  timely  written  notice.  If  the  Participant 
has  no  subscription  agreement  on  file,  Participation  shall  be  at  a  0%  withholding  rate  until  changed  by  the 
Participant. No Participant shall be automatically re-enrolled whose participation has terminated by operation of 
Section 11 of this Plan.

3

6.  Payroll Deductions.

(a)  Each  Participant  shall  have  withheld  a  percentage  of  his  or  her  Compensation  received  during  an 
Offering Period. Withholding shall be in whole percentages, up to a maximum (not to exceed 15%) established 
by the Administrator from time to time, as specified by the Participant in his or her subscription agreement. 
Payroll deductions for a Participant during an Offering Period shall begin with the first payroll following the 
Offering Date or Interim Offering Date and shall end on the last Exercise Date of the Offering Period, unless 
sooner terminated by the Participant as provided in Section 11 of this Plan.

(b)  All payroll deductions made by a Participant shall be credited to the Participant’s account under this 

Plan. A Participant may not make any additional payments into such account.

(c)  A Participant may change the rate of his or her payroll deductions during an Offering Period by filing 
with  the  Administrator  a  new  subscription  agreement  authorizing  the  change.  The  change  shall  take  effect 
15 days after the Administrator’s receipt of the new subscription agreement, except that increases in rate shall 
take effect on the day after the first Exercise Date on or after the 15th day.

7.  Purchase Rights.

(a)  Grant  of  Purchase  Rights.  On  the  Offering  Date,  or  (if  applicable)  Interim  Offering  Date  of  each 
Offering Period, the Participant shall be granted a Purchase Right to purchase (at the per-share price) during the 
Offering Period up to the lesser of (a) the number of shares of Common Stock determined by dividing (i) $25,000 
multiplied by the number of (whole or part) calendar years in the Offering Period by (ii) the fair market value of 
a share of Common Stock on the Offering Date or Interim Offering Date; or (b) the Maximum Share Amount.

(b)  Terms  of  Purchase  Rights.  Except  as  otherwise  determined  by  the  Administrator,  each  Purchase 

Right shall have the following terms:

(i)  The per-share price of the shares subject to a Purchase Right shall be 85% of the lower of the fair 
market values of a share of Common Stock on (a) the Offering Date, or Interim Offering Date, 
on which the Purchase Right was granted and (b) the Exercise Date. The fair market value of the 
Common Stock on a given date shall be the closing price as reported in the Wall Street Journal; 
provided, however, that if there is no public trading of the Common Stock on that date, then fair 
market value shall be determined by the Administrator in its discretion.

(ii)  Payment for shares purchased by exercise of Purchase Rights shall be made only through payroll 

deductions in accordance with Section 6 of this Plan.

(iii)  Upon purchase or disposition of shares acquired by exercise of a Purchase Right, the Participant 
shall  pay,  or  make  provision  adequate  to  the  Administrator  for  payment  of,  all  tax  (and 
similar)  withholdings  that  the  Administrator  determines,  in  its  discretion,  are  required  due 
to  the  acquisition  or  disposition,  including  without  limitation  any  such  withholding  that  the 
Administrator determines in its discretion is necessary to allow the Company and its Subsidiaries 
to claim tax deductions or other benefits in connection with the acquisition or disposition.

(iv)  During his or her lifetime, a Participant’s Purchase Right is exercisable only by the Participant.

(v)  The Purchase Rights will in all respects be subject to the terms and conditions of this Plan, as 

interpreted by the Administrator from time to time.

8.  Exercise Dates; Purchase of Shares; Refund of Excess Cash.

(a)  The Administrator shall establish one or more Exercise Dates for each Offering Period.

(b)  Each Participant’s Purchase Right shall be exercised automatically on each Exercise Date during the 
Offering  Period  to  purchase  the  maximum  number  of  full  shares  up  to  the  Maximum  Share  Amount  at  the 
applicable price using the Participant’s accumulated payroll deductions.

4

(c)  The  shares  purchased  upon  exercise  of  a  Purchase  Right  shall  be  deemed  to  be  transferred  to  the 
Participant  on  the  Exercise  Date.  A  Participant  will  have  no  interest  or  voting  right  in  shares  covered  by  a 
Purchase Right until the Purchase Right has been exercised.

(d)  Any cash remaining in a Participant’s payroll deduction account after the purchase of shares on an 
Exercise Date shall be carried forward in that account for application on the next Exercise Date; provided that at 
the termination of an Offering Period, any such cash shall be promptly refunded returned to the Participant.

9.  Limitations on Aggregate Shares to be Purchased.

If the number of shares to be purchased on an Exercise Date by all Participants in this Plan exceeds the 
number of shares then available for issuance under this Plan, then the Company shall make a pro rata allocation 
of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Administrator shall 
determine to be equitable. In such event, the Company shall give written notice of such reduction of the number 
of shares to be purchased under a participant’s option to each participant affected.

10. Registration and Delivery of Share Certificates.

(a)  Shares purchased by a Participant under this Plan will be registered in the name of the Participant, or 
in the name of the Participant and his or her spouse, or in the name of the Participant and joint tenant(s) (with 
right of survivorship), as designated by the Participant.

(b)  As  soon  as  administratively  feasible  after  each  Exercise  Date,  the  Company  shall  deliver  to  the 
Participant a certificate representing the shares purchased upon exercise of a Purchase Right. If approved by the 
Administrator in its discretion, the Company may instead (i) deliver a certificate (or equivalent) to a broker for 
crediting to the Participant’s account or (ii) make a notation in the Participant’s favor of non-certificated shares 
on the Company’s stock records.

11.  Withdrawal; Termination of Employment.

(a)  A Participant may withdraw all, but not less than all, of the payroll deductions credited to his account 
under this Plan at any time before an Exercise Date by giving written notice to the Administrator in a form the 
Administrator prescribes from time to time. The Participant’s Purchase Right will automatically terminate on 
the date of receipt of the notice, all payroll deductions credited to the Participant’s account will be refunded 
promptly thereafter, and no further payroll deductions will be made during the Offering Period.

(b)  Upon  termination  of  a  Participant’s  Continuous  Status  as  an  Employee  for  any  reason,  including 
retirement or death, the payroll deductions credited to the Participant’s account will be promptly refunded to the 
Participant or, in the case of death, to the person or persons entitled thereto under Section 15 of this Plan, and the 
Participant’s Purchase Right will automatically terminate.

(c)  If a Participant fails to remain in Continuous Status as an Employee during an Offering Period, the 
Participant will be deemed to have withdrawn from this Plan, the payroll deductions credited to the Participant’s 
account will be promptly refunded, and the Participant’s Purchase Right shall terminate.

(d)  A Participant’s withdrawal from an offering will not affect the Participant’s eligibility to participate in 

a succeeding Offering Period or in any similar plan that may be adopted by the Company.

12. Use of Funds; No Interest.

Amounts withheld from Participants’ Compensation under this Plan shall constitute general funds of the 
Company and may be used for any corporate purpose, and the Company shall not be obligated to segregate such 
payroll deductions. No interest shall accrue on the payroll deductions of a Participant in this Plan.

5

13. Number of Shares Reserved.

(a)  Subject to adjustment as provided in Section 18, the maximum aggregate number of shares of Common 
Stock which shall be made available for sale under the Plan shall be 9,000,0001 shares herein, consisting of the 
following:

(i) 

3,000,0001 shares may be issued at any time before termination of this Plan from the number of 
authorized and previously unissued shares of Common Stock of the Company; and

(ii)  an additional share (up to a total of 6,000,0001 additional shares) may be issued for each share of 
Common Stock that the Company redeems, in public-market or private purchases, and designates 
for this purpose after the date of Board approval of this Plan.

(b)  Subject to adjustment as provided in Section 18, the number of shares that may be issued, on a one-for-
one basis, for each share of Common Stock that the Company redeems, in public-market or private purchases, 
and designates for this purpose shall be increased on the first business day of each calendar year commencing 
with 2004 by a number of shares equal to the lesser of (i) 2,000,0002 , (ii) one and one-half percent (1.5%) of 
the number of shares of all classes of common stock of the Company outstanding on the first business day of 
such  calendar  year,  or  (iii)  a  lesser  number  determined  by  the  Administrator,  (the  “Annual  Increase”).  The 
Administrator may, in its discretion, transfer shares reserved for issuance under this Plan into a plan of similar 
terms,  as  approved  by  the  Board,  providing  for  the  purchase  of  shares  of  Common  Stock  by  employees  of 
Subsidiaries designated by the Board that do not (or do not thereafter) participate in this plan. Such plan may, 
without limitation, provide for variances from the terms of this Plan to take into account special circumstances 
(such as foreign legal restrictions) affecting the employees of such designated Subsidiaries.

14. Administration.

This Plan shall be administered by the Administrator. The administration, interpretation, and application 
of this Plan by the Administrator shall be final, conclusive, and binding upon all persons. Neither Members of 
the Board nor the Administrator shall be liable for any action or determination taken or made in good faith with 
respect to the Plan, or any shares purchased or issued or Purchase Right exercised thereunder . The Administrator 
may also adopt rules, procedures or sub-plans applicable to particular Subsidiaries or locations. Any such sub-
plans may be designed to be outside the scope of Section 423(b) of the Code. The rules of such sub-plans may 
take precedence over other provisions of this Plan, but unless otherwise superseded by the specific terms of 
such sub-plan, the provisions of this Plan shall govern the operation of such sub-plan. To the extent inconsistent 
with the requirements of Section 423(b), such sub-plan and rights granted thereunder shall not be considered to 
comply with Section 423(b) of the Code.

15. Designation of Beneficiary.

(a)  A Participant may file a written designation of a beneficiary who is to receive any shares and cash, if 

any, from the Participant’s account under this Plan in the event of the Participant’s death.

(b)  A designation of beneficiary may be changed by the Participant at any time by written notice. In the 
event of the death of a Participant, and in the absence of a beneficiary validly designated under this Plan who 
is living at the time of the Participant’s death, the Administrator shall deliver such shares and/or cash to the 
executor or administrator of the Participant’s estate, or if no such executor or administrator has been appointed 
(to the Administrator’s knowledge), the Administrator, in its discretion, may deliver such shares and/or cash to 
the spouse or to any one or more dependents or relatives of the Participant or, if no spouse, dependent, or relative 
is known to the Administrator, then to such other person as the Administrator may designate.

1 

2 

Number has been adjusted to account for Lam’s March 2000 three-for-one stock split.

Provision added to Plan pursuant to November 2003 amendment and restatement. Therefore, no adjustment 
for March 2000 stock split required. This number is, however, subject to adjustment upon future changes 
to capitalization pursuant to Section 18.

6

16. Transferability.

Neither payroll deductions credited to a Participant’s account nor any rights with regard to the exercise of a 
Purchase Right or to receive shares under this Plan may be assigned, transferred, pledged, or otherwise disposed 
of in any way (other than by will, the laws of descent and distribution, or as provided in Section 15 hereof) by 
the Participant. Any such attempt at assignment, transfer, pledge, or other disposition shall be without effect, 
except that the Administrator may treat such act as an election to withdraw funds in accordance with Section 11 
hereof.

17.  Reports.

Individual accounts will be maintained for each Participant in this Plan. Statements of account will be 
given to participating Employees promptly following each Exercise Date, which statements will set forth the 
amounts of payroll deductions, the per share purchase price, the number of shares purchased and the remaining 
cash balance, if any.

18. Adjustments upon Changes in Capitalization.

(a)  Subject to any required action by the stockholders of the Company, the number of shares of Common 
Stock covered by each Purchase Right under this Plan that has not yet been exercised and the number of shares 
of Common Stock that have been authorized for issuance under this Plan but have not yet been placed under 
a Purchase Right, including, but not limited to, the Annual Increase (collectively, the “Reserves” ), as well as 
the price per share of Common Stock covered by each Purchase Right under this Plan that has not yet been 
exercised,  shall  be  proportionately  adjusted  for  any  increase  or  decrease  in  the  number  of  issued  shares  of 
Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of 
the Common Stock, or any other increase or decrease in the number of shares of Common Stock effected without 
receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the 
Company and any repurchase of shares of Common Stock pursuant to Section 13 herein shall not be deemed 
to have been “effected without receipt of consideration.” Such adjustment shall be made by the Administrator, 
whose determination shall be final, binding, and conclusive. Except as expressly provided herein, no issue by the 
Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, 
and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common 
Stock subject to a Purchase Right.

(b)  In  the  event  of  the  proposed  dissolution  or  liquidation  of  the  Company,  the  then-current  Offering 
Period will terminate immediately before the consummation of such proposed action, unless otherwise provided 
by the Board or the Administrator (if the Administrator is not the Board). In the event of a proposed sale of all 
or substantially all of the assets of the Company, or the merger of the Company with or into another corporation 
(if stockholders of the Company own less than 50% of the total outstanding voting power in the surviving entity 
or a parent of the surviving entity after the merger), each Purchase Right under this Plan shall be assumed or 
an equivalent purchase right shall be substituted by the successor corporation or a parent or subsidiary of the 
successor  corporation,  unless  the  successor  corporation  does  not  agree  to  assume  the  Purchase  Right  or  to 
substitute  an  equivalent  purchase  right,  in  which  case  the  Administrator  may,  in  lieu  of  such  assumption  or 
substitution, accelerate the exercisability of Purchase Rights, and allow Purchase Rights to be exercisable (if the 
Board approves) as to shares as to which the Purchase Right would not otherwise be exercisable, on terms and 
for a period that the Administrator determines in its discretion. To the extent that the Administrator accelerates 
exercisability of Purchase Rights as described above, it shall promptly so notify all Participants in writing.

(c) The Administrator may, in its discretion, also make provision for adjusting the Reserves, as well as 
the  price  per  share  of  Common  Stock  covered  by  each  outstanding  Purchase  Right,  if  the  Company  effects 
one or more reorganizations, recapitalizations, rights offerings, or other increases or reductions of shares of its 
outstanding Common Stock, or if the Company consolidates with or merges into any other corporation.

7

19. Amendment or Termination.

(a)  The Board may at any time terminate or amend in any manner this Plan; except, however, that no 
amendment may be made without prior approval of the stockholders of the Company (obtained in the manner 
described in paragraph 21) if it would:

(i) 

Increase the number of shares that may be issued under this Plan;

(ii)  Change the designation of the employees (or class of employees) eligible for participation in this 

Plan; or

(iii)  If  the  Company  has  a  class  of  equity  securities  registered  under  Section  12  of  the  Securities 
Exchange  Act  of  1934,  as  amended  (the  “Exchange  Act”),  at  the  time  of  such  amendment, 
materially increase the benefits that may accrue to Participants under this Plan.

If any amendment requiring stockholder approval under this paragraph 19 of this Plan is made after the 
first registration of any class of equity securities by the Company under Section 12 of the Exchange Act, such 
stockholder approval shall be solicited as described in paragraph 21 of this Plan.

(b)  The Board may elect to terminate any or all outstanding Purchase Rights at any time, except to the 
extent that exercisability of such Purchase Rights has been accelerated pursuant to Section 18(b) hereof. If this 
Plan is terminated, the Board may also elect to terminate Purchase Rights upon completion of the next purchase 
of shares on the next Exercise Date or to permit Purchase Rights to expire in accordance with their terms (with 
participation to continue through such expiration dates). If Purchase Rights are terminated before expiration, 
any funds contributed to this Plan that have not been used to purchase shares shall be refunded to Participants as 
soon as administratively feasible.

20. Notices.

All notices or other communications by a Participant to the Company or the Administrator under or in 
connection with this Plan shall be deemed to have been duly given when received in the form specified by the 
Administrator at the location, or by the person, designated by the Administrator for the receipt thereof.

21.  Stockholder Approval.

(a)  Any required approval of the stockholders of the Company pursuant to paragraph 19(a) of this Plan 
shall be solicited substantially in accordance with Section 14(a) of the Exchange Act and the rules and regulations 
promulgated thereunder.

(b)  If any required approval by the stockholders of this Plan itself or of any amendment thereto is solicited 
at  any  time  otherwise  than  in  the  manner  described  in  Section  21(a)  hereof,  then  the  Company  shall,  at  or 
before the first annual meeting of stockholders held after the later of (i) the first registration of any class of 
equity securities of the Company under Section 12 of the Exchange Act or (ii) the granting of a Purchase Right 
hereunder to an Officer and Director after such registration, do the following:

(i) 

furnish in writing to the holders entitled to vote for this Plan substantially the same information 
that would be required (if proxies to be voted with respect to approval or disapproval of this Plan 
or amendment were then being solicited) by the rules and regulations in effect under Section 
14(a) of the Exchange Act at the time such information is furnished; and

(ii) 

file with, or mail for filing to, the Securities and Exchange Commission four copies of the written 
information referred to in subsection (i) hereof not later than the date on which such information 
is first sent or given to stockholders.

22. Conditions upon Issuance of Shares.

(a)  Shares shall not be issued with respect to a Purchase Right unless the exercise of such Purchase Right 
and  the  issuance  and  delivery  of  such  shares  pursuant  thereto  shall  comply  with  all  applicable  provisions  of 
law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the Securities 

8

Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of 
any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of 
counsel for the Company with respect to such compliance.

(b)  As a condition to the exercise of a Purchase Right, the Company may require the person exercising 
such Purchase Right to represent and warrant at the time of any such exercise that the shares are being purchased 
only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel 
for the Company, such a representation is required by any of the aforementioned applicable provisions of law.

23. Term of Plan.

This Plan shall become effective upon the earlier to occur of its adoption by the Board of Directors or its 
approval by the stockholders of the Company as described in Section 21 hereof. It shall continue in effect for a 
term of 20 years unless sooner terminated under Section 19 hereof.

24. Additional Restrictions of Rule 16b-3.

The terms and conditions of Purchase Rights granted hereunder to, and the purchase of shares by, persons 
subject to Section 16 of the Securities Exchange Act of 1934 shall comply with the applicable provisions of Rule 
16b-3 of such Act. This Plan shall be deemed to contain, and such Purchase Rights shall contain, and the shares 
issued upon exercise thereof shall be subject to, such additional conditions and restrictions as may be required 
by Rule 16b-3 to qualify for the maximum exemption from Section 16 of the Securities Exchange Act of 1934 
with respect to Plan transactions.

9

EXHIBIT 4.14

LAM RESEARCH CORPORATION 
2004 EXECUTIVE INCENTIVE PLAN

Amended and Restated
Effective as of May 20, 2010

The Compensation Committee (the “Compensation Committee”) of the Board of Directors of Lam Research 
Corporation (“Company”) hereby adopts this amended and restated version of the 2004 Executive Incentive Plan 
(“Plan”), effective as of May 20, 2010.

1.  Purpose.

The  purpose  of  the  Plan  is  to  provide  performance-based  incentive  compensation  in  the  form  of  cash 
payments or stock awards to executive officers and senior management of the Company and any affiliates which 
might subsequently adopt the Plan. The Plan is intended to qualify as performance-based compensation under 
Section 162(m) of the Internal Revenue Code (“Section 162(m)”).

2.  Administration.

The  Plan  has  been  established  by,  and  shall  be  administered  by,  the  Compensation  Committee.  The 
Compensation Committee is composed solely of 2 or more outside directors as defined in Section 162(m) and, 
therefore, qualifies as an independent compensation committee under Section 162(m).

3.  Stockholder Approval.

The Plan shall initially be effective if, and only if, the Company’s stockholders, by a majority of the votes 
considered present or represented and entitled to vote with respect to this matter, approve the material terms 
of the Plan, specifically, the employees eligible to receive compensation under the Plan; the business criteria 
on which the performance goals may be based; and the maximum amount of compensation that may be paid 
to  any  employee  under  the  Plan  in  any  year.  No  compensation  or  award  will  be  paid  and  vested  under  the 
Plan until after this approval is obtained. To the extent necessary for the Plan to qualify as performance-based 
compensation under Section 162(m) or its successor under then applicable law, these material terms of the Plan 
shall be disclosed to and reapproved by the stockholders no later than the first stockholder meeting that occurs 
in the fifth year following the year in which stockholders previously approved the material terms of the Plan.

4.  Participants.

For each measurement period (which may but need not be a fiscal year), the Compensation Committee will 
choose, in its sole discretion, those eligible employees who will participate in the Plan during that measurement 
period and will be eligible to receive payment under the Plan for that measurement period.

a) 

b) 

 Eligible  Employees.  Persons  who  are  eligible  to  participate  in  the  Plan  are  all  members  of  senior 
management of the Company and its affiliates. For purposes of the Plan, senior management is defined 
as any officer who is subject to the reporting rules of Section 16(a) of the Securities Exchange Act of 
1934, or who is designated as eligible for the Plan by the Compensation Committee in its discretion.

 Employment Criteria. In general, to participate in the Plan an eligible employee must be continuously 
employed  by  the  Company  or  an  affiliate  for  the  entire  measurement  period.  The  foregoing 
notwithstanding: (i) if an otherwise eligible employee joins the Company or an affiliate during the 
measurement period, the Compensation Committee may, in its discretion, add the employee to the Plan 
for the partial measurement period, and (ii) if the employment of an otherwise eligible employee ends 
before the end of the measurement period because of death, disability or termination of employment 
(as determined in the discretion of the Compensation Committee), the employee shall be paid a pro-
rata portion of the compensation, if any, that otherwise would have been payable under the Plan based 
upon the actual achievement of the performance goals applicable during the measurement period in 

Page 1 of 5

which termination of employment occurs, unless the Committee determines in its sole discretion that 
payment is not appropriate. If a participant is on unpaid leave status for any portion of the measurement 
period, the Compensation Committee, in its discretion, may reduce the participant’s payment on a pro-
rata basis.

 All determinations under the Plan, including those related to interpretation of the Plan, eligibility, or 
the payment or pro-ration of any payment shall be made by the Compensation Committee pursuant to 
the above terms, and those determinations shall be final and binding on all employees.

5.  Awards.

The Compensation Committee shall determine the size and terms of an individual award that can be made 
in cash or stock. Stock awards may be made from and in such forms permitted under any stock option, equity 
incentive or similar plan adopted by the Company’s Board of Directors and approved by its stockholders. The 
stock  awards  shall  be  granted  and/or  vested  based  upon  the  attainment  of  performance  goals  as  set  forth  in 
Section 6.

6.  Business Criteria on Which Performance Goals Shall be Based.

Payment under the Plan shall be based on the Company’s attainment of performance goals based on one or 
more of the following business criteria: Either individually, alternatively or in any combination, applied to either 
the Company as a whole or to a business unit, affiliate or business segment, either individually, alternatively or 
in any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or 
relative to a pre-established target, to previous years’ results or to a designated comparison group, in each case 
as specified by the Compensation Committee in the award, and may include actual, growth, or performance-to-
target for: (i) cash flow, including free cash flow; (ii) earnings (including revenue, gross margin, operating profit, 
earnings before interest and taxes, earnings before taxes, and net earnings) or earnings per share; (iii) stock price; 
(iv) return on equity or average shareholders’ equity; (v) total stockholder return, either actual or relative to share 
price or market capitalization; (vi) return on capital; (vii) return on assets or net assets; (viii) return on investment 
or invested capital; (ix) return on operating revenue; (x) income, net income, operating income, net operating 
income,  operating  profit,  net  operating  profit,  or  operating  margin  (with  or  without  regard  to  amortization/
impairment of goodwill); (xi) market share or applications won; (xii) operational performance, including orders, 
backlog, deferred revenues, revenue per employee, overhead, days sales outstanding, inventory turns, or other 
expense levels; (xiii) stockholder value or return relative to the moving average of the S&P 500 Index or a peer 
group index; (xiv) asset turns; and (xv) strategic plan development and implementation (including individually 
designed goals and objectives that are consistent with the participant’s specific duties and responsibilities and 
that are designed to improve the organizational performance of the Company, an affiliate, or a specific business 
unit  thereof  and  that  are  consistent  with  and  derived  from  the  strategic  operating  plan  of  the  Company,  an 
affiliate or any of their business units for the applicable performance period). The Compensation Committee may 
appropriately adjust any evaluation of performance under the business criteria to exclude any of the following 
events  that  occurs  during  a  performance  period:  (A)  asset  write-downs;  (B)  litigation  or  claim  judgments  or 
settlements; (C) the effect of changes in tax law, accounting principles or other such laws or provisions affecting 
reported results; (D) accruals for reorganization and restructuring programs; and (E) any extraordinary non-
recurring items as described in Accounting Principles Board Opinion No. 30 and/or in management’s discussion 
and  analysis  of  financial  condition  and  results  of  operations  appearing  in  the  Company’s  annual  report  to 
shareholders for the applicable year.

7.  Establishing Performance Goals.

The Compensation Committee shall establish, for each measurement period:

a) 

the length of the measurement period;

b) 

the specific business criterion or criteria, or combination thereof, that will be used;

c) 

the specific performance targets that will be used for the selected business criterion or criteria;

Page 2 of 5

 
d) 

e) 

 any special adjustments that will be applied in calculating whether the performance targets have been 
met to factor out extraordinary items;

 the  formula  for  calculating  compensation  eligible  for  payment  under  the  Plan  in  relation  to  the 
performance targets;

f) 

the eligible employees who will participate in the Plan for that measurement period; and

g) 

if applicable, the target amounts for each participant for the measurement period.

The  Compensation  Committee  shall  make  these  determinations  in  writing  no  later  than  90  days  after 
the  start  of  each  measurement  period,  on  or  before  25%  of  the  measurement  period  has  elapsed,  and  while 
the outcome is substantially uncertain. Cash awards paid to any one participant under the Plan in respect of 
performance goals for any twelve-month measurement period shall not exceed $15,000,000; provided however 
that (a) in the event a measurement period of longer or shorter duration than twelve-months, this limit will be 
increased or decreased, respectively, on a proportionate basis; and (b) receipt by a participant of payment until 
a later period of an award amount earned with respect to a measurement period, either through elective deferral 
by the participant or a deferral included as part of the award structure, shall not affect application of the above 
cash limit to the participant during the later period. Stock awards or restricted stock unit awards granted to any 
one participant in any one calendar year (which may vest over multiple years) under the Plan shall not exceed 
300,000 shares of the Company’s common stock. The 300,000 shares shall be adjusted in the discretion of the 
Compensation Committee in the event of stock dividend, stock split, extraordinary cash dividend, or similar 
recapitalization of the Company.

If  an  employee  joins  the  Company  or  an  affiliate  during  the  measurement  period  and  becomes  an 
eligible employee pursuant to Paragraph 4(b), and if the employee is a “covered employee” within the meaning 
of  Section  162(m),  then  to  the  extent  necessary  for  the  Plan  to  qualify  as  performance-based  compensation 
under Section 162(m) or its successor under then applicable law, all relevant elements of the performance goals 
established pursuant to paragraph 6 of this Plan for that employee must be established on or before the date on 
which 25% of the time from the commencement of employment to the end of the measurement period has elapsed, 
and the outcome under the performance goals for the measurement period must be substantially uncertain at the 
time those elements are established.

8.  Determination of Attainment of Performance Goals.

The  Compensation  Committee  shall  determine,  pursuant  to  the  performance  goals  and  other  elements 
established pursuant to section 6 of the Plan, the amounts to be paid to each employee for each measurement 
period or the extent to which awards have vested. The Compensation Committee’s determinations shall be final 
and binding on all participants. However, with respect to the Chief Executive Officer and Executive Chairman, 
the  Company’s  outside  directors  shall  be  entitled  (but  are  not  required)  to  review  and  approve  (by  majority 
vote) the Compensation Committee’s determination. These determinations must be certified in writing before 
payments are made, which requirement may be satisfied by approved minutes of the Compensation Committee 
meeting setting out the determinations made. The Compensation Committee shall not have discretion to increase 
the amount of an award or accelerate the vesting of an award to any employee who is a “covered employee” within 
the meaning of Section 162(m) if such action would cause the award or any part thereof to not be deductible 
under the Internal Revenue Code. The Compensation Committee may exercise negative discretion in a manner 
consistent with Section 162(m).

9.  Amendments.

The Compensation Committee may not amend or terminate the Plan so as to increase, reduce or eliminate 
awards under the Plan for any given measurement period retroactively, that is, on any date later than 90 days 
after the start of the measurement period. The Compensation Committee may amend or terminate the Plan at any 
time on a prospective basis and/or in any fashion that does not increase, reduce or eliminate awards retroactively. 
The foregoing notwithstanding, except as required by applicable law, the Compensation Committee shall not 
have the power to amend the Plan in any fashion that would cause the Plan to fail to qualify as performance-
based compensation with respect to any “covered employee” as defined under Section 162(m) or its successor. 

Page 3 of 5

Without  limiting  the  generality  of  the  foregoing,  to  the  extent  it  would  cause  the  Plan  to  fail  to  qualify  as 
performance-based  compensation  with  respect  to  any  “covered  employee”  as  defined  under  Section  162(m) 
or its successor under then applicable law, the Compensation Committee shall not have the power to change 
the material terms of the performance goals unless (i) the modified performance goals are established by the 
Compensation  Committee  no  later  than  90  days  after  the  start  of  the  applicable  measurement  period,  on  or 
before 25 percent of the measurement period has elapsed, and while the outcome is substantially uncertain; and 
(ii) no payments are made under the modified performance goals until after the material terms of the modified 
performance goals are disclosed to and approved by the Company’s stockholders.

10. Time and Form of Payment. 

All payments in respect of awards granted under this Plan shall be made in cash on or before March 15th 
of  the  year  following  the  year  in  which  the  measurement  period  ends.  The  Committee  may  also  provide  for 
payment in the form of shares or share awards as provided in Section 5.

11.  Section 409A of the Code. 

Awards  under  the  Plan  are  intended  to  comply  with  Section  409A  of  the  Code  and  all  awards  shall  be 
interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other 
interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that 
may be issued after the effective date of the Plan. Notwithstanding any provision of the Plan or any Award to the 
contrary, in the event that the Committee determines that any Award may or does not comply with Section 409A 
of the Code, the Company may adopt such amendments to the Plan and the affected Award (without employee 
consent) or adopt other policies and procedures (including amendments, policies and procedures with retroactive 
effect), or take any other actions, that the Compensation Committee determines are necessary or appropriate to 
(i) exempt the Plan and any award from the application of Section 409A of the Code and/or preserve the intended 
tax treatment of the benefits provided with respect to Award, or (ii) comply with the requirements of Section 
409A of the Code.

Notwithstanding any provisions of this Plan to the contrary, if an employee is a “specified employee” (within 
the meaning of Section 409A of the Code and determined pursuant to policies adopted by the Company) on his 
or her date of separation from service and if any portion of an award to be received by the employee upon his 
or her separation from service would be considered deferred compensation under Section 409A of the Code, 
amounts of deferred compensation that would otherwise be payable pursuant to this Plan during the six-month 
period immediately following the employee’s separation from service will instead be paid or made available 
on the earlier of (i) the first day of the seventh month following the date of the Participant’s separation from 
service and (ii) the employee’s death. In the event that payments are delayed pursuant to this section, then such 
payments shall be paid at the time specified in this section without interest. The Company shall consult with 
the employee in good faith regarding the implementation of the provisions of this section, provided that neither 
the Company nor any of its employees or representatives shall have any liability to the employee with respect 
thereto.  Any  amount  under  this  program  that  satisfies  the  requirements  of  the  “short-term  deferral”  rule  set 
forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute a deferred payment for purposes 
of  this  Plan.  Any  amounts  scheduled  for  payment  hereunder  when  they  are  ordinarily  paid,  will  nonetheless 
be  paid  to  employee  on  or  before  March  15th  of  the  year  following  the  year  when  the  payment  is  no  longer 
subject  to  a  substantial  risk  of  forfeiture.  For  purposes  of  Section  409A  of  the  Code,  the  right  to  a  series  of 
installment payments shall be treated as a right to a series of separate payments, and references herein to the 
employee’s termination of employment shall refer to employee’s separation of services with the Company within 
the meaning of Section 409A of the Code.

12. Rule 10b5-1 Trading Plans; Stock Withholding.

It is expected that participants under the Plan will establish or modify stock trading plans under Rule 10b5-1 
of the Securities Exchange Act of 1934, as amended, to provide for the sale of Company shares and remit to 
the  Company  the  proceeds  to  meet  the  Company’s  withholding  obligations  in  connection  with  stock  awards 
hereunder. To the extent participants fail to establish or modify 10b5-1 plans in accordance with the foregoing, 

Page 4 of 5

the Company shall at its election either require the participant to pay cash sufficient to meet the withholding 
obligation or the Company shall withhold the number of shares under a stock award sufficient (based on the fair 
market value of the Shares) to meet such withholding obligation.

13. Effect on Employment/Right to Receive.

Employment with the Company and its affiliates is on an at-will basis. Nothing in the Plan shall interfere 
with or limit in any way the right of the Company to terminate any participant’s employment or service at any 
time, with or without cause or notice. Furthermore, the Company expressly reserves the right, which may be 
exercised at any time and without regard to any measurement period, to terminate any individual’s employment 
with or without cause, and to treat him or her without regard to the effect which such treatment might have 
upon him or her as a participant under this Plan. For purposes of this Plan, transfers of employment between the 
Company and/or its affiliates shall not be deemed a termination of employment. No person shall have the right 
to be selected to receive a Stock Award under the Plan, or, having been so selected, have the right to receive a 
future award.

14. Successors.

All obligations of the Company under the Plan, with respect to awards granted hereunder, shall be binding 
on any successor to the Company, whether the existence of such successor is the result of a direct or indirect 
purchase, merger, consolidation, or otherwise, of all or substantially all the business or assets of the Company.

15. Nontransferability of Awards.

No  award  granted  under  this  Plan  may  be  sold,  transferred,  pledged,  assigned,  or  otherwise  alienated 
or hypothecated, other than by will, by the laws of descent and distribution, or to the extent permitted by the 
Company’s 1997 Stock Incentive Plan, 1999 Stock Incentive Plan or other equity plan, to the extent an award is 
payable from such plans. All rights with respect to an award granted under this Plan shall be available during his 
or her lifetime only to the participant to whom the award under this Plan is granted.

Page 5 of 5

SUBSIDIARIES OF THE REGISTRANT

EXHIBIT 21

SUBSIDIARY
Lam Research AG
Lam Research Management GmbH
Lam Research (Shanghai) Co., Ltd.
Lam Research Semiconductor (Suzhou) Co., Ltd.
Lam Research Service Co., Ltd.
SEZ China Ltd.
Lam Research SAS
Lam Research GmbH
Lam Research (Ireland) Limited
Lam Research (Israel) Ltd.
Lam Research S.r.l.
Lam Research Co., Ltd.
Lam Research Korea Limited
Lam Research Luxembourg S.a.r.l.
LAM Research B.V.
Lam Research International B.V.
Silfex Incorporated
Lam Research Singapore Pte Ltd
SEZ Asia Pacific Pte. Ltd.
SEZ Singapore Pte. Ltd.
SEZ Slovakia S.T.O.
Lam Research Holding AG
Lam Research International Sarl
Lam Research Co., Ltd.
SEZ Taiwan Ltd.
Lam Research Ltd.

STATE OR OTHER
JURISDICTION OF OPERATION
Austria
Austria
China
China
China
China
France
Germany
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Netherlands
Netherlands
Ohio, United States
Singapore
Singapore
Singapore
Slovakia
Switzerland
Switzerland
Taiwan
Taiwan
United Kingdom

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Form S-4 No. 333-30545) of 
Lam Research Corporation and in the related Prospectus and in the Registration Statements (Form S-8 Nos. 333-
01011, 333-18115, 333-32981, 333-45265, 333-66833, 333-72751, 333-93115, 333-74500, 333-84638, 333-127936, 
333-138545 and 333-156335) pertaining to the amended and restated 1996 Performance-Based Restricted Stock 
Plan,  1997  Stock  Incentive  Plan,  1999  Employee  Stock  Purchase  Plan,  1999  Stock  Option  Plan,  2007  Stock 
Incentive Plan, and the Savings Plus Plan, 401(k) of Lam Research Corporation of our reports dated August 20, 
2010, with respect to the consolidated financial statements and schedule of Lam Research Corporation and the 
effectiveness of internal control over financial reporting of Lam Research Corporation included in its Annual 
Report (Form 10-K) for the year ended June 27, 2010, filed with the Securities and Exchange Commission.

San Jose, California
August 20, 2010

 
EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

I, Stephen G. Newberry, certify that:

1. 

2. 

3. 

4. 

I have reviewed this Annual Report on Form 10-K of Lam Research Corporation;

 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to 
state a material fact necessary to make the statements made, in light of the circumstances under which such 
statements were made, not misleading with respect to the period covered by this report;

 Based on my knowledge, the financial statements, and other financial information included in this report, 
fairly present in all material respects the financial condition, results of operations and cash flows of the 
registrant as of, and for, the periods presented in this report;

 The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure 
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control 
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and 
have:

a)  

b) 

c) 

d) 

designed such disclosure controls and procedures, or caused such disclosure controls and procedures 
to be designed under our supervision, to ensure that material information relating to the registrant, 
including its consolidated subsidiaries, is made known to us by others within those entities, particularly 
during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial 
reporting  to  be  designed  under  our  supervision,  to  provide  reasonable  assurance  regarding  the 
reliability of financial reporting and the preparation of financial statements for external purposes in 
accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this 
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end 
of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that 
occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the 
case of an annual report) that has materially affected, or is reasonably likely to materially affect, the 
registrant’s internal control over financial reporting; and

5.  

 The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal 
control  over  financial  reporting,  to  the  registrant’s  auditors  and  the  audit  committee  of  the  registrant’s 
board of directors (or persons performing the equivalent functions):

a) 

b) 

all significant deficiencies and material weaknesses in the design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, 
process, summarize and report financial information; and

any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a 
significant role in the registrant’s internal control over financial reporting.

August 20, 2010

/s/ Stephen G. Newberry 
Stephen G. Newberry
President and Chief Executive Officer

 
 
 
 
 
 
 
 
EXHIBIT 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

I, Ernest E. Maddock, certify that:

1. 

2. 

3. 

4. 

I have reviewed this Annual Report on Form 10-K of Lam Research Corporation;

 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to 
state a material fact necessary to make the statements made, in light of the circumstances under which such 
statements were made, not misleading with respect to the period covered by this report;

 Based on my knowledge, the financial statements, and other financial information included in this report, 
fairly present in all material respects the financial condition, results of operations and cash flows of the 
registrant as of, and for, the periods presented in this report;

 The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure 
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control 
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and 
have:

a) 

b) 

c) 

d) 

designed such disclosure controls and procedures, or caused such disclosure controls and procedures 
to be designed under our supervision, to ensure that material information relating to the registrant, 
including its consolidated subsidiaries, is made known to us by others within those entities, particularly 
during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial 
reporting  to  be  designed  under  our  supervision,  to  provide  reasonable  assurance  regarding  the 
reliability of financial reporting and the preparation of financial statements for external purposes in 
accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this 
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end 
of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that 
occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the 
case of an annual report) that has materially affected, or is reasonably likely to materially affect, the 
registrant’s internal control over financial reporting; and

5. 

 The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal 
control  over  financial  reporting,  to  the  registrant’s  auditors  and  the  audit  committee  of  the  registrant’s 
board of directors (or persons performing the equivalent functions):

a) 

b) 

all significant deficiencies and material weaknesses in the design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, 
process, summarize and report financial information; and

any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a 
significant role in the registrant’s internal control over financial reporting.

August 20, 2010

/s/ Ernest E. Maddock  
Ernest E. Maddock
Senior Vice President, Chief Financial Officer
and Chief Accounting Officer

 
 
 
 
 
 
 
 
 
 
EXHIBIT 32.1

SECTION 1350 CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

In connection with the Annual Report of Lam Research Corporation (the “Company”) on Form 10-K for 
the fiscal period ending June 27, 2010 as filed with the Securities and Exchange Commission on the date hereof 
(the “Report”), I, Stephen G. Newberry, President and Chief Executive Officer of the Company, certify, pursuant 
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) 

(2) 

 The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act 
of 1934; and

 The information contained in the Report fairly presents, in all material respects, the financial condition 
and results of operations of the Company.

August 20, 2010

/s/ Stephen G. Newberry 
Stephen G. Newberry
President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350, as adopted pursuant 
to § 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the 
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that 
section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities 
Act of 1933, as amended, or the Exchange Act, except to the extent that Lam Research Corporation specifically 
incorporates it by reference.

 
 
 
 
 
 
 
 
EXHIBIT 32.2

SECTION 1350 CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

In connection with the Annual Report of Lam Research Corporation (the “Company”) on Form 10-K for 
the fiscal period ending June 27, 2010 as filed with the Securities and Exchange Commission on the date hereof 
(the  “Report”),  I,  Ernest  E.  Maddock,  Senior  Vice  President,  Chief  Financial  Officer  and  Chief  Accounting 
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the 
Sarbanes-Oxley Act of 2002, that:

(1) 

(2) 

 The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act 
of 1934; and

 The information contained in the Report fairly presents, in all material respects, the financial condition 
and results of operations of the Company.

August 20, 2010

/s/ Ernest E. Maddock  
Ernest E. Maddock
Senior Vice President, Chief Financial Officer
and Chief Accounting Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350, as adopted pursuant 
to § 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the 
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that 
section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities 
Act of 1933, as amended, or the Exchange Act, except to the extent that Lam Research Corporation specifically 
incorporates it by reference.

 
 
 
 
 
 
 
 
 
 
BOARD OF DIRECTORS 

EXECUTIVE OFFICERS 

James W. Bagley 
Executive Chairman

Stephen G. Newberry 
President and Chief Executive Officer

Stephen G. Newberry 
President and Chief Executive Officer

James W. Bagley 
Executive Chairman

David G. Arscott 
General Partner, 
Compass Technology Group

Robert M. Berdahl 
President, 
Association of American Universities

Eric K. Brandt 
Executive Vice President and  
Chief Financial Officer, 
Broadcom Corporation

Grant M. Inman 
General Partner, 
Inman Investment Management

Catherine P. Lego 
Member, 
Lego Ventures, LLC 

Martin B. Anstice 
Executive Vice President and 
Chief Operating Officer

Ernest E. Maddock 
Senior Vice President and 
Chief Financial Officer

Richard A. Gottscho, Ph.D. 
Senior Vice President, Global Products 
and General Manager, Etch Businesses

Abdi Hariri 
Group Vice President, 
Global Operations

Sarah O’Dowd, Esq. 
Group Vice President, 
Human Resources and Chief Legal Officer

Thomas J. Bondur 
Vice President and General Manager, 
Sales and Marketing

Mukund Srinivasan, Ph.D. 
Vice President and General Manager, 
Clean Product Group

© 2010 Lam Research Corporation.  

All rights reserved. 

201010-01608/15K

Lam Research Corporation
4650 Cushing Parkway
Fremont, California 94538

Phone: 1.510.572.0200
www.lamresearch.com